{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {
    "collapsed": true
   },
   "source": [
    "# Chemprot Shortcut analysis"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "s3_test_prediction = \"s3://aegovan-data/chemprot/predictions_chemprot-bert-f1-2022-05-22-23-18-21-560/prediction_chemprot_test.json\"\n",
    "s3_train_prediction = \"s3://aegovan-data/chemprot/predictions_chemprot-bert-f1-2022-05-22-23-18-21-560/prediction_chemprot_train.json\"\n",
    "s3_val_prediction = \"s3://aegovan-data/chemprot/predictions_chemprot-bert-f1-2022-05-22-23-18-21-560/prediction_chemprot_dev.json\"\n",
    "\n",
    "\n",
    "\n",
    "participants_to_replace = {\n",
    "    \"_GENE-Y_\" : \"_GENE_\",\n",
    "    \"_GENE-N_\" : \"_GENE_\"\n",
    "}\n",
    "\n",
    "\n",
    "\n",
    "x_column = \"sentence_anonymised\"\n",
    "gold_y_column = \"label\"\n",
    "prediction_y_column = \"prediction\"\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "s3_test_prediction =\"s3://aegovan-data/chemprot/predictions_chemprot-abstract-bert-f1-2022-07-30-22-34-07-969/prediction_chemprot_abstract_test_marker.json\"\n",
    "s3_val_prediction =\"s3://aegovan-data/chemprot/predictions_chemprot-abstract-bert-f1-2022-07-30-22-34-07-969/prediction_chemprot_abstract_val_marker.json\"\n",
    "s3_train_prediction =\"s3://aegovan-data/chemprot/predictions_chemprot-abstract-bert-f1-2022-07-30-22-34-07-969/prediction_chemprot_abstract_train_marker.json\"\n",
    "\n",
    "s3_largescale_high_quality_prediction = \"s3://aegovan-data/chemprot/predictions_chemprot-abstract-bert-f1-2022-07-30-22-34-07-969/2022080621_negative_generalisation/highquality_sample.json\"\n",
    "s3_largescale_low_quality_prediction = \"s3://aegovan-data/chemprot/predictions_chemprot-abstract-bert-f1-2022-07-30-22-34-07-969/2022080621_negative_generalisation/lowquality_sample.json\"\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "x_column = \"x\"\n",
    "gold_y_column = \"y_raw\"\n",
    "prediction_y_column = \"prediction\"\n",
    "participants_to_replace = {\n",
    "    \"GENEPART0\" : \"_GENE_\",\n",
    "    \"GENEPART1\" : \"_GENE_\",\n",
    "    \"CHEMPART1\" : \"_CHEMICAL_\",\n",
    "    \"CHEMPART0\" : \"_CHEMICAL_\",\n",
    "\n",
    "\n",
    "}\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "other_genes_to_replace = {f\"GENEIG{i} \":\"_OTHER_ \" for i in range(20)}\n",
    "other_chem_to_replace = {f\"CHEMIG{i} \":\"_OTHER_ \" for i in range(20)}\n",
    "\n",
    "other_ignore = {**other_genes_to_replace, **other_chem_to_replace}\n",
    "\n",
    "# markers_to_replace = {**participants_to_replace, **other_ignore }\n",
    "markers_to_replace = {**participants_to_replace}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'GENEPART0': '_GENE_',\n",
       " 'GENEPART1': '_GENE_',\n",
       " 'CHEMPART1': '_CHEMICAL_',\n",
       " 'CHEMPART0': '_CHEMICAL_'}"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "markers_to_replace"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Get the gold dataset from https://biocreative.bioinformatics.udel.edu/media/store/files/2017/ChemProt_Corpus.zip"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "s3_test_gold_file = \"s3://aegovan-data/chemprotner/test/chemprot_test_gold_standard.tsv\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {
    "pycharm": {
     "is_executing": true
    }
   },
   "outputs": [],
   "source": [
    "import sys, pandas as pd, os, matplotlib.pyplot as plt, sklearn\n",
    "from sklearn import tree\n",
    "\n",
    "sys.path.append(\"../src\")\n",
    "\n",
    "\n",
    "label_names = [\"NEGATIVE\",\n",
    "                            \"CPR:3\",\n",
    "                            \"CPR:4\",\n",
    "                            \"CPR:5\",\n",
    "                            \"CPR:6\",\n",
    "                            \"CPR:9\"]\n",
    "\n",
    "all_labels = list(range(len(label_names)))\n",
    "pos_labels = list(range(1, len(label_names)))\n",
    "\n",
    "trigger_words =  [\"induced\", \"activator\",\"upregulator\" , \"inhibitor\",\"downregulator\" , \"agonist\", \"kinase\",\"regulator\",\"modulator\"]\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "import sys, os, pandas as pd\n",
    "pd.set_option('display.max_colwidth',None)\n",
    "\n",
    "\n",
    "sys.path.append(\"../src\")\n",
    "\n",
    "from utils.s3_utils import download_file as download_s3_file"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Download prediction"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "local_temp= \"temp\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "local_prediction_dir = os.path.join(local_temp, \"prediction\")\n",
    "os.makedirs(local_prediction_dir, exist_ok=True)\n",
    "local_test_prediction_file  = download_s3_file( s3_test_prediction, local_prediction_dir)\n",
    "local_train_prediction_file  = download_s3_file( s3_train_prediction, local_prediction_dir)\n",
    "local_val_prediction_file  = download_s3_file( s3_val_prediction, local_prediction_dir)\n",
    "test_gold_file  = download_s3_file( s3_test_gold_file, local_prediction_dir)\n",
    "local_highquality_file = download_s3_file(s3_largescale_high_quality_prediction, local_prediction_dir)\n",
    "local_lowquality_file = download_s3_file(s3_largescale_low_quality_prediction, local_prediction_dir)\n",
    "\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Utils"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "def add_key_column(df):\n",
    "    df[\"key\"] = df.apply(lambda x:\"{}#{}#{}\".format( x[\"abstract_id\"], x[\"participant1_id\"].replace(\"Arg1:\",\"\"), x[\"participant2_id\"].replace(\"Arg2:\",\"\")), axis=1)\n",
    "    return df\n",
    "\n",
    "def load_gold(file):\n",
    "    df = pd.read_csv(file, delimiter=\"\\t\", header=None, names = [\"abstract_id\", \"relationship_type\", \"participant1_id\",\"participant2_id\"])\n",
    "    \n",
    "    return df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "def replace_in_place(x, replacement_dict):\n",
    "    for k,v in replacement_dict.items():\n",
    "        x = x.replace(k,v)\n",
    "    return x\n",
    "    \n",
    "\n",
    "def load_valtest_pred(file, labels_order = label_names, markers_replacement=markers_to_replace):\n",
    "    df = pd.read_json(file, orient=\"records\")\n",
    "    \n",
    "    \n",
    "\n",
    "    df[\"x\"] = df[x_column].apply(lambda x: replace_in_place(x,markers_replacement))\n",
    "    df[\"gold\"] = df[gold_y_column].apply(lambda x: labels_order.index(x))\n",
    "    df[\"gold_raw\"] = df[gold_y_column]\n",
    "\n",
    "    df[\"y\"] = df[prediction_y_column].apply(lambda x: labels_order.index(x))\n",
    "    df[\"y_raw\"] = df[prediction_y_column]\n",
    "\n",
    "\n",
    "    #df = df.query(\"is_eval == 'Y'\").copy()\n",
    "\n",
    "    return df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "from model_nb_relation_classifier import ModelNBRelationClassifier\n",
    "from model_nb_tree_relation_classifier import ModelNBTreeRelationClassifier\n",
    "from model_tree_relation_classifier import ModelTreeRelationClassifier\n",
    "\n",
    "NAIVE_BAYES=\"Naive Bayes\"\n",
    "NAIVE_BAYES_WITH_TREE = \"Naive Bayes + Tree\"\n",
    "TREE = \"Tree\"\n",
    "\n",
    "def  train_and_predict_all_classifiers(df, min_df=None, ngram_range=(1,1), stop_words = 'english', classifiers={NAIVE_BAYES, NAIVE_BAYES_WITH_TREE}, max_words_per_class=100, classwise_vocab=True):\n",
    "    \n",
    "    max_tree_depth = 4\n",
    "    min_df = min_df or 3\n",
    "    \n",
    "    nb_kwargs = {\n",
    "        \"min_df\": min_df,\n",
    "        \"max_words_per_class\":max_words_per_class, \n",
    "        \"stop_words\": stop_words, \n",
    "        \"ngram_range\": ngram_range, \n",
    "        \"classwise_vocab\": classwise_vocab\n",
    "    }\n",
    "    \n",
    "    classifiers_map = {\n",
    "        NAIVE_BAYES : ModelNBRelationClassifier(\"_CHEMICAL_\", \"_GENE_\", **nb_kwargs),\n",
    "        NAIVE_BAYES_WITH_TREE : ModelNBTreeRelationClassifier(\"_CHEMICAL_\", \"_GENE_\", trigger_words=trigger_words, max_tree_depth = max_tree_depth, extract_span=True, **nb_kwargs ),\n",
    "      #  TREE : ModelTreeRelationClassifier(\"_CHEMICAL_\", \"_GENE_\", trigger_words=trigger_words, max_tree_depth = max_tree_depth)\n",
    "\n",
    "    }\n",
    "    \n",
    "    result = {}\n",
    "    for k in filter(lambda x: x in classifiers,  classifiers_map):\n",
    "    \n",
    "        m = classifiers_map[k]\n",
    "        \n",
    "        print(f\"Training {k}\")\n",
    "        \n",
    "        m.train(df[\"x\"], df[\"y\"])\n",
    "        p, p_conf = m.predict(df[\"x\"])\n",
    "        result[k] = {\n",
    "            \"m\" : m,\n",
    "            \"predictions\" : p,\n",
    "             \"predictions_conf\": p_conf\n",
    "        }\n",
    "    return result\n",
    "\n",
    "\n",
    "def  predict_all_classifiers(df, models_dict):\n",
    "   \n",
    "    \n",
    "   \n",
    "    \n",
    "    result = {}\n",
    "    for k, v in models_dict.items():\n",
    "        m = v[\"m\"]\n",
    "        \n",
    "        p, p_conf = m.predict(df[\"x\"])\n",
    "        result[k] = {\n",
    "            \"m\" : m,\n",
    "            \"predictions\" : p,\n",
    "            \"predictions_conf\": p_conf\n",
    "        }\n",
    "    return result\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "import tempfile\n",
    "\n",
    "def isint(a):\n",
    "    try:\n",
    "        t = int(a)\n",
    "        return True\n",
    "    except:\n",
    "        return False\n",
    "\n",
    "def float_percent_format(x):\n",
    "     return \"{:.1f}\".format(x*100)\n",
    "\n",
    "def int_format(x):\n",
    "     return str(int(x))\n",
    "\n",
    "def print_report(actual, pred, labels=None, label_names = all_labels):\n",
    "\n",
    "    pos_f1 = sklearn.metrics.f1_score(actual, pred, labels=labels, average='micro',\n",
    "                                  sample_weight=None, zero_division=0)\n",
    "    all_f1 = sklearn.metrics.f1_score(actual, pred, average='micro', sample_weight=None, zero_division=0)\n",
    "    \n",
    "    \n",
    "    \n",
    "  \n",
    "        \n",
    "    d = sklearn.metrics.classification_report(actual,\n",
    "                                            pred,\n",
    "                                            output_dict=True,\n",
    "                                            labels=labels,zero_division=0)\n",
    "    df =  pd.DataFrame(d).T\n",
    "    df.index = list(map(lambda x: label_names[int(x)] if isint( x) else x, df.index))\n",
    "\n",
    "    return df\n",
    "    \n",
    "\n",
    "def print_report_all_classifiers(actual, results_dict, *args, **kwargs):\n",
    "    result = []\n",
    "    for k, v in results_dict.items():\n",
    "        df = print_report(actual,v[\"predictions\"],  *args, **kwargs)\n",
    "        df.insert (0, \"model\", k)\n",
    "        \n",
    "        result.append(df)\n",
    "    df = pd.concat(result)\n",
    "    df.insert(1, \"index\", df.index)\n",
    "    print(df.to_latex(index=False, formatters = {\"precision\": float_percent_format, \"recall\":float_percent_format, \"f1-score\":float_percent_format,\"support\":int_format }))\n",
    "    return df    \n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "    \n",
    "import subprocess\n",
    "\n",
    "def _write_chemprot_eval(df,y_col, dest_file):\n",
    "   \n",
    "    df = df[[\"abstract_id\",y_col, \"participant1_id\", \"participant2_id\"]].query(f\"{y_col} != 'NEGATIVE' \").copy(deep=True)\n",
    "    \n",
    "\n",
    "    df[\"participant1_id\"] = df[\"participant1_id\"].apply(lambda x: f\"Arg1:{x}\")\n",
    "    df[\"participant2_id\"] = df[\"participant2_id\"].apply(lambda x: f\"Arg2:{x}\")\n",
    "    df.to_csv(dest_file, sep=\"\\t\", header=False, index=False)\n",
    "\n",
    "    \n",
    "def _run_shell( cmd):\n",
    "        \"\"\"\n",
    "        Runs a shell command\n",
    "        :param cmd: The cmd to run\n",
    "        \"\"\"\n",
    "        print(\"Running command\\n{}\".format(\" \".join(cmd)))\n",
    "\n",
    "        out = subprocess.Popen(\n",
    "            cmd,\n",
    "            stdout=subprocess.PIPE,\n",
    "            stderr=subprocess.STDOUT)\n",
    "        stdout, stderr = out.communicate()\n",
    "        result = stdout.decode(encoding='utf-8')\n",
    "        if stderr:\n",
    "            error_msg = stderr.decode(encoding='utf-8')\n",
    "            print(error_msg)\n",
    "            raise Exception(error_msg)\n",
    "\n",
    "        return result\n",
    "    \n",
    "def print_report_original(df,y_col, gold_file, latex=True,  jar_path=\"../thirdparty\"):\n",
    "   \n",
    "    # Run original eval script to double check numbers\n",
    "    _, pred_file = tempfile.mkstemp()\n",
    "    _write_chemprot_eval(df,y_col, pred_file)\n",
    "    output_dir = \"out\"\n",
    "    os.makedirs(output_dir, exist_ok = True)\n",
    "    cmd = [\"java\", \"-cp\" , f\"{jar_path}/bc6chemprot_eval.jar\", \"org.biocreative.tasks.chemprot.main.Main\",\n",
    "           \"-TP\", \"TRUE\", \"-FP\", \"TRUE\", \"-FN\", \"TRUE\", pred_file, gold_file]\n",
    "    cmd_result = _run_shell(cmd)\n",
    "    print(cmd_result)\n",
    "\n",
    "    # Result summary written to eval .txt\n",
    "    with open(os.path.join(output_dir,\"eval.txt\"), \"r\") as f:\n",
    "        result = f.readlines()\n",
    "        print(result)\n",
    "        \n",
    "    # Parse detailed output file to obtain classwise stats\n",
    "    names = [\"abstract_id\", \"y\", \"participant1_id\", \"participant2_id\"]\n",
    "    df_fp = pd.read_csv(os.path.join(output_dir,\"fp.txt\"),sep=\"\\t\", header=None, names=names)\n",
    "    df_fp[\"c\"] =\"FP\"\n",
    "    df_fn = pd.read_csv(os.path.join(output_dir,\"fn.txt\"),sep=\"\\t\", header=None, names=names)\n",
    "    df_fn[\"c\"] =\"FN\"\n",
    "    df_tp = pd.read_csv(os.path.join(output_dir,\"tp.txt\"),sep=\"\\t\", header=None, names=names)\n",
    "    df_tp[\"c\"] =\"TP\"\n",
    "    df = pd.concat([df_fp, df_tp, df_fn])\n",
    "    \n",
    "    df_test_summary = df.groupby([\"y\" , \"c\"]).size()\\\n",
    "                .reset_index().rename(columns={0:\"total\"})\\\n",
    "                .pivot(index=\"y\", columns=\"c\", values=\"total\")\n",
    "    df_test_summary.loc[\"total\", \"FN\"] = df_test_summary[\"FN\"].sum()\n",
    "    df_test_summary.loc[\"total\", \"FP\"] = df_test_summary[\"FP\"].sum()\n",
    "    df_test_summary.loc[\"total\", \"TP\"] = df_test_summary[\"TP\"].sum()\n",
    "\n",
    "    df_test_summary[\"P\"] = df_test_summary[\"TP\"].div(df_test_summary[\"TP\"] + df_test_summary[\"FP\"])\n",
    "    df_test_summary[\"R\"] = df_test_summary[\"TP\"].div(df_test_summary[\"TP\"] + df_test_summary[\"FN\"])\n",
    "    df_test_summary[\"F\"] = (2*df_test_summary[\"P\"] * df_test_summary[\"R\"]).div(df_test_summary[\"P\"] +df_test_summary[\"R\"])\n",
    "\n",
    "\n",
    "    \n",
    "    # Clean up\n",
    "    os.remove(pred_file)\n",
    "    return df_test_summary"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [],
   "source": [
    "def plot_tree(m):\n",
    "    _, ax = plt.subplots(1,1, figsize=(45,15))\n",
    "\n",
    "    tree.plot_tree(m.tree_model, ax=ax, fontsize=10, feature_names=m.feature_names)\n",
    "\n",
    "    plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [],
   "source": [
    "def get_top_discrimintary_keywords(model, label_index ) :\n",
    "    index_to_vocab = {i:v  for v,i in model.vocab.items()}\n",
    "\n",
    "    return sorted( [ (index_to_vocab[i],p) for i,p in enumerate(model.nb_model.feature_log_prob_[label_index])], \n",
    "           reverse=True, key=lambda x: x[1])\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [],
   "source": [
    "from sklearn.metrics import confusion_matrix, ConfusionMatrixDisplay\n",
    "\n",
    "\n",
    "def consolidate_label_names(actual, pred, label_names):\n",
    "    label_indices = list(set(actual).union(pred))\n",
    "    return [label_names[i] for i in sorted(label_indices)]\n",
    "\n",
    "def plot_confusionmatrix(y_true,y_pred, normalize=None):\n",
    "    cm = confusion_matrix(y_true,y_pred, normalize=normalize)\n",
    "    labels = consolidate_label_names( y_true,y_pred,label_names)\n",
    "    disp = ConfusionMatrixDisplay(confusion_matrix=cm, display_labels = labels)\n",
    "    disp.plot(cmap=\"PuBu\", xticks_rotation=\"vertical\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [],
   "source": [
    "import math\n",
    "from scipy.spatial import distance\n",
    "\n",
    "\n",
    "def _build_list(l1,l2, use_common_only=True):\n",
    "    word_index = {w:i for i,(w,p) in enumerate(l1)}\n",
    "    for w,_ in l2:\n",
    "        if w not in word_index: word_index[w]=len(word_index)\n",
    "           \n",
    "    if use_common_only:\n",
    "        intersection = set([w for w,_ in l2]).intersection(set([w for w,_ in l1]))\n",
    "        word_index = {w:i for i,w in enumerate(intersection)}\n",
    "\n",
    "\n",
    "    \n",
    "    l1_r = [0.00000000   for _ in range(len(word_index))]\n",
    "    for i, (w,p) in enumerate( filter(lambda x:x[0] in word_index ,l1)):        \n",
    "        l1_r[word_index[w] ] = math.exp(p)\n",
    "        \n",
    "    l2_r = [0.00000000   for _ in range(len(word_index))]\n",
    "    for i, (w,p) in enumerate( filter(lambda x:x[0] in word_index ,l2)):\n",
    "        l2_r[word_index[w] ] = math.exp(p)\n",
    "    \n",
    "    return l1_r,l2_r\n",
    "\n",
    "def js_divergence(p_keyword, q_keyword, use_common_only=True):\n",
    "    p,q = _build_list(p_keyword, q_keyword, use_common_only=use_common_only)\n",
    "    return distance.jensenshannon(p,q, 2.71828)\n",
    "\n",
    "def kl_divergence(p_keyword, q_keyword, use_common_only=True):\n",
    "    p,q = _build_list(p_keyword, q_keyword, use_common_only=use_common_only)\n",
    "    return sum(p[i] * math.log(p[i]/q[i]) for i in range(len(p)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [],
   "source": [
    "import scipy\n",
    "\n",
    "def jaccard(list1, list2):\n",
    "    intersection = len(list(set(list1).intersection(list2)))\n",
    "    union = (len(list1) + len(list2)) - intersection\n",
    "    return float(intersection) / union\n",
    "\n",
    "# def compare_discrimintary_keywords(nb_m1,nb_m2, label_index):\n",
    "#     list1 = [w for w,s in get_top_discrimintary_keywords(nb_m1, label_index)]\n",
    "#     list2 = [w for w,s in get_top_discrimintary_keywords(nb_m2, label_index)]\n",
    "#     max_size = min(len(list1), len(list2))\n",
    "#     print(jaccard(list1[:max_size], list2[:max_size]))\n",
    "#     print(scipy.stats.kendalltau(list1[:max_size], list2[:max_size]))\n",
    "#     return scipy.stats.kendalltau(list1[:max_size], list2[:max_size])\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [],
   "source": [
    "def filter_eval(df):\n",
    "    return df[df[\"is_eval\"].apply(lambda r: r == 'Y')].copy() \n",
    "\n",
    "def add_unique_genes_chem(df):\n",
    "    df[\"unique_chemprot_names\"] = df[\"annotations\"].apply(lambda x: sorted(list(set([ i[\"entity_name\"] for i in x]))))\n",
    "    return df\n",
    "\n",
    "\n",
    "\n",
    "def extract_span(item: str, marker1: str, marker2: str):\n",
    "    def _swap( marker1, marker2):\n",
    "        return marker2, marker1\n",
    "\n",
    "    m1 = item.find(marker1)\n",
    "    m2 = item.find(marker2)\n",
    "    \n",
    "    # m1 occurs first\n",
    "    if m1 > m2:\n",
    "        marker1, marker2 = _swap(marker1, marker2)\n",
    "\n",
    "    m1_start = item.find(marker1)\n",
    "\n",
    "    m1_end = item.rfind(marker1)\n",
    "    m2_end = item.rfind(marker2)\n",
    "\n",
    "    end = m1_end + len(marker1) if m1_end > m2_end else m2_end + len(marker2)\n",
    "\n",
    "    return item[m1_start: end]\n",
    "\n",
    "\n",
    "def add_span_genes_chem(df):\n",
    "    df[\"x_span\"] = df[\"x\"].apply(lambda x: extract_span(x, \"_GENE_\", \"_CHEMICAL_\"))\n",
    "    df[\"x_span_word_len\"] = df[\"x_span\"].apply(lambda x: len(x.split(\" \")))\n",
    "    return df\n",
    "\n",
    "def filter_include_min_word_len(df, min_len=5):\n",
    "    return df.query(f\"x_span_word_len > {min_len}\").copy()\n",
    "\n",
    "def filter_include_max_word_len(df, max_len=15):\n",
    "    return df.query(f\"x_span_word_len <= {max_len}\").copy()\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Train GT Train predictions"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_train = load_valtest_pred(local_train_prediction_file)\\\n",
    "                .pipe(add_unique_genes_chem)\\\n",
    "                .pipe(add_span_genes_chem)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Training Naive Bayes\n",
      "Max words :  325\n",
      "Training Naive Bayes + Tree\n",
      "Max words :  325\n",
      "Extracting features..for 6437\n",
      "Completed..\n",
      "\\begin{tabular}{llrrrr}\n",
      "\\toprule\n",
      "             model &        index & precision & recall & f1-score & support \\\\\n",
      "\\midrule\n",
      "       Naive Bayes &            0 &      60.4 &   64.2 &     62.3 &    2265 \\\\\n",
      "       Naive Bayes &            1 &      58.7 &   55.3 &     57.0 &     777 \\\\\n",
      "       Naive Bayes &            2 &      58.9 &   71.3 &     64.5 &    2260 \\\\\n",
      "       Naive Bayes &            3 &      80.4 &   47.4 &     59.6 &     173 \\\\\n",
      "       Naive Bayes &            4 &      70.7 &   45.1 &     55.1 &     235 \\\\\n",
      "       Naive Bayes &            5 &      73.5 &   31.2 &     43.8 &     727 \\\\\n",
      "       Naive Bayes &     accuracy &      60.8 &   60.8 &     60.8 &       0 \\\\\n",
      "       Naive Bayes &    macro avg &      67.1 &   52.4 &     57.1 &    6437 \\\\\n",
      "       Naive Bayes & weighted avg &      62.1 &   60.8 &     60.0 &    6437 \\\\\n",
      "Naive Bayes + Tree &            0 &      53.9 &   77.4 &     63.6 &    2265 \\\\\n",
      "Naive Bayes + Tree &            1 &      59.2 &   58.4 &     58.8 &     777 \\\\\n",
      "Naive Bayes + Tree &            2 &      71.9 &   59.2 &     64.9 &    2260 \\\\\n",
      "Naive Bayes + Tree &            3 &       0.0 &    0.0 &      0.0 &     173 \\\\\n",
      "Naive Bayes + Tree &            4 &      43.7 &   46.8 &     45.2 &     235 \\\\\n",
      "Naive Bayes + Tree &            5 &      73.5 &   31.2 &     43.8 &     727 \\\\\n",
      "Naive Bayes + Tree &     accuracy &      60.3 &   60.3 &     60.3 &       0 \\\\\n",
      "Naive Bayes + Tree &    macro avg &      50.4 &   45.5 &     46.0 &    6437 \\\\\n",
      "Naive Bayes + Tree & weighted avg &      61.3 &   60.3 &     58.9 &    6437 \\\\\n",
      "\\bottomrule\n",
      "\\end{tabular}\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>model</th>\n",
       "      <th>index</th>\n",
       "      <th>precision</th>\n",
       "      <th>recall</th>\n",
       "      <th>f1-score</th>\n",
       "      <th>support</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>0</td>\n",
       "      <td>0.603985</td>\n",
       "      <td>0.642384</td>\n",
       "      <td>0.622593</td>\n",
       "      <td>2265.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>1</td>\n",
       "      <td>0.587432</td>\n",
       "      <td>0.553411</td>\n",
       "      <td>0.569914</td>\n",
       "      <td>777.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>2</td>\n",
       "      <td>0.589397</td>\n",
       "      <td>0.713274</td>\n",
       "      <td>0.645445</td>\n",
       "      <td>2260.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>3</td>\n",
       "      <td>0.803922</td>\n",
       "      <td>0.473988</td>\n",
       "      <td>0.596364</td>\n",
       "      <td>173.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>4</td>\n",
       "      <td>0.706667</td>\n",
       "      <td>0.451064</td>\n",
       "      <td>0.550649</td>\n",
       "      <td>235.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>5</td>\n",
       "      <td>0.734628</td>\n",
       "      <td>0.312242</td>\n",
       "      <td>0.438224</td>\n",
       "      <td>727.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>accuracy</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>accuracy</td>\n",
       "      <td>0.607737</td>\n",
       "      <td>0.607737</td>\n",
       "      <td>0.607737</td>\n",
       "      <td>0.607737</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>macro avg</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>macro avg</td>\n",
       "      <td>0.671005</td>\n",
       "      <td>0.524394</td>\n",
       "      <td>0.570532</td>\n",
       "      <td>6437.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>weighted avg</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>weighted avg</td>\n",
       "      <td>0.620742</td>\n",
       "      <td>0.607737</td>\n",
       "      <td>0.600103</td>\n",
       "      <td>6437.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>0</td>\n",
       "      <td>0.539409</td>\n",
       "      <td>0.773510</td>\n",
       "      <td>0.635589</td>\n",
       "      <td>2265.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>1</td>\n",
       "      <td>0.591917</td>\n",
       "      <td>0.584299</td>\n",
       "      <td>0.588083</td>\n",
       "      <td>777.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>2</td>\n",
       "      <td>0.718968</td>\n",
       "      <td>0.592035</td>\n",
       "      <td>0.649357</td>\n",
       "      <td>2260.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>3</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>173.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>4</td>\n",
       "      <td>0.436508</td>\n",
       "      <td>0.468085</td>\n",
       "      <td>0.451745</td>\n",
       "      <td>235.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>5</td>\n",
       "      <td>0.734628</td>\n",
       "      <td>0.312242</td>\n",
       "      <td>0.438224</td>\n",
       "      <td>727.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>accuracy</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>accuracy</td>\n",
       "      <td>0.602921</td>\n",
       "      <td>0.602921</td>\n",
       "      <td>0.602921</td>\n",
       "      <td>0.602921</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>macro avg</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>macro avg</td>\n",
       "      <td>0.503572</td>\n",
       "      <td>0.455029</td>\n",
       "      <td>0.460500</td>\n",
       "      <td>6437.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>weighted avg</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>weighted avg</td>\n",
       "      <td>0.612584</td>\n",
       "      <td>0.602921</td>\n",
       "      <td>0.588604</td>\n",
       "      <td>6437.000000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                           model         index  precision    recall  f1-score  \\\n",
       "0                    Naive Bayes             0   0.603985  0.642384  0.622593   \n",
       "1                    Naive Bayes             1   0.587432  0.553411  0.569914   \n",
       "2                    Naive Bayes             2   0.589397  0.713274  0.645445   \n",
       "3                    Naive Bayes             3   0.803922  0.473988  0.596364   \n",
       "4                    Naive Bayes             4   0.706667  0.451064  0.550649   \n",
       "5                    Naive Bayes             5   0.734628  0.312242  0.438224   \n",
       "accuracy             Naive Bayes      accuracy   0.607737  0.607737  0.607737   \n",
       "macro avg            Naive Bayes     macro avg   0.671005  0.524394  0.570532   \n",
       "weighted avg         Naive Bayes  weighted avg   0.620742  0.607737  0.600103   \n",
       "0             Naive Bayes + Tree             0   0.539409  0.773510  0.635589   \n",
       "1             Naive Bayes + Tree             1   0.591917  0.584299  0.588083   \n",
       "2             Naive Bayes + Tree             2   0.718968  0.592035  0.649357   \n",
       "3             Naive Bayes + Tree             3   0.000000  0.000000  0.000000   \n",
       "4             Naive Bayes + Tree             4   0.436508  0.468085  0.451745   \n",
       "5             Naive Bayes + Tree             5   0.734628  0.312242  0.438224   \n",
       "accuracy      Naive Bayes + Tree      accuracy   0.602921  0.602921  0.602921   \n",
       "macro avg     Naive Bayes + Tree     macro avg   0.503572  0.455029  0.460500   \n",
       "weighted avg  Naive Bayes + Tree  weighted avg   0.612584  0.602921  0.588604   \n",
       "\n",
       "                  support  \n",
       "0             2265.000000  \n",
       "1              777.000000  \n",
       "2             2260.000000  \n",
       "3              173.000000  \n",
       "4              235.000000  \n",
       "5              727.000000  \n",
       "accuracy         0.607737  \n",
       "macro avg     6437.000000  \n",
       "weighted avg  6437.000000  \n",
       "0             2265.000000  \n",
       "1              777.000000  \n",
       "2             2260.000000  \n",
       "3              173.000000  \n",
       "4              235.000000  \n",
       "5              727.000000  \n",
       "accuracy         0.602921  \n",
       "macro avg     6437.000000  \n",
       "weighted avg  6437.000000  "
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "train_result = train_and_predict_all_classifiers(df_train, min_df=1)\n",
    "\n",
    "\n",
    "\n",
    "print_report_all_classifiers(df_train[\"gold\"],train_result, labels=all_labels)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>x</th>\n",
       "      <th>y</th>\n",
       "      <th>y_raw</th>\n",
       "      <th>abstract_id</th>\n",
       "      <th>abstract</th>\n",
       "      <th>annotations</th>\n",
       "      <th>prediction</th>\n",
       "      <th>confidence</th>\n",
       "      <th>is_eval</th>\n",
       "      <th>relationship_type</th>\n",
       "      <th>relationship_group</th>\n",
       "      <th>participant1_id</th>\n",
       "      <th>participant2_id</th>\n",
       "      <th>gold</th>\n",
       "      <th>gold_raw</th>\n",
       "      <th>unique_chemprot_names</th>\n",
       "      <th>x_span</th>\n",
       "      <th>x_span_word_len</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>New aspects in the management of obesity: operation and the impact of GENEIG0 inhibitors. Obesity is an increasing health problem in most developed countries and its prevalence is also increasing in developing countries. There has been no great success with dietary means and life style modification for permanent weight loss. Various surgical treatment methods for obesity are now available. They are aimed at limiting oral energy intake with or without causing dumping or inducing selective maldigestion and malabsorption. Based on current literature, up to 75% of excess weight is lost by surgical treatment with concomitant disappearance of hyperlipidaemias, type 2 diabetes, hypertension or sleep apnoea. The main indication for operative treatment is morbid obesity (body mass index greater than 40 kg/m2) or severe obesity (body mass index &gt; 35 kg/m2) with comorbidities of obesity. CHEMIG6 is a new inhibitor of GENEIG4 enzyme. At doses of 120 mg three times per day with meals it results in a 30% reduction in dietary fat absorption, which equals approximately 200 kcal daily energy deficit. In the long term, CHEMIG1 has been shown to be more effective than placebo in reducing body weight and serum total and GENEIG5 CHEMIG3 levels. CHEMIG6 has a lowering effect on serum CHEMIG3 independent of weight loss. Along with weight loss, _CHEMICAL_ also favourably affects blood pressure and CHEMIG2 and _GENE_ levels in obese individuals and in obese type 2 diabetic patients.</td>\n",
       "      <td>0</td>\n",
       "      <td>NEGATIVE</td>\n",
       "      <td>10095983</td>\n",
       "      <td>New aspects in the management of obesity: operation and the impact of lipase inhibitors. Obesity is an increasing health problem in most developed countries and its prevalence is also increasing in developing countries. There has been no great success with dietary means and life style modification for permanent weight loss. Various surgical treatment methods for obesity are now available. They are aimed at limiting oral energy intake with or without causing dumping or inducing selective maldigestion and malabsorption. Based on current literature, up to 75% of excess weight is lost by surgical treatment with concomitant disappearance of hyperlipidaemias, type 2 diabetes, hypertension or sleep apnoea. The main indication for operative treatment is morbid obesity (body mass index greater than 40 kg/m2) or severe obesity (body mass index &gt; 35 kg/m2) with comorbidities of obesity. Orlistat is a new inhibitor of pancreatic lipase enzyme. At doses of 120 mg three times per day with meals it results in a 30% reduction in dietary fat absorption, which equals approximately 200 kcal daily energy deficit. In the long term, orlistat has been shown to be more effective than placebo in reducing body weight and serum total and low-density lipoprotein cholesterol levels. Orlistat has a lowering effect on serum cholesterol independent of weight loss. Along with weight loss, orlistat also favourably affects blood pressure and glucose and insulin levels in obese individuals and in obese type 2 diabetic patients.</td>\n",
       "      <td>[{'abstract_id': '10095983', 'id': 'T1', 'entity_type': 'CHEMICAL', 'charOffset': 1129, 'len': 8, 'entity_name': 'orlistat', 'text': 'T1'}, {'abstract_id': '10095983', 'id': 'T2', 'entity_type': 'CHEMICAL', 'charOffset': 1255, 'len': 11, 'entity_name': 'cholesterol', 'text': 'T2'}, {'abstract_id': '10095983', 'id': 'T3', 'entity_type': 'CHEMICAL', 'charOffset': 1275, 'len': 8, 'entity_name': 'Orlistat', 'text': 'T3'}, {'abstract_id': '10095983', 'id': 'T4', 'entity_type': 'CHEMICAL', 'charOffset': 1315, 'len': 11, 'entity_name': 'cholesterol', 'text': 'T4'}, {'abstract_id': '10095983', 'id': 'T5', 'entity_type': 'CHEMICAL', 'charOffset': 1379, 'len': 8, 'entity_name': 'orlistat', 'text': 'T5'}, {'abstract_id': '10095983', 'id': 'T6', 'entity_type': 'CHEMICAL', 'charOffset': 1431, 'len': 7, 'entity_name': 'glucose', 'text': 'T6'}, {'abstract_id': '10095983', 'id': 'T7', 'entity_type': 'CHEMICAL', 'charOffset': 889, 'len': 8, 'entity_name': 'Orlistat', 'text': 'T7'}, {'abstract_id': '10095983', 'id': 'T8', 'entity_type': 'GENE-N', 'charOffset': 1231, 'len': 23, 'entity_name': 'low-density lipoprotein', 'text': 'T8'}, {'abstract_id': '10095983', 'id': 'T9', 'entity_type': 'GENE-Y', 'charOffset': 1443, 'len': 7, 'entity_name': 'insulin', 'text': 'T9'}, {'abstract_id': '10095983', 'id': 'T10', 'entity_type': 'GENE-Y', 'charOffset': 920, 'len': 17, 'entity_name': 'pancreatic lipase', 'text': 'T10'}, {'abstract_id': '10095983', 'id': 'T11', 'entity_type': 'GENE-N', 'charOffset': 70, 'len': 6, 'entity_name': 'lipase', 'text': 'T11'}]</td>\n",
       "      <td>NEGATIVE</td>\n",
       "      <td>0.990430</td>\n",
       "      <td>N</td>\n",
       "      <td>INDIRECT-REGULATOR</td>\n",
       "      <td>CPR:2</td>\n",
       "      <td>T5</td>\n",
       "      <td>T9</td>\n",
       "      <td>0</td>\n",
       "      <td>NEGATIVE</td>\n",
       "      <td>[Orlistat, cholesterol, glucose, insulin, lipase, low-density lipoprotein, orlistat, pancreatic lipase]</td>\n",
       "      <td>_CHEMICAL_ also favourably affects blood pressure and CHEMIG2 and _GENE_</td>\n",
       "      <td>10</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>CHEMIG15 suppress activation of microglia: down-regulation of GENEIG16 by CHEMIG8. Mechanisms leading to down-regulation of activated microglia and astrocytes are poorly understood, in spite of the potentially detrimental role of activated glia in neurodegeneration. CHEMIG13, produced both by neurons and glia, may serve as mediators of glial and neuronal functions. We examined the influence of CHEMIG2 and their precursors on activated glia. As models of glial activation, production of GENEIG16 (GENEIG6) was studied in lipopolysaccharide-stimulated rat microglia, a murine microglial cell line BV-2, and GENEIG7-stimulated rat astrocytes. CHEMIG15 were potent inhibitors of GENEIG6 induction and were more effective than their precursors, CHEMIG0. CHEMIG9 (CHEMIG1) was the most potent CHEMIG3 among those tested. In activated microglia, CHEMIG1 suppressed GENEIG12 activity, GENEIG6 mRNA, and protein levels. The action of _CHEMICAL_ does not appear to involve its nuclear receptor _GENE_ (GENEIG5) because CHEMIG10, a specific ligand of GENEIG5, was unable to inhibit GENEIG6 induction, and neither CHEMIG10 nor CHEMIG1 could stimulate the activity of a GENEIG14-dependent promoter in the absence of cotransfected GENEIG5. CHEMIG1 did not block nuclear translocation or DNA-binding activity of the transcription factor GENEIG11, but it did inhibit the activity of an GENEIG11 reporter construct, suggesting that the mechanism of suppression of microglial GENEIG6 by CHEMIG1 may involve interference with GENEIG11 transcriptional activity in the nucleus. Thus, our data suggest the existence of a novel pathway mediated by CHEMIG2, which may represent part of a feedback mechanism leading to the cessation of inflammatory glial responses in the brain.</td>\n",
       "      <td>0</td>\n",
       "      <td>NEGATIVE</td>\n",
       "      <td>10200320</td>\n",
       "      <td>Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2. Mechanisms leading to down-regulation of activated microglia and astrocytes are poorly understood, in spite of the potentially detrimental role of activated glia in neurodegeneration. Prostaglandins, produced both by neurons and glia, may serve as mediators of glial and neuronal functions. We examined the influence of cyclopentenone prostaglandins and their precursors on activated glia. As models of glial activation, production of inducible nitric-oxide synthase (iNOS) was studied in lipopolysaccharide-stimulated rat microglia, a murine microglial cell line BV-2, and IL-1beta-stimulated rat astrocytes. Cyclopentenone prostaglandins were potent inhibitors of iNOS induction and were more effective than their precursors, prostaglandins E2 and D2. 15-Deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) was the most potent prostaglandin among those tested. In activated microglia, 15d-PGJ2 suppressed iNOS promoter activity, iNOS mRNA, and protein levels. The action of 15d-PGJ2 does not appear to involve its nuclear receptor peroxisome proliferator-activated receptor gamma (PPARgamma) because troglitazone, a specific ligand of PPARgamma, was unable to inhibit iNOS induction, and neither troglitazone nor 15d-PGJ2 could stimulate the activity of a PPAR-dependent promoter in the absence of cotransfected PPARgamma. 15d-PGJ2 did not block nuclear translocation or DNA-binding activity of the transcription factor NFkappaB, but it did inhibit the activity of an NFkappaB reporter construct, suggesting that the mechanism of suppression of microglial iNOS by 15d-PGJ2 may involve interference with NFkappaB transcriptional activity in the nucleus. Thus, our data suggest the existence of a novel pathway mediated by cyclopentenone prostaglandins, which may represent part of a feedback mechanism leading to the cessation of inflammatory glial responses in the brain.</td>\n",
       "      <td>[{'abstract_id': '10200320', 'id': 'T1', 'entity_type': 'CHEMICAL', 'charOffset': 1251, 'len': 12, 'entity_name': 'troglitazone', 'text': 'T1'}, {'abstract_id': '10200320', 'id': 'T2', 'entity_type': 'CHEMICAL', 'charOffset': 1347, 'len': 12, 'entity_name': 'troglitazone', 'text': 'T2'}, {'abstract_id': '10200320', 'id': 'T3', 'entity_type': 'CHEMICAL', 'charOffset': 1364, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T3'}, {'abstract_id': '10200320', 'id': 'T4', 'entity_type': 'CHEMICAL', 'charOffset': 1474, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T4'}, {'abstract_id': '10200320', 'id': 'T5', 'entity_type': 'CHEMICAL', 'charOffset': 1715, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T5'}, {'abstract_id': '10200320', 'id': 'T6', 'entity_type': 'CHEMICAL', 'charOffset': 1872, 'len': 29, 'entity_name': 'cyclopentenone prostaglandins', 'text': 'T6'}, {'abstract_id': '10200320', 'id': 'T7', 'entity_type': 'CHEMICAL', 'charOffset': 340, 'len': 14, 'entity_name': 'Prostaglandins', 'text': 'T7'}, {'abstract_id': '10200320', 'id': 'T8', 'entity_type': 'CHEMICAL', 'charOffset': 476, 'len': 29, 'entity_name': 'cyclopentenone prostaglandins', 'text': 'T8'}, {'abstract_id': '10200320', 'id': 'T9', 'entity_type': 'CHEMICAL', 'charOffset': 601, 'len': 12, 'entity_name': 'nitric-oxide', 'text': 'T9'}, {'abstract_id': '10200320', 'id': 'T10', 'entity_type': 'CHEMICAL', 'charOffset': 766, 'len': 29, 'entity_name': 'Cyclopentenone prostaglandins', 'text': 'T10'}, {'abstract_id': '10200320', 'id': 'T11', 'entity_type': 'CHEMICAL', 'charOffset': 884, 'len': 24, 'entity_name': 'prostaglandins E2 and D2', 'text': 'T11'}, {'abstract_id': '10200320', 'id': 'T12', 'entity_type': 'CHEMICAL', 'charOffset': 910, 'len': 36, 'entity_name': '15-Deoxy-Delta12,14-prostaglandin J2', 'text': 'T12'}, {'abstract_id': '10200320', 'id': 'T13', 'entity_type': 'CHEMICAL', 'charOffset': 948, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T13'}, {'abstract_id': '10200320', 'id': 'T14', 'entity_type': 'CHEMICAL', 'charOffset': 978, 'len': 13, 'entity_name': 'prostaglandin', 'text': 'T14'}, {'abstract_id': '10200320', 'id': 'T15', 'entity_type': 'CHEMICAL', 'charOffset': 1036, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T15'}, {'abstract_id': '10200320', 'id': 'T16', 'entity_type': 'CHEMICAL', 'charOffset': 1125, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T16'}, {'abstract_id': '10200320', 'id': 'T17', 'entity_type': 'CHEMICAL', 'charOffset': 0, 'len': 29, 'entity_name': 'Cyclopentenone prostaglandins', 'text': 'T17'}, {'abstract_id': '10200320', 'id': 'T18', 'entity_type': 'CHEMICAL', 'charOffset': 118, 'len': 36, 'entity_name': '15-deoxy-Delta12,14-prostaglandin J2', 'text': 'T18'}, {'abstract_id': '10200320', 'id': 'T19', 'entity_type': 'CHEMICAL', 'charOffset': 93, 'len': 12, 'entity_name': 'nitric-oxide', 'text': 'T19'}, {'abstract_id': '10200320', 'id': 'T20', 'entity_type': 'GENE-Y', 'charOffset': 1182, 'len': 48, 'entity_name': 'peroxisome proliferator-activated receptor gamma', 'text': 'T20'}, {'abstract_id': '10200320', 'id': 'T21', 'entity_type': 'GENE-Y', 'charOffset': 1232, 'len': 9, 'entity_name': 'PPARgamma', 'text': 'T21'}, {'abstract_id': '10200320', 'id': 'T22', 'entity_type': 'GENE-Y', 'charOffset': 1286, 'len': 9, 'entity_name': 'PPARgamma', 'text': 'T22'}, {'abstract_id': '10200320', 'id': 'T23', 'entity_type': 'GENE-Y', 'charOffset': 1319, 'len': 4, 'entity_name': 'iNOS', 'text': 'T23'}, {'abstract_id': '10200320', 'id': 'T24', 'entity_type': 'GENE-N', 'charOffset': 1407, 'len': 4, 'entity_name': 'PPAR', 'text': 'T24'}, {'abstract_id': '10200320', 'id': 'T25', 'entity_type': 'GENE-Y', 'charOffset': 1463, 'len': 9, 'entity_name': 'PPARgamma', 'text': 'T25'}, {'abstract_id': '10200320', 'id': 'T26', 'entity_type': 'GENE-N', 'charOffset': 1571, 'len': 8, 'entity_name': 'NFkappaB', 'text': 'T26'}, {'abstract_id': '10200320', 'id': 'T27', 'entity_type': 'GENE-N', 'charOffset': 1619, 'len': 8, 'entity_name': 'NFkappaB', 'text': 'T27'}, {'abstract_id': '10200320', 'id': 'T28', 'entity_type': 'GENE-Y', 'charOffset': 1707, 'len': 4, 'entity_name': 'iNOS', 'text': 'T28'}, {'abstract_id': '10200320', 'id': 'T29', 'entity_type': 'GENE-N', 'charOffset': 1754, 'len': 8, 'entity_name': 'NFkappaB', 'text': 'T29'}, {'abstract_id': '10200320', 'id': 'T30', 'entity_type': 'GENE-Y', 'charOffset': 591, 'len': 31, 'entity_name': 'inducible nitric-oxide synthase', 'text': 'T30'}, {'abstract_id': '10200320', 'id': 'T31', 'entity_type': 'GENE-Y', 'charOffset': 624, 'len': 4, 'entity_name': 'iNOS', 'text': 'T31'}, {'abstract_id': '10200320', 'id': 'T32', 'entity_type': 'GENE-Y', 'charOffset': 730, 'len': 8, 'entity_name': 'IL-1beta', 'text': 'T32'}, {'abstract_id': '10200320', 'id': 'T33', 'entity_type': 'GENE-Y', 'charOffset': 822, 'len': 4, 'entity_name': 'iNOS', 'text': 'T33'}, {'abstract_id': '10200320', 'id': 'T34', 'entity_type': 'GENE-N', 'charOffset': 1056, 'len': 13, 'entity_name': 'iNOS promoter', 'text': 'T34'}, {'abstract_id': '10200320', 'id': 'T35', 'entity_type': 'GENE-Y', 'charOffset': 1080, 'len': 4, 'entity_name': 'iNOS', 'text': 'T35'}, {'abstract_id': '10200320', 'id': 'T36', 'entity_type': 'GENE-Y', 'charOffset': 83, 'len': 31, 'entity_name': 'inducible nitric-oxide synthase', 'text': 'T36'}]</td>\n",
       "      <td>NEGATIVE</td>\n",
       "      <td>0.994522</td>\n",
       "      <td>N</td>\n",
       "      <td>NOT</td>\n",
       "      <td>CPR:10</td>\n",
       "      <td>T16</td>\n",
       "      <td>T20</td>\n",
       "      <td>0</td>\n",
       "      <td>NEGATIVE</td>\n",
       "      <td>[15-Deoxy-Delta12,14-prostaglandin J2, 15-deoxy-Delta12,14-prostaglandin J2, 15d-PGJ2, Cyclopentenone prostaglandins, IL-1beta, NFkappaB, PPAR, PPARgamma, Prostaglandins, cyclopentenone prostaglandins, iNOS, iNOS promoter, inducible nitric-oxide synthase, nitric-oxide, peroxisome proliferator-activated receptor gamma, prostaglandin, prostaglandins E2 and D2, troglitazone]</td>\n",
       "      <td>_CHEMICAL_ does not appear to involve its nuclear receptor _GENE_</td>\n",
       "      <td>10</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>CHEMIG4 suppress activation of microglia: down-regulation of GENEIG12 by CHEMIG7. Mechanisms leading to down-regulation of activated microglia and astrocytes are poorly understood, in spite of the potentially detrimental role of activated glia in neurodegeneration. CHEMIG17, produced both by neurons and glia, may serve as mediators of glial and neuronal functions. We examined the influence of CHEMIG2 and their precursors on activated glia. As models of glial activation, production of GENEIG12 (GENEIG16) was studied in lipopolysaccharide-stimulated rat microglia, a murine microglial cell line BV-2, and GENEIG15-stimulated rat astrocytes. CHEMIG4 were potent inhibitors of GENEIG16 induction and were more effective than their precursors, CHEMIG1. CHEMIG14 (CHEMIG9) was the most potent CHEMIG6 among those tested. In activated microglia, CHEMIG9 suppressed GENEIG5 activity, GENEIG16 mRNA, and protein levels. The action of _CHEMICAL_ does not appear to involve its nuclear receptor GENEIG3 (_GENE_) because CHEMIG0, a specific ligand of GENEIG11, was unable to inhibit GENEIG16 induction, and neither CHEMIG0 nor CHEMIG9 could stimulate the activity of a GENEIG8-dependent promoter in the absence of cotransfected GENEIG11. CHEMIG9 did not block nuclear translocation or DNA-binding activity of the transcription factor GENEIG10, but it did inhibit the activity of an GENEIG10 reporter construct, suggesting that the mechanism of suppression of microglial GENEIG16 by CHEMIG9 may involve interference with GENEIG10 transcriptional activity in the nucleus. Thus, our data suggest the existence of a novel pathway mediated by CHEMIG2, which may represent part of a feedback mechanism leading to the cessation of inflammatory glial responses in the brain.</td>\n",
       "      <td>0</td>\n",
       "      <td>NEGATIVE</td>\n",
       "      <td>10200320</td>\n",
       "      <td>Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2. Mechanisms leading to down-regulation of activated microglia and astrocytes are poorly understood, in spite of the potentially detrimental role of activated glia in neurodegeneration. Prostaglandins, produced both by neurons and glia, may serve as mediators of glial and neuronal functions. We examined the influence of cyclopentenone prostaglandins and their precursors on activated glia. As models of glial activation, production of inducible nitric-oxide synthase (iNOS) was studied in lipopolysaccharide-stimulated rat microglia, a murine microglial cell line BV-2, and IL-1beta-stimulated rat astrocytes. Cyclopentenone prostaglandins were potent inhibitors of iNOS induction and were more effective than their precursors, prostaglandins E2 and D2. 15-Deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) was the most potent prostaglandin among those tested. In activated microglia, 15d-PGJ2 suppressed iNOS promoter activity, iNOS mRNA, and protein levels. The action of 15d-PGJ2 does not appear to involve its nuclear receptor peroxisome proliferator-activated receptor gamma (PPARgamma) because troglitazone, a specific ligand of PPARgamma, was unable to inhibit iNOS induction, and neither troglitazone nor 15d-PGJ2 could stimulate the activity of a PPAR-dependent promoter in the absence of cotransfected PPARgamma. 15d-PGJ2 did not block nuclear translocation or DNA-binding activity of the transcription factor NFkappaB, but it did inhibit the activity of an NFkappaB reporter construct, suggesting that the mechanism of suppression of microglial iNOS by 15d-PGJ2 may involve interference with NFkappaB transcriptional activity in the nucleus. Thus, our data suggest the existence of a novel pathway mediated by cyclopentenone prostaglandins, which may represent part of a feedback mechanism leading to the cessation of inflammatory glial responses in the brain.</td>\n",
       "      <td>[{'abstract_id': '10200320', 'id': 'T1', 'entity_type': 'CHEMICAL', 'charOffset': 1251, 'len': 12, 'entity_name': 'troglitazone', 'text': 'T1'}, {'abstract_id': '10200320', 'id': 'T2', 'entity_type': 'CHEMICAL', 'charOffset': 1347, 'len': 12, 'entity_name': 'troglitazone', 'text': 'T2'}, {'abstract_id': '10200320', 'id': 'T3', 'entity_type': 'CHEMICAL', 'charOffset': 1364, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T3'}, {'abstract_id': '10200320', 'id': 'T4', 'entity_type': 'CHEMICAL', 'charOffset': 1474, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T4'}, {'abstract_id': '10200320', 'id': 'T5', 'entity_type': 'CHEMICAL', 'charOffset': 1715, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T5'}, {'abstract_id': '10200320', 'id': 'T6', 'entity_type': 'CHEMICAL', 'charOffset': 1872, 'len': 29, 'entity_name': 'cyclopentenone prostaglandins', 'text': 'T6'}, {'abstract_id': '10200320', 'id': 'T7', 'entity_type': 'CHEMICAL', 'charOffset': 340, 'len': 14, 'entity_name': 'Prostaglandins', 'text': 'T7'}, {'abstract_id': '10200320', 'id': 'T8', 'entity_type': 'CHEMICAL', 'charOffset': 476, 'len': 29, 'entity_name': 'cyclopentenone prostaglandins', 'text': 'T8'}, {'abstract_id': '10200320', 'id': 'T9', 'entity_type': 'CHEMICAL', 'charOffset': 601, 'len': 12, 'entity_name': 'nitric-oxide', 'text': 'T9'}, {'abstract_id': '10200320', 'id': 'T10', 'entity_type': 'CHEMICAL', 'charOffset': 766, 'len': 29, 'entity_name': 'Cyclopentenone prostaglandins', 'text': 'T10'}, {'abstract_id': '10200320', 'id': 'T11', 'entity_type': 'CHEMICAL', 'charOffset': 884, 'len': 24, 'entity_name': 'prostaglandins E2 and D2', 'text': 'T11'}, {'abstract_id': '10200320', 'id': 'T12', 'entity_type': 'CHEMICAL', 'charOffset': 910, 'len': 36, 'entity_name': '15-Deoxy-Delta12,14-prostaglandin J2', 'text': 'T12'}, {'abstract_id': '10200320', 'id': 'T13', 'entity_type': 'CHEMICAL', 'charOffset': 948, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T13'}, {'abstract_id': '10200320', 'id': 'T14', 'entity_type': 'CHEMICAL', 'charOffset': 978, 'len': 13, 'entity_name': 'prostaglandin', 'text': 'T14'}, {'abstract_id': '10200320', 'id': 'T15', 'entity_type': 'CHEMICAL', 'charOffset': 1036, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T15'}, {'abstract_id': '10200320', 'id': 'T16', 'entity_type': 'CHEMICAL', 'charOffset': 1125, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T16'}, {'abstract_id': '10200320', 'id': 'T17', 'entity_type': 'CHEMICAL', 'charOffset': 0, 'len': 29, 'entity_name': 'Cyclopentenone prostaglandins', 'text': 'T17'}, {'abstract_id': '10200320', 'id': 'T18', 'entity_type': 'CHEMICAL', 'charOffset': 118, 'len': 36, 'entity_name': '15-deoxy-Delta12,14-prostaglandin J2', 'text': 'T18'}, {'abstract_id': '10200320', 'id': 'T19', 'entity_type': 'CHEMICAL', 'charOffset': 93, 'len': 12, 'entity_name': 'nitric-oxide', 'text': 'T19'}, {'abstract_id': '10200320', 'id': 'T20', 'entity_type': 'GENE-Y', 'charOffset': 1182, 'len': 48, 'entity_name': 'peroxisome proliferator-activated receptor gamma', 'text': 'T20'}, {'abstract_id': '10200320', 'id': 'T21', 'entity_type': 'GENE-Y', 'charOffset': 1232, 'len': 9, 'entity_name': 'PPARgamma', 'text': 'T21'}, {'abstract_id': '10200320', 'id': 'T22', 'entity_type': 'GENE-Y', 'charOffset': 1286, 'len': 9, 'entity_name': 'PPARgamma', 'text': 'T22'}, {'abstract_id': '10200320', 'id': 'T23', 'entity_type': 'GENE-Y', 'charOffset': 1319, 'len': 4, 'entity_name': 'iNOS', 'text': 'T23'}, {'abstract_id': '10200320', 'id': 'T24', 'entity_type': 'GENE-N', 'charOffset': 1407, 'len': 4, 'entity_name': 'PPAR', 'text': 'T24'}, {'abstract_id': '10200320', 'id': 'T25', 'entity_type': 'GENE-Y', 'charOffset': 1463, 'len': 9, 'entity_name': 'PPARgamma', 'text': 'T25'}, {'abstract_id': '10200320', 'id': 'T26', 'entity_type': 'GENE-N', 'charOffset': 1571, 'len': 8, 'entity_name': 'NFkappaB', 'text': 'T26'}, {'abstract_id': '10200320', 'id': 'T27', 'entity_type': 'GENE-N', 'charOffset': 1619, 'len': 8, 'entity_name': 'NFkappaB', 'text': 'T27'}, {'abstract_id': '10200320', 'id': 'T28', 'entity_type': 'GENE-Y', 'charOffset': 1707, 'len': 4, 'entity_name': 'iNOS', 'text': 'T28'}, {'abstract_id': '10200320', 'id': 'T29', 'entity_type': 'GENE-N', 'charOffset': 1754, 'len': 8, 'entity_name': 'NFkappaB', 'text': 'T29'}, {'abstract_id': '10200320', 'id': 'T30', 'entity_type': 'GENE-Y', 'charOffset': 591, 'len': 31, 'entity_name': 'inducible nitric-oxide synthase', 'text': 'T30'}, {'abstract_id': '10200320', 'id': 'T31', 'entity_type': 'GENE-Y', 'charOffset': 624, 'len': 4, 'entity_name': 'iNOS', 'text': 'T31'}, {'abstract_id': '10200320', 'id': 'T32', 'entity_type': 'GENE-Y', 'charOffset': 730, 'len': 8, 'entity_name': 'IL-1beta', 'text': 'T32'}, {'abstract_id': '10200320', 'id': 'T33', 'entity_type': 'GENE-Y', 'charOffset': 822, 'len': 4, 'entity_name': 'iNOS', 'text': 'T33'}, {'abstract_id': '10200320', 'id': 'T34', 'entity_type': 'GENE-N', 'charOffset': 1056, 'len': 13, 'entity_name': 'iNOS promoter', 'text': 'T34'}, {'abstract_id': '10200320', 'id': 'T35', 'entity_type': 'GENE-Y', 'charOffset': 1080, 'len': 4, 'entity_name': 'iNOS', 'text': 'T35'}, {'abstract_id': '10200320', 'id': 'T36', 'entity_type': 'GENE-Y', 'charOffset': 83, 'len': 31, 'entity_name': 'inducible nitric-oxide synthase', 'text': 'T36'}]</td>\n",
       "      <td>NEGATIVE</td>\n",
       "      <td>0.994391</td>\n",
       "      <td>N</td>\n",
       "      <td>NOT</td>\n",
       "      <td>CPR:10</td>\n",
       "      <td>T16</td>\n",
       "      <td>T21</td>\n",
       "      <td>0</td>\n",
       "      <td>NEGATIVE</td>\n",
       "      <td>[15-Deoxy-Delta12,14-prostaglandin J2, 15-deoxy-Delta12,14-prostaglandin J2, 15d-PGJ2, Cyclopentenone prostaglandins, IL-1beta, NFkappaB, PPAR, PPARgamma, Prostaglandins, cyclopentenone prostaglandins, iNOS, iNOS promoter, inducible nitric-oxide synthase, nitric-oxide, peroxisome proliferator-activated receptor gamma, prostaglandin, prostaglandins E2 and D2, troglitazone]</td>\n",
       "      <td>_CHEMICAL_ does not appear to involve its nuclear receptor GENEIG3 (_GENE_</td>\n",
       "      <td>11</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>CHEMIG11 suppress activation of microglia: down-regulation of GENEIG9 by CHEMIG15. Mechanisms leading to down-regulation of activated microglia and astrocytes are poorly understood, in spite of the potentially detrimental role of activated glia in neurodegeneration. CHEMIG10, produced both by neurons and glia, may serve as mediators of glial and neuronal functions. We examined the influence of CHEMIG12 and their precursors on activated glia. As models of glial activation, production of GENEIG9 (GENEIG1) was studied in lipopolysaccharide-stimulated rat microglia, a murine microglial cell line BV-2, and GENEIG0-stimulated rat astrocytes. CHEMIG11 were potent inhibitors of GENEIG1 induction and were more effective than their precursors, CHEMIG17. CHEMIG5 (CHEMIG3) was the most potent CHEMIG6 among those tested. In activated microglia, CHEMIG3 suppressed GENEIG13 activity, GENEIG1 mRNA, and protein levels. The action of CHEMIG3 does not appear to involve its nuclear receptor GENEIG2 (GENEIG7) because _CHEMICAL_, a specific ligand of GENEIG7, was unable to inhibit _GENE_ induction, and neither CHEMIG8 nor CHEMIG3 could stimulate the activity of a GENEIG14-dependent promoter in the absence of cotransfected GENEIG7. CHEMIG3 did not block nuclear translocation or DNA-binding activity of the transcription factor GENEIG16, but it did inhibit the activity of an GENEIG16 reporter construct, suggesting that the mechanism of suppression of microglial GENEIG1 by CHEMIG3 may involve interference with GENEIG16 transcriptional activity in the nucleus. Thus, our data suggest the existence of a novel pathway mediated by CHEMIG12, which may represent part of a feedback mechanism leading to the cessation of inflammatory glial responses in the brain.</td>\n",
       "      <td>0</td>\n",
       "      <td>NEGATIVE</td>\n",
       "      <td>10200320</td>\n",
       "      <td>Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2. Mechanisms leading to down-regulation of activated microglia and astrocytes are poorly understood, in spite of the potentially detrimental role of activated glia in neurodegeneration. Prostaglandins, produced both by neurons and glia, may serve as mediators of glial and neuronal functions. We examined the influence of cyclopentenone prostaglandins and their precursors on activated glia. As models of glial activation, production of inducible nitric-oxide synthase (iNOS) was studied in lipopolysaccharide-stimulated rat microglia, a murine microglial cell line BV-2, and IL-1beta-stimulated rat astrocytes. Cyclopentenone prostaglandins were potent inhibitors of iNOS induction and were more effective than their precursors, prostaglandins E2 and D2. 15-Deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) was the most potent prostaglandin among those tested. In activated microglia, 15d-PGJ2 suppressed iNOS promoter activity, iNOS mRNA, and protein levels. The action of 15d-PGJ2 does not appear to involve its nuclear receptor peroxisome proliferator-activated receptor gamma (PPARgamma) because troglitazone, a specific ligand of PPARgamma, was unable to inhibit iNOS induction, and neither troglitazone nor 15d-PGJ2 could stimulate the activity of a PPAR-dependent promoter in the absence of cotransfected PPARgamma. 15d-PGJ2 did not block nuclear translocation or DNA-binding activity of the transcription factor NFkappaB, but it did inhibit the activity of an NFkappaB reporter construct, suggesting that the mechanism of suppression of microglial iNOS by 15d-PGJ2 may involve interference with NFkappaB transcriptional activity in the nucleus. Thus, our data suggest the existence of a novel pathway mediated by cyclopentenone prostaglandins, which may represent part of a feedback mechanism leading to the cessation of inflammatory glial responses in the brain.</td>\n",
       "      <td>[{'abstract_id': '10200320', 'id': 'T1', 'entity_type': 'CHEMICAL', 'charOffset': 1251, 'len': 12, 'entity_name': 'troglitazone', 'text': 'T1'}, {'abstract_id': '10200320', 'id': 'T2', 'entity_type': 'CHEMICAL', 'charOffset': 1347, 'len': 12, 'entity_name': 'troglitazone', 'text': 'T2'}, {'abstract_id': '10200320', 'id': 'T3', 'entity_type': 'CHEMICAL', 'charOffset': 1364, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T3'}, {'abstract_id': '10200320', 'id': 'T4', 'entity_type': 'CHEMICAL', 'charOffset': 1474, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T4'}, {'abstract_id': '10200320', 'id': 'T5', 'entity_type': 'CHEMICAL', 'charOffset': 1715, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T5'}, {'abstract_id': '10200320', 'id': 'T6', 'entity_type': 'CHEMICAL', 'charOffset': 1872, 'len': 29, 'entity_name': 'cyclopentenone prostaglandins', 'text': 'T6'}, {'abstract_id': '10200320', 'id': 'T7', 'entity_type': 'CHEMICAL', 'charOffset': 340, 'len': 14, 'entity_name': 'Prostaglandins', 'text': 'T7'}, {'abstract_id': '10200320', 'id': 'T8', 'entity_type': 'CHEMICAL', 'charOffset': 476, 'len': 29, 'entity_name': 'cyclopentenone prostaglandins', 'text': 'T8'}, {'abstract_id': '10200320', 'id': 'T9', 'entity_type': 'CHEMICAL', 'charOffset': 601, 'len': 12, 'entity_name': 'nitric-oxide', 'text': 'T9'}, {'abstract_id': '10200320', 'id': 'T10', 'entity_type': 'CHEMICAL', 'charOffset': 766, 'len': 29, 'entity_name': 'Cyclopentenone prostaglandins', 'text': 'T10'}, {'abstract_id': '10200320', 'id': 'T11', 'entity_type': 'CHEMICAL', 'charOffset': 884, 'len': 24, 'entity_name': 'prostaglandins E2 and D2', 'text': 'T11'}, {'abstract_id': '10200320', 'id': 'T12', 'entity_type': 'CHEMICAL', 'charOffset': 910, 'len': 36, 'entity_name': '15-Deoxy-Delta12,14-prostaglandin J2', 'text': 'T12'}, {'abstract_id': '10200320', 'id': 'T13', 'entity_type': 'CHEMICAL', 'charOffset': 948, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T13'}, {'abstract_id': '10200320', 'id': 'T14', 'entity_type': 'CHEMICAL', 'charOffset': 978, 'len': 13, 'entity_name': 'prostaglandin', 'text': 'T14'}, {'abstract_id': '10200320', 'id': 'T15', 'entity_type': 'CHEMICAL', 'charOffset': 1036, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T15'}, {'abstract_id': '10200320', 'id': 'T16', 'entity_type': 'CHEMICAL', 'charOffset': 1125, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T16'}, {'abstract_id': '10200320', 'id': 'T17', 'entity_type': 'CHEMICAL', 'charOffset': 0, 'len': 29, 'entity_name': 'Cyclopentenone prostaglandins', 'text': 'T17'}, {'abstract_id': '10200320', 'id': 'T18', 'entity_type': 'CHEMICAL', 'charOffset': 118, 'len': 36, 'entity_name': '15-deoxy-Delta12,14-prostaglandin J2', 'text': 'T18'}, {'abstract_id': '10200320', 'id': 'T19', 'entity_type': 'CHEMICAL', 'charOffset': 93, 'len': 12, 'entity_name': 'nitric-oxide', 'text': 'T19'}, {'abstract_id': '10200320', 'id': 'T20', 'entity_type': 'GENE-Y', 'charOffset': 1182, 'len': 48, 'entity_name': 'peroxisome proliferator-activated receptor gamma', 'text': 'T20'}, {'abstract_id': '10200320', 'id': 'T21', 'entity_type': 'GENE-Y', 'charOffset': 1232, 'len': 9, 'entity_name': 'PPARgamma', 'text': 'T21'}, {'abstract_id': '10200320', 'id': 'T22', 'entity_type': 'GENE-Y', 'charOffset': 1286, 'len': 9, 'entity_name': 'PPARgamma', 'text': 'T22'}, {'abstract_id': '10200320', 'id': 'T23', 'entity_type': 'GENE-Y', 'charOffset': 1319, 'len': 4, 'entity_name': 'iNOS', 'text': 'T23'}, {'abstract_id': '10200320', 'id': 'T24', 'entity_type': 'GENE-N', 'charOffset': 1407, 'len': 4, 'entity_name': 'PPAR', 'text': 'T24'}, {'abstract_id': '10200320', 'id': 'T25', 'entity_type': 'GENE-Y', 'charOffset': 1463, 'len': 9, 'entity_name': 'PPARgamma', 'text': 'T25'}, {'abstract_id': '10200320', 'id': 'T26', 'entity_type': 'GENE-N', 'charOffset': 1571, 'len': 8, 'entity_name': 'NFkappaB', 'text': 'T26'}, {'abstract_id': '10200320', 'id': 'T27', 'entity_type': 'GENE-N', 'charOffset': 1619, 'len': 8, 'entity_name': 'NFkappaB', 'text': 'T27'}, {'abstract_id': '10200320', 'id': 'T28', 'entity_type': 'GENE-Y', 'charOffset': 1707, 'len': 4, 'entity_name': 'iNOS', 'text': 'T28'}, {'abstract_id': '10200320', 'id': 'T29', 'entity_type': 'GENE-N', 'charOffset': 1754, 'len': 8, 'entity_name': 'NFkappaB', 'text': 'T29'}, {'abstract_id': '10200320', 'id': 'T30', 'entity_type': 'GENE-Y', 'charOffset': 591, 'len': 31, 'entity_name': 'inducible nitric-oxide synthase', 'text': 'T30'}, {'abstract_id': '10200320', 'id': 'T31', 'entity_type': 'GENE-Y', 'charOffset': 624, 'len': 4, 'entity_name': 'iNOS', 'text': 'T31'}, {'abstract_id': '10200320', 'id': 'T32', 'entity_type': 'GENE-Y', 'charOffset': 730, 'len': 8, 'entity_name': 'IL-1beta', 'text': 'T32'}, {'abstract_id': '10200320', 'id': 'T33', 'entity_type': 'GENE-Y', 'charOffset': 822, 'len': 4, 'entity_name': 'iNOS', 'text': 'T33'}, {'abstract_id': '10200320', 'id': 'T34', 'entity_type': 'GENE-N', 'charOffset': 1056, 'len': 13, 'entity_name': 'iNOS promoter', 'text': 'T34'}, {'abstract_id': '10200320', 'id': 'T35', 'entity_type': 'GENE-Y', 'charOffset': 1080, 'len': 4, 'entity_name': 'iNOS', 'text': 'T35'}, {'abstract_id': '10200320', 'id': 'T36', 'entity_type': 'GENE-Y', 'charOffset': 83, 'len': 31, 'entity_name': 'inducible nitric-oxide synthase', 'text': 'T36'}]</td>\n",
       "      <td>NEGATIVE</td>\n",
       "      <td>0.989973</td>\n",
       "      <td>N</td>\n",
       "      <td>NOT</td>\n",
       "      <td>CPR:10</td>\n",
       "      <td>T1</td>\n",
       "      <td>T23</td>\n",
       "      <td>0</td>\n",
       "      <td>NEGATIVE</td>\n",
       "      <td>[15-Deoxy-Delta12,14-prostaglandin J2, 15-deoxy-Delta12,14-prostaglandin J2, 15d-PGJ2, Cyclopentenone prostaglandins, IL-1beta, NFkappaB, PPAR, PPARgamma, Prostaglandins, cyclopentenone prostaglandins, iNOS, iNOS promoter, inducible nitric-oxide synthase, nitric-oxide, peroxisome proliferator-activated receptor gamma, prostaglandin, prostaglandins E2 and D2, troglitazone]</td>\n",
       "      <td>_CHEMICAL_, a specific ligand of GENEIG7, was unable to inhibit _GENE_</td>\n",
       "      <td>11</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>CHEMIG16 suppress activation of microglia: down-regulation of GENEIG6 by CHEMIG10. Mechanisms leading to down-regulation of activated microglia and astrocytes are poorly understood, in spite of the potentially detrimental role of activated glia in neurodegeneration. CHEMIG1, produced both by neurons and glia, may serve as mediators of glial and neuronal functions. We examined the influence of CHEMIG9 and their precursors on activated glia. As models of glial activation, production of GENEIG6 (GENEIG3) was studied in lipopolysaccharide-stimulated rat microglia, a murine microglial cell line BV-2, and GENEIG15-stimulated rat astrocytes. CHEMIG16 were potent inhibitors of GENEIG3 induction and were more effective than their precursors, CHEMIG8. CHEMIG5 (CHEMIG4) was the most potent CHEMIG13 among those tested. In activated microglia, CHEMIG4 suppressed GENEIG0 activity, GENEIG3 mRNA, and protein levels. The action of CHEMIG4 does not appear to involve its nuclear receptor GENEIG12 (GENEIG7) because CHEMIG2, a specific ligand of GENEIG7, was unable to inhibit GENEIG3 induction, and neither _CHEMICAL_ nor CHEMIG4 could stimulate the activity of a _GENE_-dependent promoter in the absence of cotransfected GENEIG7. CHEMIG4 did not block nuclear translocation or DNA-binding activity of the transcription factor GENEIG14, but it did inhibit the activity of an GENEIG14 reporter construct, suggesting that the mechanism of suppression of microglial GENEIG3 by CHEMIG4 may involve interference with GENEIG14 transcriptional activity in the nucleus. Thus, our data suggest the existence of a novel pathway mediated by CHEMIG9, which may represent part of a feedback mechanism leading to the cessation of inflammatory glial responses in the brain.</td>\n",
       "      <td>0</td>\n",
       "      <td>NEGATIVE</td>\n",
       "      <td>10200320</td>\n",
       "      <td>Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2. Mechanisms leading to down-regulation of activated microglia and astrocytes are poorly understood, in spite of the potentially detrimental role of activated glia in neurodegeneration. Prostaglandins, produced both by neurons and glia, may serve as mediators of glial and neuronal functions. We examined the influence of cyclopentenone prostaglandins and their precursors on activated glia. As models of glial activation, production of inducible nitric-oxide synthase (iNOS) was studied in lipopolysaccharide-stimulated rat microglia, a murine microglial cell line BV-2, and IL-1beta-stimulated rat astrocytes. Cyclopentenone prostaglandins were potent inhibitors of iNOS induction and were more effective than their precursors, prostaglandins E2 and D2. 15-Deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) was the most potent prostaglandin among those tested. In activated microglia, 15d-PGJ2 suppressed iNOS promoter activity, iNOS mRNA, and protein levels. The action of 15d-PGJ2 does not appear to involve its nuclear receptor peroxisome proliferator-activated receptor gamma (PPARgamma) because troglitazone, a specific ligand of PPARgamma, was unable to inhibit iNOS induction, and neither troglitazone nor 15d-PGJ2 could stimulate the activity of a PPAR-dependent promoter in the absence of cotransfected PPARgamma. 15d-PGJ2 did not block nuclear translocation or DNA-binding activity of the transcription factor NFkappaB, but it did inhibit the activity of an NFkappaB reporter construct, suggesting that the mechanism of suppression of microglial iNOS by 15d-PGJ2 may involve interference with NFkappaB transcriptional activity in the nucleus. Thus, our data suggest the existence of a novel pathway mediated by cyclopentenone prostaglandins, which may represent part of a feedback mechanism leading to the cessation of inflammatory glial responses in the brain.</td>\n",
       "      <td>[{'abstract_id': '10200320', 'id': 'T1', 'entity_type': 'CHEMICAL', 'charOffset': 1251, 'len': 12, 'entity_name': 'troglitazone', 'text': 'T1'}, {'abstract_id': '10200320', 'id': 'T2', 'entity_type': 'CHEMICAL', 'charOffset': 1347, 'len': 12, 'entity_name': 'troglitazone', 'text': 'T2'}, {'abstract_id': '10200320', 'id': 'T3', 'entity_type': 'CHEMICAL', 'charOffset': 1364, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T3'}, {'abstract_id': '10200320', 'id': 'T4', 'entity_type': 'CHEMICAL', 'charOffset': 1474, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T4'}, {'abstract_id': '10200320', 'id': 'T5', 'entity_type': 'CHEMICAL', 'charOffset': 1715, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T5'}, {'abstract_id': '10200320', 'id': 'T6', 'entity_type': 'CHEMICAL', 'charOffset': 1872, 'len': 29, 'entity_name': 'cyclopentenone prostaglandins', 'text': 'T6'}, {'abstract_id': '10200320', 'id': 'T7', 'entity_type': 'CHEMICAL', 'charOffset': 340, 'len': 14, 'entity_name': 'Prostaglandins', 'text': 'T7'}, {'abstract_id': '10200320', 'id': 'T8', 'entity_type': 'CHEMICAL', 'charOffset': 476, 'len': 29, 'entity_name': 'cyclopentenone prostaglandins', 'text': 'T8'}, {'abstract_id': '10200320', 'id': 'T9', 'entity_type': 'CHEMICAL', 'charOffset': 601, 'len': 12, 'entity_name': 'nitric-oxide', 'text': 'T9'}, {'abstract_id': '10200320', 'id': 'T10', 'entity_type': 'CHEMICAL', 'charOffset': 766, 'len': 29, 'entity_name': 'Cyclopentenone prostaglandins', 'text': 'T10'}, {'abstract_id': '10200320', 'id': 'T11', 'entity_type': 'CHEMICAL', 'charOffset': 884, 'len': 24, 'entity_name': 'prostaglandins E2 and D2', 'text': 'T11'}, {'abstract_id': '10200320', 'id': 'T12', 'entity_type': 'CHEMICAL', 'charOffset': 910, 'len': 36, 'entity_name': '15-Deoxy-Delta12,14-prostaglandin J2', 'text': 'T12'}, {'abstract_id': '10200320', 'id': 'T13', 'entity_type': 'CHEMICAL', 'charOffset': 948, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T13'}, {'abstract_id': '10200320', 'id': 'T14', 'entity_type': 'CHEMICAL', 'charOffset': 978, 'len': 13, 'entity_name': 'prostaglandin', 'text': 'T14'}, {'abstract_id': '10200320', 'id': 'T15', 'entity_type': 'CHEMICAL', 'charOffset': 1036, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T15'}, {'abstract_id': '10200320', 'id': 'T16', 'entity_type': 'CHEMICAL', 'charOffset': 1125, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T16'}, {'abstract_id': '10200320', 'id': 'T17', 'entity_type': 'CHEMICAL', 'charOffset': 0, 'len': 29, 'entity_name': 'Cyclopentenone prostaglandins', 'text': 'T17'}, {'abstract_id': '10200320', 'id': 'T18', 'entity_type': 'CHEMICAL', 'charOffset': 118, 'len': 36, 'entity_name': '15-deoxy-Delta12,14-prostaglandin J2', 'text': 'T18'}, {'abstract_id': '10200320', 'id': 'T19', 'entity_type': 'CHEMICAL', 'charOffset': 93, 'len': 12, 'entity_name': 'nitric-oxide', 'text': 'T19'}, {'abstract_id': '10200320', 'id': 'T20', 'entity_type': 'GENE-Y', 'charOffset': 1182, 'len': 48, 'entity_name': 'peroxisome proliferator-activated receptor gamma', 'text': 'T20'}, {'abstract_id': '10200320', 'id': 'T21', 'entity_type': 'GENE-Y', 'charOffset': 1232, 'len': 9, 'entity_name': 'PPARgamma', 'text': 'T21'}, {'abstract_id': '10200320', 'id': 'T22', 'entity_type': 'GENE-Y', 'charOffset': 1286, 'len': 9, 'entity_name': 'PPARgamma', 'text': 'T22'}, {'abstract_id': '10200320', 'id': 'T23', 'entity_type': 'GENE-Y', 'charOffset': 1319, 'len': 4, 'entity_name': 'iNOS', 'text': 'T23'}, {'abstract_id': '10200320', 'id': 'T24', 'entity_type': 'GENE-N', 'charOffset': 1407, 'len': 4, 'entity_name': 'PPAR', 'text': 'T24'}, {'abstract_id': '10200320', 'id': 'T25', 'entity_type': 'GENE-Y', 'charOffset': 1463, 'len': 9, 'entity_name': 'PPARgamma', 'text': 'T25'}, {'abstract_id': '10200320', 'id': 'T26', 'entity_type': 'GENE-N', 'charOffset': 1571, 'len': 8, 'entity_name': 'NFkappaB', 'text': 'T26'}, {'abstract_id': '10200320', 'id': 'T27', 'entity_type': 'GENE-N', 'charOffset': 1619, 'len': 8, 'entity_name': 'NFkappaB', 'text': 'T27'}, {'abstract_id': '10200320', 'id': 'T28', 'entity_type': 'GENE-Y', 'charOffset': 1707, 'len': 4, 'entity_name': 'iNOS', 'text': 'T28'}, {'abstract_id': '10200320', 'id': 'T29', 'entity_type': 'GENE-N', 'charOffset': 1754, 'len': 8, 'entity_name': 'NFkappaB', 'text': 'T29'}, {'abstract_id': '10200320', 'id': 'T30', 'entity_type': 'GENE-Y', 'charOffset': 591, 'len': 31, 'entity_name': 'inducible nitric-oxide synthase', 'text': 'T30'}, {'abstract_id': '10200320', 'id': 'T31', 'entity_type': 'GENE-Y', 'charOffset': 624, 'len': 4, 'entity_name': 'iNOS', 'text': 'T31'}, {'abstract_id': '10200320', 'id': 'T32', 'entity_type': 'GENE-Y', 'charOffset': 730, 'len': 8, 'entity_name': 'IL-1beta', 'text': 'T32'}, {'abstract_id': '10200320', 'id': 'T33', 'entity_type': 'GENE-Y', 'charOffset': 822, 'len': 4, 'entity_name': 'iNOS', 'text': 'T33'}, {'abstract_id': '10200320', 'id': 'T34', 'entity_type': 'GENE-N', 'charOffset': 1056, 'len': 13, 'entity_name': 'iNOS promoter', 'text': 'T34'}, {'abstract_id': '10200320', 'id': 'T35', 'entity_type': 'GENE-Y', 'charOffset': 1080, 'len': 4, 'entity_name': 'iNOS', 'text': 'T35'}, {'abstract_id': '10200320', 'id': 'T36', 'entity_type': 'GENE-Y', 'charOffset': 83, 'len': 31, 'entity_name': 'inducible nitric-oxide synthase', 'text': 'T36'}]</td>\n",
       "      <td>NEGATIVE</td>\n",
       "      <td>0.991110</td>\n",
       "      <td>N</td>\n",
       "      <td>NOT</td>\n",
       "      <td>CPR:10</td>\n",
       "      <td>T2</td>\n",
       "      <td>T24</td>\n",
       "      <td>0</td>\n",
       "      <td>NEGATIVE</td>\n",
       "      <td>[15-Deoxy-Delta12,14-prostaglandin J2, 15-deoxy-Delta12,14-prostaglandin J2, 15d-PGJ2, Cyclopentenone prostaglandins, IL-1beta, NFkappaB, PPAR, PPARgamma, Prostaglandins, cyclopentenone prostaglandins, iNOS, iNOS promoter, inducible nitric-oxide synthase, nitric-oxide, peroxisome proliferator-activated receptor gamma, prostaglandin, prostaglandins E2 and D2, troglitazone]</td>\n",
       "      <td>_CHEMICAL_ nor CHEMIG4 could stimulate the activity of a _GENE_</td>\n",
       "      <td>10</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   x  \\\n",
       "19                                                                                                                                                                                                                                                                                        New aspects in the management of obesity: operation and the impact of GENEIG0 inhibitors. Obesity is an increasing health problem in most developed countries and its prevalence is also increasing in developing countries. There has been no great success with dietary means and life style modification for permanent weight loss. Various surgical treatment methods for obesity are now available. They are aimed at limiting oral energy intake with or without causing dumping or inducing selective maldigestion and malabsorption. Based on current literature, up to 75% of excess weight is lost by surgical treatment with concomitant disappearance of hyperlipidaemias, type 2 diabetes, hypertension or sleep apnoea. The main indication for operative treatment is morbid obesity (body mass index greater than 40 kg/m2) or severe obesity (body mass index > 35 kg/m2) with comorbidities of obesity. CHEMIG6 is a new inhibitor of GENEIG4 enzyme. At doses of 120 mg three times per day with meals it results in a 30% reduction in dietary fat absorption, which equals approximately 200 kcal daily energy deficit. In the long term, CHEMIG1 has been shown to be more effective than placebo in reducing body weight and serum total and GENEIG5 CHEMIG3 levels. CHEMIG6 has a lowering effect on serum CHEMIG3 independent of weight loss. Along with weight loss, _CHEMICAL_ also favourably affects blood pressure and CHEMIG2 and _GENE_ levels in obese individuals and in obese type 2 diabetic patients.   \n",
       "22     CHEMIG15 suppress activation of microglia: down-regulation of GENEIG16 by CHEMIG8. Mechanisms leading to down-regulation of activated microglia and astrocytes are poorly understood, in spite of the potentially detrimental role of activated glia in neurodegeneration. CHEMIG13, produced both by neurons and glia, may serve as mediators of glial and neuronal functions. We examined the influence of CHEMIG2 and their precursors on activated glia. As models of glial activation, production of GENEIG16 (GENEIG6) was studied in lipopolysaccharide-stimulated rat microglia, a murine microglial cell line BV-2, and GENEIG7-stimulated rat astrocytes. CHEMIG15 were potent inhibitors of GENEIG6 induction and were more effective than their precursors, CHEMIG0. CHEMIG9 (CHEMIG1) was the most potent CHEMIG3 among those tested. In activated microglia, CHEMIG1 suppressed GENEIG12 activity, GENEIG6 mRNA, and protein levels. The action of _CHEMICAL_ does not appear to involve its nuclear receptor _GENE_ (GENEIG5) because CHEMIG10, a specific ligand of GENEIG5, was unable to inhibit GENEIG6 induction, and neither CHEMIG10 nor CHEMIG1 could stimulate the activity of a GENEIG14-dependent promoter in the absence of cotransfected GENEIG5. CHEMIG1 did not block nuclear translocation or DNA-binding activity of the transcription factor GENEIG11, but it did inhibit the activity of an GENEIG11 reporter construct, suggesting that the mechanism of suppression of microglial GENEIG6 by CHEMIG1 may involve interference with GENEIG11 transcriptional activity in the nucleus. Thus, our data suggest the existence of a novel pathway mediated by CHEMIG2, which may represent part of a feedback mechanism leading to the cessation of inflammatory glial responses in the brain.   \n",
       "23  CHEMIG4 suppress activation of microglia: down-regulation of GENEIG12 by CHEMIG7. Mechanisms leading to down-regulation of activated microglia and astrocytes are poorly understood, in spite of the potentially detrimental role of activated glia in neurodegeneration. CHEMIG17, produced both by neurons and glia, may serve as mediators of glial and neuronal functions. We examined the influence of CHEMIG2 and their precursors on activated glia. As models of glial activation, production of GENEIG12 (GENEIG16) was studied in lipopolysaccharide-stimulated rat microglia, a murine microglial cell line BV-2, and GENEIG15-stimulated rat astrocytes. CHEMIG4 were potent inhibitors of GENEIG16 induction and were more effective than their precursors, CHEMIG1. CHEMIG14 (CHEMIG9) was the most potent CHEMIG6 among those tested. In activated microglia, CHEMIG9 suppressed GENEIG5 activity, GENEIG16 mRNA, and protein levels. The action of _CHEMICAL_ does not appear to involve its nuclear receptor GENEIG3 (_GENE_) because CHEMIG0, a specific ligand of GENEIG11, was unable to inhibit GENEIG16 induction, and neither CHEMIG0 nor CHEMIG9 could stimulate the activity of a GENEIG8-dependent promoter in the absence of cotransfected GENEIG11. CHEMIG9 did not block nuclear translocation or DNA-binding activity of the transcription factor GENEIG10, but it did inhibit the activity of an GENEIG10 reporter construct, suggesting that the mechanism of suppression of microglial GENEIG16 by CHEMIG9 may involve interference with GENEIG10 transcriptional activity in the nucleus. Thus, our data suggest the existence of a novel pathway mediated by CHEMIG2, which may represent part of a feedback mechanism leading to the cessation of inflammatory glial responses in the brain.   \n",
       "24     CHEMIG11 suppress activation of microglia: down-regulation of GENEIG9 by CHEMIG15. Mechanisms leading to down-regulation of activated microglia and astrocytes are poorly understood, in spite of the potentially detrimental role of activated glia in neurodegeneration. CHEMIG10, produced both by neurons and glia, may serve as mediators of glial and neuronal functions. We examined the influence of CHEMIG12 and their precursors on activated glia. As models of glial activation, production of GENEIG9 (GENEIG1) was studied in lipopolysaccharide-stimulated rat microglia, a murine microglial cell line BV-2, and GENEIG0-stimulated rat astrocytes. CHEMIG11 were potent inhibitors of GENEIG1 induction and were more effective than their precursors, CHEMIG17. CHEMIG5 (CHEMIG3) was the most potent CHEMIG6 among those tested. In activated microglia, CHEMIG3 suppressed GENEIG13 activity, GENEIG1 mRNA, and protein levels. The action of CHEMIG3 does not appear to involve its nuclear receptor GENEIG2 (GENEIG7) because _CHEMICAL_, a specific ligand of GENEIG7, was unable to inhibit _GENE_ induction, and neither CHEMIG8 nor CHEMIG3 could stimulate the activity of a GENEIG14-dependent promoter in the absence of cotransfected GENEIG7. CHEMIG3 did not block nuclear translocation or DNA-binding activity of the transcription factor GENEIG16, but it did inhibit the activity of an GENEIG16 reporter construct, suggesting that the mechanism of suppression of microglial GENEIG1 by CHEMIG3 may involve interference with GENEIG16 transcriptional activity in the nucleus. Thus, our data suggest the existence of a novel pathway mediated by CHEMIG12, which may represent part of a feedback mechanism leading to the cessation of inflammatory glial responses in the brain.   \n",
       "25        CHEMIG16 suppress activation of microglia: down-regulation of GENEIG6 by CHEMIG10. Mechanisms leading to down-regulation of activated microglia and astrocytes are poorly understood, in spite of the potentially detrimental role of activated glia in neurodegeneration. CHEMIG1, produced both by neurons and glia, may serve as mediators of glial and neuronal functions. We examined the influence of CHEMIG9 and their precursors on activated glia. As models of glial activation, production of GENEIG6 (GENEIG3) was studied in lipopolysaccharide-stimulated rat microglia, a murine microglial cell line BV-2, and GENEIG15-stimulated rat astrocytes. CHEMIG16 were potent inhibitors of GENEIG3 induction and were more effective than their precursors, CHEMIG8. CHEMIG5 (CHEMIG4) was the most potent CHEMIG13 among those tested. In activated microglia, CHEMIG4 suppressed GENEIG0 activity, GENEIG3 mRNA, and protein levels. The action of CHEMIG4 does not appear to involve its nuclear receptor GENEIG12 (GENEIG7) because CHEMIG2, a specific ligand of GENEIG7, was unable to inhibit GENEIG3 induction, and neither _CHEMICAL_ nor CHEMIG4 could stimulate the activity of a _GENE_-dependent promoter in the absence of cotransfected GENEIG7. CHEMIG4 did not block nuclear translocation or DNA-binding activity of the transcription factor GENEIG14, but it did inhibit the activity of an GENEIG14 reporter construct, suggesting that the mechanism of suppression of microglial GENEIG3 by CHEMIG4 may involve interference with GENEIG14 transcriptional activity in the nucleus. Thus, our data suggest the existence of a novel pathway mediated by CHEMIG9, which may represent part of a feedback mechanism leading to the cessation of inflammatory glial responses in the brain.   \n",
       "\n",
       "    y     y_raw  abstract_id  \\\n",
       "19  0  NEGATIVE     10095983   \n",
       "22  0  NEGATIVE     10200320   \n",
       "23  0  NEGATIVE     10200320   \n",
       "24  0  NEGATIVE     10200320   \n",
       "25  0  NEGATIVE     10200320   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  abstract  \\\n",
       "19                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           New aspects in the management of obesity: operation and the impact of lipase inhibitors. Obesity is an increasing health problem in most developed countries and its prevalence is also increasing in developing countries. There has been no great success with dietary means and life style modification for permanent weight loss. Various surgical treatment methods for obesity are now available. They are aimed at limiting oral energy intake with or without causing dumping or inducing selective maldigestion and malabsorption. Based on current literature, up to 75% of excess weight is lost by surgical treatment with concomitant disappearance of hyperlipidaemias, type 2 diabetes, hypertension or sleep apnoea. The main indication for operative treatment is morbid obesity (body mass index greater than 40 kg/m2) or severe obesity (body mass index > 35 kg/m2) with comorbidities of obesity. Orlistat is a new inhibitor of pancreatic lipase enzyme. At doses of 120 mg three times per day with meals it results in a 30% reduction in dietary fat absorption, which equals approximately 200 kcal daily energy deficit. In the long term, orlistat has been shown to be more effective than placebo in reducing body weight and serum total and low-density lipoprotein cholesterol levels. Orlistat has a lowering effect on serum cholesterol independent of weight loss. Along with weight loss, orlistat also favourably affects blood pressure and glucose and insulin levels in obese individuals and in obese type 2 diabetic patients.   \n",
       "22  Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2. Mechanisms leading to down-regulation of activated microglia and astrocytes are poorly understood, in spite of the potentially detrimental role of activated glia in neurodegeneration. Prostaglandins, produced both by neurons and glia, may serve as mediators of glial and neuronal functions. We examined the influence of cyclopentenone prostaglandins and their precursors on activated glia. As models of glial activation, production of inducible nitric-oxide synthase (iNOS) was studied in lipopolysaccharide-stimulated rat microglia, a murine microglial cell line BV-2, and IL-1beta-stimulated rat astrocytes. Cyclopentenone prostaglandins were potent inhibitors of iNOS induction and were more effective than their precursors, prostaglandins E2 and D2. 15-Deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) was the most potent prostaglandin among those tested. In activated microglia, 15d-PGJ2 suppressed iNOS promoter activity, iNOS mRNA, and protein levels. The action of 15d-PGJ2 does not appear to involve its nuclear receptor peroxisome proliferator-activated receptor gamma (PPARgamma) because troglitazone, a specific ligand of PPARgamma, was unable to inhibit iNOS induction, and neither troglitazone nor 15d-PGJ2 could stimulate the activity of a PPAR-dependent promoter in the absence of cotransfected PPARgamma. 15d-PGJ2 did not block nuclear translocation or DNA-binding activity of the transcription factor NFkappaB, but it did inhibit the activity of an NFkappaB reporter construct, suggesting that the mechanism of suppression of microglial iNOS by 15d-PGJ2 may involve interference with NFkappaB transcriptional activity in the nucleus. Thus, our data suggest the existence of a novel pathway mediated by cyclopentenone prostaglandins, which may represent part of a feedback mechanism leading to the cessation of inflammatory glial responses in the brain.   \n",
       "23  Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2. Mechanisms leading to down-regulation of activated microglia and astrocytes are poorly understood, in spite of the potentially detrimental role of activated glia in neurodegeneration. Prostaglandins, produced both by neurons and glia, may serve as mediators of glial and neuronal functions. We examined the influence of cyclopentenone prostaglandins and their precursors on activated glia. As models of glial activation, production of inducible nitric-oxide synthase (iNOS) was studied in lipopolysaccharide-stimulated rat microglia, a murine microglial cell line BV-2, and IL-1beta-stimulated rat astrocytes. Cyclopentenone prostaglandins were potent inhibitors of iNOS induction and were more effective than their precursors, prostaglandins E2 and D2. 15-Deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) was the most potent prostaglandin among those tested. In activated microglia, 15d-PGJ2 suppressed iNOS promoter activity, iNOS mRNA, and protein levels. The action of 15d-PGJ2 does not appear to involve its nuclear receptor peroxisome proliferator-activated receptor gamma (PPARgamma) because troglitazone, a specific ligand of PPARgamma, was unable to inhibit iNOS induction, and neither troglitazone nor 15d-PGJ2 could stimulate the activity of a PPAR-dependent promoter in the absence of cotransfected PPARgamma. 15d-PGJ2 did not block nuclear translocation or DNA-binding activity of the transcription factor NFkappaB, but it did inhibit the activity of an NFkappaB reporter construct, suggesting that the mechanism of suppression of microglial iNOS by 15d-PGJ2 may involve interference with NFkappaB transcriptional activity in the nucleus. Thus, our data suggest the existence of a novel pathway mediated by cyclopentenone prostaglandins, which may represent part of a feedback mechanism leading to the cessation of inflammatory glial responses in the brain.   \n",
       "24  Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2. Mechanisms leading to down-regulation of activated microglia and astrocytes are poorly understood, in spite of the potentially detrimental role of activated glia in neurodegeneration. Prostaglandins, produced both by neurons and glia, may serve as mediators of glial and neuronal functions. We examined the influence of cyclopentenone prostaglandins and their precursors on activated glia. As models of glial activation, production of inducible nitric-oxide synthase (iNOS) was studied in lipopolysaccharide-stimulated rat microglia, a murine microglial cell line BV-2, and IL-1beta-stimulated rat astrocytes. Cyclopentenone prostaglandins were potent inhibitors of iNOS induction and were more effective than their precursors, prostaglandins E2 and D2. 15-Deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) was the most potent prostaglandin among those tested. In activated microglia, 15d-PGJ2 suppressed iNOS promoter activity, iNOS mRNA, and protein levels. The action of 15d-PGJ2 does not appear to involve its nuclear receptor peroxisome proliferator-activated receptor gamma (PPARgamma) because troglitazone, a specific ligand of PPARgamma, was unable to inhibit iNOS induction, and neither troglitazone nor 15d-PGJ2 could stimulate the activity of a PPAR-dependent promoter in the absence of cotransfected PPARgamma. 15d-PGJ2 did not block nuclear translocation or DNA-binding activity of the transcription factor NFkappaB, but it did inhibit the activity of an NFkappaB reporter construct, suggesting that the mechanism of suppression of microglial iNOS by 15d-PGJ2 may involve interference with NFkappaB transcriptional activity in the nucleus. Thus, our data suggest the existence of a novel pathway mediated by cyclopentenone prostaglandins, which may represent part of a feedback mechanism leading to the cessation of inflammatory glial responses in the brain.   \n",
       "25  Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2. Mechanisms leading to down-regulation of activated microglia and astrocytes are poorly understood, in spite of the potentially detrimental role of activated glia in neurodegeneration. Prostaglandins, produced both by neurons and glia, may serve as mediators of glial and neuronal functions. We examined the influence of cyclopentenone prostaglandins and their precursors on activated glia. As models of glial activation, production of inducible nitric-oxide synthase (iNOS) was studied in lipopolysaccharide-stimulated rat microglia, a murine microglial cell line BV-2, and IL-1beta-stimulated rat astrocytes. Cyclopentenone prostaglandins were potent inhibitors of iNOS induction and were more effective than their precursors, prostaglandins E2 and D2. 15-Deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) was the most potent prostaglandin among those tested. In activated microglia, 15d-PGJ2 suppressed iNOS promoter activity, iNOS mRNA, and protein levels. The action of 15d-PGJ2 does not appear to involve its nuclear receptor peroxisome proliferator-activated receptor gamma (PPARgamma) because troglitazone, a specific ligand of PPARgamma, was unable to inhibit iNOS induction, and neither troglitazone nor 15d-PGJ2 could stimulate the activity of a PPAR-dependent promoter in the absence of cotransfected PPARgamma. 15d-PGJ2 did not block nuclear translocation or DNA-binding activity of the transcription factor NFkappaB, but it did inhibit the activity of an NFkappaB reporter construct, suggesting that the mechanism of suppression of microglial iNOS by 15d-PGJ2 may involve interference with NFkappaB transcriptional activity in the nucleus. Thus, our data suggest the existence of a novel pathway mediated by cyclopentenone prostaglandins, which may represent part of a feedback mechanism leading to the cessation of inflammatory glial responses in the brain.   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   annotations  \\\n",
       "19                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             [{'abstract_id': '10095983', 'id': 'T1', 'entity_type': 'CHEMICAL', 'charOffset': 1129, 'len': 8, 'entity_name': 'orlistat', 'text': 'T1'}, {'abstract_id': '10095983', 'id': 'T2', 'entity_type': 'CHEMICAL', 'charOffset': 1255, 'len': 11, 'entity_name': 'cholesterol', 'text': 'T2'}, {'abstract_id': '10095983', 'id': 'T3', 'entity_type': 'CHEMICAL', 'charOffset': 1275, 'len': 8, 'entity_name': 'Orlistat', 'text': 'T3'}, {'abstract_id': '10095983', 'id': 'T4', 'entity_type': 'CHEMICAL', 'charOffset': 1315, 'len': 11, 'entity_name': 'cholesterol', 'text': 'T4'}, {'abstract_id': '10095983', 'id': 'T5', 'entity_type': 'CHEMICAL', 'charOffset': 1379, 'len': 8, 'entity_name': 'orlistat', 'text': 'T5'}, {'abstract_id': '10095983', 'id': 'T6', 'entity_type': 'CHEMICAL', 'charOffset': 1431, 'len': 7, 'entity_name': 'glucose', 'text': 'T6'}, {'abstract_id': '10095983', 'id': 'T7', 'entity_type': 'CHEMICAL', 'charOffset': 889, 'len': 8, 'entity_name': 'Orlistat', 'text': 'T7'}, {'abstract_id': '10095983', 'id': 'T8', 'entity_type': 'GENE-N', 'charOffset': 1231, 'len': 23, 'entity_name': 'low-density lipoprotein', 'text': 'T8'}, {'abstract_id': '10095983', 'id': 'T9', 'entity_type': 'GENE-Y', 'charOffset': 1443, 'len': 7, 'entity_name': 'insulin', 'text': 'T9'}, {'abstract_id': '10095983', 'id': 'T10', 'entity_type': 'GENE-Y', 'charOffset': 920, 'len': 17, 'entity_name': 'pancreatic lipase', 'text': 'T10'}, {'abstract_id': '10095983', 'id': 'T11', 'entity_type': 'GENE-N', 'charOffset': 70, 'len': 6, 'entity_name': 'lipase', 'text': 'T11'}]   \n",
       "22  [{'abstract_id': '10200320', 'id': 'T1', 'entity_type': 'CHEMICAL', 'charOffset': 1251, 'len': 12, 'entity_name': 'troglitazone', 'text': 'T1'}, {'abstract_id': '10200320', 'id': 'T2', 'entity_type': 'CHEMICAL', 'charOffset': 1347, 'len': 12, 'entity_name': 'troglitazone', 'text': 'T2'}, {'abstract_id': '10200320', 'id': 'T3', 'entity_type': 'CHEMICAL', 'charOffset': 1364, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T3'}, {'abstract_id': '10200320', 'id': 'T4', 'entity_type': 'CHEMICAL', 'charOffset': 1474, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T4'}, {'abstract_id': '10200320', 'id': 'T5', 'entity_type': 'CHEMICAL', 'charOffset': 1715, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T5'}, {'abstract_id': '10200320', 'id': 'T6', 'entity_type': 'CHEMICAL', 'charOffset': 1872, 'len': 29, 'entity_name': 'cyclopentenone prostaglandins', 'text': 'T6'}, {'abstract_id': '10200320', 'id': 'T7', 'entity_type': 'CHEMICAL', 'charOffset': 340, 'len': 14, 'entity_name': 'Prostaglandins', 'text': 'T7'}, {'abstract_id': '10200320', 'id': 'T8', 'entity_type': 'CHEMICAL', 'charOffset': 476, 'len': 29, 'entity_name': 'cyclopentenone prostaglandins', 'text': 'T8'}, {'abstract_id': '10200320', 'id': 'T9', 'entity_type': 'CHEMICAL', 'charOffset': 601, 'len': 12, 'entity_name': 'nitric-oxide', 'text': 'T9'}, {'abstract_id': '10200320', 'id': 'T10', 'entity_type': 'CHEMICAL', 'charOffset': 766, 'len': 29, 'entity_name': 'Cyclopentenone prostaglandins', 'text': 'T10'}, {'abstract_id': '10200320', 'id': 'T11', 'entity_type': 'CHEMICAL', 'charOffset': 884, 'len': 24, 'entity_name': 'prostaglandins E2 and D2', 'text': 'T11'}, {'abstract_id': '10200320', 'id': 'T12', 'entity_type': 'CHEMICAL', 'charOffset': 910, 'len': 36, 'entity_name': '15-Deoxy-Delta12,14-prostaglandin J2', 'text': 'T12'}, {'abstract_id': '10200320', 'id': 'T13', 'entity_type': 'CHEMICAL', 'charOffset': 948, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T13'}, {'abstract_id': '10200320', 'id': 'T14', 'entity_type': 'CHEMICAL', 'charOffset': 978, 'len': 13, 'entity_name': 'prostaglandin', 'text': 'T14'}, {'abstract_id': '10200320', 'id': 'T15', 'entity_type': 'CHEMICAL', 'charOffset': 1036, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T15'}, {'abstract_id': '10200320', 'id': 'T16', 'entity_type': 'CHEMICAL', 'charOffset': 1125, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T16'}, {'abstract_id': '10200320', 'id': 'T17', 'entity_type': 'CHEMICAL', 'charOffset': 0, 'len': 29, 'entity_name': 'Cyclopentenone prostaglandins', 'text': 'T17'}, {'abstract_id': '10200320', 'id': 'T18', 'entity_type': 'CHEMICAL', 'charOffset': 118, 'len': 36, 'entity_name': '15-deoxy-Delta12,14-prostaglandin J2', 'text': 'T18'}, {'abstract_id': '10200320', 'id': 'T19', 'entity_type': 'CHEMICAL', 'charOffset': 93, 'len': 12, 'entity_name': 'nitric-oxide', 'text': 'T19'}, {'abstract_id': '10200320', 'id': 'T20', 'entity_type': 'GENE-Y', 'charOffset': 1182, 'len': 48, 'entity_name': 'peroxisome proliferator-activated receptor gamma', 'text': 'T20'}, {'abstract_id': '10200320', 'id': 'T21', 'entity_type': 'GENE-Y', 'charOffset': 1232, 'len': 9, 'entity_name': 'PPARgamma', 'text': 'T21'}, {'abstract_id': '10200320', 'id': 'T22', 'entity_type': 'GENE-Y', 'charOffset': 1286, 'len': 9, 'entity_name': 'PPARgamma', 'text': 'T22'}, {'abstract_id': '10200320', 'id': 'T23', 'entity_type': 'GENE-Y', 'charOffset': 1319, 'len': 4, 'entity_name': 'iNOS', 'text': 'T23'}, {'abstract_id': '10200320', 'id': 'T24', 'entity_type': 'GENE-N', 'charOffset': 1407, 'len': 4, 'entity_name': 'PPAR', 'text': 'T24'}, {'abstract_id': '10200320', 'id': 'T25', 'entity_type': 'GENE-Y', 'charOffset': 1463, 'len': 9, 'entity_name': 'PPARgamma', 'text': 'T25'}, {'abstract_id': '10200320', 'id': 'T26', 'entity_type': 'GENE-N', 'charOffset': 1571, 'len': 8, 'entity_name': 'NFkappaB', 'text': 'T26'}, {'abstract_id': '10200320', 'id': 'T27', 'entity_type': 'GENE-N', 'charOffset': 1619, 'len': 8, 'entity_name': 'NFkappaB', 'text': 'T27'}, {'abstract_id': '10200320', 'id': 'T28', 'entity_type': 'GENE-Y', 'charOffset': 1707, 'len': 4, 'entity_name': 'iNOS', 'text': 'T28'}, {'abstract_id': '10200320', 'id': 'T29', 'entity_type': 'GENE-N', 'charOffset': 1754, 'len': 8, 'entity_name': 'NFkappaB', 'text': 'T29'}, {'abstract_id': '10200320', 'id': 'T30', 'entity_type': 'GENE-Y', 'charOffset': 591, 'len': 31, 'entity_name': 'inducible nitric-oxide synthase', 'text': 'T30'}, {'abstract_id': '10200320', 'id': 'T31', 'entity_type': 'GENE-Y', 'charOffset': 624, 'len': 4, 'entity_name': 'iNOS', 'text': 'T31'}, {'abstract_id': '10200320', 'id': 'T32', 'entity_type': 'GENE-Y', 'charOffset': 730, 'len': 8, 'entity_name': 'IL-1beta', 'text': 'T32'}, {'abstract_id': '10200320', 'id': 'T33', 'entity_type': 'GENE-Y', 'charOffset': 822, 'len': 4, 'entity_name': 'iNOS', 'text': 'T33'}, {'abstract_id': '10200320', 'id': 'T34', 'entity_type': 'GENE-N', 'charOffset': 1056, 'len': 13, 'entity_name': 'iNOS promoter', 'text': 'T34'}, {'abstract_id': '10200320', 'id': 'T35', 'entity_type': 'GENE-Y', 'charOffset': 1080, 'len': 4, 'entity_name': 'iNOS', 'text': 'T35'}, {'abstract_id': '10200320', 'id': 'T36', 'entity_type': 'GENE-Y', 'charOffset': 83, 'len': 31, 'entity_name': 'inducible nitric-oxide synthase', 'text': 'T36'}]   \n",
       "23  [{'abstract_id': '10200320', 'id': 'T1', 'entity_type': 'CHEMICAL', 'charOffset': 1251, 'len': 12, 'entity_name': 'troglitazone', 'text': 'T1'}, {'abstract_id': '10200320', 'id': 'T2', 'entity_type': 'CHEMICAL', 'charOffset': 1347, 'len': 12, 'entity_name': 'troglitazone', 'text': 'T2'}, {'abstract_id': '10200320', 'id': 'T3', 'entity_type': 'CHEMICAL', 'charOffset': 1364, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T3'}, {'abstract_id': '10200320', 'id': 'T4', 'entity_type': 'CHEMICAL', 'charOffset': 1474, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T4'}, {'abstract_id': '10200320', 'id': 'T5', 'entity_type': 'CHEMICAL', 'charOffset': 1715, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T5'}, {'abstract_id': '10200320', 'id': 'T6', 'entity_type': 'CHEMICAL', 'charOffset': 1872, 'len': 29, 'entity_name': 'cyclopentenone prostaglandins', 'text': 'T6'}, {'abstract_id': '10200320', 'id': 'T7', 'entity_type': 'CHEMICAL', 'charOffset': 340, 'len': 14, 'entity_name': 'Prostaglandins', 'text': 'T7'}, {'abstract_id': '10200320', 'id': 'T8', 'entity_type': 'CHEMICAL', 'charOffset': 476, 'len': 29, 'entity_name': 'cyclopentenone prostaglandins', 'text': 'T8'}, {'abstract_id': '10200320', 'id': 'T9', 'entity_type': 'CHEMICAL', 'charOffset': 601, 'len': 12, 'entity_name': 'nitric-oxide', 'text': 'T9'}, {'abstract_id': '10200320', 'id': 'T10', 'entity_type': 'CHEMICAL', 'charOffset': 766, 'len': 29, 'entity_name': 'Cyclopentenone prostaglandins', 'text': 'T10'}, {'abstract_id': '10200320', 'id': 'T11', 'entity_type': 'CHEMICAL', 'charOffset': 884, 'len': 24, 'entity_name': 'prostaglandins E2 and D2', 'text': 'T11'}, {'abstract_id': '10200320', 'id': 'T12', 'entity_type': 'CHEMICAL', 'charOffset': 910, 'len': 36, 'entity_name': '15-Deoxy-Delta12,14-prostaglandin J2', 'text': 'T12'}, {'abstract_id': '10200320', 'id': 'T13', 'entity_type': 'CHEMICAL', 'charOffset': 948, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T13'}, {'abstract_id': '10200320', 'id': 'T14', 'entity_type': 'CHEMICAL', 'charOffset': 978, 'len': 13, 'entity_name': 'prostaglandin', 'text': 'T14'}, {'abstract_id': '10200320', 'id': 'T15', 'entity_type': 'CHEMICAL', 'charOffset': 1036, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T15'}, {'abstract_id': '10200320', 'id': 'T16', 'entity_type': 'CHEMICAL', 'charOffset': 1125, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T16'}, {'abstract_id': '10200320', 'id': 'T17', 'entity_type': 'CHEMICAL', 'charOffset': 0, 'len': 29, 'entity_name': 'Cyclopentenone prostaglandins', 'text': 'T17'}, {'abstract_id': '10200320', 'id': 'T18', 'entity_type': 'CHEMICAL', 'charOffset': 118, 'len': 36, 'entity_name': '15-deoxy-Delta12,14-prostaglandin J2', 'text': 'T18'}, {'abstract_id': '10200320', 'id': 'T19', 'entity_type': 'CHEMICAL', 'charOffset': 93, 'len': 12, 'entity_name': 'nitric-oxide', 'text': 'T19'}, {'abstract_id': '10200320', 'id': 'T20', 'entity_type': 'GENE-Y', 'charOffset': 1182, 'len': 48, 'entity_name': 'peroxisome proliferator-activated receptor gamma', 'text': 'T20'}, {'abstract_id': '10200320', 'id': 'T21', 'entity_type': 'GENE-Y', 'charOffset': 1232, 'len': 9, 'entity_name': 'PPARgamma', 'text': 'T21'}, {'abstract_id': '10200320', 'id': 'T22', 'entity_type': 'GENE-Y', 'charOffset': 1286, 'len': 9, 'entity_name': 'PPARgamma', 'text': 'T22'}, {'abstract_id': '10200320', 'id': 'T23', 'entity_type': 'GENE-Y', 'charOffset': 1319, 'len': 4, 'entity_name': 'iNOS', 'text': 'T23'}, {'abstract_id': '10200320', 'id': 'T24', 'entity_type': 'GENE-N', 'charOffset': 1407, 'len': 4, 'entity_name': 'PPAR', 'text': 'T24'}, {'abstract_id': '10200320', 'id': 'T25', 'entity_type': 'GENE-Y', 'charOffset': 1463, 'len': 9, 'entity_name': 'PPARgamma', 'text': 'T25'}, {'abstract_id': '10200320', 'id': 'T26', 'entity_type': 'GENE-N', 'charOffset': 1571, 'len': 8, 'entity_name': 'NFkappaB', 'text': 'T26'}, {'abstract_id': '10200320', 'id': 'T27', 'entity_type': 'GENE-N', 'charOffset': 1619, 'len': 8, 'entity_name': 'NFkappaB', 'text': 'T27'}, {'abstract_id': '10200320', 'id': 'T28', 'entity_type': 'GENE-Y', 'charOffset': 1707, 'len': 4, 'entity_name': 'iNOS', 'text': 'T28'}, {'abstract_id': '10200320', 'id': 'T29', 'entity_type': 'GENE-N', 'charOffset': 1754, 'len': 8, 'entity_name': 'NFkappaB', 'text': 'T29'}, {'abstract_id': '10200320', 'id': 'T30', 'entity_type': 'GENE-Y', 'charOffset': 591, 'len': 31, 'entity_name': 'inducible nitric-oxide synthase', 'text': 'T30'}, {'abstract_id': '10200320', 'id': 'T31', 'entity_type': 'GENE-Y', 'charOffset': 624, 'len': 4, 'entity_name': 'iNOS', 'text': 'T31'}, {'abstract_id': '10200320', 'id': 'T32', 'entity_type': 'GENE-Y', 'charOffset': 730, 'len': 8, 'entity_name': 'IL-1beta', 'text': 'T32'}, {'abstract_id': '10200320', 'id': 'T33', 'entity_type': 'GENE-Y', 'charOffset': 822, 'len': 4, 'entity_name': 'iNOS', 'text': 'T33'}, {'abstract_id': '10200320', 'id': 'T34', 'entity_type': 'GENE-N', 'charOffset': 1056, 'len': 13, 'entity_name': 'iNOS promoter', 'text': 'T34'}, {'abstract_id': '10200320', 'id': 'T35', 'entity_type': 'GENE-Y', 'charOffset': 1080, 'len': 4, 'entity_name': 'iNOS', 'text': 'T35'}, {'abstract_id': '10200320', 'id': 'T36', 'entity_type': 'GENE-Y', 'charOffset': 83, 'len': 31, 'entity_name': 'inducible nitric-oxide synthase', 'text': 'T36'}]   \n",
       "24  [{'abstract_id': '10200320', 'id': 'T1', 'entity_type': 'CHEMICAL', 'charOffset': 1251, 'len': 12, 'entity_name': 'troglitazone', 'text': 'T1'}, {'abstract_id': '10200320', 'id': 'T2', 'entity_type': 'CHEMICAL', 'charOffset': 1347, 'len': 12, 'entity_name': 'troglitazone', 'text': 'T2'}, {'abstract_id': '10200320', 'id': 'T3', 'entity_type': 'CHEMICAL', 'charOffset': 1364, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T3'}, {'abstract_id': '10200320', 'id': 'T4', 'entity_type': 'CHEMICAL', 'charOffset': 1474, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T4'}, {'abstract_id': '10200320', 'id': 'T5', 'entity_type': 'CHEMICAL', 'charOffset': 1715, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T5'}, {'abstract_id': '10200320', 'id': 'T6', 'entity_type': 'CHEMICAL', 'charOffset': 1872, 'len': 29, 'entity_name': 'cyclopentenone prostaglandins', 'text': 'T6'}, {'abstract_id': '10200320', 'id': 'T7', 'entity_type': 'CHEMICAL', 'charOffset': 340, 'len': 14, 'entity_name': 'Prostaglandins', 'text': 'T7'}, {'abstract_id': '10200320', 'id': 'T8', 'entity_type': 'CHEMICAL', 'charOffset': 476, 'len': 29, 'entity_name': 'cyclopentenone prostaglandins', 'text': 'T8'}, {'abstract_id': '10200320', 'id': 'T9', 'entity_type': 'CHEMICAL', 'charOffset': 601, 'len': 12, 'entity_name': 'nitric-oxide', 'text': 'T9'}, {'abstract_id': '10200320', 'id': 'T10', 'entity_type': 'CHEMICAL', 'charOffset': 766, 'len': 29, 'entity_name': 'Cyclopentenone prostaglandins', 'text': 'T10'}, {'abstract_id': '10200320', 'id': 'T11', 'entity_type': 'CHEMICAL', 'charOffset': 884, 'len': 24, 'entity_name': 'prostaglandins E2 and D2', 'text': 'T11'}, {'abstract_id': '10200320', 'id': 'T12', 'entity_type': 'CHEMICAL', 'charOffset': 910, 'len': 36, 'entity_name': '15-Deoxy-Delta12,14-prostaglandin J2', 'text': 'T12'}, {'abstract_id': '10200320', 'id': 'T13', 'entity_type': 'CHEMICAL', 'charOffset': 948, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T13'}, {'abstract_id': '10200320', 'id': 'T14', 'entity_type': 'CHEMICAL', 'charOffset': 978, 'len': 13, 'entity_name': 'prostaglandin', 'text': 'T14'}, {'abstract_id': '10200320', 'id': 'T15', 'entity_type': 'CHEMICAL', 'charOffset': 1036, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T15'}, {'abstract_id': '10200320', 'id': 'T16', 'entity_type': 'CHEMICAL', 'charOffset': 1125, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T16'}, {'abstract_id': '10200320', 'id': 'T17', 'entity_type': 'CHEMICAL', 'charOffset': 0, 'len': 29, 'entity_name': 'Cyclopentenone prostaglandins', 'text': 'T17'}, {'abstract_id': '10200320', 'id': 'T18', 'entity_type': 'CHEMICAL', 'charOffset': 118, 'len': 36, 'entity_name': '15-deoxy-Delta12,14-prostaglandin J2', 'text': 'T18'}, {'abstract_id': '10200320', 'id': 'T19', 'entity_type': 'CHEMICAL', 'charOffset': 93, 'len': 12, 'entity_name': 'nitric-oxide', 'text': 'T19'}, {'abstract_id': '10200320', 'id': 'T20', 'entity_type': 'GENE-Y', 'charOffset': 1182, 'len': 48, 'entity_name': 'peroxisome proliferator-activated receptor gamma', 'text': 'T20'}, {'abstract_id': '10200320', 'id': 'T21', 'entity_type': 'GENE-Y', 'charOffset': 1232, 'len': 9, 'entity_name': 'PPARgamma', 'text': 'T21'}, {'abstract_id': '10200320', 'id': 'T22', 'entity_type': 'GENE-Y', 'charOffset': 1286, 'len': 9, 'entity_name': 'PPARgamma', 'text': 'T22'}, {'abstract_id': '10200320', 'id': 'T23', 'entity_type': 'GENE-Y', 'charOffset': 1319, 'len': 4, 'entity_name': 'iNOS', 'text': 'T23'}, {'abstract_id': '10200320', 'id': 'T24', 'entity_type': 'GENE-N', 'charOffset': 1407, 'len': 4, 'entity_name': 'PPAR', 'text': 'T24'}, {'abstract_id': '10200320', 'id': 'T25', 'entity_type': 'GENE-Y', 'charOffset': 1463, 'len': 9, 'entity_name': 'PPARgamma', 'text': 'T25'}, {'abstract_id': '10200320', 'id': 'T26', 'entity_type': 'GENE-N', 'charOffset': 1571, 'len': 8, 'entity_name': 'NFkappaB', 'text': 'T26'}, {'abstract_id': '10200320', 'id': 'T27', 'entity_type': 'GENE-N', 'charOffset': 1619, 'len': 8, 'entity_name': 'NFkappaB', 'text': 'T27'}, {'abstract_id': '10200320', 'id': 'T28', 'entity_type': 'GENE-Y', 'charOffset': 1707, 'len': 4, 'entity_name': 'iNOS', 'text': 'T28'}, {'abstract_id': '10200320', 'id': 'T29', 'entity_type': 'GENE-N', 'charOffset': 1754, 'len': 8, 'entity_name': 'NFkappaB', 'text': 'T29'}, {'abstract_id': '10200320', 'id': 'T30', 'entity_type': 'GENE-Y', 'charOffset': 591, 'len': 31, 'entity_name': 'inducible nitric-oxide synthase', 'text': 'T30'}, {'abstract_id': '10200320', 'id': 'T31', 'entity_type': 'GENE-Y', 'charOffset': 624, 'len': 4, 'entity_name': 'iNOS', 'text': 'T31'}, {'abstract_id': '10200320', 'id': 'T32', 'entity_type': 'GENE-Y', 'charOffset': 730, 'len': 8, 'entity_name': 'IL-1beta', 'text': 'T32'}, {'abstract_id': '10200320', 'id': 'T33', 'entity_type': 'GENE-Y', 'charOffset': 822, 'len': 4, 'entity_name': 'iNOS', 'text': 'T33'}, {'abstract_id': '10200320', 'id': 'T34', 'entity_type': 'GENE-N', 'charOffset': 1056, 'len': 13, 'entity_name': 'iNOS promoter', 'text': 'T34'}, {'abstract_id': '10200320', 'id': 'T35', 'entity_type': 'GENE-Y', 'charOffset': 1080, 'len': 4, 'entity_name': 'iNOS', 'text': 'T35'}, {'abstract_id': '10200320', 'id': 'T36', 'entity_type': 'GENE-Y', 'charOffset': 83, 'len': 31, 'entity_name': 'inducible nitric-oxide synthase', 'text': 'T36'}]   \n",
       "25  [{'abstract_id': '10200320', 'id': 'T1', 'entity_type': 'CHEMICAL', 'charOffset': 1251, 'len': 12, 'entity_name': 'troglitazone', 'text': 'T1'}, {'abstract_id': '10200320', 'id': 'T2', 'entity_type': 'CHEMICAL', 'charOffset': 1347, 'len': 12, 'entity_name': 'troglitazone', 'text': 'T2'}, {'abstract_id': '10200320', 'id': 'T3', 'entity_type': 'CHEMICAL', 'charOffset': 1364, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T3'}, {'abstract_id': '10200320', 'id': 'T4', 'entity_type': 'CHEMICAL', 'charOffset': 1474, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T4'}, {'abstract_id': '10200320', 'id': 'T5', 'entity_type': 'CHEMICAL', 'charOffset': 1715, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T5'}, {'abstract_id': '10200320', 'id': 'T6', 'entity_type': 'CHEMICAL', 'charOffset': 1872, 'len': 29, 'entity_name': 'cyclopentenone prostaglandins', 'text': 'T6'}, {'abstract_id': '10200320', 'id': 'T7', 'entity_type': 'CHEMICAL', 'charOffset': 340, 'len': 14, 'entity_name': 'Prostaglandins', 'text': 'T7'}, {'abstract_id': '10200320', 'id': 'T8', 'entity_type': 'CHEMICAL', 'charOffset': 476, 'len': 29, 'entity_name': 'cyclopentenone prostaglandins', 'text': 'T8'}, {'abstract_id': '10200320', 'id': 'T9', 'entity_type': 'CHEMICAL', 'charOffset': 601, 'len': 12, 'entity_name': 'nitric-oxide', 'text': 'T9'}, {'abstract_id': '10200320', 'id': 'T10', 'entity_type': 'CHEMICAL', 'charOffset': 766, 'len': 29, 'entity_name': 'Cyclopentenone prostaglandins', 'text': 'T10'}, {'abstract_id': '10200320', 'id': 'T11', 'entity_type': 'CHEMICAL', 'charOffset': 884, 'len': 24, 'entity_name': 'prostaglandins E2 and D2', 'text': 'T11'}, {'abstract_id': '10200320', 'id': 'T12', 'entity_type': 'CHEMICAL', 'charOffset': 910, 'len': 36, 'entity_name': '15-Deoxy-Delta12,14-prostaglandin J2', 'text': 'T12'}, {'abstract_id': '10200320', 'id': 'T13', 'entity_type': 'CHEMICAL', 'charOffset': 948, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T13'}, {'abstract_id': '10200320', 'id': 'T14', 'entity_type': 'CHEMICAL', 'charOffset': 978, 'len': 13, 'entity_name': 'prostaglandin', 'text': 'T14'}, {'abstract_id': '10200320', 'id': 'T15', 'entity_type': 'CHEMICAL', 'charOffset': 1036, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T15'}, {'abstract_id': '10200320', 'id': 'T16', 'entity_type': 'CHEMICAL', 'charOffset': 1125, 'len': 8, 'entity_name': '15d-PGJ2', 'text': 'T16'}, {'abstract_id': '10200320', 'id': 'T17', 'entity_type': 'CHEMICAL', 'charOffset': 0, 'len': 29, 'entity_name': 'Cyclopentenone prostaglandins', 'text': 'T17'}, {'abstract_id': '10200320', 'id': 'T18', 'entity_type': 'CHEMICAL', 'charOffset': 118, 'len': 36, 'entity_name': '15-deoxy-Delta12,14-prostaglandin J2', 'text': 'T18'}, {'abstract_id': '10200320', 'id': 'T19', 'entity_type': 'CHEMICAL', 'charOffset': 93, 'len': 12, 'entity_name': 'nitric-oxide', 'text': 'T19'}, {'abstract_id': '10200320', 'id': 'T20', 'entity_type': 'GENE-Y', 'charOffset': 1182, 'len': 48, 'entity_name': 'peroxisome proliferator-activated receptor gamma', 'text': 'T20'}, {'abstract_id': '10200320', 'id': 'T21', 'entity_type': 'GENE-Y', 'charOffset': 1232, 'len': 9, 'entity_name': 'PPARgamma', 'text': 'T21'}, {'abstract_id': '10200320', 'id': 'T22', 'entity_type': 'GENE-Y', 'charOffset': 1286, 'len': 9, 'entity_name': 'PPARgamma', 'text': 'T22'}, {'abstract_id': '10200320', 'id': 'T23', 'entity_type': 'GENE-Y', 'charOffset': 1319, 'len': 4, 'entity_name': 'iNOS', 'text': 'T23'}, {'abstract_id': '10200320', 'id': 'T24', 'entity_type': 'GENE-N', 'charOffset': 1407, 'len': 4, 'entity_name': 'PPAR', 'text': 'T24'}, {'abstract_id': '10200320', 'id': 'T25', 'entity_type': 'GENE-Y', 'charOffset': 1463, 'len': 9, 'entity_name': 'PPARgamma', 'text': 'T25'}, {'abstract_id': '10200320', 'id': 'T26', 'entity_type': 'GENE-N', 'charOffset': 1571, 'len': 8, 'entity_name': 'NFkappaB', 'text': 'T26'}, {'abstract_id': '10200320', 'id': 'T27', 'entity_type': 'GENE-N', 'charOffset': 1619, 'len': 8, 'entity_name': 'NFkappaB', 'text': 'T27'}, {'abstract_id': '10200320', 'id': 'T28', 'entity_type': 'GENE-Y', 'charOffset': 1707, 'len': 4, 'entity_name': 'iNOS', 'text': 'T28'}, {'abstract_id': '10200320', 'id': 'T29', 'entity_type': 'GENE-N', 'charOffset': 1754, 'len': 8, 'entity_name': 'NFkappaB', 'text': 'T29'}, {'abstract_id': '10200320', 'id': 'T30', 'entity_type': 'GENE-Y', 'charOffset': 591, 'len': 31, 'entity_name': 'inducible nitric-oxide synthase', 'text': 'T30'}, {'abstract_id': '10200320', 'id': 'T31', 'entity_type': 'GENE-Y', 'charOffset': 624, 'len': 4, 'entity_name': 'iNOS', 'text': 'T31'}, {'abstract_id': '10200320', 'id': 'T32', 'entity_type': 'GENE-Y', 'charOffset': 730, 'len': 8, 'entity_name': 'IL-1beta', 'text': 'T32'}, {'abstract_id': '10200320', 'id': 'T33', 'entity_type': 'GENE-Y', 'charOffset': 822, 'len': 4, 'entity_name': 'iNOS', 'text': 'T33'}, {'abstract_id': '10200320', 'id': 'T34', 'entity_type': 'GENE-N', 'charOffset': 1056, 'len': 13, 'entity_name': 'iNOS promoter', 'text': 'T34'}, {'abstract_id': '10200320', 'id': 'T35', 'entity_type': 'GENE-Y', 'charOffset': 1080, 'len': 4, 'entity_name': 'iNOS', 'text': 'T35'}, {'abstract_id': '10200320', 'id': 'T36', 'entity_type': 'GENE-Y', 'charOffset': 83, 'len': 31, 'entity_name': 'inducible nitric-oxide synthase', 'text': 'T36'}]   \n",
       "\n",
       "   prediction  confidence is_eval   relationship_type relationship_group  \\\n",
       "19   NEGATIVE    0.990430       N  INDIRECT-REGULATOR              CPR:2   \n",
       "22   NEGATIVE    0.994522       N                 NOT             CPR:10   \n",
       "23   NEGATIVE    0.994391       N                 NOT             CPR:10   \n",
       "24   NEGATIVE    0.989973       N                 NOT             CPR:10   \n",
       "25   NEGATIVE    0.991110       N                 NOT             CPR:10   \n",
       "\n",
       "   participant1_id participant2_id  gold  gold_raw  \\\n",
       "19              T5              T9     0  NEGATIVE   \n",
       "22             T16             T20     0  NEGATIVE   \n",
       "23             T16             T21     0  NEGATIVE   \n",
       "24              T1             T23     0  NEGATIVE   \n",
       "25              T2             T24     0  NEGATIVE   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                     unique_chemprot_names  \\\n",
       "19                                                                                                                                                                                                                                                                                 [Orlistat, cholesterol, glucose, insulin, lipase, low-density lipoprotein, orlistat, pancreatic lipase]   \n",
       "22  [15-Deoxy-Delta12,14-prostaglandin J2, 15-deoxy-Delta12,14-prostaglandin J2, 15d-PGJ2, Cyclopentenone prostaglandins, IL-1beta, NFkappaB, PPAR, PPARgamma, Prostaglandins, cyclopentenone prostaglandins, iNOS, iNOS promoter, inducible nitric-oxide synthase, nitric-oxide, peroxisome proliferator-activated receptor gamma, prostaglandin, prostaglandins E2 and D2, troglitazone]   \n",
       "23  [15-Deoxy-Delta12,14-prostaglandin J2, 15-deoxy-Delta12,14-prostaglandin J2, 15d-PGJ2, Cyclopentenone prostaglandins, IL-1beta, NFkappaB, PPAR, PPARgamma, Prostaglandins, cyclopentenone prostaglandins, iNOS, iNOS promoter, inducible nitric-oxide synthase, nitric-oxide, peroxisome proliferator-activated receptor gamma, prostaglandin, prostaglandins E2 and D2, troglitazone]   \n",
       "24  [15-Deoxy-Delta12,14-prostaglandin J2, 15-deoxy-Delta12,14-prostaglandin J2, 15d-PGJ2, Cyclopentenone prostaglandins, IL-1beta, NFkappaB, PPAR, PPARgamma, Prostaglandins, cyclopentenone prostaglandins, iNOS, iNOS promoter, inducible nitric-oxide synthase, nitric-oxide, peroxisome proliferator-activated receptor gamma, prostaglandin, prostaglandins E2 and D2, troglitazone]   \n",
       "25  [15-Deoxy-Delta12,14-prostaglandin J2, 15-deoxy-Delta12,14-prostaglandin J2, 15d-PGJ2, Cyclopentenone prostaglandins, IL-1beta, NFkappaB, PPAR, PPARgamma, Prostaglandins, cyclopentenone prostaglandins, iNOS, iNOS promoter, inducible nitric-oxide synthase, nitric-oxide, peroxisome proliferator-activated receptor gamma, prostaglandin, prostaglandins E2 and D2, troglitazone]   \n",
       "\n",
       "                                                                        x_span  \\\n",
       "19    _CHEMICAL_ also favourably affects blood pressure and CHEMIG2 and _GENE_   \n",
       "22           _CHEMICAL_ does not appear to involve its nuclear receptor _GENE_   \n",
       "23  _CHEMICAL_ does not appear to involve its nuclear receptor GENEIG3 (_GENE_   \n",
       "24      _CHEMICAL_, a specific ligand of GENEIG7, was unable to inhibit _GENE_   \n",
       "25             _CHEMICAL_ nor CHEMIG4 could stimulate the activity of a _GENE_   \n",
       "\n",
       "    x_span_word_len  \n",
       "19               10  \n",
       "22               10  \n",
       "23               11  \n",
       "24               11  \n",
       "25               10  "
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_train.query(\"gold_raw == 'NEGATIVE'\").head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<AxesSubplot:ylabel='Frequency'>"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "df_train[\"x_span_word_len\"].plot.hist(bins=100, cumulative=True, density=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>count</th>\n",
       "      <th>mean</th>\n",
       "      <th>std</th>\n",
       "      <th>min</th>\n",
       "      <th>25%</th>\n",
       "      <th>50%</th>\n",
       "      <th>75%</th>\n",
       "      <th>90%</th>\n",
       "      <th>max</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gold_raw</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>CPR:3</th>\n",
       "      <td>777.0</td>\n",
       "      <td>10.584299</td>\n",
       "      <td>7.530242</td>\n",
       "      <td>1.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>9.0</td>\n",
       "      <td>14.0</td>\n",
       "      <td>20.0</td>\n",
       "      <td>45.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>CPR:4</th>\n",
       "      <td>2260.0</td>\n",
       "      <td>9.400442</td>\n",
       "      <td>7.070147</td>\n",
       "      <td>1.0</td>\n",
       "      <td>4.0</td>\n",
       "      <td>8.0</td>\n",
       "      <td>13.0</td>\n",
       "      <td>19.0</td>\n",
       "      <td>43.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>CPR:5</th>\n",
       "      <td>173.0</td>\n",
       "      <td>8.317919</td>\n",
       "      <td>7.442616</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>6.0</td>\n",
       "      <td>11.0</td>\n",
       "      <td>20.8</td>\n",
       "      <td>37.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>CPR:6</th>\n",
       "      <td>235.0</td>\n",
       "      <td>6.442553</td>\n",
       "      <td>7.202793</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.5</td>\n",
       "      <td>4.0</td>\n",
       "      <td>7.5</td>\n",
       "      <td>17.0</td>\n",
       "      <td>36.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>CPR:9</th>\n",
       "      <td>727.0</td>\n",
       "      <td>7.969739</td>\n",
       "      <td>6.667149</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>7.0</td>\n",
       "      <td>11.0</td>\n",
       "      <td>18.0</td>\n",
       "      <td>31.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NEGATIVE</th>\n",
       "      <td>2265.0</td>\n",
       "      <td>9.568653</td>\n",
       "      <td>7.429337</td>\n",
       "      <td>1.0</td>\n",
       "      <td>4.0</td>\n",
       "      <td>8.0</td>\n",
       "      <td>13.0</td>\n",
       "      <td>19.6</td>\n",
       "      <td>47.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "           count       mean       std  min  25%  50%   75%   90%   max\n",
       "gold_raw                                                              \n",
       "CPR:3      777.0  10.584299  7.530242  1.0  5.0  9.0  14.0  20.0  45.0\n",
       "CPR:4     2260.0   9.400442  7.070147  1.0  4.0  8.0  13.0  19.0  43.0\n",
       "CPR:5      173.0   8.317919  7.442616  1.0  3.0  6.0  11.0  20.8  37.0\n",
       "CPR:6      235.0   6.442553  7.202793  1.0  2.5  4.0   7.5  17.0  36.0\n",
       "CPR:9      727.0   7.969739  6.667149  1.0  2.0  7.0  11.0  18.0  31.0\n",
       "NEGATIVE  2265.0   9.568653  7.429337  1.0  4.0  8.0  13.0  19.6  47.0"
      ]
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_train.groupby(\"gold_raw\")[\"x_span_word_len\"].describe(percentiles=[.25,.5,.75,.90])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<AxesSubplot:ylabel='Frequency'>"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAYUAAAD4CAYAAAAD6PrjAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjUuMCwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy8/fFQqAAAACXBIWXMAAAsTAAALEwEAmpwYAAAVCUlEQVR4nO3da7Bd5X3f8e/PXMwlscXlVKUSinCtscM0BmOZ4CFNHahbLg6iLca4ttEwapS2SmuXdGLF0ylJp+7gmdTY9EKqGifC9Q1jO6gxkxYLkrQvAEuYcI0HmYCRLJCMudgmhuL8+2I9WmyLI2lLsPY5Ouf7mdmzn/WsZ+3zZw06v7OetfZaqSokSQJ41UwXIEmaPQwFSVLPUJAk9QwFSVLPUJAk9Q6d6QJejuOPP76WLl0602VI0kFl8+bN362qqenWHdShsHTpUjZt2jTTZUjSQSXJI3ta5/SRJKlnKEiSeoaCJKlnKEiSeoaCJKlnKEiSeoaCJKlnKEiSeoaCJKl3UH+j+eVYuvarffvhK8+fwUokafbwSEGS1DMUJEk9Q0GS1DMUJEk9Q0GS1Bs0FJL8qyT3Jbk3yeeSHJHkpCS3J9mS5AtJDm9jX92Wt7T1S4esTZL0UoOFQpJFwL8EllfV3wIOAS4BPgpcVVWvB54EVrVNVgFPtv6r2jhJ0gQNPX10KHBkkkOBo4DtwFnADW39euDC1l7Rlmnrz06SgeuTJI0YLBSqahvwO8C36cLgaWAz8FRVvdCGbQUWtfYi4NG27Qtt/HG7f26S1Uk2Jdm0c+fOocqXpHlpyOmjY+j++j8J+BvA0cA5L/dzq2pdVS2vquVTU9M+d1qSdICGnD76u8BfVNXOqvp/wJeBM4EFbToJYDGwrbW3AScCtPWvBZ4YsD5J0m6GDIVvA2ckOaqdGzgbuB+4FbiojVkJ3NjaG9oybf0tVVUD1idJ2s2Q5xRupzthfCdwT/tZ64APAZcn2UJ3zuDatsm1wHGt/3Jg7VC1SZKmN+hdUqvqCuCK3bofAk6fZuyPgHcNWY8kae/8RrMkqWcoSJJ6hoIkqWcoSJJ6hoIkqWcoSJJ6hoIkqWcoSJJ6hoIkqWcoSJJ6hoIkqWcoSJJ6hoIkqWcoSJJ6hoIkqWcoSJJ6g4VCkjckuWvk9UySDyY5NsnNSR5s78e08UlydZItSe5OctpQtUmSpjfk4zi/WVWnVtWpwFuAZ4Gv0D1mc2NVLQM28uJjN88FlrXXauCaoWqTJE1vUtNHZwPfqqpHgBXA+ta/HriwtVcA11XnNmBBkhMmVJ8kicmFwiXA51p7YVVtb+3HgIWtvQh4dGSbra3vJyRZnWRTkk07d+4cql5JmpcGD4UkhwMXAF/cfV1VFVD783lVta6qllfV8qmpqVeoSkkSTOZI4Vzgzqp6vC0/vmtaqL3vaP3bgBNHtlvc+iRJEzKJUHgPL04dAWwAVrb2SuDGkf5L21VIZwBPj0wzSZIm4NAhPzzJ0cA7gF8d6b4SuD7JKuAR4OLWfxNwHrCF7kqly4asTZL0UoOGQlX9EDhut74n6K5G2n1sAWuGrEeStHd+o1mS1DMUJEk9Q0GS1DMUJEk9Q0GS1DMUJEk9Q0GS1DMUJEk9Q0GS1DMUJEk9Q0GS1DMUJEk9Q0GS1DMUJEk9Q0GS1DMUJEm9QUMhyYIkNyT58yQPJHlbkmOT3JzkwfZ+TBubJFcn2ZLk7iSnDVmbJOmlhj5S+ATwR1X1RuAU4AFgLbCxqpYBG9sywLnAsvZaDVwzcG2SpN0MFgpJXgv8InAtQFU9X1VPASuA9W3YeuDC1l4BXFed24AFSU4Yqj5J0ksNeaRwErAT+L0k30jyySRHAwuransb8xiwsLUXAY+ObL+19f2EJKuTbEqyaefOnQOWL0nzz5ChcChwGnBNVb0Z+CEvThUBUFUF1P58aFWtq6rlVbV8amrqFStWkjRsKGwFtlbV7W35BrqQeHzXtFB739HWbwNOHNl+ceuTJE3IYKFQVY8BjyZ5Q+s6G7gf2ACsbH0rgRtbewNwabsK6Qzg6ZFpJknSBBw68Of/C+AzSQ4HHgIuowui65OsAh4BLm5jbwLOA7YAz7axkqQJGjQUquouYPk0q86eZmwBa4asR5K0d36jWZLUMxQkST1DQZLUMxQkST1DQZLUMxQkST1DQZLUMxQkST1DQZLUMxQkSb2xQiHJzw1diCRp5o17pPBfk9yR5J+3J6pJkuagsUKhqv428F665x1sTvLZJO8YtDJJ0sSNfU6hqh4E/g3wIeDvAFcn+fMk/3Co4iRJkzXuOYU3JbkKeAA4C/jlqvrZ1r5qwPokSRM07pHCfwLuBE6pqjVVdSdAVX2H7uhhWkkeTnJPkruSbGp9xya5OcmD7f2Y1p8kVyfZkuTuJKe9vP80SdL+GjcUzgc+W1V/CZDkVUmOAqiqT+9j21+qqlOratfDdtYCG6tqGbCxLQOcCyxrr9XANeP/Z0iSXgnjhsLXgCNHlo9qfQdiBbC+tdcDF470X1ed24AFSU44wJ8hSToA44bCEVX1g10LrX3UGNsV8L+TbE6yuvUtrKrtrf0YsLC1FwGPjmy7tfX9hCSrk2xKsmnnzp1jli9JGse4ofDD0Tn+JG8B/nKM7X6hqk6jmxpak+QXR1e25zLXuMW2bdZV1fKqWj41NbU/m0qS9uHQMcd9EPhiku8AAf468O59bVRV29r7jiRfAU4HHk9yQlVtb9NDO9rwbXTfg9hlceuTJE3IuF9e+zrwRuCfAf8U+Nmq2ry3bZIcneSnd7WBvwfcC2wAVrZhK4EbW3sDcGm7CukM4OmRaSZJ0gSMe6QA8FZgadvmtCRU1XV7Gb8Q+EqSXT/ns1X1R0m+DlyfZBXwCHBxG38TcB6wBXgWuGx//kMkSS/fWKGQ5NPA3wTuAn7cugvYYyhU1UPAKdP0PwGcPU1/AWvGqUeSNIxxjxSWAye3X9ySpDlq3KuP7qU7uSxJmsPGPVI4Hrg/yR3Ac7s6q+qCQao6yCxd+9W+/fCV589gJZL08owbCr81ZBGSpNlhrFCoqj9J8jPAsqr6Wrvv0SHDliZJmrRxrz76Fbqb1B1LdxXSIuB3meYqorlqdIoInCaSNDeNe6J5DXAm8Az0D9z5a0MVJUmaGeOGwnNV9fyuhSSHsp/3LJIkzX7jhsKfJPkwcGR7NvMXgf85XFmSpJkwbiisBXYC9wC/SndLij0+cU2SdHAa9+qjvwL+e3tJkuaoca8++gumOYdQVa97xSuSJM2Y/bn30S5HAO+iuzxVkjSHjPs8hSdGXtuq6uOAF+pL0hwz7vTRaSOLr6I7ctifZzFIkg4C4/5i/48j7ReAh3nx4TiSpDli3KuPfulAf0CSQ4BNwLaqemeSk4DPA8cBm4H3V9XzSV5N99CetwBPAO+uqocP9OdKkvbfuNNHl+9tfVV9bC+rPwA8ALymLX8UuKqqPp/kd4FVwDXt/cmqen2SS9q4d49T31zk7bglzYT9ufrorcCGtvzLwB3Ag3vbKMliuhPSHwEuT/fA5rOAf9yGrKe7Lfc1wApevEX3DcB/TpK5+LS3l/ML37CQNKRxQ2ExcFpVfR8gyW8BX62q9+1ju48DvwH8dFs+Dniqql5oy1vp7rhKe38UoKpeSPJ0G//d0Q9Msprujq0sWbJkzPJnhr/AJR1sxr3NxULg+ZHl51vfHiV5J7CjqjYfYG3Tqqp1VbW8qpZPTU29kh8tSfPeuEcK1wF3JPlKW76Qbupnb84ELkhyHt0X3l4DfAJYkOTQdrSwGNjWxm8DTgS2truwvpbuhLMkaULG/fLaR4DLgCfb67Kq+g/72OY3q2pxVS0FLgFuqar3ArcCF7VhK4EbW3tDW6atv2Uunk+QpNls3OkjgKOAZ6rqE3R/zZ90gD/zQ3QnnbfQnTO4tvVfCxzX+i+nuzOrJGmCxr0k9Qq6K5DeAPwecBjwP+imiPapqv4Y+OPWfgg4fZoxP6K7p5IkaYaMe6TwD4ALgB8CVNV3ePGKIknSHDFuKDzf5vcLIMnRw5UkSZop44bC9Un+G92VQ78CfA0fuCNJc84+zym0byF/AXgj8AzdeYV/W1U3D1ybJGnC9hkKVVVJbqqqnwMMAkmaw8adProzyVsHrUSSNOPG/UbzzwPvS/Iw3RVIoTuIeNNQhUmSJm+voZBkSVV9G/j7E6pHkjSD9nWk8Ad0d0d9JMmXquofTaAmHYA93ZHVO7VK2h/7OqeQkfbrhixEkjTz9hUKtYe2JGkO2tf00SlJnqE7YjiyteHFE82v2fOmkqSDzV5DoaoOmVQhkqSZtz+3zpYkzXGGgiSpZyhIknqDhUKSI5LckeTPktyX5Ldb/0lJbk+yJckXkhze+l/dlre09UuHqk2SNL0hjxSeA86qqlOAU4FzkpwBfBS4qqpeT/e851Vt/CrgydZ/VRsnSZqgwUKhOj9oi4e1VwFnATe0/vXAha29oi3T1p/dbtstSZqQQc8pJDkkyV3ADrrbbn8LeKqqXmhDtgKLWnsR8ChAW/80cNw0n7k6yaYkm3bu3Dlk+ZI07wwaClX146o6FVgMnE73oJ6X+5nrqmp5VS2fmpp6uR8nSRoxkauPquop4FbgbXSP9Nz1pbnFwLbW3gacCNDWvxZ4YhL1SZI6Q159NJVkQWsfCbwDeIAuHC5qw1YCN7b2hrZMW39LVXm/pYEsXfvV/iVJu4z7kJ0DcQKwPskhdOFzfVX9YZL7gc8n+ffAN4Br2/hrgU8n2QJ8D7hkwNokSdMYLBSq6m7gzdP0P0R3fmH3/h8B7xqqHknSvvmNZklSz1CQJPUMBUlSz1CQJPWGvPpIB6HRS1QfvvL8GaxE0kzwSEGS1DMUJEk9Q0GS1DMUJEk9Q0GS1DMUJEk9Q0GS1PN7CtpvfpdBmrs8UpAk9QwFSVJvyCevnZjk1iT3J7kvyQda/7FJbk7yYHs/pvUnydVJtiS5O8lpQ9UmSZrekEcKLwC/XlUnA2cAa5KcDKwFNlbVMmBjWwY4F1jWXquBawasTZI0jcFCoaq2V9Wdrf19uuczLwJWAOvbsPXAha29AriuOrcBC5KcMFR9kqSXmsjVR0mW0j2a83ZgYVVtb6seAxa29iLg0ZHNtra+7SN9JFlNdyTBkiVLhitaB8Qrk6SD2+AnmpP8FPAl4INV9czouqoqoPbn86pqXVUtr6rlU1NTr2ClkqRBQyHJYXSB8Jmq+nLrfnzXtFB739H6twEnjmy+uPVJkiZkyKuPAlwLPFBVHxtZtQFY2dorgRtH+i9tVyGdATw9Ms0kSZqAIc8pnAm8H7gnyV2t78PAlcD1SVYBjwAXt3U3AecBW4BngcsGrE2SNI3BQqGq/i+QPaw+e5rxBawZqh5J0r75jWZJUs9QkCT1vEuqJsLvL0gHB48UJEk9Q0GS1DMUJEk9Q0GS1DMUJEk9Q0GS1POS1N146eRkub+l2cVQ0KxkWEgzw+kjSVLPUJAk9QwFSVLPUJAk9QwFSVJvyMdxfirJjiT3jvQdm+TmJA+292Naf5JcnWRLkruTnDZUXZKkPRvySOH3gXN261sLbKyqZcDGtgxwLrCsvVYD1wxYlyRpDwYLhar6U+B7u3WvANa39nrgwpH+66pzG7AgyQlD1SZJmt6kv7y2sKq2t/ZjwMLWXgQ8OjJua+vbzm6SrKY7mmDJkiXDVapZyS+1ScOasRPNVVVAHcB266pqeVUtn5qaGqAySZq/Jn2k8HiSE6pqe5se2tH6twEnjoxb3Pqk/ebRhHTgJn2ksAFY2dorgRtH+i9tVyGdATw9Ms0kSZqQwY4UknwOeDtwfJKtwBXAlcD1SVYBjwAXt+E3AecBW4BngcuGqkuStGeDhUJVvWcPq86eZmwBa4aqRdobp5ukF3nrbM0b/vKX9s3bXEiSeoaCJKlnKEiSep5TkPbAcxCajzxSkCT1DAVJUs/pI2k/jTOtNDpm93F72t7pKs0GHilIknqGgiSpZyhIknqeU5BmOc81aJIMBekgZVhoCIaCNMfs79VRBopGeU5BktTzSEFSz+9QaFaFQpJzgE8AhwCfrKorZ7gkSXthiMw9syYUkhwC/BfgHcBW4OtJNlTV/TNbmaTZznB65cyaUABOB7ZU1UMAST4PrAAMBWmO2NvtP/Y0bohf8kOExf7WPFsDK93jkWdekouAc6rqn7Tl9wM/X1W/ttu41cDqtvgG4Jv7+Ojjge++wuUejNwPHfdDx/3Qma/74Weqamq6FbPpSGEsVbUOWDfu+CSbqmr5gCUdFNwPHfdDx/3QcT+81Gy6JHUbcOLI8uLWJ0makNkUCl8HliU5KcnhwCXAhhmuSZLmlVkzfVRVLyT5NeB/0V2S+qmquu8V+Oixp5rmOPdDx/3QcT903A+7mTUnmiVJM282TR9JkmaYoSBJ6s3ZUEhyTpJvJtmSZO1M1zNJST6VZEeSe0f6jk1yc5IH2/sxM1nj0JKcmOTWJPcnuS/JB1r/vNoPAEmOSHJHkj9r++K3W/9JSW5v/0a+0C7wmPOSHJLkG0n+sC3Py/2wJ3MyFEZumXEucDLwniQnz2xVE/X7wDm79a0FNlbVMmBjW57LXgB+vapOBs4A1rT/B+bbfgB4Djirqk4BTgXOSXIG8FHgqqp6PfAksGrmSpyoDwAPjCzP1/0wrTkZCozcMqOqngd23TJjXqiqPwW+t1v3CmB9a68HLpxkTZNWVdur6s7W/j7dL4FFzLP9AFCdH7TFw9qrgLOAG1r/vNgXSRYD5wOfbMthHu6HvZmrobAIeHRkeWvrm88WVtX21n4MWDiTxUxSkqXAm4Hbmaf7oU2Z3AXsAG4GvgU8VVUvtCHz5d/Ix4HfAP6qLR/H/NwPezRXQ0F7Ud11yPPiWuQkPwV8CfhgVT0zum4+7Yeq+nFVnUp3p4DTgTfObEWTl+SdwI6q2jzTtcxms+bLa68wb5nxUo8nOaGqtic5ge4vxjktyWF0gfCZqvpy6553+2FUVT2V5FbgbcCCJIe2v5Lnw7+RM4ELkpwHHAG8hu75LfNtP+zVXD1S8JYZL7UBWNnaK4EbZ7CWwbW54muBB6rqYyOr5tV+AEgylWRBax9J98ySB4BbgYvasDm/L6rqN6tqcVUtpfudcEtVvZd5th/2Zc5+o7n9NfBxXrxlxkdmtqLJSfI54O10twV+HLgC+APgemAJ8AhwcVXtfjJ6zkjyC8D/Ae7hxfnjD9OdV5g3+wEgyZvoTqAeQveH4PVV9e+SvI7uIoxjgW8A76uq52au0slJ8nbgX1fVO+fzfpjOnA0FSdL+m6vTR5KkA2AoSJJ6hoIkqWcoSJJ6hoIkqWcoSJJ6hoIkqff/ATzac09v4tooAAAAAElFTkSuQmCC\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "df_train[\"x_span_word_len\"].plot.hist(bins=100)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Training Naive Bayes\n",
      "Max words :  331\n",
      "Training Naive Bayes + Tree\n",
      "Max words :  331\n",
      "Extracting features..for 4131\n",
      "Completed..\n",
      "\\begin{tabular}{llrrrr}\n",
      "\\toprule\n",
      "             model &        index & precision & recall & f1-score & support \\\\\n",
      "\\midrule\n",
      "       Naive Bayes &            0 &      65.8 &   70.3 &     68.0 &    1506 \\\\\n",
      "       Naive Bayes &            1 &      56.9 &   62.2 &     59.4 &     555 \\\\\n",
      "       Naive Bayes &            2 &      70.2 &   71.8 &     71.0 &    1491 \\\\\n",
      "       Naive Bayes &            3 &      76.9 &   46.0 &     57.6 &      87 \\\\\n",
      "       Naive Bayes &            4 &      57.0 &   57.7 &     57.3 &      78 \\\\\n",
      "       Naive Bayes &            5 &      76.7 &   48.6 &     59.5 &     414 \\\\\n",
      "       Naive Bayes &     accuracy &      66.8 &   66.8 &     66.8 &       0 \\\\\n",
      "       Naive Bayes &    macro avg &      67.3 &   59.4 &     62.1 &    4131 \\\\\n",
      "       Naive Bayes & weighted avg &      67.4 &   66.8 &     66.6 &    4131 \\\\\n",
      "Naive Bayes + Tree &            0 &      66.5 &   71.1 &     68.7 &    1506 \\\\\n",
      "Naive Bayes + Tree &            1 &      57.7 &   62.2 &     59.8 &     555 \\\\\n",
      "Naive Bayes + Tree &            2 &      70.2 &   72.0 &     71.1 &    1491 \\\\\n",
      "Naive Bayes + Tree &            3 &       0.0 &    0.0 &      0.0 &      87 \\\\\n",
      "Naive Bayes + Tree &            4 &      35.9 &   60.3 &     45.0 &      78 \\\\\n",
      "Naive Bayes + Tree &            5 &      76.7 &   48.6 &     59.5 &     414 \\\\\n",
      "Naive Bayes + Tree &     accuracy &      66.3 &   66.3 &     66.3 &       0 \\\\\n",
      "Naive Bayes + Tree &    macro avg &      51.2 &   52.4 &     50.7 &    4131 \\\\\n",
      "Naive Bayes + Tree & weighted avg &      65.7 &   66.3 &     65.6 &    4131 \\\\\n",
      "\\bottomrule\n",
      "\\end{tabular}\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>model</th>\n",
       "      <th>index</th>\n",
       "      <th>precision</th>\n",
       "      <th>recall</th>\n",
       "      <th>f1-score</th>\n",
       "      <th>support</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>0</td>\n",
       "      <td>0.658370</td>\n",
       "      <td>0.702523</td>\n",
       "      <td>0.679730</td>\n",
       "      <td>1506.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>1</td>\n",
       "      <td>0.569307</td>\n",
       "      <td>0.621622</td>\n",
       "      <td>0.594315</td>\n",
       "      <td>555.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>2</td>\n",
       "      <td>0.701639</td>\n",
       "      <td>0.717639</td>\n",
       "      <td>0.709549</td>\n",
       "      <td>1491.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>3</td>\n",
       "      <td>0.769231</td>\n",
       "      <td>0.459770</td>\n",
       "      <td>0.575540</td>\n",
       "      <td>87.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>4</td>\n",
       "      <td>0.569620</td>\n",
       "      <td>0.576923</td>\n",
       "      <td>0.573248</td>\n",
       "      <td>78.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>5</td>\n",
       "      <td>0.767176</td>\n",
       "      <td>0.485507</td>\n",
       "      <td>0.594675</td>\n",
       "      <td>414.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>accuracy</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>accuracy</td>\n",
       "      <td>0.667877</td>\n",
       "      <td>0.667877</td>\n",
       "      <td>0.667877</td>\n",
       "      <td>0.667877</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>macro avg</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>macro avg</td>\n",
       "      <td>0.672557</td>\n",
       "      <td>0.593997</td>\n",
       "      <td>0.621176</td>\n",
       "      <td>4131.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>weighted avg</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>weighted avg</td>\n",
       "      <td>0.673585</td>\n",
       "      <td>0.667877</td>\n",
       "      <td>0.666288</td>\n",
       "      <td>4131.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>0</td>\n",
       "      <td>0.665217</td>\n",
       "      <td>0.711155</td>\n",
       "      <td>0.687420</td>\n",
       "      <td>1506.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>1</td>\n",
       "      <td>0.576923</td>\n",
       "      <td>0.621622</td>\n",
       "      <td>0.598439</td>\n",
       "      <td>555.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>2</td>\n",
       "      <td>0.701961</td>\n",
       "      <td>0.720322</td>\n",
       "      <td>0.711023</td>\n",
       "      <td>1491.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>3</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>87.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>4</td>\n",
       "      <td>0.358779</td>\n",
       "      <td>0.602564</td>\n",
       "      <td>0.449761</td>\n",
       "      <td>78.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>5</td>\n",
       "      <td>0.767176</td>\n",
       "      <td>0.485507</td>\n",
       "      <td>0.594675</td>\n",
       "      <td>414.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>accuracy</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>accuracy</td>\n",
       "      <td>0.662794</td>\n",
       "      <td>0.662794</td>\n",
       "      <td>0.662794</td>\n",
       "      <td>0.662794</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>macro avg</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>macro avg</td>\n",
       "      <td>0.511676</td>\n",
       "      <td>0.523528</td>\n",
       "      <td>0.506886</td>\n",
       "      <td>4131.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>weighted avg</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>weighted avg</td>\n",
       "      <td>0.657039</td>\n",
       "      <td>0.662794</td>\n",
       "      <td>0.655725</td>\n",
       "      <td>4131.000000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                           model         index  precision    recall  f1-score  \\\n",
       "0                    Naive Bayes             0   0.658370  0.702523  0.679730   \n",
       "1                    Naive Bayes             1   0.569307  0.621622  0.594315   \n",
       "2                    Naive Bayes             2   0.701639  0.717639  0.709549   \n",
       "3                    Naive Bayes             3   0.769231  0.459770  0.575540   \n",
       "4                    Naive Bayes             4   0.569620  0.576923  0.573248   \n",
       "5                    Naive Bayes             5   0.767176  0.485507  0.594675   \n",
       "accuracy             Naive Bayes      accuracy   0.667877  0.667877  0.667877   \n",
       "macro avg            Naive Bayes     macro avg   0.672557  0.593997  0.621176   \n",
       "weighted avg         Naive Bayes  weighted avg   0.673585  0.667877  0.666288   \n",
       "0             Naive Bayes + Tree             0   0.665217  0.711155  0.687420   \n",
       "1             Naive Bayes + Tree             1   0.576923  0.621622  0.598439   \n",
       "2             Naive Bayes + Tree             2   0.701961  0.720322  0.711023   \n",
       "3             Naive Bayes + Tree             3   0.000000  0.000000  0.000000   \n",
       "4             Naive Bayes + Tree             4   0.358779  0.602564  0.449761   \n",
       "5             Naive Bayes + Tree             5   0.767176  0.485507  0.594675   \n",
       "accuracy      Naive Bayes + Tree      accuracy   0.662794  0.662794  0.662794   \n",
       "macro avg     Naive Bayes + Tree     macro avg   0.511676  0.523528  0.506886   \n",
       "weighted avg  Naive Bayes + Tree  weighted avg   0.657039  0.662794  0.655725   \n",
       "\n",
       "                  support  \n",
       "0             1506.000000  \n",
       "1              555.000000  \n",
       "2             1491.000000  \n",
       "3               87.000000  \n",
       "4               78.000000  \n",
       "5              414.000000  \n",
       "accuracy         0.667877  \n",
       "macro avg     4131.000000  \n",
       "weighted avg  4131.000000  \n",
       "0             1506.000000  \n",
       "1              555.000000  \n",
       "2             1491.000000  \n",
       "3               87.000000  \n",
       "4               78.000000  \n",
       "5              414.000000  \n",
       "accuracy         0.662794  \n",
       "macro avg     4131.000000  \n",
       "weighted avg  4131.000000  "
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_train_filter = df_train\\\n",
    "                    .pipe(add_span_genes_chem)\\\n",
    "                    .pipe(filter_include_min_word_len)\n",
    "\n",
    "\n",
    "train_result_filter = train_and_predict_all_classifiers(df_train_filter, min_df=1)\n",
    "\n",
    "\n",
    "print_report_all_classifiers(df_train_filter[\"gold\"],train_result_filter, labels=all_labels)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_train = df_train.pipe(add_span_genes_chem)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['x', 'y', 'y_raw', 'abstract_id', 'abstract', 'annotations',\n",
       "       'prediction', 'confidence', 'is_eval', 'relationship_type',\n",
       "       'relationship_group', 'participant1_id', 'participant2_id', 'gold',\n",
       "       'gold_raw', 'unique_chemprot_names', 'x_span', 'x_span_word_len'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_train.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAWoAAAEwCAYAAACezTtyAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjUuMCwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy8/fFQqAAAACXBIWXMAAAsTAAALEwEAmpwYAABRQUlEQVR4nO3dd3hU1dbA4d9KQm8JvfcO0psiRbEhCojYryKCiIqo1wYWqqiIig0LKiKooF5FURGwISjSm1QFQekQIPSQZLK+P85JGELKANMy33p55mHOPm3NJFmzZ5999hZVxRhjTPiKCnUAxhhjsmeJ2hhjwpwlamOMCXOWqI0xJsxZojbGmDBnidoYY8KcJWpjjPGBiEwQkT0isjpD+X0isl5E1ojI817lg0Vko4hsEJHLvcqvcMs2isggn85t/aiNMSZnItIeOAJMUtWGbtlFwBNAF1U9ISKlVXWPiNQHpgCtgPLAD0Bt91B/ApcC24DFwE2quja7c8cE4gX9fyD5CioFY0MdRromVcqGOoTTHDqeHOoQThFXOG+oQziV1ZGyteXff4iPj5dzOYbEllNSTvi28dEDs1T1iqxWq+pcEamaofhu4DlVPeFus8ct7wZMdcs3i8hGnKQNsFFV/wYQkanutpaoA6JgLNEX9Qt1FOl+Gf9IqEM4zcw/doY6hFNcf37VUIdwCo8nNdQhhLXW7c4/94OkJBHV+EqfNk2d/1FdEVniVTReVcfnsFttoJ2IjAISgYdVdTFQAVjgtd02twxga4by1jnFZonaGBPZxOdLcfGq2uIMjx4DFAfaAC2BT0Wk+hkew6eTGGNMZBI5k0R9NrYBX6hzsW+RiKQCJYHtQCWv7Sq6ZWRTniXr9WGMiWwivj3OzpfARc5ppDaQF4gHpgM3ikg+EakG1AIW4Vw8rCUi1UQkL3Cju222rEZtjIlsfqpRi8gUoCNQUkS2AUOBCcAEt8teEtDLrV2vEZFPcS4SpgD3qqrHPc4AYBYQDUxQ1TU5ndsStTEmgvmv6UNVb8pi1X+y2H4UMCqT8hnAjDM5tyVqY0zkEpDo6FBHcc4sURtjIljALyYGhSVqY0xkO/sLhWHDErUxJrJZjdoYY8JY4PtRB4UlamNMZIuyi4nGGBPGrEZtMvFOv6vo0rQWew4dpcljp47n8uCVrRnzn0spc9eL7Dt8nA71qvDFQ9exeU8CAF8u3sDT0+YBsPGVARw+noQnNZWU1FTaPDnBL/ENeOV9Zi1eRcliRfh93IhT1r0+bRZPTfiMjR+OpUSxIiQcOcqAVyayedce8ufJw2v396Z+lQpZHPns3ff8ixTIl5eoqCiioqJ45t672bJjJ+99NZ3klBSioqK4o+vV1KxUkSPHj/P259PYvX8/eWNiuKvHNVQqW8bvMWUm4chR7hzzHms2b0NEePfRvpzfoFZQzg2wdc8+7hg9nt0HDiECfbtcxH09LmPlpn8Z8PJEjhw/QZWyJZk0uD9FCxUISkyJSUlc/OAznEhOIcXjoUf7lgzt1YOLHhjF4eOJAOxNOESLOtX5fMT9QYnpNHYxMWsiosBLqvqQu/wwUFhVh4nIMOBOYK/XLh1VNUFEWgHP44w0dRjYCQxS1T+8jr0CWK+qN4pIbyDtN6A+sAHwADOB9UAL4DOcoQjP9zpGDM499k2BZ4AOwEF39TFVveBsXvekuat4Y/YS3r+76ynlFYsX5dJG1fln78FTyn9dv5VuL3yS6bEuGTWZfYePn00YWbqpU1vu7HIx/ce+d0r5tr37+Xn5WiqWKp5e9uKnMziveiU+fOJe/ty6k0fe+oivRj3s13jSPNn3DooWKpS+/PHMWVx78UU0qVOb5Rv+5OOZsxhyZx++mvMLVcqV5aH/3Mz2PXt5f/o3PNm3d0BiyuiB1z7k8laN+Gz4QJKSUzh2wsfhM/0kJjqa5/vfRNNaVTl87Dit7x5Kp+YN6P/iBEbfdSPtG9dl4ndzefHTGQzvfW1QYsqXJw+zXxhE4QL5SU5JoeMDo7iiZSN+fvmJ9G2uH/YaV1/QNCjxnEaIiBp1IF/BCaCHiJTMYv1YVW3i9UgQkTLAp8DjqlpLVZsBzwI10nYSkXo4t162E5FCqvp+2jGAHcBF7rL3zAnzgIoiUsWr7BJgjarucJcf8YrlrJI0wLz1/7L/yOnJ9cVbL2XQxz+iIR6EuG3D2sQVKXRa+RPvfsKw3j0Rr9rHhq07aNeoLgC1K5Xj3z372HPg4Gn7BoKIcNxNhMcSE4krUgSAbXv20rC6MzhZhdKl2JtwgITDRwIez8Ejx5i3aj19ruwAQN48McQWPv19DKRyJWJpWqsqAEUKFqBu5fLsiD/AX9t20a5RHQA6NW/AtHlLsjmKf4kIhQvkByA5xUNyiueU36FDR48zZ8VaurVtHrSYMkToJGpfHmEskNGlAOOBB89gnwHAB6o6P61AVX9V1S+9trkJmAzMxhlwO0eqmorzAXCjV/GNODMwBNzVzWuz/cBhVv2757R1bWpVYOmzd/LNozdSv8LJzzRV+G7QzSwc1Ye+Fwe2NjJjwXLKlYjlvGqVTilvWK0S38xfBsDSP/9m65597Nh3wO/nF4Fn3/+Ax19/kx8XLQbgti6d+ei7Wdw7egwffTeTGy+/DIAqZcuyaK0zxvrGrduITzjI/kOB//DYvGsvpWKLcsfo8TS/80nuHPMuR92v9qGwZddeVm78h1Z1a1C/agWmuz+nz+cuZtve/UGNxeNJpcVdT1Gh5310at6AVvXS61V89dtSLmpaP2hNMZkK7KBMQRHoj5FxwC0iUiyTdQ+KyAr38bNb1gBYlsMxbwCm4iTZrO69z8wU3EQtIvmAK4HPvdaP8Yrno8wOICL9RGSJiCzhxDGfTlogbwyDu7Vl2Ge/nLZu2ZadVB/4Gs0Hv8O42Yv5/KHr09d1GP4BrZ54j6tGT+HuS1vQrm5ln1/omTiWeIKXPpvB4FtO/8x7oGdnDh49RruBwxn/9U80ql6Z6Cj//8oM63cnzw64h8duv5XZCxaybvMWvl+4mFu7dGbcY49w65WdGf/FNAC6dmjHseOJDHptHLN+X0DVcuWICkJtKMXjYdmfW+jftRNL33maQvnzMXrKNwE/b2aOHE/khuGv8cI9t1C0UAHGP9yHt6f/SOu7h3D42HHyxgS3l0N0dBRL3h7J5qljWbL+b1Zv3pa+7tOfF3DDRW2CGs+pBKJifHuEsYBGp6qHRGQSMBDI2B4wVlVfyG5/EVkIFAVmq+r9ItICZ3Dvf0VkO86oVcVVNccqhKouEZHCIlIHqAcszLDfI6r6vxyOMR7nWwISV96nNowaZeKoWiqWZc/dCTht1YtH9eX8pyaw++DR9O2+W7GJ13pHUaJIAfYdPs6OA4cB2HvoGF8t2UDLGuWZt/5fX055Rjbv2ss/u+NpN3A4ADviD9DhgZH8+NITlIkrxrgH7gBAVWncdxBVypbyewzFixUFoFjhwrSsX59N27Yxd9lyel3lzMzR5ryGvDPtKwAK5s9P/5490mMaOOYlSheP83tMGVUsVZyKpYrTun5NAK7t0IrRH38d8PNmlJySwg3DXuOmThdwTTtnjPu6lcszY/SjAPy5bRffLVwZ9LgAYgsXokOTesxevIqG1SoSf/Awi9f/zWfDB4YkHsBpo44K79qyL4LRMPMy0AfwpUFvDdAsbUFVWwNPAWk18puAuiKyBdiEk8TP5KpJWq06aM0eq7fupfzdY6l5/+vUvP91tu0/RMsn3mX3waOUKXbyLWlZozxRIuw7fJyC+fJQOL8zv1/BfHm49LxqrNl6erOJPzSoWpG/PhzLqvdGs+q90ZQvGccvLz9FmbhiHDxyjKTkFAAmzZ7HBQ1qU7Sgf7/CJiYlpbdFJyYlsWrjRiqWKUNc0SKs27wFgDWb/qZsiRIAHD1+nJQUJ6afliylXrUqFMyf368xZaZs8VgqlS7Ohn+d6cV+WraG+lX93wMmO6pKvxfeo26V8jzQ8+TUfnsOHAIgNTWVZz/8in5XXRy0mPYmHCLhiFPhOH4iiR+XrqFO5fIAfDF3MVe2aUL+vKGdq1IkyqdHOAt4fV9V97vjsvbBGbs1O+OAhSIyy6uduiCAOO/k9cB5aRcA3RmAnwLe8TGcKTiDdBdz4/G7DwdcQ4d6lSlZpCBbXhvI8M/n8v6cFZlue23retx1SXNSPKkkJiVzy2vO1/syxQrxvwevAyAmOoqpv61m1qq//RJfnzHj+e2PDew7dIQGtz/CoJu7cutl7TLddsO2ndwzdgIiTq3ttYG3+yUGbwePHOGlDz8GwJOaStvGjWhSuxb583Zn0jcz8KR6yBOTh77XOL1otu/dy5uffYEIVCxdmn7XXuP3mLLyysDbuHXUmySlpFCtXCkmPBbcOTPnr/6Lj36YT8NqFWlx11MAjLyjJxu37+bNr34AoPuFLeh1ReY/z0DYuT+BPqPfwZOaSqoqPTu0okubJgB8+vNCHrmxS9BiyVxk9KMWZ4zrABxY5IiqFnaflwE2A89n0z2vu6puEZE2wGic7nl7cGZLGIFTIx+tqm28zhGN28VOVXe6Ne0Wqhrvrr/dXR7gtc8K3K59XmUTObV7HkArVU3K8vXFlddwmtx2v01umyOb3DZ3ad3ufJYsW3pus5AXr6Axne72aduU/z219CzmTAyKgNWo05K0+3w3bs3YXR4GDMtivwU4STMzbTJs6wHKei1XzbB+IjAxQ1mTTM55exbnM8bkdhFQow7vS53GGHNOJCLG+sj9HzXGGJMdP93wIiITRGSPOz9ixnUPiYim3eAnjldFZKOIrBKRZl7b9hKRv9xHL19egiVqY0zkEr/emTgRuCJjoYhUAi4DvPvPdsaZebwW0A940922OM6kuK2BVsBQEcmxf6klamNMZPPTnYmqOhfI7J6NscCjcMr4EN2ASepYAMSKSDngcuB7Vd2vqgeA78kk+WdkbdTGmMjm++3hJUXEe6CU8e5NbtkcWroB21V1pZx6ngrAVq/lbW5ZVuXZskRtjIlgZ9SPOv5MuueJSEHgcZxmj4Cypg9jTGQL3Oh5NYBqwEr3Ho6KwDIRKYtzf4f3KGcV3bKsyrNlidoYE7mEgI2ep6p/qGppVa3q3sOxDWimqrtw7oC+ze390QY4qKo7gVnAZSIS515EvMwty5Y1fRhjIpx/BmUSkSlAR5y27G3AUFV9L4vNZ+CM0LkROAb0hvQhNUYCi93tRvgyqJwlamNMBPPfWNOqmu2wyt53RqszNse9WWw3gZzHPTqFJWpjTGQL80kBfGGJ+iw1qVKWn98KzPyBZ2PD1oRQh3CayxuWzXmj/8eio8PvElFqaminigsIG+vDGGPCnNWojTEmnAn+upgYSpaojTGRK617Xi5nidoYE9msjdoYY8Kd1aiNMSZsCYJEWY3aGGPCm7VRG2NMuLNEbYwx4essB1wKN5aojTGRzRK1McaEOeueZ4wxYc5q1MYYE86ESJgfxRK1MSayWY3a5OS+Vycye8kqShYrwm+vDU8vH//Nj7w3Yw7RUcJlLRox7PaeJCWn8N83JrNi0z9EifBM3xu58Lw6fo/Jk5pK7+deplRsMV68pw+jJn/Kun+3ogqVy5TkqVtvpGD+fCQlpzD8gyls2LqNooUK8nSfWylforhfYxnwysn3Z/7rGd6fb+cQ5b4/w3v3ZP+hI9w++i2W/7WFmy6+gOf73+zXWHLSZ/Q7fLtgOaVji7Lq/eeCeu6Mtu7Zx+3Pvs3uAwcRhDuvuoiBPS8Pehx9x7zDjAUrKB1blBXvPXvKurGffsejb09h5xfjKFmsSNBjAyJmrI9c9Z1ARMqKyFQR2SQiS0VkhojUFpHjIrJCRNaKyFsiEiUiVTOUTxKRPJkcs5W7zQoRWSki1/gz5ps6XcCnQ+8/pWzeqvV8t3Alc18ZwvzXR3Bvd2cS40mz5wHw66vD+Hz4gwx5/1NSU1P9GQ4An/w8j6ply6QvP9CzKx8+8RAfPfkQZeLi+N8vvwEwff5CihYswP+GD+ami9szbtq3fo/l5k4X8NmwLN6fV4fw+7gRDLjGeX/y5c3D47d0Y0Tvnn6Pwxe9rmjHjNGPhuTcGcVERzPm7ptZPXE0898Yyhtf/cDaLTnOkep3vS5vxzfPPnJa+dY9+/h+6R9ULl0i6DGdTnx8hK9ck6hFRIBpwBxVraGqzYHBQBlgk6o2ARoB9YHu7m5p5efhzPZ7fSaHXg20cLe7AnhbRPz2TeOCBrWJK1zolLL3Z87h/muvIF8e53OjVGxRADZs3UG7RnXTy4oWKsjyjf/4KxQA9hxIYP7qdXRt2yq9rFCB/ACoKieSk9N/Z+etWsOVbVoAcFHTRizZ8BfODEP+c0HD09+fCd9l/v4Uyp+PNvVrkS/vaZ+3QdG+cV2KFy2U84ZBUK5ELM1qVwWgSMEC1K1cnu3xOU6953ftGmX+njz8xsc82+9GJOS1WYGoKN8eOR1JZIKI7BGR1V5lY0RkvYisEpFpIhLrtW6wiGwUkQ0icrlX+RVu2UYRGeTLq8g1iRq4CEhW1bfSClR1JbDVazkFmA/U9N5RVT3AIqBCxoOq6jF3P4D8QMCnuNi0YzcL1v7FpQ8/w9WPj2HZX5sBaFitEjMXrSTF4+Gf3XtZuekfv//xjf3fVwy45qrT/oBGTprKlYOG88+uPVzf8UIA9iYcpExcLODU4AoXKMDBo8f8Gk9mNu3Yze9r/+KSh5/hqsEn3x+TuS279rJi4z+0rlcz542DYPpvSylfMo7GNSqHOhSX32rUE3Eqc96+BxqqaiPgT5zKIyJSH7gRaODu84aIRItINDAO6IxTqbzJ3TZbuSlRNwSWZreBiBQEOgF/ZCjPD7QGZrrLXUVkhNf61iKyxt2vv1fiznj8fiKyRESWxO+LP+sXkuJJ5cCRo8weM5hht/ekz/Nvo6rccklbypeIo9NDT/P4u5/Qqm4Nov04oMyvf6wlrnBh6laueNq6p267kW+eHULVsqX5YekKv53zbKR4Ukk4fJTvxwxmeO+e3DH6bb/X5CPFkeOJXDfkVV669xaKFioQ6nA4lniC5z7+mmG39wh1KCel3Z2Y0yMHqjoX2J+hbLZXvliA880doBswVVVPqOpmnNnIW7mPjar6t6omAVPdbbMVKRcTa4jICpza8Feq+p2IVPUqrwZ8q6qrAFR1OjA9bWdVXQg0EJF6wAci8p2qJmY8iaqOB8YDNG3S7KwzR/kScVzVphkiQvPa1YiKimLfoSOULFaEUX1vSN/uikefo0b5Mtkc6cys2rSFeX+sZf6a9SSlpHD0eCJD3/+Y4b2di3LRUVFc2qIJH34/h6vOb0Wp2GLsPpBA6bhYUjwejhw/TrFCBf0WT1bKl4jjqvMzf3/MSckpKfQc8io3X3IBPdq3DHU4AGzasYctu/bSvN+TAGzbu59W/Z9i/rhhlC0eG5KYonxvfikpIku8lse7f/O+ugP4xH1eASdxp9nGyW/0WzOUt87pwLkpUa8BsrqKlNYWnWm5iJQEfhORrm6SzpSqrhORIzi19yVZbXeurmzdhF//2EC7RnXZuH0XSckplChamGMnTqDqtMX+vGItMdFR1K1c3m/nvaf7ldzT/UoAlv65kY9/+IVht9/E1j3xVCpdElVl3qq1VClTGoB2jRowY8ESzqtelZ+Xr6JFnZpBaXPs0qYJ87zfnxTn/TEnqSp9n3+XelXK8+D1nUMdTrrzqldix+fj0pdr3vxfFrw5PKS9Ps7gVzZeVVuc1WlEngBSgI/OZv+c5KZE/RPwjIj0S/uUE5FGQLGcdlTVeLfRfjBeNWn3GNWAraqaIiJVgLrAFn8FfecL4/lt9Z/sO3SEhnc8wqCbunLLJRdy32sTaXvfUPLGxDDugd6ICPEJh+k57GWiooRyxeN488E+/gojS6rKiElTOZaYiKpSs2J5HrvxWgCuvqAVwydOoefQZylasCAj+/zH7+fvO+bk+9Ogt9f78+pELhjgvD9v3N87/QOicd9BHD52nOQUD98uXM7nwx/064dZdm4eOY5fVqwj/uARKl83kKG396BPl45BOXdGv63+kw+//43zqleiWd8nAHi673Vc2aZJUOP4z9Nv8MtK5z2pesP9DOnVgzuu7BDUGLIjCDFRga1ciMjtwFVAJz3ZRrcdqOS1WUW3jGzKsz5Hbmr7E5HywMtAcyARJ6E+AExT1YYZtq0KfJNW7vYaWQEMAOJwenoMEZFbgUFAMpAKjFDVL3OKpWmTZvrz7Ll+eFX+8df2g6EO4TS1K+b4GRpUxYrkD3UIYS81NXzyQasL27Bk2dJzyrLRZWtpodvG+rTt4TFXL82pRp1JXrkCeAnooKp7vbZrAHyM0yZdHvgRqIVz1fJPnGtp24HFwM2quia78+amGjWquoPMu9g1zGTbLd7l7iddY69Nprvlk4HJfg3UGBMWBPBXhVpEpgAdcdqytwFDcb6l5wO+d7/1LVDV/qq6RkQ+BdbiNInc6/Y+Q0QGALOAaGBCTkkaclmiNsaYMyL47bqKqt6USfF72Ww/ChiVSfkMYMaZnNsStTEmogW4iTooLFEbYyJa6O+OPHeWqI0xEUuA6AioUluiNsZELrGmD2OMCWuCWNOHMcaEO6tRG2NMmLMatTHGhDF/3vASSpaojTGRS6zXhzHGhDWnRm2J2hhjwloE5GlL1Gfr+IkUVm05EOow0jWrEQ6TiJ6q2FWBH6b1TKT8NCnUIZwiHC9y5abRNH1lNWpjjAlnZzZxQNiyRG2MiViC2MVEY4wJd9b0YYwxYUywpg9jjAlvYjVqY4wJexGQp4kKdQDGGBMoaTe8+PLI8VgiE0Rkj4is9iorLiLfi8hf7v9xbrmIyKsislFEVolIM699ernb/yUivXx5HZaojTERLTpKfHr4YCJwRYayQcCPqloLZ6bxQW55Z5xZx2sB/YA3wUnsOJPitsaZoXxoWnLPjiVqY0zEEnfiAF8eOVHVucD+DMXdgA/c5x8A3b3KJ6ljARArIuWAy4HvVXW/qh4Avuf05H8aa6M2xkQw35o1XCVFZInX8nhVHZ/DPmVUdaf7fBdQxn1eAdjqtd02tyyr8mxZojbGRLQzuN8lXlVbnO15VFVFJCD34FvThzEmYvnzYmIWdrtNGrj/73HLtwOVvLar6JZlVZ4tS9TGmIgW5ePjLE0H0npu9AK+8iq/ze390QY46DaRzAIuE5E49yLiZW5ZtqzpIwg8qan0f+FVShYryrN33cHAV97g2IkTACQcPkLdKpV5uq/zs17x1yZenzadFE8qxQoV5JWBd/s1lntfnsDMxasoVawIC94YCcCTEz5l5qKV5I2JoVrZUox74A5iCxckKTmFB8ZNYvlfW4gS4bl+N9GuUd1zjuHdR/vSpU1T9iQcovEdg0/Gds2l3NP9EjypqcxYsJJBb0+leNHCfDrsPlrWrc4HM+cx8FVnBLwC+fLy6bD7qF6+NJ7UVL6Zv5zH3/n0nGPLzqufz+K9b+egCn26dOD+njleAwqoxKQkOt4/ihNJyaR4Urm2Q0uG9b426DFc/OAznEhOIcXjoUf7lgzt1YM3vvye176YzaYde9jx+euULFYkqHGlET9OHCAiU4COOG3Z23B6bzwHfCoifYB/gOvdzWcAVwIbgWNAbwBV3S8iI4HF7nYjVDXjBcrTZJmoReQ1IMv2FlUdmNPB/U1EygIvAy2BBGA38ACwEtgA5AXmAvcAlYF1XuVLgD6qmpzFsSsDa4FhqvqCP+P+/JdfqVymNMcSEwF49f570tcNeW8Sbc9rAMCRY8d5+bNpjO7fhzLF4zhw+Ig/wwDg5kvacudVnej/0rvpZRc1qc+wXtcSEx3NkPc/46XPvmVE7+v4YNZcAH4fN4K9CYe4dujLzBn7JFFR5/ZF7IOZ8xg37XsmDu6fXtaxST26tm1G075PkJScQqnYogAkJiUzdMLnNKxWkQbVKp5ynBc/mcGcFevIExPN9y8O5opWjZi5aNU5xZaV1Zu38d63c/j9jWHkzRPDlY+Nocv5TalZoUzOOwdIvjx5+OGlwRQukJ/klBTa3zeSK1o3pk39mkGNYfYLg9Jj6PjAKK5o2YjzG9TmyjZNuPSh54IWS1b8NSaTqt6UxapOmWyrwL1ZHGcCMOFMzp3dX9wSYGk2j6ASZ/DeacAcVa2hqs2BwThXWTepahOgEVCfk11k0srPw2kLup6svQR85++49yYksGDNerqc3+q0dUcTE1n+1yYubOQk6h+WLqdd44aUKe50q4wrUtjf4dC2YR3iihQ6paxTs4bEREcD0LJODXbEO+Nsr9+6g/ZuDbpUbFGKFSrA8r+2nHMM81ZtYP+ho6eU9e/Wiec//oak5BQA9iYcAuBY4gl+W/0niUmnfr4eP5HEnBXrAEhO8bD8ry1ULFX8nGPLyvp/dtCqXg0K5s9HTHQ07RvXZdq8JTnvGEAiQuEC+QHnPUj2eAj2TXinxZDiQURoWqsKVcuWCnI0pwtCG3VQZFmjVtUPvJdFpKCqHgt8SFm6CEhW1bfSClR1pYhU9VpOEZH5QE1gmVe5R0QWkUU3GBHpDmwGjma2/ly8/sXX3NXtSo4nnjht3a+r1tCsdk0K5Xd+0bftjSfF4+GB197iWOIJru1wIZe3au7vkLL14fe/0qN9SwAaVqvEjIUr6NmhNdv27mflpn/YFr+f5nWq+/28tSqW5cJGdRjZ9zoSk5J59M2PWbJhs0/7FitUkKvOb8qrn+fY1HfWGlSrwFMTPmPfwcMUyJeX7xaupEXtagE7n688nlRa3vUUG7fv5p7ul9A6iLVp7xha3zOUTdt3079bJ1rVqxH0GLITCRficnwNInK+iKwF1rvLjUXkjYBHdrqG5FCTF5GCOF9D/shQnh/nTqCZ7nJXERnhPi8MPAYMzykAEeknIktEZElCQo7NSvy+ei2xhQtTp1LFTNf/tGwFFzdrkr7sSU3lz63bebbfHYy5uy+TZ/3A1j17czyPv4z55BtioqO4vmMbAG699EIqlCxOxwdGMvidqbSqW5Poc2z2yEpMdDTFixTignuG8dhbU5g69D6f9ouOiuLjp+7htS9ms3ln4N6relUq8MiNV9H50TFc+dgLNKlRJWDvxZmIjo5i2buj+PezV1i8/m9Wb96a804BiGHJ2yPZPHUsS9b/zerN24IeQ3Yiukbt5WWcu2mmQ3ottn0ggzoLNURkBU6b+leq+p1b004rrwZ8q6qrAFR1Ou7rAYYBY1X1SE5TI7md38cD1K3XKMf+kqs3/8P81WtZuG49ScnJHEs8wahJU3jitps4eOQo6//Zysg+t6VvX6pYMYrWLUiBfHkpkC8vjWpUZ9P2nVQqHfivkB/98CuzFq1k+qiH06eIiomO5tk7b0zf5tKHn6FmhbIBOf/2vfvTmxIWr/+b1NRUShYrQvzBw9nu9/bDd/DX9t0BrU2nuePKDtxxZQcAnnj3MyqWyvHO36CJLVyIjk3qMWvRKhpWq5TzDgGKoUOTesxevIqG1TKvnASbiBATARMH+FQlUNWMH9OeAMSSkzVAVu0Am1S1iao2VdVhGcuBGkBzEemayb6tgedFZAvOhcnHRWSAPwK+8+rOfDbiCaYOHcyQXrfQtFYNnrjNuR7xy4pVtGlQj7x58qRv3/a8+vzx9xY8Hg+JSUms++dfqpQp7Y9QsvXD0j945fOZTB0ykIL586WXH0s8wVG3yean5WuIiY6ibuXyAYnhq1+X0rFpPcBpBsmbJybHJD3ijp4UK1SQB1//MCAxZbTngNNu/u/ueL6ct4SbOp0flPNmZW/CIRKOOK11x08k8cPS1dQJ0M/H1xh+XLom6DFkRwh497yg8KVGvVVELgBURPIA9+P0pgi2n4BnRKRf2m2dItIIKJbTjqoaLyKDcC4+Ts+wrl3acxEZBhxR1df9GXhmflq+kpsvueiUsiply9CqXm36jB6LiNDl/FZUK+/fGuwdz7/Nr39sYN+hI9Tr9TCDb+nGS5/NICk5me5PvghAizrVeXnAbew9eJgeQ14iSqIoVyKWtx/q65cYPnryHjo0qUfJYoX559NXGD7xCyZ89wvvPXonKyc8S1JyCr2fO3nn7qYpL1G0YAHy5omh24XNueKR0Rw6epwnbu3Gun+2s2S8083wjWnf896MX/wSY2auG/Yq+w8dIU90NK/efxuxhQvlvFMA7dyXQO/nxuNJTSU1NZXrOrbmqvObBjeG/Qn0Gf2OE4MqPTu0okubJrw+bTYvfjKDXfsP0rzfk1zRqhFvPxSayY7DvVnDF5LTrMMiUhJ4BbgE54NnFnC/qu4LfHinxVIepymmOZAIbMGpBU9T1YYZtq0KfJNW7vYaWQEMAOKAFqo6JMM+w3ASdY7d8+rWa6TjP/j2XF6OX9ks5DmzWchz5vGkhjqEdK3bnc+SZUvP6U0qXrWednrqfZ+2/V/f85eeyy3kgZRjjVpV44FbghBLjlR1B5l3sWuYybZbvMvdfo2NvTaZnsk+w845SGNMWImEGrUvvT6qi8jXIrLXHTT7KxHxf/8sY4wJAH8NcxpKvrShfwx8CpQDygOfAVMCGZQxxviDCMSI+PQIZ74k6oKqOllVU9zHh0D+QAdmjDHnKuLvTHSnjAH4zu0xMRWnn/INOAOOGGNM2Av3Zg1fZHcxcSlOYk57mXd5rVOcrm7GGBPGwr+27IvsxvoI/UAGxhhzDgSCPlBVIPg0HrWINMQZlS69bVpVw6tTqjHGZJQLenT4IsdELSJDcQbLro/TNt0Z+BWwRG2MCWsC/2/G+uiJMyLdLlXtjXPTSI63bRtjTDiIQnx6hDNfmj6Oq2qqiKSISFGcyRtDMzyXMcacAad7XqijOHe+1KiXiEgs8A5OT5BlwO+BDMoYY/zFn/2oReRBEVkjIqtFZIqI5BeRaiKyUEQ2isgnIpLX3Tafu7zRXV/1rF9DThuo6j2qmuDOrHIp0MttAjHGmPDm4+3jvtS6RaQCMBBnQLeGQDRwIzAaZ0z7msABIG00sj7AAbd8rLvdWcnuhpdm2a1T1WVZrf//oFCBPJxfP3QTm2aUJyb8RtRN+uGDnDcKohNJoRhGPWv58kaHOoTTREeH0e+RH5osBPx9e3gMUEBEkoGCwE7gYuBmd/0HOJORvAl0c58D/A94XUREcxqyNIuTZuXFbNapG5wxxoQxOZPhZEuKiPeMxePTxr4HUNXtIvIC8C9wHJiN0xycoKop7mbbODk3awVgq7tviogcBEoA8Wf6KrK74eWirNYZY0xucIYXE+OzG49aROJwasnVgAScAequOLcIfRNG33OMMcb/xMeHDy4BNqvqXlVNBr4A2gKxIpJW6a0IbHefb8ftIeeuLwac1YQrlqiNMRHNj70+/gXaiEhBd8aoTsBa4Gec+00AegFfuc+nu8u46386m/Zp8PEWcmOMyY3SJrf1B1VdKCL/w+minAIsB8YD3wJTReRpt+w9d5f3gMkishHYj9ND5Kz4cgu54EzFVV1VR4hIZaCsqi4625MaY0xQCET78Y4XVR0KDM1Q/DfQKpNtE4Hr/HFeXz5s3gDOB25ylw8D4/xxcmOMCSRf26fD/eZFX5o+WqtqMxFZDqCqB9LuvDHGmHAX0eNRe0kWkWicvtOISCkgfOaUN8aYbERAnvap6eNVYBpQWkRG4Qxx+kxAozLGGD9Iu5joyyOc5VijVtWPRGQpTlcUAbqr6rqAR2aMMX4QHQFVal96fVQGjgFfe5ep6r+BDMwYY86V/H+Z4QWnj2DaJLf5cW6f3AA0CGBcxhjjB2c01kfY8qXp4zzvZXdUvXsCFlGE83hSueDeoZQvGce0p//LT8vW8Pg7n5CaqhQqkI93H7mTGhWCPypfYlISHe8fxYmkZFI8qVzboSXDel8b9BgufvAZTiSnkOLx0KN9S4b26sHmnXv5z6g32H/oCE1rVWXioLvImyc492q99sUsPpg5F0RoULUibz/Uh7vHTmD5n1uIiYmmRZ1qvDawF3lighNP3+ff4dsFKygdW5SVE54FYP+hI9w0chz/7IqnStmSTB0ygLgihYIST0YzF63iwdcn4/Gk0qdLRx67+eqQxOEt3NuffXHGr8Ed3rR1AGLJkYiUFZGpIrJJRJaKyAwRqS0ix0VkhYisFZG3RCRKRKpmKJ8kInkyOab3ditE5K1AvobXp82mTuXy6csDX/2AiYP6s+jtkdx48fk8+9H0QJ4+S/ny5OGHlwaz/L1nWPbu08xatIoFazcGPYbZLwxi6finWfL2SGYv/oOFazfy+DufMPDay1k3aQxxRQrx/ne/BCWeHfEHePOrH5j32lCWvP00qampfDZnITdc1Ibl7z7D4rdGcvxEMhNnzg1KPAC3Xd6Ob5975JSy0VO+4eKm9Vk/eQwXN63P6CnfBC0ebx5PKve98gHfPvcIqyeOZuqPv7N2y/acdwwwEfHpEc5yTNQi8l+vx8Mi8jGwIwixZYxDcHqfzFHVGqraHBgMlAE2qWoToBHOJLzd3d3Sys/DGSzl+iwOv0lVm7iP/oF6Ddv27ue7hSvp3blDepmIcOjYcQAOHj1GuRKxgTp9tkSEwgWcSeaTUzwkezxBvwngtBhSPIgIc1as49r2LQG49bILmf5b8IZCT/F4OJ6URIrHw7ETSZQrEcsVrRqn/3G3qFON7fEHghZP+8Z1KV701Nry178t47bL2wFOIp/+69KgxeNt0fpN1ChfhurlS5M3Tww3XNyG6b+FJpY0aaPn+WPigFDy5ftaEa/nKTht1p8HJpxsXQQkuzPNAKCqK72nt3HHfJ0P1MS5Hz+t3CMiizg5TmxIPPLmRzxz5/UcPp6YXvbmf++g+xMvUiBfXooULMDcV4eELD6PJ5WWdz3Fxu27uaf7JbSuXzMkMbS+Zyibtu+mf7dOVC9fmtjCBYmJdgbZr1Ayju37gpMYy5eM4/6eV1D31ocpkC8PFzdryCXNG6avT05JYcqP8xlz9y1BiScruw8cSv+AL1u8GLsPHApJHNvjD1CpdPH05QqlirNo3aaQxOItEnp9ZFujdm90KaKqw93HKFX9yL2HPdga4gzSnSURKYjTjfCPDOX5cZprZrrLXUVkhNcm1URkuYj8IiLt/Bu2Y8aCFZSKLUqz2tVOKX/t81l8OeohNk15mdsub8ejb30ciNP7JDo6imXvjuLfz15h8fq/Wb15a0hiWPL2SDZPHcuS9X+z4d+dQY8hzYHDR/nm9+Wsmfg8Gz8ay7HEE0z5cX76+gden0zb8+rQtmHtkMWYkVPTD3UU4SPi+1GLSIxbQ20bzIDOUg0RWYHTO+UrVf3OrWmnlVcDvlXVVQCqOh1nCEJwptKprKr7RKQ58KWINFDV06olItIP6AdQuVLlMwpw/po/+fb35cxctIoTSckcOnac7k+8xIatO2hVrwYAPTu2puvgF874xftbbOFCdGxSj1mLVtGwWmgmnI8tXIgOTeqxYO1GEo4cI8XjISY6mu3xB6hQIi4oMfy8fC1Vy5SiVGxRALq2bc7CdRu5qdMFPPPhl8QfPMyUgb1yOErglYkrys59CZQrEcvOfQmUduMNtgol49i6Z3/68va9+6lQMjg/qyxJ5N+ZmDY63goRmS4it4pIj7RHMILLYA3QPIt1aW3MTVV1WMZyoAbQXES6ZtxRVU+o6j73+VJgE5BpFUlVx6tqC1VtUbJkyTMK/uk+17Npysv8+eGLTHribjo2qcf/RtzPoaPH+WvbLgB+XLqaul4XGoNpb8IhEo4cBeD4iSR+WLr6lIueoYjhx6VrqFulPB2a1OPzuYsBmDz7V66+IMvpPP2qUuniLF6/iWOJJ1BV5qxYS51K5Zn43S/8sHQ1Ewf1Jyoq9HWxqy5oyqRZ8wCYNGseV7cNzvuTUcu61dm4fRebd+4hKTmFT35aELSfVXb8OQt5qPjSRp0fZ1aCiznZn1pxZjcIpp+AZ0SkX9o8ZiLSCGfWhGyparyIDMK5+HhKtwp37JL9bjt2daAWzrCFARcTHc0bD/bmxuGvERUlxBYuxNsP98l5xwDYuS+B3s+Nx5OaSmpqKtd1bM1V5zcNbgz7E+gz+h0nBlV6dmhFlzZNqFe5PP8Z9QbD3v+cxjWr0Ltz+6DE07JuDbq3a0HbAcOIjo6mcY3K3NG5A6W696dymRJc9ODTAHRr25zBt3QLSky3jHyDX1auI/7gEapcfz9Db+/BYzddxY0jxvH+d3OpXKYEU4cMCEosGcVER/PqwNvo/OgYPKmp9O7cngbVKoYkljS5YWQ8X0hWEw6IyDbgJU4mZu/Xq6r6UuDDOy2m8sDLODXrRGAL8AAwzZ2+3XvbqsA3aeVur5EVwAAgDmfK9yEici0wAkjGGWxqqKp+TQ6aN2uuC+b+7o+X5RfhOAu5xxNeY3clp4RXPOE4C3k4dVNr0bY1S5YuPaeAqtZuqE+97ludsu/ldZZmN2diKGVXo44GCpP5B9JZTSdzrlR1B5l3sWuYybZbvMvdKXAae20y3S3/nND0YjHGBJgA0eHz2XPWskvUO1V1RDbrjTEmzIV/+7Mvsvu+nPtfnTHm/ze314cvD58OJxIrIv8TkfUisk5EzheR4iLyvYj85f4f524rIvKqiGwUkVXu8BtnJbtE3elsD2qMMeEgAP2oXwFmqmpdnKbUdcAg4EdVrQX86C4DdMbpnFALp1vvm2f7OrKMT1X3Z7XOGGNyC3+N9SEixYD2uLOMq2qSqiYA3YAP3M0+4OQQFt2ASepYAMSKSLmzeQ3h11XAGGP8xLmYKD49gJIissTr0S/D4aoBe4H33TuZ3xWRQkAZVU27hXYXzvhD4AxZ4X177zbOchiL4IzNaIwxIXIG1xLjc+ieFwM0A+5T1YUi8gonmzkAp3eZiPi9V5zVqI0xEc2PbdTbgG2qutBd/h9O4t6d1qTh/r/HXb8d8B6DoaJbdlavwRhjIpa/2qhVdRewVUTquEWdgLU492SkDfrSC/jKfT4duM3t/dEGOOjVRHJGrOnDGBOxzqTrnY/uAz4Skbw4Q030xqnwfioifYB/OHlT3gzgSmAjzryzvc/2pJaojTERzZ/NBqq6AsisHfu07szu3dD3+uO8lqiNMREtEu5MtERtjIlYaVNx5XaWqE3ApITZ6Hn584XXr/ux48mhDuE0BQucNv9zLhf+E9f6Irx+c40xxs9yf5q2RG2MiWDW9GGMMeFOwmsyhLNlidoYE9EifeIAY4zJ1Zw5E3N/prZEbYyJaBHQ8mGJ2hgT2exiojHGhDlr+jDGmDAmAlERMEaoJWpjTESLshq1McaEN7uYaIwxYUywW8iNMSbMiQ1zaowx4S4C8rQl6mDzeFK54N6hlC8Zx7Sn/8vPy9cyePxUklJSaFqrKm8/1IeY6Oigx9Vn9Dt8u2A5pWOLsur954J+foA/t+7k1mfeTF/esmsvT916DQlHj/H+d79QslgRAIb3vpYrWjUOSYweTyqt+g+hfMk4vn72oaCc8+6xE5i5aCWlYouy6M2RAOw/fITbn32Lf/fEU7l0ST4YfDdxRQoBMG/Veh4bP4XkFA8lihZm5vODsju8X81ctIoHX5+Mx5NKny4deezmq4N27swIEB0BmTpXdVwRkbIiMlVENonIUhGZISK1ReS4iKwQkbUi8paIRIlI1Qzlk0Qk08F2RaSRiPwuImtE5A8RyR+o1/D6tNnUqVwegNTUVPqOeYfJT9zDsneeoXLpkkye/WugTp2tXle0Y8boR0Ny7jS1K5Vj4ZsjWPjmCOa/PowC+fLStW0zAO675rL0daFK0gCvfj6Luu7PL1huuaQt00b+95Sylz6dQYcm9Vjx7nN0aFKPlz6bAUDCkWM8OG4ynwwZyOK3nmby4/cELU6PJ5X7XvmAb597hNUTRzP1x99Zu+WsJt32Hzk5b2JOD58OJxItIstF5Bt3uZqILBSRjSLyiTuXIiKSz13e6K6vei4vI9ckanGGwJoGzFHVGqraHBgMlAE2qWoToBFQH+ju7pZWfh7OVO3XZzgsIhIDfAj0V9UGQEcgICO6b9u7n+8WrqR35w4A7Dt0hLwx0dSqWBaATs0b8OW8JYE4dY7aN65L8aKFQnLuzPy8Yi3Vy5WmcpmSoQ4l3ba9+5mxYAV9unQI6nkvPK9Oem05zbcLlnPLJW0BJ5F/8/syAD6bs4CuFzSnUukSAJSKLRq0OBet30SN8mWoXr40efPEcMPFbZj+29KgnT8r4uM/H90PrPNaHg2MVdWawAGgj1veBzjglo91tztruSZRAxcByar6VlqBqq4EtnotpwDzgZreO6qqB1gEVMjkuJcBq9xjoar73O397pE3P+KZO68nyr2ntWSxIqR4Ulm6YTMA0+YuZtve/YE4da7z2ZyFXNexdfryW1//SKv+T3HXi+9x4PDRkMT04Osf8txdNxIVBndQ7E04RNnisQCUiSvG3oRDAGzcvouEI0fp/Nho2g0czsc//ha0mLbHH6BS6eLpyxVKFWd7/IGgnT8zaeNR+/LI8VgiFYEuwLvusgAXA/9zN/mAk5XEbu4y7vpOcg7jrYb+N853DYFsP55FpCDObMB/ZCjPD7QGZrrLXUVkhLu6NqAiMktElolIlt//RaSfiCwRkSXx8fFnFPyMBSsoFVuUZrWreR+PyU/cwyNvfcyFA4ZRuGB+osMgCYRaUnIKMxasoEf7lgDcedVFrHn/eRa8MZyyxWMZNH5q0GP65nen/b55nWo5bxxkIienm0rxpLJ84z/8b/gDTBv5X56f8jV/bdsV4ghD6wyaPkqm/X27j34ZDvUy8CiQNsdcCSDBrSACbONkZbACbiXSXX/Q3f6sRMrFxBoisgJQ4CtV/c5tE0orrwZ8q6qrAFR1OjDd3TcGuBBoCRwDfhSRpar6Y8aTqOp4YDxA82bN9UwCnL/mT779fTkzF63iRFIyh44d5/bn3mLioP78NPYJAL5f8gcb/5//UQHMWryKJjWrUCauGED6/wB3dO7AtUNeDnpM81f/ydfzl/HdwpUkuj+/W0e9yeQn7g56LOA0aezan0DZ4rHs2p+QfqG1fMk4ihctTKH8+SiUPx8XNKzN6s1b05vXAqlCyTi27jn5jXD73v1UKBkX8PPm5AyaNeJVtUWmxxC5CtijqktFpKOfQvNZbqq+rQGaZ7Fuk6o2UdWmqjosYzlQA2guIl0z2XcbMFdV41X1GDADaObHuAF4us/1bJryMn9++CKTnribjk3qMXFQf/YccL6ynkhK5sVPZtD3qov9fepcJ2Ozx859CenPp89fSv2qmbVgBdYzd97Av5+9yt9Tx/LxkHu5qGn9kCVpgCvbNOWjH5xmjY9++I0ubZoC0KVNU35f8xcpHg/HEk+wZMNm6lQqF5SYWtatzsbtu9i8cw9JySl88tMCrr7A739KZ0yifHvkoC3QVUS2AFNxmjxeAWLd61zgXAdLu3q6HagE6dfBigH7zvY15KYa9U/AMyLSz63ZIiKNcN6AbKlqvIgMwrn4OD3D6lnAo26zSRLQAafxPyjGfjaDGQtWkKpKv6sv5qKm9YN16lPcPHIcv6xYR/zBI1S+biBDb+9Bny4dgx7H0cQT/LRsDa/d3yu97Mn3PmXVpn8RESqXKclrA3tlc4TI03v0W8xbtYF9h45Q59aHePw/3fjvdVfS69k3mTx7HpVKl+CDwc6HRt3K5bmkeUPa3DOEqKgoel3ejvpVKwYlzpjoaF4deBudHx2DJzWV3p3b06BacM6dHX+Mnqeqg3HyB26N+mFVvUVEPgN64iTvXsBX7i7T3eXf3fU/qeoZfQv3Juewb9CJSHmcdqLmQCKwBXgAmKaqDTNsWxX4Jq3cbchfAQwA4oAWqjrEXfcfnB+CAjNUNcd+as2bNdcFc3/3w6vyjzwx4ffl6ERSSs4bBVG+vOFVLzl2PCCdi85JwQKZ9mANiRZtW7Nk6dJzyrINGzbWTz+d7dO2DRqUXZpV04c3r0R9lYhUx0nSxYHlwH9U9YR7XWwy0BTYD9yoqn+f3avIXTVqVHUHmXSxw7nQmHHbLd7l7qeZdwfc6V7rPsTpomeMiSgnL7T6i6rOAea4z/8GWmWyTSJwnb/OmasStTHGnKncf1+iJWpjTISLioC5uMKvYdMYY8wprEZtjIlYgo2eZ4wx4U3w+8XEULBEbYyJaLk/TVuiNsZEOKtRG2NMGBMgEsY5s0RtjIlo/riFPNQsURtjIlvuz9OWqI0xEewMptkKZ5aojTER7Iym2QpblqjPkseTysHDiaEOI13xYgVCHcJp9h44HuoQTlGxTJFQh3CKcBqpLs3ufaGZ5iwzySmpOW/kA6tRG2NMGHPmTMz9mdoStTEmokVAnrZEbYyJbJFww0sEdAU3xpjIZjVqY0zkipDueVajNsZELOcWcvHpkeOxRCqJyM8islZE1ojI/W55cRH5XkT+cv+Pc8tFRF4VkY0iskpEznpKdkvUxpgIJj7/80EK8JCq1gfaAPeKSH1gEPCjqtYCfnSXAToDtdxHP+DNs30VlqiNMRFNxLdHTlR1p6ouc58fBtYBFYBuwAfuZh8A3d3n3YBJ6lgAxIpIubN5DZaojTERTXx8ACVFZInXo1+WxxSpCjQFFgJlVHWnu2oXUMZ9XgHY6rXbNrfsjNnFRGNMZPP9amK8qrbI+XBSGPgceEBVD3l3/1NVFRE9qzizYTVqY0zE8rU27WsqF5E8OEn6I1X9wi3endak4f6/xy3fDlTy2r2iW3bGLFEbYyKXj+3TvlS6xak6vwesU9WXvFZNB3q5z3sBX3mV3+b2/mgDHPRqIjkj1vRhjIlofrwzsS1wK/CHiKxwyx4HngM+FZE+wD/A9e66GcCVwEbgGND7bE9siTqAtsfvZ8Cr7xOfcBgR+M+l7eh3VSemz1/KC598zZ/bdjFz9CCa1KwKwC8r1vL0h9NISkkhb0wMQ3pdS7vz6gYsvq179tH7ufHsOXAQEaFPl44MvPZy9h86ws0jx/HP7niqlCnJlCEDiCtSKCAx7Ijfz4NvfED8wcOICDdf3JY7rrwYgPdn/szk2XOJiori4qYNePyWHiSneHhs/Ies3ryVFI+Ha9u35t7uVwQktoxmLlrFg69PxuNJpU+Xjjx289VBOW84xbM9fj/3vzaRvQcPIQj/ufRC+nbpxIhJn/P9klXkjYmhStmSjL23F8UKFeSLuQt5Y/r36fuv+2c7s55/nIbVKmVzlvCkqr+SdStJp0y2V+Bef5w7VyVqESkLvAy0BBKA3cADwEpgA5AXmAvcA1TG6T6TVr4E6KOqyRmOmRd4G2gBpAL3q+ocf8QbExXN8F7X0ahGZY4cT+TSh0fRoXE96lYuz4RH+/PIWx+dsn3xooWZ/Pi9lC0ey7p/tnPjyFdZ+e5of4SSeXzR0Tzf/yaa1a7K4WPHad1/CJc0b8ikWfO4uFl9Hr3pap6f8jXPT/mGZ/vdEJAYoqOjefLWazmvmvMeXTX4OS5sVI/4g4f4fskqvhv9OPny5CH+4GEAvl2wjKTkFGaPeZLjJ5K45KERdL2gJZVKlwhIfGk8nlTue+UDZo15jIqlitO6/xCuvqAZ9aue1UX8XBtPTHQ0Q3r1pFF15+d1xaPP0L5RPdo3qsfjt3QnJjqapyd/wWtfzOTJW3vQo31rerRvDThJ+o7n3wx6krY7E4PIbR+aBsxR1Rqq2hwYjNMVZpOqNgEaAfU52Y8xrfw8nIb86zndnQCqeh5wKfCiiPjlfSlTvBiNalQGoHCB/NSqWI5d+xKoXbEcNSuUPW3786pXpmzxWADqVi5PYlISJ5KTT9vOX8qViKVZ7aoAFClYgLpVyrMj/gBfz1/GrZe1A+DWy9ox/belAYuhTFwxzqt28j2qWaEsu/cn8OH387in2+Xky+OM2VyymDOWtAgcO3GCFI+HxKQk8sTEUKRg/oDFl2bR+k3UKF+G6uVLkzdPDDdc3Cag70u4xlMmrhiNqp/689q5P4GOTeoTEx0NQPPa1di578Bp+37562K6tc2xU0UA+PNyYmjkmkQNXAQkq+pbaQWquhKvfoqqmgLMB2p676iqHmARmfdhrA/85G63B6em7vffpn/3xLN68780q13Np+2/+X0Z51WvnJ6oAm3Lrr2s2PgPrerVYPeBQ5QrEQtA2eLF2H3gUFBi2LpnH2u2bKVJzaps3rmHRes30u2J57l++Eus3LQFgCtbN6Ngvny07D+Y8wc8Sb+rLiG2cGCaZbxtjz9ApdLF05crlCrO9vjTk1GwhEM8W/fEs3rLVprVOvV3espP87m4WcPTtp8+fwndL2wZrPAANwX76WJiKOWmRN0QyLbKICIFcdqK/shQnh9oDcx0l7uKyAh39Uqgq4jEiEg1oDmndqnxPk6/tM7w+/bt8znwo8cT6fP824y843qKFMx5Jpb1/+5g5OQveKH/f3w+x7k4cjyR64e9xov33ELRQqfGJyJB+SU+mphI/7HjGdKrJ0UKFiDF4yHhyFG+fPoRHr+lB/e8/B6qyopNW4iKimLRm8/y66sjeefbH/h3d3zgAzSnOHo8kb4vjGfE7af+Tr/y+QxioqPo0a7VKdsv+3MzBfLlpW7l4DcVWaIOHzXcq7C/Ad+q6ncZyncDO1V1FYCqTlfVIe42E3DuGFqC0/49H/BkdhJVHa+qLVS1RYkSvrWJJqd4uGPM21zbvhVd2uQ8JsuO+AP0Hv0mrw/sTdWypXw6x7lITknh+mGvclOn87mmnVPbKRNXlJ37EgDYuS+B0rFFAxyDh/4vvUP3C1vRuVVTAMqViOOKVk0QEZrUrEqUCPsPH+Gr3xbTsXF98sREU7JYEZrXqcGqv/8JaHwAFUrGsXXP/vTl7Xv3U6FkXMDPG47xJKd46PvCeHq0a8WVbZqml3/y83x+WPoHr9/f57SeFl/9tpjubYNbm07jx7E+QiY3Jeo1OLXdzGxS1Saq2lRVh2UsB2oAzUWka8YdVTVFVR909+8GxAJ/+iNgVeXBcZOoVaEs/btemuP2B48e45ZRr/PkrdfQql7NHLf3R3x3vvAedSuX58HrOqeXX3VBUybPngfA5NnzuPqCsx70y6cYHn17MjUrlOXOLicvnF/WohG/r3F+DH/v2E1ySgrFixSmQonizF+zAYBjiSdY/tdmapQvk+mx/all3eps3L6LzTv3kJScwic/LQjo+xKu8agqD70xiVoVy3LX1Zekl/+8fA1vfDWbiY/dQ8F8eU/ZJzU1la9/X0q3C0PQPu3vO15CRJweJOHPvZi4AHhPVce7ZY2AYsCbqtoww/ZVgW/SykXkGuBRVT0/w3YFcd6HoyJyKfCUqrbPKZ4mjZvqDzN/yXabhes20vWJMdSrUiF93rbHb+lOUnIKj787lX2HjlC0UAEaVqvEJ0Pu56XPvuXVL2ZSvVzp9GN8MuR+SvlQoz2byW1//WMDFz0wiobVKqUP8/h0n+toVbc6N40cx9Y9+6hcpgRTnhpA8aKFz/j4O/YeyXGbxes30nPYS9StXJ4o9xruIzd25cLz6vLIW5NZu2UbeWJieOI/PWjbsA5HExN5+M3J/LV9F6rKdR3Pp//VOX8IwrlPbjtjwQr+O+4jPKmp9O7cnsf/0+2cjneuAhFPTpPbLly3kWueeoF6lSsg7u/M4Ju78dSETzmRnJLejbN5rWqMvusWAOav3sAzH33JN88+dkaxXHZlR1auXH5OKbRZ02b660+/+bRtoeIFl/pyC3ko5JpEDSAi5XGaJ5oDicAWnO5503xI1AKsAAYAcUALVR3ibjcLp2vedpwufDl+l/YlUQdTOM5C7kuiDqZwm4U8HIXTLOR+S9Q/+5io48I3UeeqftSquoPMu9iddolZVbd4l7udzxt7bTLda7s6/ozTGBMeBImIWchzUxu1Mcb8v5SratTGGHOmbBZyY4wxAWc1amNM5MoFN7P4whK1MSaiRUCetkRtjIlskdBGbYnaGBPZcn+etkRtjIlczt3huT9TW6I2xkS0CGj5sO55xhjjKxG5QkQ2iMhGERkUrPNaojbGRDRnTPWcHz4cJxoYB3TGmXDkJhGpH+DwAUvUxphI5uOkAT42j7QCNqrq36qaBEwFgjKEorVRn6WVq1bElypfzB8j1pcEwmmKEosnZ+EWU6TGU+VcD7B02bJZUiBPSR83zy8iS7yWx6cNqeyqgNfUfzgTjrQ+1xh9YYn6LKmqX6ZfEZEl4TS0osWTs3CLyeLJmqpeEeoY/MGaPowxxjfbOXU+1YpuWcBZojbGGN8sBmqJSDURyQvciDuufaBZ00fojc95k6CyeHIWbjFZPEGgqikiMgBnRqhoYIKqrgnGuXPVVFzGGPP/kTV9GGNMmLNEbYwxYc4StTHGhDlL1MYYE+YsUYcJEQlJDxwRiRKRKPd5XhFpJiLFQxFLZkTknlDHkEZECrvvT2yIzp9XvAalEJGLROQhEekcini8iUgLEblGRLqKSN1QxxNprHteEInIr6p6oft8sqre6rV6EdAsyPF0B94GUkWkP/A4cASoIyJ3q+rXQY7nvxmLgMEikh9AVV8KcjxvqOo97vMLgY+BTUBNEblLVWcEMx6cfrwdgQMi8ghwDTAD+K+ItFfVwUGOBxHpALwIJADNgd+AOBFJBm5V1a3Z7G58ZIk6uAp5PW+QYV0oRs0dCjQGCgArgZaqukFEqgCfA0FN1MBwnMSzhpPvRzRQJMhxpGnj9Xwk0F1Vl4lIdeBTnFiDKVpVD7jPbwDaqepxEXkOWAYEPVEDLwOXqepeEakGvKSqbUXkUuA94LIQxBRxrOkjuLLrtB6SDu2quktVNwP/quoGt+wfQvO70cA9byFgjKoOBw6o6nD3eSgVVdVlAKr6N6F5fw6JSEP3eTyQ330eE6J4wPnw2Os+/xd3ICVV/R5nECPjB1ajDq5YEbkG548qVkR6uOUCFAtFQCISpaqpwB1eZdFA3mDHoqr/AteJSDfgexEZG+wYMqgrIqtwfj5VRSROVQ+4bfpBf3+A/sBHIrIS2AMsEZG5wHnAMyGIBzeG94CfgK7AHAARKYjzbcj4gd2ZGEQi8n5261W1d7BiARCRlsAfqpqYobwqcKGqfhjMeDLEUAgYBrRW1fYhiiHjMJs7VDVZREoC7VX1ixDEFI3TnFAbp6K1DZilqgnBjsWNJw9wJ85A+itxbqv2iEgBoLT77cycI0vUQSQiZVV1V6jjMMbkLtZGHVwrROQHEekTqi5eWRGRYdktB5vFk71wiyezGMIhpkhhiTq4KgBjgAuBDSLylYjc6H5NDLWlOSwHm8WTvXCLB8IzpohgiTqIVNWjqrPctuhKwAScOdc2i8hHIY4tY1e8/SEJxGXxZC/c4oHwjClSWK+PEFHVJBFZC6zDuVGgXrBjcC9MXY9T05+pqqtF5CqcG18KAE0tHosnt8UUiexiYpCJSCWcmSFuwukvPAWYqqrrQxDLRJya/SKcSTp3AC2AQar6pcVj8eTGmCKRJeogEpH5ODWPz4ApqhrSNjwRWQ00UtVU9zbtXUANVd1n8Vg8uTWmSGRNH8E1CJin4fPpmOTe7IKqJorI3yH+A7N4clc84RpTxLEadRCJyGtkc6u4qg4MYjiIyDFgY9oiUMNdFiccbWTxWDy5LaZIZDXq4FoS6gAyCPoFzBxYPNkLt3ggPGOKOFajDiIReUZVHw91HN7coU5r4txKPivE4Vg8OQi3eCA8Y4o0lqiDSESWqWpQx5zOjoi8gTNi3XygE/C1qo60eCye3BxTJLJEHUTuqGcdyWLsaVUN6g0C7hX7xu4gOgVxLnQ2D2YMFk/ujSdcY4pE1kYdXHVxbqvNLFErUD244ZCkqh4AVT0mIpl+gFg8Fk82wjGmiGM16iASkeWqGjZ3amVzxR6AMOrVYPGEYTzhGlMkshp1mBCRMqq6O8inbQyUATLOa1cJ58aFYLN4shdu8UB4xhRxbFCm4HrFe0FEYt0hT38ElocgnrHAQVX9x/sBHHTXWTwWT26MKeJYjTqIVHWiO6RpN+BmnAFrigDdgbkhCKmMqv6RsVBV/3BnebF4LJ6chGNMEcdq1EEkIh8DfwKXAq8BVXEmb52TdhtukMVmsy4UY2THZrPO4gm/eCA8Y4o4lqiDqz5wAGdo03Xu1fJQXs1dIiJ3ZiwUkb6EZtB3iyd3xQPhGVPEsV4fQSYidXGGOL0BiAfqAA1DcCERESkDTAOSOPlH1QJnhu1rNMjzO1o8uSuecI0pElmiDiERaY7TVn0dsE1VLwhRHBcBDd3FNar6UyjisHhyZzwQnjFFEkvUYcC9SaCdqobigqIxJsxZr48gEpEGOIOqT3eXxwLF3NWvhywwY0xYs4uJwfUcTrt0msuBb4GfgSEhicgYE/asRh1c5VR1vtfyIVX9HEBE7gpRTMaYMGc16uAq4r2gqm28FksHORZjTC5hiTq4dohI64yFItIGZ/ZmY4w5jfX6CCIRaQV8AkwElrnFzYFewA2quihEoRljwpgl6iATkdLAAJxZMQDWAONCccOLMSZ3sEQdRCJSVFUPZbGusqr+G+yYjDHhz9qog2tO2hN3aFNvXwY1EmNMrmGJOri8pykqns06Y4xJZ4k6uDSL55ktG2MMYDe8BFtpEfkvTu057TnucqnQhWWMCWd2MTGIRGRodutVdXiwYjHG5B6WqI0xJsxZ00cQiUh2Ay+pqo4MWjDGmFzDatRBJCIPZVJcCOgDlFDVwkEOyRiTC1iiDhERKQLcj5OkPwVeVNU9oY3KGBOOrOkjyESkOPBf4BbgA6CZqh4IbVTGmHBmiTqIRGQM0AMYD5ynqkdCHJIxJhewpo8gEpFU4ASQwqk3uAjOxcSiIQnMGBPWLFEbY0yYs1vIjTEmzFmiNsaYMGeJ2gSEiHhEZIWIrBaRz0Sk4Dkca6KI9HSfvysi9bPZtqOIXHAW59giIiV9Lc+wzRldFBaRYSLy8JnGaP7/skRtAuW4qjZR1YZAEtDfe6WInFWPI1Xtq6prs9mkI3DGidqYcGaJ2gTDPKCmW9udJyLTgbUiEi0iY0RksYisEpG7AMTxuohsEJEf8JqhXUTmiEgL9/kVIrJMRFaKyI8iUhXnA+FBtzbfTkRKicjn7jkWi0hbd98SIjJbRNaIyLv4MB64iHwpIkvdffplWDfWLf9RREq5ZTVEZKa7zzwRqeuXd9P8v2P9qE1AuTXnzsBMt6gZ0FBVN7vJ7qCqthSRfMBvIjIbaArUAeoDZYC1wIQMxy0FvAO0d49VXFX3i8hbwBFVfcHd7mNgrKr+KiKVgVlAPWAo8KuqjhCRLjh3iObkDvccBYDFIvK5qu7DGQZgiao+6I7nMhRnXszxQH9V/cudff4N4OKzeBvN/3OWqE2gFBCRFe7zecB7OE0Si1R1s1t+GdAorf0ZKAbUAtoDU1TVA+wQkZ8yOX4bYG7asVR1fxZxXALUF0mvMBcVkcLuOXq4+34rIr7cHTpQRK5xn1dyY90HpOLMLg/wIfCFe44LgM+8zp3Ph3MYcxpL1CZQjqtqE+8CN2Ed9S4C7lPVWRm2u9KPcUQBbVQ1MZNYfCYiHXGS/vmqekxE5gD5s9hc3fMmZHwPjDkb1kZtQmkWcLeI5AEQkdoiUgiYC9zgtmGXAy7KZN8FQHsRqebumzYH5WGgiNd2s4H70hZEpIn7dC5ws1vWGYjLIdZiwAE3SdfFqdGniQLSvhXcjNOkcgjYLCLXuecQEWmcwzmMyZQlahNK7+K0Py8TkdXA2zjf8qYBf7nrJgG/Z9xRVfcC/XCaGVZysunha+CatIuJwECghXuxci0ne58Mx0n0a3CaQP7NIdaZQIyIrAOew/mgSHMUaOW+houBEW75LUAfN741QDcf3hNjTmO3kBtjTJizGrUxxoQ5S9TGGBPmLFEbY0yYs0RtjDFhzhK1McaEOUvUxhgT5ixRG2NMmPs/3CHjaFdjpQcAAAAASUVORK5CYII=\n",
      "text/plain": [
       "<Figure size 432x288 with 2 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "plot_confusionmatrix(df_train[\"gold\"], train_result[NAIVE_BAYES][\"predictions\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 2 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "plot_confusionmatrix(df_train[\"gold\"], train_result[NAIVE_BAYES][\"predictions\"], normalize='pred')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<AxesSubplot:ylabel='Frequency'>"
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "df_train[\"x_span\"].apply(lambda x: len(x.split(\" \"))).plot.hist(bins=100)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>participant1_id</th>\n",
       "      <th>participant2_id</th>\n",
       "      <th>x_span</th>\n",
       "      <th>x</th>\n",
       "      <th>y_raw</th>\n",
       "      <th>gold_raw</th>\n",
       "      <th>unique_chemprot_names</th>\n",
       "      <th>abstract</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1134</th>\n",
       "      <td>T1</td>\n",
       "      <td>T24</td>\n",
       "      <td></td>\n",
       "      <td>Tissue expression and translational control of GENEIG7e/CHEMIG3 transaminase K mRNAs. _CHEMICAL_ (CHEMIG10) is an endogenous CHEMIG4 receptor antagonist at the level of the different GENEIG1. One of the enzymes responsible for the production of CHEMIG10, CHEMIG11 aminotransferase I (GENEIG5), also catalyses the reversible transamination of CHEMIG3 to CHEMIG17 (GENEIG14, GENEIG13). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different GENEIG5 mRNAs coding for a protein respectively with and without GENEIG20 targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new GENEIG5 cDNAs containing different GENEIG6 (GENEIG16). One of the transcripts (+14GENEIG5 cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several GENEIG5 mRNAs are constitutively expressed in ubiquitous manner, while +14GENEIG5 mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each GENEIG5 mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of GENEIG18 enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the GENEIG19/GENEIG14 gene was also studied. The expression of several GENEIG5 mRNAs with different GENEIG9 represents an interesting example of transcriptional/translational control on the expression of CHEMIG12 (CHEMIG15)-dependent aminotransferases.</td>\n",
       "      <td>CPR:6</td>\n",
       "      <td>CPR:6</td>\n",
       "      <td>[5' untranslated regions, 5'UTRs, EC 2.6.1.15, GTK, KA, KAT, KATI, Kynurenic acid, PLP, UTRs, glutamate, glutamate receptor, glutamine, glutamine transaminase K, ionotropic glutamate receptors, kynurenine, kynurenine aminotransferase I, leader sequence, oxoglutaramic acid, pyridoxal phosphate, pyridoxal phosphate (PLP)-dependent aminotransferases, rat KATI, rat kynurenine aminotransferas]</td>\n",
       "      <td>Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs. Kynurenic acid (KA) is an endogenous glutamate receptor antagonist at the level of the different ionotropic glutamate receptors. One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different KATI mRNAs coding for a protein respectively with and without leader sequence targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new KATI cDNAs containing different 5' untranslated regions (UTRs). One of the transcripts (+14KATI cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several KATI mRNAs are constitutively expressed in ubiquitous manner, while +14KATI mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each KATI mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of KAT enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the rat KATI/GTK gene was also studied. The expression of several KATI mRNAs with different 5'UTRs represents an interesting example of transcriptional/translational control on the expression of pyridoxal phosphate (PLP)-dependent aminotransferases.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1135</th>\n",
       "      <td>T1</td>\n",
       "      <td>T33</td>\n",
       "      <td>_CHEMICAL_ (CHEMIG1) is an endogenous CHEMIG5 receptor antagonist at the level of the different _GENE_</td>\n",
       "      <td>Tissue expression and translational control of GENEIG10e/CHEMIG14 transaminase K mRNAs. _CHEMICAL_ (CHEMIG1) is an endogenous CHEMIG5 receptor antagonist at the level of the different _GENE_. One of the enzymes responsible for the production of CHEMIG1, CHEMIG13 aminotransferase I (GENEIG2), also catalyses the reversible transamination of CHEMIG14 to CHEMIG8 (GENEIG16, GENEIG3). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different GENEIG2 mRNAs coding for a protein respectively with and without GENEIG9 targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new GENEIG2 cDNAs containing different GENEIG19 (GENEIG15). One of the transcripts (+14GENEIG2 cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several GENEIG2 mRNAs are constitutively expressed in ubiquitous manner, while +14GENEIG2 mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each GENEIG2 mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of GENEIG6 enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the GENEIG12/GENEIG16 gene was also studied. The expression of several GENEIG2 mRNAs with different GENEIG4 represents an interesting example of transcriptional/translational control on the expression of CHEMIG0 (CHEMIG7)-dependent aminotransferases.</td>\n",
       "      <td>CPR:6</td>\n",
       "      <td>CPR:6</td>\n",
       "      <td>[5' untranslated regions, 5'UTRs, EC 2.6.1.15, GTK, KA, KAT, KATI, Kynurenic acid, PLP, UTRs, glutamate, glutamate receptor, glutamine, glutamine transaminase K, ionotropic glutamate receptors, kynurenine, kynurenine aminotransferase I, leader sequence, oxoglutaramic acid, pyridoxal phosphate, pyridoxal phosphate (PLP)-dependent aminotransferases, rat KATI, rat kynurenine aminotransferas]</td>\n",
       "      <td>Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs. Kynurenic acid (KA) is an endogenous glutamate receptor antagonist at the level of the different ionotropic glutamate receptors. One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different KATI mRNAs coding for a protein respectively with and without leader sequence targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new KATI cDNAs containing different 5' untranslated regions (UTRs). One of the transcripts (+14KATI cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several KATI mRNAs are constitutively expressed in ubiquitous manner, while +14KATI mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each KATI mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of KAT enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the rat KATI/GTK gene was also studied. The expression of several KATI mRNAs with different 5'UTRs represents an interesting example of transcriptional/translational control on the expression of pyridoxal phosphate (PLP)-dependent aminotransferases.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1136</th>\n",
       "      <td>T3</td>\n",
       "      <td>T24</td>\n",
       "      <td></td>\n",
       "      <td>Tissue expression and translational control of GENEIG15e/CHEMIG6 transaminase K mRNAs. CHEMIG10 (_CHEMICAL_) is an endogenous CHEMIG2 receptor antagonist at the level of the different GENEIG18. One of the enzymes responsible for the production of CHEMIG19, CHEMIG8 aminotransferase I (GENEIG3), also catalyses the reversible transamination of CHEMIG6 to CHEMIG9 (GENEIG14, GENEIG0). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different GENEIG3 mRNAs coding for a protein respectively with and without GENEIG16 targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new GENEIG3 cDNAs containing different GENEIG7 (GENEIG11). One of the transcripts (+14GENEIG3 cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several GENEIG3 mRNAs are constitutively expressed in ubiquitous manner, while +14GENEIG3 mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each GENEIG3 mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of GENEIG5 enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the GENEIG21/GENEIG14 gene was also studied. The expression of several GENEIG3 mRNAs with different GENEIG17 represents an interesting example of transcriptional/translational control on the expression of CHEMIG12 (CHEMIG13)-dependent aminotransferases.</td>\n",
       "      <td>CPR:6</td>\n",
       "      <td>CPR:6</td>\n",
       "      <td>[5' untranslated regions, 5'UTRs, EC 2.6.1.15, GTK, KA, KAT, KATI, Kynurenic acid, PLP, UTRs, glutamate, glutamate receptor, glutamine, glutamine transaminase K, ionotropic glutamate receptors, kynurenine, kynurenine aminotransferase I, leader sequence, oxoglutaramic acid, pyridoxal phosphate, pyridoxal phosphate (PLP)-dependent aminotransferases, rat KATI, rat kynurenine aminotransferas]</td>\n",
       "      <td>Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs. Kynurenic acid (KA) is an endogenous glutamate receptor antagonist at the level of the different ionotropic glutamate receptors. One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different KATI mRNAs coding for a protein respectively with and without leader sequence targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new KATI cDNAs containing different 5' untranslated regions (UTRs). One of the transcripts (+14KATI cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several KATI mRNAs are constitutively expressed in ubiquitous manner, while +14KATI mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each KATI mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of KAT enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the rat KATI/GTK gene was also studied. The expression of several KATI mRNAs with different 5'UTRs represents an interesting example of transcriptional/translational control on the expression of pyridoxal phosphate (PLP)-dependent aminotransferases.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1137</th>\n",
       "      <td>T3</td>\n",
       "      <td>T33</td>\n",
       "      <td>_CHEMICAL_) is an endogenous CHEMIG15 receptor antagonist at the level of the different _GENE_</td>\n",
       "      <td>Tissue expression and translational control of GENEIG12e/CHEMIG21 transaminase K mRNAs. CHEMIG11 (_CHEMICAL_) is an endogenous CHEMIG15 receptor antagonist at the level of the different _GENE_. One of the enzymes responsible for the production of CHEMIG9, CHEMIG18 aminotransferase I (GENEIG10), also catalyses the reversible transamination of CHEMIG21 to CHEMIG3 (GENEIG6, GENEIG2). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different GENEIG10 mRNAs coding for a protein respectively with and without GENEIG14 targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new GENEIG10 cDNAs containing different GENEIG16 (GENEIG17). One of the transcripts (+14GENEIG10 cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several GENEIG10 mRNAs are constitutively expressed in ubiquitous manner, while +14GENEIG10 mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each GENEIG10 mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of GENEIG0 enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the GENEIG4/GENEIG6 gene was also studied. The expression of several GENEIG10 mRNAs with different GENEIG8 represents an interesting example of transcriptional/translational control on the expression of CHEMIG19 (CHEMIG13)-dependent aminotransferases.</td>\n",
       "      <td>CPR:6</td>\n",
       "      <td>CPR:6</td>\n",
       "      <td>[5' untranslated regions, 5'UTRs, EC 2.6.1.15, GTK, KA, KAT, KATI, Kynurenic acid, PLP, UTRs, glutamate, glutamate receptor, glutamine, glutamine transaminase K, ionotropic glutamate receptors, kynurenine, kynurenine aminotransferase I, leader sequence, oxoglutaramic acid, pyridoxal phosphate, pyridoxal phosphate (PLP)-dependent aminotransferases, rat KATI, rat kynurenine aminotransferas]</td>\n",
       "      <td>Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs. Kynurenic acid (KA) is an endogenous glutamate receptor antagonist at the level of the different ionotropic glutamate receptors. One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different KATI mRNAs coding for a protein respectively with and without leader sequence targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new KATI cDNAs containing different 5' untranslated regions (UTRs). One of the transcripts (+14KATI cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several KATI mRNAs are constitutively expressed in ubiquitous manner, while +14KATI mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each KATI mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of KAT enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the rat KATI/GTK gene was also studied. The expression of several KATI mRNAs with different 5'UTRs represents an interesting example of transcriptional/translational control on the expression of pyridoxal phosphate (PLP)-dependent aminotransferases.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1138</th>\n",
       "      <td>T6</td>\n",
       "      <td>T20</td>\n",
       "      <td></td>\n",
       "      <td>Tissue expression and translational control of GENEIG18e/CHEMIG10 transaminase K mRNAs. CHEMIG21 (CHEMIG3) is an endogenous CHEMIG19 receptor antagonist at the level of the different GENEIG9. One of the enzymes responsible for the production of _CHEMICAL_, CHEMIG4 aminotransferase I (GENEIG15), also catalyses the reversible transamination of CHEMIG10 to CHEMIG13 (GENEIG17, GENEIG1). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different GENEIG15 mRNAs coding for a protein respectively with and without GENEIG20 targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new GENEIG15 cDNAs containing different GENEIG8 (GENEIG6). One of the transcripts (+14GENEIG15 cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several GENEIG15 mRNAs are constitutively expressed in ubiquitous manner, while +14GENEIG15 mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each GENEIG15 mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of GENEIG0 enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the GENEIG11/GENEIG17 gene was also studied. The expression of several GENEIG15 mRNAs with different GENEIG12 represents an interesting example of transcriptional/translational control on the expression of CHEMIG5 (CHEMIG2)-dependent aminotransferases.</td>\n",
       "      <td>CPR:9</td>\n",
       "      <td>CPR:9</td>\n",
       "      <td>[5' untranslated regions, 5'UTRs, EC 2.6.1.15, GTK, KA, KAT, KATI, Kynurenic acid, PLP, UTRs, glutamate, glutamate receptor, glutamine, glutamine transaminase K, ionotropic glutamate receptors, kynurenine, kynurenine aminotransferase I, leader sequence, oxoglutaramic acid, pyridoxal phosphate, pyridoxal phosphate (PLP)-dependent aminotransferases, rat KATI, rat kynurenine aminotransferas]</td>\n",
       "      <td>Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs. Kynurenic acid (KA) is an endogenous glutamate receptor antagonist at the level of the different ionotropic glutamate receptors. One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different KATI mRNAs coding for a protein respectively with and without leader sequence targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new KATI cDNAs containing different 5' untranslated regions (UTRs). One of the transcripts (+14KATI cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several KATI mRNAs are constitutively expressed in ubiquitous manner, while +14KATI mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each KATI mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of KAT enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the rat KATI/GTK gene was also studied. The expression of several KATI mRNAs with different 5'UTRs represents an interesting example of transcriptional/translational control on the expression of pyridoxal phosphate (PLP)-dependent aminotransferases.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1139</th>\n",
       "      <td>T6</td>\n",
       "      <td>T21</td>\n",
       "      <td>_CHEMICAL_, CHEMIG10 aminotransferase I (_GENE_</td>\n",
       "      <td>Tissue expression and translational control of GENEIG11e/CHEMIG12 transaminase K mRNAs. CHEMIG13 (CHEMIG14) is an endogenous CHEMIG4 receptor antagonist at the level of the different GENEIG9. One of the enzymes responsible for the production of _CHEMICAL_, CHEMIG10 aminotransferase I (_GENE_), also catalyses the reversible transamination of CHEMIG12 to CHEMIG16 (GENEIG8, GENEIG6). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different GENEIG18 mRNAs coding for a protein respectively with and without GENEIG21 targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new GENEIG18 cDNAs containing different GENEIG2 (GENEIG19). One of the transcripts (+14GENEIG18 cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several GENEIG18 mRNAs are constitutively expressed in ubiquitous manner, while +14GENEIG18 mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each GENEIG18 mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of GENEIG22 enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the GENEIG7/GENEIG8 gene was also studied. The expression of several GENEIG18 mRNAs with different GENEIG1 represents an interesting example of transcriptional/translational control on the expression of CHEMIG0 (CHEMIG3)-dependent aminotransferases.</td>\n",
       "      <td>CPR:9</td>\n",
       "      <td>CPR:9</td>\n",
       "      <td>[5' untranslated regions, 5'UTRs, EC 2.6.1.15, GTK, KA, KAT, KATI, Kynurenic acid, PLP, UTRs, glutamate, glutamate receptor, glutamine, glutamine transaminase K, ionotropic glutamate receptors, kynurenine, kynurenine aminotransferase I, leader sequence, oxoglutaramic acid, pyridoxal phosphate, pyridoxal phosphate (PLP)-dependent aminotransferases, rat KATI, rat kynurenine aminotransferas]</td>\n",
       "      <td>Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs. Kynurenic acid (KA) is an endogenous glutamate receptor antagonist at the level of the different ionotropic glutamate receptors. One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different KATI mRNAs coding for a protein respectively with and without leader sequence targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new KATI cDNAs containing different 5' untranslated regions (UTRs). One of the transcripts (+14KATI cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several KATI mRNAs are constitutively expressed in ubiquitous manner, while +14KATI mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each KATI mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of KAT enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the rat KATI/GTK gene was also studied. The expression of several KATI mRNAs with different 5'UTRs represents an interesting example of transcriptional/translational control on the expression of pyridoxal phosphate (PLP)-dependent aminotransferases.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1140</th>\n",
       "      <td>T8</td>\n",
       "      <td>T20</td>\n",
       "      <td></td>\n",
       "      <td>Tissue expression and translational control of GENEIG6e/CHEMIG0 transaminase K mRNAs. CHEMIG11 (CHEMIG3) is an endogenous CHEMIG8 receptor antagonist at the level of the different GENEIG14. One of the enzymes responsible for the production of CHEMIG3, CHEMIG10 aminotransferase I (GENEIG17), also catalyses the reversible transamination of _CHEMICAL_ to CHEMIG9 (GENEIG7, GENEIG16). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different GENEIG17 mRNAs coding for a protein respectively with and without GENEIG18 targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new GENEIG17 cDNAs containing different GENEIG21 (GENEIG20). One of the transcripts (+14GENEIG17 cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several GENEIG17 mRNAs are constitutively expressed in ubiquitous manner, while +14GENEIG17 mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each GENEIG17 mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of GENEIG1 enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the GENEIG4/GENEIG7 gene was also studied. The expression of several GENEIG17 mRNAs with different GENEIG15 represents an interesting example of transcriptional/translational control on the expression of CHEMIG13 (CHEMIG2)-dependent aminotransferases.</td>\n",
       "      <td>CPR:9</td>\n",
       "      <td>CPR:9</td>\n",
       "      <td>[5' untranslated regions, 5'UTRs, EC 2.6.1.15, GTK, KA, KAT, KATI, Kynurenic acid, PLP, UTRs, glutamate, glutamate receptor, glutamine, glutamine transaminase K, ionotropic glutamate receptors, kynurenine, kynurenine aminotransferase I, leader sequence, oxoglutaramic acid, pyridoxal phosphate, pyridoxal phosphate (PLP)-dependent aminotransferases, rat KATI, rat kynurenine aminotransferas]</td>\n",
       "      <td>Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs. Kynurenic acid (KA) is an endogenous glutamate receptor antagonist at the level of the different ionotropic glutamate receptors. One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different KATI mRNAs coding for a protein respectively with and without leader sequence targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new KATI cDNAs containing different 5' untranslated regions (UTRs). One of the transcripts (+14KATI cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several KATI mRNAs are constitutively expressed in ubiquitous manner, while +14KATI mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each KATI mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of KAT enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the rat KATI/GTK gene was also studied. The expression of several KATI mRNAs with different 5'UTRs represents an interesting example of transcriptional/translational control on the expression of pyridoxal phosphate (PLP)-dependent aminotransferases.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1141</th>\n",
       "      <td>T8</td>\n",
       "      <td>T21</td>\n",
       "      <td>_GENE_), also catalyses the reversible transamination of _CHEMICAL_</td>\n",
       "      <td>Tissue expression and translational control of GENEIG10e/CHEMIG17 transaminase K mRNAs. CHEMIG9 (CHEMIG0) is an endogenous CHEMIG20 receptor antagonist at the level of the different GENEIG14. One of the enzymes responsible for the production of CHEMIG0, CHEMIG5 aminotransferase I (_GENE_), also catalyses the reversible transamination of _CHEMICAL_ to CHEMIG4 (GENEIG7, GENEIG12). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different GENEIG21 mRNAs coding for a protein respectively with and without GENEIG3 targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new GENEIG21 cDNAs containing different GENEIG22 (GENEIG15). One of the transcripts (+14GENEIG21 cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several GENEIG21 mRNAs are constitutively expressed in ubiquitous manner, while +14GENEIG21 mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each GENEIG21 mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of GENEIG19 enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the GENEIG6/GENEIG7 gene was also studied. The expression of several GENEIG21 mRNAs with different GENEIG16 represents an interesting example of transcriptional/translational control on the expression of CHEMIG18 (CHEMIG1)-dependent aminotransferases.</td>\n",
       "      <td>CPR:9</td>\n",
       "      <td>CPR:9</td>\n",
       "      <td>[5' untranslated regions, 5'UTRs, EC 2.6.1.15, GTK, KA, KAT, KATI, Kynurenic acid, PLP, UTRs, glutamate, glutamate receptor, glutamine, glutamine transaminase K, ionotropic glutamate receptors, kynurenine, kynurenine aminotransferase I, leader sequence, oxoglutaramic acid, pyridoxal phosphate, pyridoxal phosphate (PLP)-dependent aminotransferases, rat KATI, rat kynurenine aminotransferas]</td>\n",
       "      <td>Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs. Kynurenic acid (KA) is an endogenous glutamate receptor antagonist at the level of the different ionotropic glutamate receptors. One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different KATI mRNAs coding for a protein respectively with and without leader sequence targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new KATI cDNAs containing different 5' untranslated regions (UTRs). One of the transcripts (+14KATI cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several KATI mRNAs are constitutively expressed in ubiquitous manner, while +14KATI mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each KATI mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of KAT enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the rat KATI/GTK gene was also studied. The expression of several KATI mRNAs with different 5'UTRs represents an interesting example of transcriptional/translational control on the expression of pyridoxal phosphate (PLP)-dependent aminotransferases.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1142</th>\n",
       "      <td>T8</td>\n",
       "      <td>T22</td>\n",
       "      <td>_CHEMICAL_ to CHEMIG3 (_GENE_</td>\n",
       "      <td>Tissue expression and translational control of GENEIG15e/CHEMIG14 transaminase K mRNAs. CHEMIG13 (CHEMIG5) is an endogenous CHEMIG19 receptor antagonist at the level of the different GENEIG10. One of the enzymes responsible for the production of CHEMIG5, CHEMIG1 aminotransferase I (GENEIG6), also catalyses the reversible transamination of _CHEMICAL_ to CHEMIG3 (_GENE_, GENEIG4). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different GENEIG6 mRNAs coding for a protein respectively with and without GENEIG9 targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new GENEIG6 cDNAs containing different GENEIG8 (GENEIG12). One of the transcripts (+14GENEIG6 cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several GENEIG6 mRNAs are constitutively expressed in ubiquitous manner, while +14GENEIG6 mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each GENEIG6 mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of GENEIG22 enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the GENEIG18/GENEIG20 gene was also studied. The expression of several GENEIG6 mRNAs with different GENEIG2 represents an interesting example of transcriptional/translational control on the expression of CHEMIG17 (CHEMIG0)-dependent aminotransferases.</td>\n",
       "      <td>CPR:9</td>\n",
       "      <td>CPR:9</td>\n",
       "      <td>[5' untranslated regions, 5'UTRs, EC 2.6.1.15, GTK, KA, KAT, KATI, Kynurenic acid, PLP, UTRs, glutamate, glutamate receptor, glutamine, glutamine transaminase K, ionotropic glutamate receptors, kynurenine, kynurenine aminotransferase I, leader sequence, oxoglutaramic acid, pyridoxal phosphate, pyridoxal phosphate (PLP)-dependent aminotransferases, rat KATI, rat kynurenine aminotransferas]</td>\n",
       "      <td>Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs. Kynurenic acid (KA) is an endogenous glutamate receptor antagonist at the level of the different ionotropic glutamate receptors. One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different KATI mRNAs coding for a protein respectively with and without leader sequence targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new KATI cDNAs containing different 5' untranslated regions (UTRs). One of the transcripts (+14KATI cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several KATI mRNAs are constitutively expressed in ubiquitous manner, while +14KATI mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each KATI mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of KAT enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the rat KATI/GTK gene was also studied. The expression of several KATI mRNAs with different 5'UTRs represents an interesting example of transcriptional/translational control on the expression of pyridoxal phosphate (PLP)-dependent aminotransferases.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1143</th>\n",
       "      <td>T9</td>\n",
       "      <td>T20</td>\n",
       "      <td></td>\n",
       "      <td>Tissue expression and translational control of GENEIG17e/CHEMIG12 transaminase K mRNAs. CHEMIG15 (CHEMIG2) is an endogenous CHEMIG13 receptor antagonist at the level of the different GENEIG0. One of the enzymes responsible for the production of CHEMIG2, CHEMIG19 aminotransferase I (GENEIG9), also catalyses the reversible transamination of CHEMIG12 to _CHEMICAL_ (GENEIG10, GENEIG5). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different GENEIG9 mRNAs coding for a protein respectively with and without GENEIG1 targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new GENEIG9 cDNAs containing different GENEIG7 (GENEIG14). One of the transcripts (+14GENEIG9 cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several GENEIG9 mRNAs are constitutively expressed in ubiquitous manner, while +14GENEIG9 mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each GENEIG9 mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of GENEIG16 enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the GENEIG6/GENEIG10 gene was also studied. The expression of several GENEIG9 mRNAs with different GENEIG8 represents an interesting example of transcriptional/translational control on the expression of CHEMIG20 (CHEMIG18)-dependent aminotransferases.</td>\n",
       "      <td>CPR:9</td>\n",
       "      <td>CPR:9</td>\n",
       "      <td>[5' untranslated regions, 5'UTRs, EC 2.6.1.15, GTK, KA, KAT, KATI, Kynurenic acid, PLP, UTRs, glutamate, glutamate receptor, glutamine, glutamine transaminase K, ionotropic glutamate receptors, kynurenine, kynurenine aminotransferase I, leader sequence, oxoglutaramic acid, pyridoxal phosphate, pyridoxal phosphate (PLP)-dependent aminotransferases, rat KATI, rat kynurenine aminotransferas]</td>\n",
       "      <td>Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs. Kynurenic acid (KA) is an endogenous glutamate receptor antagonist at the level of the different ionotropic glutamate receptors. One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different KATI mRNAs coding for a protein respectively with and without leader sequence targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new KATI cDNAs containing different 5' untranslated regions (UTRs). One of the transcripts (+14KATI cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several KATI mRNAs are constitutively expressed in ubiquitous manner, while +14KATI mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each KATI mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of KAT enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the rat KATI/GTK gene was also studied. The expression of several KATI mRNAs with different 5'UTRs represents an interesting example of transcriptional/translational control on the expression of pyridoxal phosphate (PLP)-dependent aminotransferases.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1144</th>\n",
       "      <td>T9</td>\n",
       "      <td>T21</td>\n",
       "      <td>_GENE_), also catalyses the reversible transamination of CHEMIG15 to _CHEMICAL_</td>\n",
       "      <td>Tissue expression and translational control of GENEIG16e/CHEMIG15 transaminase K mRNAs. CHEMIG14 (CHEMIG13) is an endogenous CHEMIG7 receptor antagonist at the level of the different GENEIG5. One of the enzymes responsible for the production of CHEMIG13, CHEMIG10 aminotransferase I (_GENE_), also catalyses the reversible transamination of CHEMIG15 to _CHEMICAL_ (GENEIG0, GENEIG4). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different GENEIG17 mRNAs coding for a protein respectively with and without GENEIG3 targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new GENEIG17 cDNAs containing different GENEIG6 (GENEIG18). One of the transcripts (+14GENEIG17 cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several GENEIG17 mRNAs are constitutively expressed in ubiquitous manner, while +14GENEIG17 mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each GENEIG17 mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of GENEIG12 enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the GENEIG1/GENEIG0 gene was also studied. The expression of several GENEIG17 mRNAs with different GENEIG9 represents an interesting example of transcriptional/translational control on the expression of CHEMIG11 (CHEMIG2)-dependent aminotransferases.</td>\n",
       "      <td>CPR:9</td>\n",
       "      <td>CPR:9</td>\n",
       "      <td>[5' untranslated regions, 5'UTRs, EC 2.6.1.15, GTK, KA, KAT, KATI, Kynurenic acid, PLP, UTRs, glutamate, glutamate receptor, glutamine, glutamine transaminase K, ionotropic glutamate receptors, kynurenine, kynurenine aminotransferase I, leader sequence, oxoglutaramic acid, pyridoxal phosphate, pyridoxal phosphate (PLP)-dependent aminotransferases, rat KATI, rat kynurenine aminotransferas]</td>\n",
       "      <td>Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs. Kynurenic acid (KA) is an endogenous glutamate receptor antagonist at the level of the different ionotropic glutamate receptors. One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different KATI mRNAs coding for a protein respectively with and without leader sequence targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new KATI cDNAs containing different 5' untranslated regions (UTRs). One of the transcripts (+14KATI cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several KATI mRNAs are constitutively expressed in ubiquitous manner, while +14KATI mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each KATI mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of KAT enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the rat KATI/GTK gene was also studied. The expression of several KATI mRNAs with different 5'UTRs represents an interesting example of transcriptional/translational control on the expression of pyridoxal phosphate (PLP)-dependent aminotransferases.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1145</th>\n",
       "      <td>T9</td>\n",
       "      <td>T22</td>\n",
       "      <td>_CHEMICAL_ (_GENE_</td>\n",
       "      <td>Tissue expression and translational control of GENEIG12e/CHEMIG0 transaminase K mRNAs. CHEMIG4 (CHEMIG15) is an endogenous CHEMIG3 receptor antagonist at the level of the different GENEIG14. One of the enzymes responsible for the production of CHEMIG15, CHEMIG10 aminotransferase I (GENEIG1), also catalyses the reversible transamination of CHEMIG0 to _CHEMICAL_ (_GENE_, GENEIG21). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different GENEIG1 mRNAs coding for a protein respectively with and without GENEIG18 targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new GENEIG1 cDNAs containing different GENEIG13 (GENEIG16). One of the transcripts (+14GENEIG1 cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several GENEIG1 mRNAs are constitutively expressed in ubiquitous manner, while +14GENEIG1 mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each GENEIG1 mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of GENEIG2 enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the GENEIG7/GENEIG20 gene was also studied. The expression of several GENEIG1 mRNAs with different GENEIG6 represents an interesting example of transcriptional/translational control on the expression of CHEMIG5 (CHEMIG11)-dependent aminotransferases.</td>\n",
       "      <td>CPR:9</td>\n",
       "      <td>CPR:9</td>\n",
       "      <td>[5' untranslated regions, 5'UTRs, EC 2.6.1.15, GTK, KA, KAT, KATI, Kynurenic acid, PLP, UTRs, glutamate, glutamate receptor, glutamine, glutamine transaminase K, ionotropic glutamate receptors, kynurenine, kynurenine aminotransferase I, leader sequence, oxoglutaramic acid, pyridoxal phosphate, pyridoxal phosphate (PLP)-dependent aminotransferases, rat KATI, rat kynurenine aminotransferas]</td>\n",
       "      <td>Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs. Kynurenic acid (KA) is an endogenous glutamate receptor antagonist at the level of the different ionotropic glutamate receptors. One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different KATI mRNAs coding for a protein respectively with and without leader sequence targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new KATI cDNAs containing different 5' untranslated regions (UTRs). One of the transcripts (+14KATI cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several KATI mRNAs are constitutively expressed in ubiquitous manner, while +14KATI mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each KATI mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of KAT enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the rat KATI/GTK gene was also studied. The expression of several KATI mRNAs with different 5'UTRs represents an interesting example of transcriptional/translational control on the expression of pyridoxal phosphate (PLP)-dependent aminotransferases.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1146</th>\n",
       "      <td>T9</td>\n",
       "      <td>T23</td>\n",
       "      <td>_CHEMICAL_ (GENEIG0, _GENE_</td>\n",
       "      <td>Tissue expression and translational control of GENEIG4e/CHEMIG14 transaminase K mRNAs. CHEMIG7 (CHEMIG3) is an endogenous CHEMIG2 receptor antagonist at the level of the different GENEIG1. One of the enzymes responsible for the production of CHEMIG3, CHEMIG13 aminotransferase I (GENEIG19), also catalyses the reversible transamination of CHEMIG14 to _CHEMICAL_ (GENEIG0, _GENE_). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different GENEIG19 mRNAs coding for a protein respectively with and without GENEIG17 targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new GENEIG19 cDNAs containing different GENEIG12 (GENEIG6). One of the transcripts (+14GENEIG19 cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several GENEIG19 mRNAs are constitutively expressed in ubiquitous manner, while +14GENEIG19 mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each GENEIG19 mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of GENEIG5 enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the GENEIG15/GENEIG0 gene was also studied. The expression of several GENEIG19 mRNAs with different GENEIG9 represents an interesting example of transcriptional/translational control on the expression of CHEMIG10 (CHEMIG8)-dependent aminotransferases.</td>\n",
       "      <td>CPR:9</td>\n",
       "      <td>CPR:9</td>\n",
       "      <td>[5' untranslated regions, 5'UTRs, EC 2.6.1.15, GTK, KA, KAT, KATI, Kynurenic acid, PLP, UTRs, glutamate, glutamate receptor, glutamine, glutamine transaminase K, ionotropic glutamate receptors, kynurenine, kynurenine aminotransferase I, leader sequence, oxoglutaramic acid, pyridoxal phosphate, pyridoxal phosphate (PLP)-dependent aminotransferases, rat KATI, rat kynurenine aminotransferas]</td>\n",
       "      <td>Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs. Kynurenic acid (KA) is an endogenous glutamate receptor antagonist at the level of the different ionotropic glutamate receptors. One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different KATI mRNAs coding for a protein respectively with and without leader sequence targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new KATI cDNAs containing different 5' untranslated regions (UTRs). One of the transcripts (+14KATI cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several KATI mRNAs are constitutively expressed in ubiquitous manner, while +14KATI mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each KATI mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of KAT enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the rat KATI/GTK gene was also studied. The expression of several KATI mRNAs with different 5'UTRs represents an interesting example of transcriptional/translational control on the expression of pyridoxal phosphate (PLP)-dependent aminotransferases.</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     participant1_id participant2_id  \\\n",
       "1134              T1             T24   \n",
       "1135              T1             T33   \n",
       "1136              T3             T24   \n",
       "1137              T3             T33   \n",
       "1138              T6             T20   \n",
       "1139              T6             T21   \n",
       "1140              T8             T20   \n",
       "1141              T8             T21   \n",
       "1142              T8             T22   \n",
       "1143              T9             T20   \n",
       "1144              T9             T21   \n",
       "1145              T9             T22   \n",
       "1146              T9             T23   \n",
       "\n",
       "                                                                                                      x_span  \\\n",
       "1134                                                                                                           \n",
       "1135  _CHEMICAL_ (CHEMIG1) is an endogenous CHEMIG5 receptor antagonist at the level of the different _GENE_   \n",
       "1136                                                                                                           \n",
       "1137          _CHEMICAL_) is an endogenous CHEMIG15 receptor antagonist at the level of the different _GENE_   \n",
       "1138                                                                                                           \n",
       "1139                                                         _CHEMICAL_, CHEMIG10 aminotransferase I (_GENE_   \n",
       "1140                                                                                                           \n",
       "1141                                     _GENE_), also catalyses the reversible transamination of _CHEMICAL_   \n",
       "1142                                                                           _CHEMICAL_ to CHEMIG3 (_GENE_   \n",
       "1143                                                                                                           \n",
       "1144                         _GENE_), also catalyses the reversible transamination of CHEMIG15 to _CHEMICAL_   \n",
       "1145                                                                                      _CHEMICAL_ (_GENE_   \n",
       "1146                                                                             _CHEMICAL_ (GENEIG0, _GENE_   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 x  \\\n",
       "1134        Tissue expression and translational control of GENEIG7e/CHEMIG3 transaminase K mRNAs. _CHEMICAL_ (CHEMIG10) is an endogenous CHEMIG4 receptor antagonist at the level of the different GENEIG1. One of the enzymes responsible for the production of CHEMIG10, CHEMIG11 aminotransferase I (GENEIG5), also catalyses the reversible transamination of CHEMIG3 to CHEMIG17 (GENEIG14, GENEIG13). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different GENEIG5 mRNAs coding for a protein respectively with and without GENEIG20 targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new GENEIG5 cDNAs containing different GENEIG6 (GENEIG16). One of the transcripts (+14GENEIG5 cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several GENEIG5 mRNAs are constitutively expressed in ubiquitous manner, while +14GENEIG5 mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each GENEIG5 mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of GENEIG18 enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the GENEIG19/GENEIG14 gene was also studied. The expression of several GENEIG5 mRNAs with different GENEIG9 represents an interesting example of transcriptional/translational control on the expression of CHEMIG12 (CHEMIG15)-dependent aminotransferases.   \n",
       "1135             Tissue expression and translational control of GENEIG10e/CHEMIG14 transaminase K mRNAs. _CHEMICAL_ (CHEMIG1) is an endogenous CHEMIG5 receptor antagonist at the level of the different _GENE_. One of the enzymes responsible for the production of CHEMIG1, CHEMIG13 aminotransferase I (GENEIG2), also catalyses the reversible transamination of CHEMIG14 to CHEMIG8 (GENEIG16, GENEIG3). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different GENEIG2 mRNAs coding for a protein respectively with and without GENEIG9 targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new GENEIG2 cDNAs containing different GENEIG19 (GENEIG15). One of the transcripts (+14GENEIG2 cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several GENEIG2 mRNAs are constitutively expressed in ubiquitous manner, while +14GENEIG2 mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each GENEIG2 mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of GENEIG6 enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the GENEIG12/GENEIG16 gene was also studied. The expression of several GENEIG2 mRNAs with different GENEIG4 represents an interesting example of transcriptional/translational control on the expression of CHEMIG0 (CHEMIG7)-dependent aminotransferases.   \n",
       "1136         Tissue expression and translational control of GENEIG15e/CHEMIG6 transaminase K mRNAs. CHEMIG10 (_CHEMICAL_) is an endogenous CHEMIG2 receptor antagonist at the level of the different GENEIG18. One of the enzymes responsible for the production of CHEMIG19, CHEMIG8 aminotransferase I (GENEIG3), also catalyses the reversible transamination of CHEMIG6 to CHEMIG9 (GENEIG14, GENEIG0). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different GENEIG3 mRNAs coding for a protein respectively with and without GENEIG16 targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new GENEIG3 cDNAs containing different GENEIG7 (GENEIG11). One of the transcripts (+14GENEIG3 cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several GENEIG3 mRNAs are constitutively expressed in ubiquitous manner, while +14GENEIG3 mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each GENEIG3 mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of GENEIG5 enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the GENEIG21/GENEIG14 gene was also studied. The expression of several GENEIG3 mRNAs with different GENEIG17 represents an interesting example of transcriptional/translational control on the expression of CHEMIG12 (CHEMIG13)-dependent aminotransferases.   \n",
       "1137   Tissue expression and translational control of GENEIG12e/CHEMIG21 transaminase K mRNAs. CHEMIG11 (_CHEMICAL_) is an endogenous CHEMIG15 receptor antagonist at the level of the different _GENE_. One of the enzymes responsible for the production of CHEMIG9, CHEMIG18 aminotransferase I (GENEIG10), also catalyses the reversible transamination of CHEMIG21 to CHEMIG3 (GENEIG6, GENEIG2). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different GENEIG10 mRNAs coding for a protein respectively with and without GENEIG14 targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new GENEIG10 cDNAs containing different GENEIG16 (GENEIG17). One of the transcripts (+14GENEIG10 cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several GENEIG10 mRNAs are constitutively expressed in ubiquitous manner, while +14GENEIG10 mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each GENEIG10 mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of GENEIG0 enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the GENEIG4/GENEIG6 gene was also studied. The expression of several GENEIG10 mRNAs with different GENEIG8 represents an interesting example of transcriptional/translational control on the expression of CHEMIG19 (CHEMIG13)-dependent aminotransferases.   \n",
       "1138  Tissue expression and translational control of GENEIG18e/CHEMIG10 transaminase K mRNAs. CHEMIG21 (CHEMIG3) is an endogenous CHEMIG19 receptor antagonist at the level of the different GENEIG9. One of the enzymes responsible for the production of _CHEMICAL_, CHEMIG4 aminotransferase I (GENEIG15), also catalyses the reversible transamination of CHEMIG10 to CHEMIG13 (GENEIG17, GENEIG1). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different GENEIG15 mRNAs coding for a protein respectively with and without GENEIG20 targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new GENEIG15 cDNAs containing different GENEIG8 (GENEIG6). One of the transcripts (+14GENEIG15 cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several GENEIG15 mRNAs are constitutively expressed in ubiquitous manner, while +14GENEIG15 mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each GENEIG15 mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of GENEIG0 enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the GENEIG11/GENEIG17 gene was also studied. The expression of several GENEIG15 mRNAs with different GENEIG12 represents an interesting example of transcriptional/translational control on the expression of CHEMIG5 (CHEMIG2)-dependent aminotransferases.   \n",
       "1139     Tissue expression and translational control of GENEIG11e/CHEMIG12 transaminase K mRNAs. CHEMIG13 (CHEMIG14) is an endogenous CHEMIG4 receptor antagonist at the level of the different GENEIG9. One of the enzymes responsible for the production of _CHEMICAL_, CHEMIG10 aminotransferase I (_GENE_), also catalyses the reversible transamination of CHEMIG12 to CHEMIG16 (GENEIG8, GENEIG6). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different GENEIG18 mRNAs coding for a protein respectively with and without GENEIG21 targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new GENEIG18 cDNAs containing different GENEIG2 (GENEIG19). One of the transcripts (+14GENEIG18 cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several GENEIG18 mRNAs are constitutively expressed in ubiquitous manner, while +14GENEIG18 mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each GENEIG18 mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of GENEIG22 enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the GENEIG7/GENEIG8 gene was also studied. The expression of several GENEIG18 mRNAs with different GENEIG1 represents an interesting example of transcriptional/translational control on the expression of CHEMIG0 (CHEMIG3)-dependent aminotransferases.   \n",
       "1140    Tissue expression and translational control of GENEIG6e/CHEMIG0 transaminase K mRNAs. CHEMIG11 (CHEMIG3) is an endogenous CHEMIG8 receptor antagonist at the level of the different GENEIG14. One of the enzymes responsible for the production of CHEMIG3, CHEMIG10 aminotransferase I (GENEIG17), also catalyses the reversible transamination of _CHEMICAL_ to CHEMIG9 (GENEIG7, GENEIG16). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different GENEIG17 mRNAs coding for a protein respectively with and without GENEIG18 targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new GENEIG17 cDNAs containing different GENEIG21 (GENEIG20). One of the transcripts (+14GENEIG17 cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several GENEIG17 mRNAs are constitutively expressed in ubiquitous manner, while +14GENEIG17 mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each GENEIG17 mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of GENEIG1 enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the GENEIG4/GENEIG7 gene was also studied. The expression of several GENEIG17 mRNAs with different GENEIG15 represents an interesting example of transcriptional/translational control on the expression of CHEMIG13 (CHEMIG2)-dependent aminotransferases.   \n",
       "1141     Tissue expression and translational control of GENEIG10e/CHEMIG17 transaminase K mRNAs. CHEMIG9 (CHEMIG0) is an endogenous CHEMIG20 receptor antagonist at the level of the different GENEIG14. One of the enzymes responsible for the production of CHEMIG0, CHEMIG5 aminotransferase I (_GENE_), also catalyses the reversible transamination of _CHEMICAL_ to CHEMIG4 (GENEIG7, GENEIG12). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different GENEIG21 mRNAs coding for a protein respectively with and without GENEIG3 targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new GENEIG21 cDNAs containing different GENEIG22 (GENEIG15). One of the transcripts (+14GENEIG21 cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several GENEIG21 mRNAs are constitutively expressed in ubiquitous manner, while +14GENEIG21 mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each GENEIG21 mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of GENEIG19 enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the GENEIG6/GENEIG7 gene was also studied. The expression of several GENEIG21 mRNAs with different GENEIG16 represents an interesting example of transcriptional/translational control on the expression of CHEMIG18 (CHEMIG1)-dependent aminotransferases.   \n",
       "1142            Tissue expression and translational control of GENEIG15e/CHEMIG14 transaminase K mRNAs. CHEMIG13 (CHEMIG5) is an endogenous CHEMIG19 receptor antagonist at the level of the different GENEIG10. One of the enzymes responsible for the production of CHEMIG5, CHEMIG1 aminotransferase I (GENEIG6), also catalyses the reversible transamination of _CHEMICAL_ to CHEMIG3 (_GENE_, GENEIG4). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different GENEIG6 mRNAs coding for a protein respectively with and without GENEIG9 targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new GENEIG6 cDNAs containing different GENEIG8 (GENEIG12). One of the transcripts (+14GENEIG6 cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several GENEIG6 mRNAs are constitutively expressed in ubiquitous manner, while +14GENEIG6 mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each GENEIG6 mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of GENEIG22 enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the GENEIG18/GENEIG20 gene was also studied. The expression of several GENEIG6 mRNAs with different GENEIG2 represents an interesting example of transcriptional/translational control on the expression of CHEMIG17 (CHEMIG0)-dependent aminotransferases.   \n",
       "1143         Tissue expression and translational control of GENEIG17e/CHEMIG12 transaminase K mRNAs. CHEMIG15 (CHEMIG2) is an endogenous CHEMIG13 receptor antagonist at the level of the different GENEIG0. One of the enzymes responsible for the production of CHEMIG2, CHEMIG19 aminotransferase I (GENEIG9), also catalyses the reversible transamination of CHEMIG12 to _CHEMICAL_ (GENEIG10, GENEIG5). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different GENEIG9 mRNAs coding for a protein respectively with and without GENEIG1 targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new GENEIG9 cDNAs containing different GENEIG7 (GENEIG14). One of the transcripts (+14GENEIG9 cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several GENEIG9 mRNAs are constitutively expressed in ubiquitous manner, while +14GENEIG9 mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each GENEIG9 mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of GENEIG16 enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the GENEIG6/GENEIG10 gene was also studied. The expression of several GENEIG9 mRNAs with different GENEIG8 represents an interesting example of transcriptional/translational control on the expression of CHEMIG20 (CHEMIG18)-dependent aminotransferases.   \n",
       "1144     Tissue expression and translational control of GENEIG16e/CHEMIG15 transaminase K mRNAs. CHEMIG14 (CHEMIG13) is an endogenous CHEMIG7 receptor antagonist at the level of the different GENEIG5. One of the enzymes responsible for the production of CHEMIG13, CHEMIG10 aminotransferase I (_GENE_), also catalyses the reversible transamination of CHEMIG15 to _CHEMICAL_ (GENEIG0, GENEIG4). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different GENEIG17 mRNAs coding for a protein respectively with and without GENEIG3 targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new GENEIG17 cDNAs containing different GENEIG6 (GENEIG18). One of the transcripts (+14GENEIG17 cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several GENEIG17 mRNAs are constitutively expressed in ubiquitous manner, while +14GENEIG17 mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each GENEIG17 mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of GENEIG12 enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the GENEIG1/GENEIG0 gene was also studied. The expression of several GENEIG17 mRNAs with different GENEIG9 represents an interesting example of transcriptional/translational control on the expression of CHEMIG11 (CHEMIG2)-dependent aminotransferases.   \n",
       "1145           Tissue expression and translational control of GENEIG12e/CHEMIG0 transaminase K mRNAs. CHEMIG4 (CHEMIG15) is an endogenous CHEMIG3 receptor antagonist at the level of the different GENEIG14. One of the enzymes responsible for the production of CHEMIG15, CHEMIG10 aminotransferase I (GENEIG1), also catalyses the reversible transamination of CHEMIG0 to _CHEMICAL_ (_GENE_, GENEIG21). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different GENEIG1 mRNAs coding for a protein respectively with and without GENEIG18 targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new GENEIG1 cDNAs containing different GENEIG13 (GENEIG16). One of the transcripts (+14GENEIG1 cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several GENEIG1 mRNAs are constitutively expressed in ubiquitous manner, while +14GENEIG1 mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each GENEIG1 mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of GENEIG2 enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the GENEIG7/GENEIG20 gene was also studied. The expression of several GENEIG1 mRNAs with different GENEIG6 represents an interesting example of transcriptional/translational control on the expression of CHEMIG5 (CHEMIG11)-dependent aminotransferases.   \n",
       "1146       Tissue expression and translational control of GENEIG4e/CHEMIG14 transaminase K mRNAs. CHEMIG7 (CHEMIG3) is an endogenous CHEMIG2 receptor antagonist at the level of the different GENEIG1. One of the enzymes responsible for the production of CHEMIG3, CHEMIG13 aminotransferase I (GENEIG19), also catalyses the reversible transamination of CHEMIG14 to _CHEMICAL_ (GENEIG0, _GENE_). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different GENEIG19 mRNAs coding for a protein respectively with and without GENEIG17 targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new GENEIG19 cDNAs containing different GENEIG12 (GENEIG6). One of the transcripts (+14GENEIG19 cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several GENEIG19 mRNAs are constitutively expressed in ubiquitous manner, while +14GENEIG19 mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each GENEIG19 mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of GENEIG5 enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the GENEIG15/GENEIG0 gene was also studied. The expression of several GENEIG19 mRNAs with different GENEIG9 represents an interesting example of transcriptional/translational control on the expression of CHEMIG10 (CHEMIG8)-dependent aminotransferases.   \n",
       "\n",
       "      y_raw gold_raw  \\\n",
       "1134  CPR:6    CPR:6   \n",
       "1135  CPR:6    CPR:6   \n",
       "1136  CPR:6    CPR:6   \n",
       "1137  CPR:6    CPR:6   \n",
       "1138  CPR:9    CPR:9   \n",
       "1139  CPR:9    CPR:9   \n",
       "1140  CPR:9    CPR:9   \n",
       "1141  CPR:9    CPR:9   \n",
       "1142  CPR:9    CPR:9   \n",
       "1143  CPR:9    CPR:9   \n",
       "1144  CPR:9    CPR:9   \n",
       "1145  CPR:9    CPR:9   \n",
       "1146  CPR:9    CPR:9   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                        unique_chemprot_names  \\\n",
       "1134  [5' untranslated regions, 5'UTRs, EC 2.6.1.15, GTK, KA, KAT, KATI, Kynurenic acid, PLP, UTRs, glutamate, glutamate receptor, glutamine, glutamine transaminase K, ionotropic glutamate receptors, kynurenine, kynurenine aminotransferase I, leader sequence, oxoglutaramic acid, pyridoxal phosphate, pyridoxal phosphate (PLP)-dependent aminotransferases, rat KATI, rat kynurenine aminotransferas]   \n",
       "1135  [5' untranslated regions, 5'UTRs, EC 2.6.1.15, GTK, KA, KAT, KATI, Kynurenic acid, PLP, UTRs, glutamate, glutamate receptor, glutamine, glutamine transaminase K, ionotropic glutamate receptors, kynurenine, kynurenine aminotransferase I, leader sequence, oxoglutaramic acid, pyridoxal phosphate, pyridoxal phosphate (PLP)-dependent aminotransferases, rat KATI, rat kynurenine aminotransferas]   \n",
       "1136  [5' untranslated regions, 5'UTRs, EC 2.6.1.15, GTK, KA, KAT, KATI, Kynurenic acid, PLP, UTRs, glutamate, glutamate receptor, glutamine, glutamine transaminase K, ionotropic glutamate receptors, kynurenine, kynurenine aminotransferase I, leader sequence, oxoglutaramic acid, pyridoxal phosphate, pyridoxal phosphate (PLP)-dependent aminotransferases, rat KATI, rat kynurenine aminotransferas]   \n",
       "1137  [5' untranslated regions, 5'UTRs, EC 2.6.1.15, GTK, KA, KAT, KATI, Kynurenic acid, PLP, UTRs, glutamate, glutamate receptor, glutamine, glutamine transaminase K, ionotropic glutamate receptors, kynurenine, kynurenine aminotransferase I, leader sequence, oxoglutaramic acid, pyridoxal phosphate, pyridoxal phosphate (PLP)-dependent aminotransferases, rat KATI, rat kynurenine aminotransferas]   \n",
       "1138  [5' untranslated regions, 5'UTRs, EC 2.6.1.15, GTK, KA, KAT, KATI, Kynurenic acid, PLP, UTRs, glutamate, glutamate receptor, glutamine, glutamine transaminase K, ionotropic glutamate receptors, kynurenine, kynurenine aminotransferase I, leader sequence, oxoglutaramic acid, pyridoxal phosphate, pyridoxal phosphate (PLP)-dependent aminotransferases, rat KATI, rat kynurenine aminotransferas]   \n",
       "1139  [5' untranslated regions, 5'UTRs, EC 2.6.1.15, GTK, KA, KAT, KATI, Kynurenic acid, PLP, UTRs, glutamate, glutamate receptor, glutamine, glutamine transaminase K, ionotropic glutamate receptors, kynurenine, kynurenine aminotransferase I, leader sequence, oxoglutaramic acid, pyridoxal phosphate, pyridoxal phosphate (PLP)-dependent aminotransferases, rat KATI, rat kynurenine aminotransferas]   \n",
       "1140  [5' untranslated regions, 5'UTRs, EC 2.6.1.15, GTK, KA, KAT, KATI, Kynurenic acid, PLP, UTRs, glutamate, glutamate receptor, glutamine, glutamine transaminase K, ionotropic glutamate receptors, kynurenine, kynurenine aminotransferase I, leader sequence, oxoglutaramic acid, pyridoxal phosphate, pyridoxal phosphate (PLP)-dependent aminotransferases, rat KATI, rat kynurenine aminotransferas]   \n",
       "1141  [5' untranslated regions, 5'UTRs, EC 2.6.1.15, GTK, KA, KAT, KATI, Kynurenic acid, PLP, UTRs, glutamate, glutamate receptor, glutamine, glutamine transaminase K, ionotropic glutamate receptors, kynurenine, kynurenine aminotransferase I, leader sequence, oxoglutaramic acid, pyridoxal phosphate, pyridoxal phosphate (PLP)-dependent aminotransferases, rat KATI, rat kynurenine aminotransferas]   \n",
       "1142  [5' untranslated regions, 5'UTRs, EC 2.6.1.15, GTK, KA, KAT, KATI, Kynurenic acid, PLP, UTRs, glutamate, glutamate receptor, glutamine, glutamine transaminase K, ionotropic glutamate receptors, kynurenine, kynurenine aminotransferase I, leader sequence, oxoglutaramic acid, pyridoxal phosphate, pyridoxal phosphate (PLP)-dependent aminotransferases, rat KATI, rat kynurenine aminotransferas]   \n",
       "1143  [5' untranslated regions, 5'UTRs, EC 2.6.1.15, GTK, KA, KAT, KATI, Kynurenic acid, PLP, UTRs, glutamate, glutamate receptor, glutamine, glutamine transaminase K, ionotropic glutamate receptors, kynurenine, kynurenine aminotransferase I, leader sequence, oxoglutaramic acid, pyridoxal phosphate, pyridoxal phosphate (PLP)-dependent aminotransferases, rat KATI, rat kynurenine aminotransferas]   \n",
       "1144  [5' untranslated regions, 5'UTRs, EC 2.6.1.15, GTK, KA, KAT, KATI, Kynurenic acid, PLP, UTRs, glutamate, glutamate receptor, glutamine, glutamine transaminase K, ionotropic glutamate receptors, kynurenine, kynurenine aminotransferase I, leader sequence, oxoglutaramic acid, pyridoxal phosphate, pyridoxal phosphate (PLP)-dependent aminotransferases, rat KATI, rat kynurenine aminotransferas]   \n",
       "1145  [5' untranslated regions, 5'UTRs, EC 2.6.1.15, GTK, KA, KAT, KATI, Kynurenic acid, PLP, UTRs, glutamate, glutamate receptor, glutamine, glutamine transaminase K, ionotropic glutamate receptors, kynurenine, kynurenine aminotransferase I, leader sequence, oxoglutaramic acid, pyridoxal phosphate, pyridoxal phosphate (PLP)-dependent aminotransferases, rat KATI, rat kynurenine aminotransferas]   \n",
       "1146  [5' untranslated regions, 5'UTRs, EC 2.6.1.15, GTK, KA, KAT, KATI, Kynurenic acid, PLP, UTRs, glutamate, glutamate receptor, glutamine, glutamine transaminase K, ionotropic glutamate receptors, kynurenine, kynurenine aminotransferase I, leader sequence, oxoglutaramic acid, pyridoxal phosphate, pyridoxal phosphate (PLP)-dependent aminotransferases, rat KATI, rat kynurenine aminotransferas]   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                abstract  \n",
       "1134  Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs. Kynurenic acid (KA) is an endogenous glutamate receptor antagonist at the level of the different ionotropic glutamate receptors. One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different KATI mRNAs coding for a protein respectively with and without leader sequence targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new KATI cDNAs containing different 5' untranslated regions (UTRs). One of the transcripts (+14KATI cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several KATI mRNAs are constitutively expressed in ubiquitous manner, while +14KATI mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each KATI mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of KAT enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the rat KATI/GTK gene was also studied. The expression of several KATI mRNAs with different 5'UTRs represents an interesting example of transcriptional/translational control on the expression of pyridoxal phosphate (PLP)-dependent aminotransferases.  \n",
       "1135  Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs. Kynurenic acid (KA) is an endogenous glutamate receptor antagonist at the level of the different ionotropic glutamate receptors. One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different KATI mRNAs coding for a protein respectively with and without leader sequence targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new KATI cDNAs containing different 5' untranslated regions (UTRs). One of the transcripts (+14KATI cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several KATI mRNAs are constitutively expressed in ubiquitous manner, while +14KATI mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each KATI mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of KAT enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the rat KATI/GTK gene was also studied. The expression of several KATI mRNAs with different 5'UTRs represents an interesting example of transcriptional/translational control on the expression of pyridoxal phosphate (PLP)-dependent aminotransferases.  \n",
       "1136  Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs. Kynurenic acid (KA) is an endogenous glutamate receptor antagonist at the level of the different ionotropic glutamate receptors. One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different KATI mRNAs coding for a protein respectively with and without leader sequence targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new KATI cDNAs containing different 5' untranslated regions (UTRs). One of the transcripts (+14KATI cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several KATI mRNAs are constitutively expressed in ubiquitous manner, while +14KATI mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each KATI mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of KAT enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the rat KATI/GTK gene was also studied. The expression of several KATI mRNAs with different 5'UTRs represents an interesting example of transcriptional/translational control on the expression of pyridoxal phosphate (PLP)-dependent aminotransferases.  \n",
       "1137  Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs. Kynurenic acid (KA) is an endogenous glutamate receptor antagonist at the level of the different ionotropic glutamate receptors. One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different KATI mRNAs coding for a protein respectively with and without leader sequence targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new KATI cDNAs containing different 5' untranslated regions (UTRs). One of the transcripts (+14KATI cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several KATI mRNAs are constitutively expressed in ubiquitous manner, while +14KATI mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each KATI mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of KAT enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the rat KATI/GTK gene was also studied. The expression of several KATI mRNAs with different 5'UTRs represents an interesting example of transcriptional/translational control on the expression of pyridoxal phosphate (PLP)-dependent aminotransferases.  \n",
       "1138  Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs. Kynurenic acid (KA) is an endogenous glutamate receptor antagonist at the level of the different ionotropic glutamate receptors. One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different KATI mRNAs coding for a protein respectively with and without leader sequence targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new KATI cDNAs containing different 5' untranslated regions (UTRs). One of the transcripts (+14KATI cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several KATI mRNAs are constitutively expressed in ubiquitous manner, while +14KATI mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each KATI mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of KAT enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the rat KATI/GTK gene was also studied. The expression of several KATI mRNAs with different 5'UTRs represents an interesting example of transcriptional/translational control on the expression of pyridoxal phosphate (PLP)-dependent aminotransferases.  \n",
       "1139  Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs. Kynurenic acid (KA) is an endogenous glutamate receptor antagonist at the level of the different ionotropic glutamate receptors. One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different KATI mRNAs coding for a protein respectively with and without leader sequence targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new KATI cDNAs containing different 5' untranslated regions (UTRs). One of the transcripts (+14KATI cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several KATI mRNAs are constitutively expressed in ubiquitous manner, while +14KATI mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each KATI mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of KAT enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the rat KATI/GTK gene was also studied. The expression of several KATI mRNAs with different 5'UTRs represents an interesting example of transcriptional/translational control on the expression of pyridoxal phosphate (PLP)-dependent aminotransferases.  \n",
       "1140  Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs. Kynurenic acid (KA) is an endogenous glutamate receptor antagonist at the level of the different ionotropic glutamate receptors. One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different KATI mRNAs coding for a protein respectively with and without leader sequence targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new KATI cDNAs containing different 5' untranslated regions (UTRs). One of the transcripts (+14KATI cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several KATI mRNAs are constitutively expressed in ubiquitous manner, while +14KATI mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each KATI mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of KAT enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the rat KATI/GTK gene was also studied. The expression of several KATI mRNAs with different 5'UTRs represents an interesting example of transcriptional/translational control on the expression of pyridoxal phosphate (PLP)-dependent aminotransferases.  \n",
       "1141  Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs. Kynurenic acid (KA) is an endogenous glutamate receptor antagonist at the level of the different ionotropic glutamate receptors. One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different KATI mRNAs coding for a protein respectively with and without leader sequence targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new KATI cDNAs containing different 5' untranslated regions (UTRs). One of the transcripts (+14KATI cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several KATI mRNAs are constitutively expressed in ubiquitous manner, while +14KATI mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each KATI mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of KAT enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the rat KATI/GTK gene was also studied. The expression of several KATI mRNAs with different 5'UTRs represents an interesting example of transcriptional/translational control on the expression of pyridoxal phosphate (PLP)-dependent aminotransferases.  \n",
       "1142  Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs. Kynurenic acid (KA) is an endogenous glutamate receptor antagonist at the level of the different ionotropic glutamate receptors. One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different KATI mRNAs coding for a protein respectively with and without leader sequence targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new KATI cDNAs containing different 5' untranslated regions (UTRs). One of the transcripts (+14KATI cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several KATI mRNAs are constitutively expressed in ubiquitous manner, while +14KATI mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each KATI mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of KAT enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the rat KATI/GTK gene was also studied. The expression of several KATI mRNAs with different 5'UTRs represents an interesting example of transcriptional/translational control on the expression of pyridoxal phosphate (PLP)-dependent aminotransferases.  \n",
       "1143  Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs. Kynurenic acid (KA) is an endogenous glutamate receptor antagonist at the level of the different ionotropic glutamate receptors. One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different KATI mRNAs coding for a protein respectively with and without leader sequence targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new KATI cDNAs containing different 5' untranslated regions (UTRs). One of the transcripts (+14KATI cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several KATI mRNAs are constitutively expressed in ubiquitous manner, while +14KATI mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each KATI mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of KAT enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the rat KATI/GTK gene was also studied. The expression of several KATI mRNAs with different 5'UTRs represents an interesting example of transcriptional/translational control on the expression of pyridoxal phosphate (PLP)-dependent aminotransferases.  \n",
       "1144  Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs. Kynurenic acid (KA) is an endogenous glutamate receptor antagonist at the level of the different ionotropic glutamate receptors. One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different KATI mRNAs coding for a protein respectively with and without leader sequence targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new KATI cDNAs containing different 5' untranslated regions (UTRs). One of the transcripts (+14KATI cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several KATI mRNAs are constitutively expressed in ubiquitous manner, while +14KATI mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each KATI mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of KAT enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the rat KATI/GTK gene was also studied. The expression of several KATI mRNAs with different 5'UTRs represents an interesting example of transcriptional/translational control on the expression of pyridoxal phosphate (PLP)-dependent aminotransferases.  \n",
       "1145  Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs. Kynurenic acid (KA) is an endogenous glutamate receptor antagonist at the level of the different ionotropic glutamate receptors. One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different KATI mRNAs coding for a protein respectively with and without leader sequence targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new KATI cDNAs containing different 5' untranslated regions (UTRs). One of the transcripts (+14KATI cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several KATI mRNAs are constitutively expressed in ubiquitous manner, while +14KATI mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each KATI mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of KAT enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the rat KATI/GTK gene was also studied. The expression of several KATI mRNAs with different 5'UTRs represents an interesting example of transcriptional/translational control on the expression of pyridoxal phosphate (PLP)-dependent aminotransferases.  \n",
       "1146  Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs. Kynurenic acid (KA) is an endogenous glutamate receptor antagonist at the level of the different ionotropic glutamate receptors. One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15). The enzyme exists in a cytosolic and in a mitochondrial form because of the presence of two different KATI mRNAs coding for a protein respectively with and without leader sequence targeting the protein into mitochondria. We have cloned from a phage library of rat kidney cDNA four new KATI cDNAs containing different 5' untranslated regions (UTRs). One of the transcripts (+14KATI cDNA) contains an alternative site of initiation of translation. The tissue distribution of the different transcripts was studied by RT-PCR. The study demonstrated that several KATI mRNAs are constitutively expressed in ubiquitous manner, while +14KATI mRNA is present only in kidney. The translational efficiency of the different transcripts was studied in vitro and enzymatic activities were measured in transiently transfected Cos-1 cells. Each KATI mRNA exhibits a different in vitro translational efficiency, which corresponds to different levels of KAT enzymatic activity in transfected cells. Both findings correlate with the predicted accessibility of the ribosomal binding sites of the different mRNAs. The structure of the rat KATI/GTK gene was also studied. The expression of several KATI mRNAs with different 5'UTRs represents an interesting example of transcriptional/translational control on the expression of pyridoxal phosphate (PLP)-dependent aminotransferases.  "
      ]
     },
     "execution_count": 33,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_train.query(\"abstract_id == 12850267\")[[ \"participant1_id\", \"participant2_id\", \"x_span\",\"x\", \"y_raw\",\"gold_raw\",\"unique_chemprot_names\",\"abstract\"]]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(NEGATIVE)                                132\n",
       "(CPR:4)                                   117\n",
       "(NEGATIVE, CPR:4)                         103\n",
       "(NEGATIVE, CPR:4, CPR:3)                   65\n",
       "(NEGATIVE, CPR:3)                          44\n",
       "(CPR:9)                                    34\n",
       "(NEGATIVE, CPR:9)                          33\n",
       "(CPR:4, CPR:3)                             31\n",
       "(CPR:3)                                    27\n",
       "(CPR:4, CPR:9)                             27\n",
       "(NEGATIVE, CPR:4, CPR:9)                   24\n",
       "(CPR:6)                                    15\n",
       "(NEGATIVE, CPR:6)                          15\n",
       "(CPR:5)                                    10\n",
       "(NEGATIVE, CPR:5)                          10\n",
       "(NEGATIVE, CPR:4, CPR:3, CPR:9)             8\n",
       "(NEGATIVE, CPR:3, CPR:9)                    7\n",
       "(CPR:4, CPR:6)                              7\n",
       "(NEGATIVE, CPR:6, CPR:5)                    7\n",
       "(NEGATIVE, CPR:4, CPR:6)                    6\n",
       "(CPR:4, CPR:6, NEGATIVE, CPR:5, CPR:3)      6\n",
       "(CPR:6, CPR:5)                              4\n",
       "(CPR:4, CPR:3, CPR:9)                       4\n",
       "(NEGATIVE, CPR:4, CPR:6, CPR:5)             3\n",
       "(CPR:3, CPR:9)                              3\n",
       "(NEGATIVE, CPR:3, CPR:5)                    2\n",
       "(NEGATIVE, CPR:4, CPR:6, CPR:3)             2\n",
       "(CPR:6, CPR:9)                              2\n",
       "(NEGATIVE, CPR:4, CPR:3, CPR:5)             2\n",
       "(NEGATIVE, CPR:4, CPR:5)                    2\n",
       "(NEGATIVE, CPR:6, CPR:3)                    2\n",
       "(NEGATIVE, CPR:6, CPR:3, CPR:5)             2\n",
       "(CPR:3, CPR:5)                              1\n",
       "(CPR:4, CPR:6, NEGATIVE, CPR:9, CPR:3)      1\n",
       "(NEGATIVE, CPR:9, CPR:5)                    1\n",
       "(CPR:4, CPR:3, CPR:5)                       1\n",
       "(NEGATIVE, CPR:3, CPR:9, CPR:5)             1\n",
       "(CPR:6, CPR:3, CPR:5)                       1\n",
       "(NEGATIVE, CPR:6, CPR:9)                    1\n",
       "(CPR:4, CPR:6, CPR:9)                       1\n",
       "(CPR:4, CPR:6, CPR:5)                       1\n",
       "(CPR:4, CPR:9, CPR:5)                       1\n",
       "(CPR:4, CPR:5)                              1\n",
       "Name: gold_raw, dtype: int64"
      ]
     },
     "execution_count": 34,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_train.groupby([\"abstract_id\"])[\"gold_raw\"].unique().apply(frozenset).value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<AxesSubplot:ylabel='Frequency'>"
      ]
     },
     "execution_count": 35,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "df_train.groupby([\"abstract_id\"])[\"gold_raw\"].nunique().plot.hist(cumulative=True, density=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<AxesSubplot:ylabel='Frequency'>"
      ]
     },
     "execution_count": 36,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "df_train.groupby([\"abstract_id\"]).size().plot.hist(bins=100, cumulative=True, density=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<AxesSubplot:ylabel='Frequency'>"
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "df_train.groupby([\"abstract_id\"]).size().plot.hist(bins=100)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(767, 767, 6437)"
      ]
     },
     "execution_count": 38,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_train[\"abstract_id\"].nunique() , 767, 6437"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(6437,)"
      ]
     },
     "execution_count": 39,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_train[\"abstract_id\"].shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [],
   "source": [
    "if TREE in train_result:\n",
    "    plot_tree(train_result[TREE][\"m\"])\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[('_gene_', -1.8386792081367762),\n",
       " ('_chemical_', -1.8386792081367762),\n",
       " ('increased', -3.561175206498607),\n",
       " ('expression', -3.690386937978613),\n",
       " ('induced', -3.6990450007217275),\n",
       " ('increase', -4.087268302395386),\n",
       " ('activity', -4.333103264911666),\n",
       " ('activation', -4.4366439438525065),\n",
       " ('significantly', -4.5121514963606515),\n",
       " ('geneig4', -4.659787495166716),\n",
       " ('geneig5', -4.682777013391416),\n",
       " ('geneig2', -4.73040506238067),\n",
       " ('geneig9', -4.755097674971042),\n",
       " ('geneig3', -4.755097674971042),\n",
       " ('cells', -4.755097674971042),\n",
       " ('geneig10', -4.780415482955331),\n",
       " ('geneig1', -4.833059216440754),\n",
       " ('phosphorylation', -4.833059216440754),\n",
       " ('treatment', -4.860458190628868),\n",
       " ('induction', -4.860458190628868),\n",
       " ('geneig6', -4.860458190628868),\n",
       " ('geneig0', -4.860458190628868),\n",
       " ('apoptosis', -4.888629067595565),\n",
       " ('geneig7', -4.917616604468816),\n",
       " ('geneig8', -4.947469567618498),\n",
       " ('protein', -4.978241226285251),\n",
       " ('geneig13', -5.042779747422822),\n",
       " ('chemig0', -5.076681299098503),\n",
       " ('caused', -5.111772618909773),\n",
       " ('regulated', -5.111772618909773),\n",
       " ('geneig12', -5.111772618909773),\n",
       " ('mrna', -5.185880591063496),\n",
       " ('geneig11', -5.185880591063496),\n",
       " ('genes', -5.225101304216777),\n",
       " ('cell', -5.265923298737032),\n",
       " ('chemig8', -5.265923298737032),\n",
       " ('mediated', -5.308482913155828),\n",
       " ('chemig7', -5.308482913155828),\n",
       " ('inhibited', -5.308482913155828),\n",
       " ('significant', -5.308482913155828),\n",
       " ('geneig16', -5.308482913155828),\n",
       " ('geneig14', -5.308482913155828),\n",
       " ('stimulated', -5.352934675726662),\n",
       " ('fold', -5.399454691361555),\n",
       " ('resulted', -5.399454691361555),\n",
       " ('levels', -5.448244855530987),\n",
       " ('chemig2', -5.448244855530987),\n",
       " ('chemig6', -5.448244855530987),\n",
       " ('chemig5', -5.448244855530987),\n",
       " ('mice', -5.448244855530987)]"
      ]
     },
     "execution_count": 41,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "get_top_discrimintary_keywords(train_result[NAIVE_BAYES][\"m\"],1)[:50]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.43859198697282853"
      ]
     },
     "execution_count": 42,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sklearn.metrics.cohen_kappa_score(df_train[\"gold\"],\n",
    "                                  train_result[NAIVE_BAYES][\"predictions\"]\n",
    "                                  )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.43251068454890507"
      ]
     },
     "execution_count": 43,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sklearn.metrics.cohen_kappa_score(df_train[\"gold\"],\n",
    "                                  train_result[NAIVE_BAYES_WITH_TREE][\"predictions\"]\n",
    "                                  )"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Val GT predictions\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Training Naive Bayes\n",
      "Max words :  327\n",
      "Training Naive Bayes + Tree\n",
      "Max words :  327\n",
      "Extracting features..for 3558\n",
      "Completed..\n",
      "\\begin{tabular}{llrrrr}\n",
      "\\toprule\n",
      "             model &        index & precision & recall & f1-score & support \\\\\n",
      "\\midrule\n",
      "       Naive Bayes &            1 &      59.3 &   55.4 &     57.3 &     552 \\\\\n",
      "       Naive Bayes &            2 &      59.0 &   76.2 &     66.5 &    1103 \\\\\n",
      "       Naive Bayes &            3 &      73.3 &   63.8 &     68.2 &     116 \\\\\n",
      "       Naive Bayes &            4 &      82.5 &   56.8 &     67.3 &     199 \\\\\n",
      "       Naive Bayes &            5 &      78.2 &   46.4 &     58.2 &     457 \\\\\n",
      "       Naive Bayes &    micro avg &      63.1 &   63.7 &     63.4 &    2427 \\\\\n",
      "       Naive Bayes &    macro avg &      70.5 &   59.7 &     63.5 &    2427 \\\\\n",
      "       Naive Bayes & weighted avg &      65.3 &   63.7 &     63.0 &    2427 \\\\\n",
      "Naive Bayes + Tree &            1 &      56.7 &   58.9 &     57.8 &     552 \\\\\n",
      "Naive Bayes + Tree &            2 &      58.9 &   76.5 &     66.6 &    1103 \\\\\n",
      "Naive Bayes + Tree &            3 &      73.3 &   63.8 &     68.2 &     116 \\\\\n",
      "Naive Bayes + Tree &            4 &      82.5 &   56.8 &     67.3 &     199 \\\\\n",
      "Naive Bayes + Tree &            5 &      79.6 &   46.2 &     58.4 &     457 \\\\\n",
      "Naive Bayes + Tree &    micro avg &      62.5 &   64.6 &     63.5 &    2427 \\\\\n",
      "Naive Bayes + Tree &    macro avg &      70.2 &   60.4 &     63.7 &    2427 \\\\\n",
      "Naive Bayes + Tree & weighted avg &      64.9 &   64.6 &     63.2 &    2427 \\\\\n",
      "\\bottomrule\n",
      "\\end{tabular}\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>model</th>\n",
       "      <th>index</th>\n",
       "      <th>precision</th>\n",
       "      <th>recall</th>\n",
       "      <th>f1-score</th>\n",
       "      <th>support</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>1</td>\n",
       "      <td>0.593023</td>\n",
       "      <td>0.554348</td>\n",
       "      <td>0.573034</td>\n",
       "      <td>552.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>2</td>\n",
       "      <td>0.589888</td>\n",
       "      <td>0.761559</td>\n",
       "      <td>0.664820</td>\n",
       "      <td>1103.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>3</td>\n",
       "      <td>0.732673</td>\n",
       "      <td>0.637931</td>\n",
       "      <td>0.682028</td>\n",
       "      <td>116.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>4</td>\n",
       "      <td>0.824818</td>\n",
       "      <td>0.567839</td>\n",
       "      <td>0.672619</td>\n",
       "      <td>199.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>5</td>\n",
       "      <td>0.782288</td>\n",
       "      <td>0.463895</td>\n",
       "      <td>0.582418</td>\n",
       "      <td>457.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>micro avg</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>micro avg</td>\n",
       "      <td>0.630870</td>\n",
       "      <td>0.636588</td>\n",
       "      <td>0.633716</td>\n",
       "      <td>2427.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>macro avg</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>macro avg</td>\n",
       "      <td>0.704538</td>\n",
       "      <td>0.597114</td>\n",
       "      <td>0.634984</td>\n",
       "      <td>2427.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>weighted avg</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>weighted avg</td>\n",
       "      <td>0.652917</td>\n",
       "      <td>0.636588</td>\n",
       "      <td>0.629890</td>\n",
       "      <td>2427.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>1</td>\n",
       "      <td>0.567190</td>\n",
       "      <td>0.588768</td>\n",
       "      <td>0.577778</td>\n",
       "      <td>552.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>2</td>\n",
       "      <td>0.589385</td>\n",
       "      <td>0.765186</td>\n",
       "      <td>0.665878</td>\n",
       "      <td>1103.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>3</td>\n",
       "      <td>0.732673</td>\n",
       "      <td>0.637931</td>\n",
       "      <td>0.682028</td>\n",
       "      <td>116.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>4</td>\n",
       "      <td>0.824818</td>\n",
       "      <td>0.567839</td>\n",
       "      <td>0.672619</td>\n",
       "      <td>199.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>5</td>\n",
       "      <td>0.796226</td>\n",
       "      <td>0.461707</td>\n",
       "      <td>0.584488</td>\n",
       "      <td>457.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>micro avg</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>micro avg</td>\n",
       "      <td>0.624801</td>\n",
       "      <td>0.645653</td>\n",
       "      <td>0.635056</td>\n",
       "      <td>2427.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>macro avg</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>macro avg</td>\n",
       "      <td>0.702059</td>\n",
       "      <td>0.604286</td>\n",
       "      <td>0.636558</td>\n",
       "      <td>2427.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>weighted avg</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>weighted avg</td>\n",
       "      <td>0.649438</td>\n",
       "      <td>0.645653</td>\n",
       "      <td>0.631839</td>\n",
       "      <td>2427.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                           model         index  precision    recall  f1-score  \\\n",
       "1                    Naive Bayes             1   0.593023  0.554348  0.573034   \n",
       "2                    Naive Bayes             2   0.589888  0.761559  0.664820   \n",
       "3                    Naive Bayes             3   0.732673  0.637931  0.682028   \n",
       "4                    Naive Bayes             4   0.824818  0.567839  0.672619   \n",
       "5                    Naive Bayes             5   0.782288  0.463895  0.582418   \n",
       "micro avg            Naive Bayes     micro avg   0.630870  0.636588  0.633716   \n",
       "macro avg            Naive Bayes     macro avg   0.704538  0.597114  0.634984   \n",
       "weighted avg         Naive Bayes  weighted avg   0.652917  0.636588  0.629890   \n",
       "1             Naive Bayes + Tree             1   0.567190  0.588768  0.577778   \n",
       "2             Naive Bayes + Tree             2   0.589385  0.765186  0.665878   \n",
       "3             Naive Bayes + Tree             3   0.732673  0.637931  0.682028   \n",
       "4             Naive Bayes + Tree             4   0.824818  0.567839  0.672619   \n",
       "5             Naive Bayes + Tree             5   0.796226  0.461707  0.584488   \n",
       "micro avg     Naive Bayes + Tree     micro avg   0.624801  0.645653  0.635056   \n",
       "macro avg     Naive Bayes + Tree     macro avg   0.702059  0.604286  0.636558   \n",
       "weighted avg  Naive Bayes + Tree  weighted avg   0.649438  0.645653  0.631839   \n",
       "\n",
       "              support  \n",
       "1               552.0  \n",
       "2              1103.0  \n",
       "3               116.0  \n",
       "4               199.0  \n",
       "5               457.0  \n",
       "micro avg      2427.0  \n",
       "macro avg      2427.0  \n",
       "weighted avg   2427.0  \n",
       "1               552.0  \n",
       "2              1103.0  \n",
       "3               116.0  \n",
       "4               199.0  \n",
       "5               457.0  \n",
       "micro avg      2427.0  \n",
       "macro avg      2427.0  \n",
       "weighted avg   2427.0  "
      ]
     },
     "execution_count": 44,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_val = load_valtest_pred(local_val_prediction_file)\n",
    "\n",
    "\n",
    "val_result = train_and_predict_all_classifiers(df_val, min_df=1)\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "print_report_all_classifiers(df_val[\"gold\"],val_result, labels=pos_labels)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Training Naive Bayes\n",
      "Max words :  327\n",
      "Training Naive Bayes + Tree\n",
      "Max words :  327\n",
      "Extracting features..for 3558\n",
      "Completed..\n",
      "\\begin{tabular}{llrrrr}\n",
      "\\toprule\n",
      "             model &        index & precision & recall & f1-score & support \\\\\n",
      "\\midrule\n",
      "       Naive Bayes &            0 &      63.0 &   67.5 &     65.2 &    1036 \\\\\n",
      "       Naive Bayes &            1 &      71.1 &   59.2 &     64.6 &     620 \\\\\n",
      "       Naive Bayes &            2 &      61.3 &   77.3 &     68.4 &    1129 \\\\\n",
      "       Naive Bayes &            3 &      81.2 &   64.1 &     71.6 &     128 \\\\\n",
      "       Naive Bayes &            4 &      83.9 &   58.7 &     69.1 &     196 \\\\\n",
      "       Naive Bayes &            5 &      84.9 &   51.2 &     63.9 &     449 \\\\\n",
      "       Naive Bayes &     accuracy &      66.5 &   66.5 &     66.5 &       0 \\\\\n",
      "       Naive Bayes &    macro avg &      74.2 &   63.0 &     67.1 &    3558 \\\\\n",
      "       Naive Bayes & weighted avg &      68.5 &   66.5 &     66.4 &    3558 \\\\\n",
      "Naive Bayes + Tree &            0 &      65.6 &   66.5 &     66.1 &    1036 \\\\\n",
      "Naive Bayes + Tree &            1 &      67.5 &   62.4 &     64.9 &     620 \\\\\n",
      "Naive Bayes + Tree &            2 &      61.5 &   77.9 &     68.7 &    1129 \\\\\n",
      "Naive Bayes + Tree &            3 &      81.2 &   64.1 &     71.6 &     128 \\\\\n",
      "Naive Bayes + Tree &            4 &      83.9 &   58.7 &     69.1 &     196 \\\\\n",
      "Naive Bayes + Tree &            5 &      86.4 &   51.0 &     64.1 &     449 \\\\\n",
      "Naive Bayes + Tree &     accuracy &      66.9 &   66.9 &     66.9 &       0 \\\\\n",
      "Naive Bayes + Tree &    macro avg &      74.4 &   63.4 &     67.4 &    3558 \\\\\n",
      "Naive Bayes + Tree & weighted avg &      68.8 &   66.9 &     66.8 &    3558 \\\\\n",
      "\\bottomrule\n",
      "\\end{tabular}\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>model</th>\n",
       "      <th>index</th>\n",
       "      <th>precision</th>\n",
       "      <th>recall</th>\n",
       "      <th>f1-score</th>\n",
       "      <th>support</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>0</td>\n",
       "      <td>0.630298</td>\n",
       "      <td>0.674710</td>\n",
       "      <td>0.651748</td>\n",
       "      <td>1036.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>1</td>\n",
       "      <td>0.711240</td>\n",
       "      <td>0.591935</td>\n",
       "      <td>0.646127</td>\n",
       "      <td>620.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>2</td>\n",
       "      <td>0.613062</td>\n",
       "      <td>0.773251</td>\n",
       "      <td>0.683901</td>\n",
       "      <td>1129.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>3</td>\n",
       "      <td>0.811881</td>\n",
       "      <td>0.640625</td>\n",
       "      <td>0.716157</td>\n",
       "      <td>128.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>4</td>\n",
       "      <td>0.839416</td>\n",
       "      <td>0.586735</td>\n",
       "      <td>0.690691</td>\n",
       "      <td>196.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>5</td>\n",
       "      <td>0.848708</td>\n",
       "      <td>0.512249</td>\n",
       "      <td>0.638889</td>\n",
       "      <td>449.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>accuracy</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>accuracy</td>\n",
       "      <td>0.664980</td>\n",
       "      <td>0.664980</td>\n",
       "      <td>0.664980</td>\n",
       "      <td>0.664980</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>macro avg</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>macro avg</td>\n",
       "      <td>0.742434</td>\n",
       "      <td>0.629918</td>\n",
       "      <td>0.671252</td>\n",
       "      <td>3558.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>weighted avg</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>weighted avg</td>\n",
       "      <td>0.684548</td>\n",
       "      <td>0.664980</td>\n",
       "      <td>0.663811</td>\n",
       "      <td>3558.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>0</td>\n",
       "      <td>0.656190</td>\n",
       "      <td>0.665058</td>\n",
       "      <td>0.660594</td>\n",
       "      <td>1036.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>1</td>\n",
       "      <td>0.675393</td>\n",
       "      <td>0.624194</td>\n",
       "      <td>0.648785</td>\n",
       "      <td>620.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>2</td>\n",
       "      <td>0.614525</td>\n",
       "      <td>0.779451</td>\n",
       "      <td>0.687232</td>\n",
       "      <td>1129.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>3</td>\n",
       "      <td>0.811881</td>\n",
       "      <td>0.640625</td>\n",
       "      <td>0.716157</td>\n",
       "      <td>128.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>4</td>\n",
       "      <td>0.839416</td>\n",
       "      <td>0.586735</td>\n",
       "      <td>0.690691</td>\n",
       "      <td>196.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>5</td>\n",
       "      <td>0.864151</td>\n",
       "      <td>0.510022</td>\n",
       "      <td>0.641457</td>\n",
       "      <td>449.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>accuracy</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>accuracy</td>\n",
       "      <td>0.669477</td>\n",
       "      <td>0.669477</td>\n",
       "      <td>0.669477</td>\n",
       "      <td>0.669477</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>macro avg</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>macro avg</td>\n",
       "      <td>0.743593</td>\n",
       "      <td>0.634347</td>\n",
       "      <td>0.674153</td>\n",
       "      <td>3558.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>weighted avg</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>weighted avg</td>\n",
       "      <td>0.688253</td>\n",
       "      <td>0.669477</td>\n",
       "      <td>0.668231</td>\n",
       "      <td>3558.000000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                           model         index  precision    recall  f1-score  \\\n",
       "0                    Naive Bayes             0   0.630298  0.674710  0.651748   \n",
       "1                    Naive Bayes             1   0.711240  0.591935  0.646127   \n",
       "2                    Naive Bayes             2   0.613062  0.773251  0.683901   \n",
       "3                    Naive Bayes             3   0.811881  0.640625  0.716157   \n",
       "4                    Naive Bayes             4   0.839416  0.586735  0.690691   \n",
       "5                    Naive Bayes             5   0.848708  0.512249  0.638889   \n",
       "accuracy             Naive Bayes      accuracy   0.664980  0.664980  0.664980   \n",
       "macro avg            Naive Bayes     macro avg   0.742434  0.629918  0.671252   \n",
       "weighted avg         Naive Bayes  weighted avg   0.684548  0.664980  0.663811   \n",
       "0             Naive Bayes + Tree             0   0.656190  0.665058  0.660594   \n",
       "1             Naive Bayes + Tree             1   0.675393  0.624194  0.648785   \n",
       "2             Naive Bayes + Tree             2   0.614525  0.779451  0.687232   \n",
       "3             Naive Bayes + Tree             3   0.811881  0.640625  0.716157   \n",
       "4             Naive Bayes + Tree             4   0.839416  0.586735  0.690691   \n",
       "5             Naive Bayes + Tree             5   0.864151  0.510022  0.641457   \n",
       "accuracy      Naive Bayes + Tree      accuracy   0.669477  0.669477  0.669477   \n",
       "macro avg     Naive Bayes + Tree     macro avg   0.743593  0.634347  0.674153   \n",
       "weighted avg  Naive Bayes + Tree  weighted avg   0.688253  0.669477  0.668231   \n",
       "\n",
       "                  support  \n",
       "0             1036.000000  \n",
       "1              620.000000  \n",
       "2             1129.000000  \n",
       "3              128.000000  \n",
       "4              196.000000  \n",
       "5              449.000000  \n",
       "accuracy         0.664980  \n",
       "macro avg     3558.000000  \n",
       "weighted avg  3558.000000  \n",
       "0             1036.000000  \n",
       "1              620.000000  \n",
       "2             1129.000000  \n",
       "3              128.000000  \n",
       "4              196.000000  \n",
       "5              449.000000  \n",
       "accuracy         0.669477  \n",
       "macro avg     3558.000000  \n",
       "weighted avg  3558.000000  "
      ]
     },
     "execution_count": 45,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_val_prediction = load_valtest_pred(local_val_prediction_file)\n",
    "\n",
    "val_prediction_result = train_and_predict_all_classifiers(df_val_prediction, min_df=1)\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "print_report_all_classifiers(df_val_prediction[\"y\"], val_prediction_result, all_labels)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 3240x1080 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "if NAIVE_BAYES_WITH_TREE in val_prediction_result: \n",
    "    plot_tree(val_prediction_result[NAIVE_BAYES_WITH_TREE][\"m\"])"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Test "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Running command\n",
      "java -cp ../thirdparty/bc6chemprot_eval.jar org.biocreative.tasks.chemprot.main.Main -TP TRUE -FP TRUE -FN TRUE /var/folders/7v/5_mr86mx7l9g94fxzdpdx0nw0000gn/T/tmpr5d53au4 temp/prediction/chemprot_test_gold_standard.tsv\n",
      "\n",
      "The file:\n",
      "\t./out/eval.txt\n",
      "was successfully created.\n",
      "\n",
      "The file:\n",
      "\t./out/tp.txt\n",
      "was successfully created.\n",
      "\n",
      "The file:\n",
      "\t./out/fp.txt\n",
      "was successfully created.\n",
      "\n",
      "The file:\n",
      "\t./out/fn.txt\n",
      "was successfully created.\n",
      "\n",
      "['\\n', 'Total annotations: 3458\\n', 'Total predictions: 3726\\n', 'TP: 2853\\n', 'FN: 605\\n', 'FP: 873\\n', 'Precision: 0.7657004830917874\\n', 'Recall: 0.8250433776749566\\n', 'F-score: 0.7942650334075724']\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>c</th>\n",
       "      <th>FN</th>\n",
       "      <th>FP</th>\n",
       "      <th>TP</th>\n",
       "      <th>P</th>\n",
       "      <th>R</th>\n",
       "      <th>F</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>y</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>CPR:3</th>\n",
       "      <td>152.0</td>\n",
       "      <td>245.0</td>\n",
       "      <td>513.0</td>\n",
       "      <td>0.676781</td>\n",
       "      <td>0.771429</td>\n",
       "      <td>0.721012</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>CPR:4</th>\n",
       "      <td>262.0</td>\n",
       "      <td>306.0</td>\n",
       "      <td>1399.0</td>\n",
       "      <td>0.820528</td>\n",
       "      <td>0.842264</td>\n",
       "      <td>0.831254</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>CPR:5</th>\n",
       "      <td>37.0</td>\n",
       "      <td>30.0</td>\n",
       "      <td>158.0</td>\n",
       "      <td>0.840426</td>\n",
       "      <td>0.810256</td>\n",
       "      <td>0.825065</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>CPR:6</th>\n",
       "      <td>48.0</td>\n",
       "      <td>49.0</td>\n",
       "      <td>245.0</td>\n",
       "      <td>0.833333</td>\n",
       "      <td>0.836177</td>\n",
       "      <td>0.834753</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>CPR:9</th>\n",
       "      <td>106.0</td>\n",
       "      <td>196.0</td>\n",
       "      <td>538.0</td>\n",
       "      <td>0.732970</td>\n",
       "      <td>0.835404</td>\n",
       "      <td>0.780842</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total</th>\n",
       "      <td>605.0</td>\n",
       "      <td>826.0</td>\n",
       "      <td>2853.0</td>\n",
       "      <td>0.775482</td>\n",
       "      <td>0.825043</td>\n",
       "      <td>0.799496</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "c         FN     FP      TP         P         R         F\n",
       "y                                                        \n",
       "CPR:3  152.0  245.0   513.0  0.676781  0.771429  0.721012\n",
       "CPR:4  262.0  306.0  1399.0  0.820528  0.842264  0.831254\n",
       "CPR:5   37.0   30.0   158.0  0.840426  0.810256  0.825065\n",
       "CPR:6   48.0   49.0   245.0  0.833333  0.836177  0.834753\n",
       "CPR:9  106.0  196.0   538.0  0.732970  0.835404  0.780842\n",
       "total  605.0  826.0  2853.0  0.775482  0.825043  0.799496"
      ]
     },
     "execution_count": 47,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_test = load_valtest_pred(local_test_prediction_file)\n",
    "\n",
    "\n",
    "print_report_original(df_test, \"y_raw\", test_gold_file )\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(152, 256, 515)"
      ]
     },
     "execution_count": 48,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "l = 'CPR:3'\n",
    "tp = df_test.query(f\"y_raw=='{l}' and gold_raw=='{l}'\").shape[0]\n",
    "fp = df_test.query(f\"y_raw=='{l}' and gold_raw!='{l}'\").shape[0]\n",
    "fn = df_test.query(f\"y_raw!='{l}' and gold_raw=='{l}'\").shape[0]\n",
    "\n",
    "\n",
    "fn, fp, tp"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>precision</th>\n",
       "      <th>recall</th>\n",
       "      <th>f1-score</th>\n",
       "      <th>support</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>0.667964</td>\n",
       "      <td>0.772114</td>\n",
       "      <td>0.716273</td>\n",
       "      <td>667.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>0.814493</td>\n",
       "      <td>0.842831</td>\n",
       "      <td>0.828420</td>\n",
       "      <td>1667.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>0.811224</td>\n",
       "      <td>0.803030</td>\n",
       "      <td>0.807107</td>\n",
       "      <td>198.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>0.816667</td>\n",
       "      <td>0.836177</td>\n",
       "      <td>0.826307</td>\n",
       "      <td>293.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>0.732970</td>\n",
       "      <td>0.835404</td>\n",
       "      <td>0.780842</td>\n",
       "      <td>644.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>micro avg</th>\n",
       "      <td>0.768116</td>\n",
       "      <td>0.825022</td>\n",
       "      <td>0.795552</td>\n",
       "      <td>3469.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>macro avg</th>\n",
       "      <td>0.768664</td>\n",
       "      <td>0.817911</td>\n",
       "      <td>0.791790</td>\n",
       "      <td>3469.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>weighted avg</th>\n",
       "      <td>0.771182</td>\n",
       "      <td>0.825022</td>\n",
       "      <td>0.796629</td>\n",
       "      <td>3469.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "              precision    recall  f1-score  support\n",
       "1              0.667964  0.772114  0.716273    667.0\n",
       "2              0.814493  0.842831  0.828420   1667.0\n",
       "3              0.811224  0.803030  0.807107    198.0\n",
       "4              0.816667  0.836177  0.826307    293.0\n",
       "5              0.732970  0.835404  0.780842    644.0\n",
       "micro avg      0.768116  0.825022  0.795552   3469.0\n",
       "macro avg      0.768664  0.817911  0.791790   3469.0\n",
       "weighted avg   0.771182  0.825022  0.796629   3469.0"
      ]
     },
     "execution_count": 49,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_test = load_valtest_pred(local_test_prediction_file)\n",
    "\n",
    "print_report(df_test[\"gold\"],df_test[\"y\"], labels=pos_labels)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>precision</th>\n",
       "      <th>recall</th>\n",
       "      <th>f1-score</th>\n",
       "      <th>support</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.820614</td>\n",
       "      <td>0.727912</td>\n",
       "      <td>0.771488</td>\n",
       "      <td>2275.00000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>0.667964</td>\n",
       "      <td>0.772114</td>\n",
       "      <td>0.716273</td>\n",
       "      <td>667.00000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>0.814493</td>\n",
       "      <td>0.842831</td>\n",
       "      <td>0.828420</td>\n",
       "      <td>1667.00000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>0.811224</td>\n",
       "      <td>0.803030</td>\n",
       "      <td>0.807107</td>\n",
       "      <td>198.00000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>0.816667</td>\n",
       "      <td>0.836177</td>\n",
       "      <td>0.826307</td>\n",
       "      <td>293.00000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>0.732970</td>\n",
       "      <td>0.835404</td>\n",
       "      <td>0.780842</td>\n",
       "      <td>644.00000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>accuracy</th>\n",
       "      <td>0.786560</td>\n",
       "      <td>0.786560</td>\n",
       "      <td>0.786560</td>\n",
       "      <td>0.78656</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>macro avg</th>\n",
       "      <td>0.777322</td>\n",
       "      <td>0.802911</td>\n",
       "      <td>0.788406</td>\n",
       "      <td>5744.00000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>weighted avg</th>\n",
       "      <td>0.790760</td>\n",
       "      <td>0.786560</td>\n",
       "      <td>0.786672</td>\n",
       "      <td>5744.00000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "              precision    recall  f1-score     support\n",
       "0              0.820614  0.727912  0.771488  2275.00000\n",
       "1              0.667964  0.772114  0.716273   667.00000\n",
       "2              0.814493  0.842831  0.828420  1667.00000\n",
       "3              0.811224  0.803030  0.807107   198.00000\n",
       "4              0.816667  0.836177  0.826307   293.00000\n",
       "5              0.732970  0.835404  0.780842   644.00000\n",
       "accuracy       0.786560  0.786560  0.786560     0.78656\n",
       "macro avg      0.777322  0.802911  0.788406  5744.00000\n",
       "weighted avg   0.790760  0.786560  0.786672  5744.00000"
      ]
     },
     "execution_count": 50,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "print_report(df_test[\"gold\"],df_test[\"y\"], labels=all_labels)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 2 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "plot_confusionmatrix(df_test[\"gold\"],df_test[\"y\"] )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "((5744,), 620)"
      ]
     },
     "execution_count": 52,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_test[\"abstract_id\"].shape, df_test[\"abstract_id\"].nunique()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Predict Test on Test GT fit"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Training Naive Bayes\n",
      "Max words :  315\n",
      "Training Naive Bayes + Tree\n",
      "Max words :  315\n",
      "Extracting features..for 5744\n",
      "Completed..\n",
      "\\begin{tabular}{llrrrr}\n",
      "\\toprule\n",
      "             model &        index & precision & recall & f1-score & support \\\\\n",
      "\\midrule\n",
      "       Naive Bayes &            1 &      51.9 &   51.4 &     51.7 &     667 \\\\\n",
      "       Naive Bayes &            2 &      70.7 &   56.9 &     63.1 &    1667 \\\\\n",
      "       Naive Bayes &            3 &      63.7 &   43.4 &     51.7 &     198 \\\\\n",
      "       Naive Bayes &            4 &      63.7 &   42.0 &     50.6 &     293 \\\\\n",
      "       Naive Bayes &            5 &      61.1 &   32.9 &     42.8 &     644 \\\\\n",
      "       Naive Bayes &    micro avg &      64.0 &   49.4 &     55.7 &    3469 \\\\\n",
      "       Naive Bayes &    macro avg &      62.2 &   45.3 &     52.0 &    3469 \\\\\n",
      "       Naive Bayes & weighted avg &      64.3 &   49.4 &     55.4 &    3469 \\\\\n",
      "Naive Bayes + Tree &            1 &      52.8 &   51.4 &     52.1 &     667 \\\\\n",
      "Naive Bayes + Tree &            2 &      71.0 &   56.9 &     63.2 &    1667 \\\\\n",
      "Naive Bayes + Tree &            3 &      63.7 &   43.4 &     51.7 &     198 \\\\\n",
      "Naive Bayes + Tree &            4 &      63.7 &   42.0 &     50.6 &     293 \\\\\n",
      "Naive Bayes + Tree &            5 &      61.1 &   32.9 &     42.8 &     644 \\\\\n",
      "Naive Bayes + Tree &    micro avg &      64.4 &   49.4 &     55.9 &    3469 \\\\\n",
      "Naive Bayes + Tree &    macro avg &      62.5 &   45.3 &     52.1 &    3469 \\\\\n",
      "Naive Bayes + Tree & weighted avg &      64.6 &   49.4 &     55.5 &    3469 \\\\\n",
      "\\bottomrule\n",
      "\\end{tabular}\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>model</th>\n",
       "      <th>index</th>\n",
       "      <th>precision</th>\n",
       "      <th>recall</th>\n",
       "      <th>f1-score</th>\n",
       "      <th>support</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>1</td>\n",
       "      <td>0.518911</td>\n",
       "      <td>0.514243</td>\n",
       "      <td>0.516566</td>\n",
       "      <td>667.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>2</td>\n",
       "      <td>0.707154</td>\n",
       "      <td>0.569286</td>\n",
       "      <td>0.630774</td>\n",
       "      <td>1667.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>3</td>\n",
       "      <td>0.637037</td>\n",
       "      <td>0.434343</td>\n",
       "      <td>0.516517</td>\n",
       "      <td>198.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>4</td>\n",
       "      <td>0.637306</td>\n",
       "      <td>0.419795</td>\n",
       "      <td>0.506173</td>\n",
       "      <td>293.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>5</td>\n",
       "      <td>0.610951</td>\n",
       "      <td>0.329193</td>\n",
       "      <td>0.427851</td>\n",
       "      <td>644.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>micro avg</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>micro avg</td>\n",
       "      <td>0.639656</td>\n",
       "      <td>0.493802</td>\n",
       "      <td>0.557345</td>\n",
       "      <td>3469.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>macro avg</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>macro avg</td>\n",
       "      <td>0.622272</td>\n",
       "      <td>0.453372</td>\n",
       "      <td>0.519576</td>\n",
       "      <td>3469.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>weighted avg</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>weighted avg</td>\n",
       "      <td>0.643198</td>\n",
       "      <td>0.493802</td>\n",
       "      <td>0.554098</td>\n",
       "      <td>3469.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>1</td>\n",
       "      <td>0.527692</td>\n",
       "      <td>0.514243</td>\n",
       "      <td>0.520881</td>\n",
       "      <td>667.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>2</td>\n",
       "      <td>0.710112</td>\n",
       "      <td>0.568686</td>\n",
       "      <td>0.631579</td>\n",
       "      <td>1667.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>3</td>\n",
       "      <td>0.637037</td>\n",
       "      <td>0.434343</td>\n",
       "      <td>0.516517</td>\n",
       "      <td>198.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>4</td>\n",
       "      <td>0.637306</td>\n",
       "      <td>0.419795</td>\n",
       "      <td>0.506173</td>\n",
       "      <td>293.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>5</td>\n",
       "      <td>0.610951</td>\n",
       "      <td>0.329193</td>\n",
       "      <td>0.427851</td>\n",
       "      <td>644.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>micro avg</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>micro avg</td>\n",
       "      <td>0.643609</td>\n",
       "      <td>0.493514</td>\n",
       "      <td>0.558656</td>\n",
       "      <td>3469.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>macro avg</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>macro avg</td>\n",
       "      <td>0.624620</td>\n",
       "      <td>0.453252</td>\n",
       "      <td>0.520600</td>\n",
       "      <td>3469.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>weighted avg</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>weighted avg</td>\n",
       "      <td>0.646309</td>\n",
       "      <td>0.493514</td>\n",
       "      <td>0.555314</td>\n",
       "      <td>3469.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                           model         index  precision    recall  f1-score  \\\n",
       "1                    Naive Bayes             1   0.518911  0.514243  0.516566   \n",
       "2                    Naive Bayes             2   0.707154  0.569286  0.630774   \n",
       "3                    Naive Bayes             3   0.637037  0.434343  0.516517   \n",
       "4                    Naive Bayes             4   0.637306  0.419795  0.506173   \n",
       "5                    Naive Bayes             5   0.610951  0.329193  0.427851   \n",
       "micro avg            Naive Bayes     micro avg   0.639656  0.493802  0.557345   \n",
       "macro avg            Naive Bayes     macro avg   0.622272  0.453372  0.519576   \n",
       "weighted avg         Naive Bayes  weighted avg   0.643198  0.493802  0.554098   \n",
       "1             Naive Bayes + Tree             1   0.527692  0.514243  0.520881   \n",
       "2             Naive Bayes + Tree             2   0.710112  0.568686  0.631579   \n",
       "3             Naive Bayes + Tree             3   0.637037  0.434343  0.516517   \n",
       "4             Naive Bayes + Tree             4   0.637306  0.419795  0.506173   \n",
       "5             Naive Bayes + Tree             5   0.610951  0.329193  0.427851   \n",
       "micro avg     Naive Bayes + Tree     micro avg   0.643609  0.493514  0.558656   \n",
       "macro avg     Naive Bayes + Tree     macro avg   0.624620  0.453252  0.520600   \n",
       "weighted avg  Naive Bayes + Tree  weighted avg   0.646309  0.493514  0.555314   \n",
       "\n",
       "              support  \n",
       "1               667.0  \n",
       "2              1667.0  \n",
       "3               198.0  \n",
       "4               293.0  \n",
       "5               644.0  \n",
       "micro avg      3469.0  \n",
       "macro avg      3469.0  \n",
       "weighted avg   3469.0  \n",
       "1               667.0  \n",
       "2              1667.0  \n",
       "3               198.0  \n",
       "4               293.0  \n",
       "5               644.0  \n",
       "micro avg      3469.0  \n",
       "macro avg      3469.0  \n",
       "weighted avg   3469.0  "
      ]
     },
     "execution_count": 53,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_test = load_valtest_pred(local_test_prediction_file)\n",
    "\n",
    "\n",
    "result_test_gt = train_and_predict_all_classifiers(df_test, min_df=1)\n",
    "\n",
    "\n",
    "\n",
    "print_report_all_classifiers(df_test[\"gold\"], result_test_gt, labels=pos_labels)\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\\begin{tabular}{llrrrr}\n",
      "\\toprule\n",
      "             model &        index & precision & recall & f1-score & support \\\\\n",
      "\\midrule\n",
      "       Naive Bayes &            0 &      57.9 &   55.2 &     56.5 &    2275 \\\\\n",
      "       Naive Bayes &            1 &      48.3 &   41.7 &     44.7 &     667 \\\\\n",
      "       Naive Bayes &            2 &      45.2 &   67.1 &     54.0 &    1667 \\\\\n",
      "       Naive Bayes &            3 &      65.8 &   24.2 &     35.4 &     198 \\\\\n",
      "       Naive Bayes &            4 &      59.3 &   27.3 &     37.4 &     293 \\\\\n",
      "       Naive Bayes &            5 &      53.5 &   26.1 &     35.1 &     644 \\\\\n",
      "       Naive Bayes &     accuracy &      51.3 &   51.3 &     51.3 &       0 \\\\\n",
      "       Naive Bayes &    macro avg &      55.0 &   40.3 &     43.8 &    5744 \\\\\n",
      "       Naive Bayes & weighted avg &      52.9 &   51.3 &     50.3 &    5744 \\\\\n",
      "Naive Bayes + Tree &            0 &      53.5 &   69.8 &     60.6 &    2275 \\\\\n",
      "Naive Bayes + Tree &            1 &      48.8 &   44.7 &     46.6 &     667 \\\\\n",
      "Naive Bayes + Tree &            2 &      57.4 &   56.4 &     56.9 &    1667 \\\\\n",
      "Naive Bayes + Tree &            3 &       0.0 &    0.0 &      0.0 &     198 \\\\\n",
      "Naive Bayes + Tree &            4 &      41.8 &   29.7 &     34.7 &     293 \\\\\n",
      "Naive Bayes + Tree &            5 &      53.5 &   26.1 &     35.1 &     644 \\\\\n",
      "Naive Bayes + Tree &     accuracy &      53.7 &   53.7 &     53.7 &       0 \\\\\n",
      "Naive Bayes + Tree &    macro avg &      42.5 &   37.8 &     39.0 &    5744 \\\\\n",
      "Naive Bayes + Tree & weighted avg &      51.6 &   53.7 &     51.6 &    5744 \\\\\n",
      "\\bottomrule\n",
      "\\end{tabular}\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>model</th>\n",
       "      <th>index</th>\n",
       "      <th>precision</th>\n",
       "      <th>recall</th>\n",
       "      <th>f1-score</th>\n",
       "      <th>support</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>0</td>\n",
       "      <td>0.578608</td>\n",
       "      <td>0.551648</td>\n",
       "      <td>0.564806</td>\n",
       "      <td>2275.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>1</td>\n",
       "      <td>0.482639</td>\n",
       "      <td>0.416792</td>\n",
       "      <td>0.447305</td>\n",
       "      <td>667.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>2</td>\n",
       "      <td>0.451756</td>\n",
       "      <td>0.671266</td>\n",
       "      <td>0.540058</td>\n",
       "      <td>1667.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>3</td>\n",
       "      <td>0.657534</td>\n",
       "      <td>0.242424</td>\n",
       "      <td>0.354244</td>\n",
       "      <td>198.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>4</td>\n",
       "      <td>0.592593</td>\n",
       "      <td>0.273038</td>\n",
       "      <td>0.373832</td>\n",
       "      <td>293.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>5</td>\n",
       "      <td>0.535032</td>\n",
       "      <td>0.260870</td>\n",
       "      <td>0.350731</td>\n",
       "      <td>644.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>accuracy</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>accuracy</td>\n",
       "      <td>0.513231</td>\n",
       "      <td>0.513231</td>\n",
       "      <td>0.513231</td>\n",
       "      <td>0.513231</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>macro avg</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>macro avg</td>\n",
       "      <td>0.549694</td>\n",
       "      <td>0.402673</td>\n",
       "      <td>0.438496</td>\n",
       "      <td>5744.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>weighted avg</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>weighted avg</td>\n",
       "      <td>0.529198</td>\n",
       "      <td>0.513231</td>\n",
       "      <td>0.502978</td>\n",
       "      <td>5744.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>0</td>\n",
       "      <td>0.534657</td>\n",
       "      <td>0.698462</td>\n",
       "      <td>0.605679</td>\n",
       "      <td>2275.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>1</td>\n",
       "      <td>0.487725</td>\n",
       "      <td>0.446777</td>\n",
       "      <td>0.466354</td>\n",
       "      <td>667.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>2</td>\n",
       "      <td>0.573520</td>\n",
       "      <td>0.563887</td>\n",
       "      <td>0.568663</td>\n",
       "      <td>1667.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>3</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>198.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>4</td>\n",
       "      <td>0.418269</td>\n",
       "      <td>0.296928</td>\n",
       "      <td>0.347305</td>\n",
       "      <td>293.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>5</td>\n",
       "      <td>0.535032</td>\n",
       "      <td>0.260870</td>\n",
       "      <td>0.350731</td>\n",
       "      <td>644.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>accuracy</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>accuracy</td>\n",
       "      <td>0.536560</td>\n",
       "      <td>0.536560</td>\n",
       "      <td>0.536560</td>\n",
       "      <td>0.536560</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>macro avg</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>macro avg</td>\n",
       "      <td>0.424867</td>\n",
       "      <td>0.377821</td>\n",
       "      <td>0.389789</td>\n",
       "      <td>5744.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>weighted avg</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>weighted avg</td>\n",
       "      <td>0.516161</td>\n",
       "      <td>0.536560</td>\n",
       "      <td>0.516116</td>\n",
       "      <td>5744.000000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                           model         index  precision    recall  f1-score  \\\n",
       "0                    Naive Bayes             0   0.578608  0.551648  0.564806   \n",
       "1                    Naive Bayes             1   0.482639  0.416792  0.447305   \n",
       "2                    Naive Bayes             2   0.451756  0.671266  0.540058   \n",
       "3                    Naive Bayes             3   0.657534  0.242424  0.354244   \n",
       "4                    Naive Bayes             4   0.592593  0.273038  0.373832   \n",
       "5                    Naive Bayes             5   0.535032  0.260870  0.350731   \n",
       "accuracy             Naive Bayes      accuracy   0.513231  0.513231  0.513231   \n",
       "macro avg            Naive Bayes     macro avg   0.549694  0.402673  0.438496   \n",
       "weighted avg         Naive Bayes  weighted avg   0.529198  0.513231  0.502978   \n",
       "0             Naive Bayes + Tree             0   0.534657  0.698462  0.605679   \n",
       "1             Naive Bayes + Tree             1   0.487725  0.446777  0.466354   \n",
       "2             Naive Bayes + Tree             2   0.573520  0.563887  0.568663   \n",
       "3             Naive Bayes + Tree             3   0.000000  0.000000  0.000000   \n",
       "4             Naive Bayes + Tree             4   0.418269  0.296928  0.347305   \n",
       "5             Naive Bayes + Tree             5   0.535032  0.260870  0.350731   \n",
       "accuracy      Naive Bayes + Tree      accuracy   0.536560  0.536560  0.536560   \n",
       "macro avg     Naive Bayes + Tree     macro avg   0.424867  0.377821  0.389789   \n",
       "weighted avg  Naive Bayes + Tree  weighted avg   0.516161  0.536560  0.516116   \n",
       "\n",
       "                  support  \n",
       "0             2275.000000  \n",
       "1              667.000000  \n",
       "2             1667.000000  \n",
       "3              198.000000  \n",
       "4              293.000000  \n",
       "5              644.000000  \n",
       "accuracy         0.513231  \n",
       "macro avg     5744.000000  \n",
       "weighted avg  5744.000000  \n",
       "0             2275.000000  \n",
       "1              667.000000  \n",
       "2             1667.000000  \n",
       "3              198.000000  \n",
       "4              293.000000  \n",
       "5              644.000000  \n",
       "accuracy         0.536560  \n",
       "macro avg     5744.000000  \n",
       "weighted avg  5744.000000  "
      ]
     },
     "execution_count": 54,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "result_train_predict_test_gt = predict_all_classifiers(df_test, train_result)\n",
    "\n",
    "print_report_all_classifiers(df_test[\"gold\"], result_train_predict_test_gt,  all_labels)\n",
    "\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\\begin{tabular}{llrrrr}\n",
      "\\toprule\n",
      "             model &        index & precision & recall & f1-score & support \\\\\n",
      "\\midrule\n",
      "       Naive Bayes &            0 &      55.7 &   59.9 &     57.7 &    2018 \\\\\n",
      "       Naive Bayes &            1 &      53.1 &   39.7 &     45.4 &     771 \\\\\n",
      "       Naive Bayes &            2 &      47.2 &   67.8 &     55.7 &    1725 \\\\\n",
      "       Naive Bayes &            3 &      71.2 &   26.5 &     38.7 &     196 \\\\\n",
      "       Naive Bayes &            4 &      60.7 &   27.3 &     37.7 &     300 \\\\\n",
      "       Naive Bayes &            5 &      64.6 &   27.7 &     38.7 &     734 \\\\\n",
      "       Naive Bayes &     accuracy &      52.6 &   52.6 &     52.6 &       0 \\\\\n",
      "       Naive Bayes &    macro avg &      58.8 &   41.5 &     45.7 &    5744 \\\\\n",
      "       Naive Bayes & weighted avg &      54.7 &   52.6 &     51.3 &    5744 \\\\\n",
      "Naive Bayes + Tree &            0 &      49.7 &   73.2 &     59.2 &    2018 \\\\\n",
      "Naive Bayes + Tree &            1 &      53.5 &   42.4 &     47.3 &     771 \\\\\n",
      "Naive Bayes + Tree &            2 &      61.3 &   58.2 &     59.7 &    1725 \\\\\n",
      "Naive Bayes + Tree &            3 &       0.0 &    0.0 &      0.0 &     196 \\\\\n",
      "Naive Bayes + Tree &            4 &      42.3 &   29.3 &     34.6 &     300 \\\\\n",
      "Naive Bayes + Tree &            5 &      64.6 &   27.7 &     38.7 &     734 \\\\\n",
      "Naive Bayes + Tree &     accuracy &      54.0 &   54.0 &     54.0 &       0 \\\\\n",
      "Naive Bayes + Tree &    macro avg &      45.2 &   38.5 &     39.9 &    5744 \\\\\n",
      "Naive Bayes + Tree & weighted avg &      53.5 &   54.0 &     51.8 &    5744 \\\\\n",
      "\\bottomrule\n",
      "\\end{tabular}\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>model</th>\n",
       "      <th>index</th>\n",
       "      <th>precision</th>\n",
       "      <th>recall</th>\n",
       "      <th>f1-score</th>\n",
       "      <th>support</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>0</td>\n",
       "      <td>0.556939</td>\n",
       "      <td>0.598612</td>\n",
       "      <td>0.577024</td>\n",
       "      <td>2018.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>1</td>\n",
       "      <td>0.531250</td>\n",
       "      <td>0.396887</td>\n",
       "      <td>0.454343</td>\n",
       "      <td>771.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>2</td>\n",
       "      <td>0.472346</td>\n",
       "      <td>0.678261</td>\n",
       "      <td>0.556878</td>\n",
       "      <td>1725.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>3</td>\n",
       "      <td>0.712329</td>\n",
       "      <td>0.265306</td>\n",
       "      <td>0.386617</td>\n",
       "      <td>196.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>4</td>\n",
       "      <td>0.607407</td>\n",
       "      <td>0.273333</td>\n",
       "      <td>0.377011</td>\n",
       "      <td>300.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>5</td>\n",
       "      <td>0.646497</td>\n",
       "      <td>0.276567</td>\n",
       "      <td>0.387405</td>\n",
       "      <td>734.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>accuracy</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>accuracy</td>\n",
       "      <td>0.525940</td>\n",
       "      <td>0.525940</td>\n",
       "      <td>0.525940</td>\n",
       "      <td>0.525940</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>macro avg</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>macro avg</td>\n",
       "      <td>0.587795</td>\n",
       "      <td>0.414828</td>\n",
       "      <td>0.456546</td>\n",
       "      <td>5744.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>weighted avg</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>weighted avg</td>\n",
       "      <td>0.547469</td>\n",
       "      <td>0.525940</td>\n",
       "      <td>0.513333</td>\n",
       "      <td>5744.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>0</td>\n",
       "      <td>0.496972</td>\n",
       "      <td>0.731913</td>\n",
       "      <td>0.591984</td>\n",
       "      <td>2018.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>1</td>\n",
       "      <td>0.535188</td>\n",
       "      <td>0.424125</td>\n",
       "      <td>0.473227</td>\n",
       "      <td>771.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>2</td>\n",
       "      <td>0.612569</td>\n",
       "      <td>0.582029</td>\n",
       "      <td>0.596908</td>\n",
       "      <td>1725.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>3</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>196.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>4</td>\n",
       "      <td>0.423077</td>\n",
       "      <td>0.293333</td>\n",
       "      <td>0.346457</td>\n",
       "      <td>300.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>5</td>\n",
       "      <td>0.646497</td>\n",
       "      <td>0.276567</td>\n",
       "      <td>0.387405</td>\n",
       "      <td>734.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>accuracy</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>accuracy</td>\n",
       "      <td>0.539519</td>\n",
       "      <td>0.539519</td>\n",
       "      <td>0.539519</td>\n",
       "      <td>0.539519</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>macro avg</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>macro avg</td>\n",
       "      <td>0.452384</td>\n",
       "      <td>0.384661</td>\n",
       "      <td>0.399330</td>\n",
       "      <td>5744.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>weighted avg</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>weighted avg</td>\n",
       "      <td>0.535106</td>\n",
       "      <td>0.539519</td>\n",
       "      <td>0.518357</td>\n",
       "      <td>5744.000000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                           model         index  precision    recall  f1-score  \\\n",
       "0                    Naive Bayes             0   0.556939  0.598612  0.577024   \n",
       "1                    Naive Bayes             1   0.531250  0.396887  0.454343   \n",
       "2                    Naive Bayes             2   0.472346  0.678261  0.556878   \n",
       "3                    Naive Bayes             3   0.712329  0.265306  0.386617   \n",
       "4                    Naive Bayes             4   0.607407  0.273333  0.377011   \n",
       "5                    Naive Bayes             5   0.646497  0.276567  0.387405   \n",
       "accuracy             Naive Bayes      accuracy   0.525940  0.525940  0.525940   \n",
       "macro avg            Naive Bayes     macro avg   0.587795  0.414828  0.456546   \n",
       "weighted avg         Naive Bayes  weighted avg   0.547469  0.525940  0.513333   \n",
       "0             Naive Bayes + Tree             0   0.496972  0.731913  0.591984   \n",
       "1             Naive Bayes + Tree             1   0.535188  0.424125  0.473227   \n",
       "2             Naive Bayes + Tree             2   0.612569  0.582029  0.596908   \n",
       "3             Naive Bayes + Tree             3   0.000000  0.000000  0.000000   \n",
       "4             Naive Bayes + Tree             4   0.423077  0.293333  0.346457   \n",
       "5             Naive Bayes + Tree             5   0.646497  0.276567  0.387405   \n",
       "accuracy      Naive Bayes + Tree      accuracy   0.539519  0.539519  0.539519   \n",
       "macro avg     Naive Bayes + Tree     macro avg   0.452384  0.384661  0.399330   \n",
       "weighted avg  Naive Bayes + Tree  weighted avg   0.535106  0.539519  0.518357   \n",
       "\n",
       "                  support  \n",
       "0             2018.000000  \n",
       "1              771.000000  \n",
       "2             1725.000000  \n",
       "3              196.000000  \n",
       "4              300.000000  \n",
       "5              734.000000  \n",
       "accuracy         0.525940  \n",
       "macro avg     5744.000000  \n",
       "weighted avg  5744.000000  \n",
       "0             2018.000000  \n",
       "1              771.000000  \n",
       "2             1725.000000  \n",
       "3              196.000000  \n",
       "4              300.000000  \n",
       "5              734.000000  \n",
       "accuracy         0.539519  \n",
       "macro avg     5744.000000  \n",
       "weighted avg  5744.000000  "
      ]
     },
     "execution_count": 55,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "result_train_predict_test_gt = predict_all_classifiers(df_test, train_result)\n",
    "\n",
    "print_report_all_classifiers(df_test[\"y\"], result_train_predict_test_gt,  all_labels)\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\\begin{tabular}{llrrrr}\n",
      "\\toprule\n",
      "             model &        index & precision & recall & f1-score & support \\\\\n",
      "\\midrule\n",
      "       Naive Bayes &            0 &      56.9 &   64.3 &     60.4 &    1395 \\\\\n",
      "       Naive Bayes &            1 &      47.5 &   44.8 &     46.1 &     502 \\\\\n",
      "       Naive Bayes &            2 &      58.2 &   65.4 &     61.6 &    1182 \\\\\n",
      "       Naive Bayes &            3 &      56.7 &   17.7 &     27.0 &      96 \\\\\n",
      "       Naive Bayes &            4 &      30.0 &    9.0 &     13.8 &     100 \\\\\n",
      "       Naive Bayes &            5 &      64.5 &   38.5 &     48.2 &     410 \\\\\n",
      "       Naive Bayes &     accuracy &      56.4 &   56.4 &     56.4 &       0 \\\\\n",
      "       Naive Bayes &    macro avg &      52.3 &   40.0 &     42.9 &    3685 \\\\\n",
      "       Naive Bayes & weighted avg &      56.1 &   56.4 &     55.3 &    3685 \\\\\n",
      "Naive Bayes + Tree &            0 &      57.1 &   64.8 &     60.7 &    1395 \\\\\n",
      "Naive Bayes + Tree &            1 &      47.6 &   44.6 &     46.0 &     502 \\\\\n",
      "Naive Bayes + Tree &            2 &      58.1 &   65.1 &     61.4 &    1182 \\\\\n",
      "Naive Bayes + Tree &            3 &       0.0 &    0.0 &      0.0 &      96 \\\\\n",
      "Naive Bayes + Tree &            4 &      21.7 &   13.0 &     16.2 &     100 \\\\\n",
      "Naive Bayes + Tree &            5 &      64.5 &   38.5 &     48.2 &     410 \\\\\n",
      "Naive Bayes + Tree &     accuracy &      56.1 &   56.1 &     56.1 &       0 \\\\\n",
      "Naive Bayes + Tree &    macro avg &      41.5 &   37.7 &     38.8 &    3685 \\\\\n",
      "Naive Bayes + Tree & weighted avg &      54.5 &   56.1 &     54.8 &    3685 \\\\\n",
      "\\bottomrule\n",
      "\\end{tabular}\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>model</th>\n",
       "      <th>index</th>\n",
       "      <th>precision</th>\n",
       "      <th>recall</th>\n",
       "      <th>f1-score</th>\n",
       "      <th>support</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>0</td>\n",
       "      <td>0.568802</td>\n",
       "      <td>0.643011</td>\n",
       "      <td>0.603634</td>\n",
       "      <td>1395.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>1</td>\n",
       "      <td>0.474684</td>\n",
       "      <td>0.448207</td>\n",
       "      <td>0.461066</td>\n",
       "      <td>502.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>2</td>\n",
       "      <td>0.581640</td>\n",
       "      <td>0.653976</td>\n",
       "      <td>0.615691</td>\n",
       "      <td>1182.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>3</td>\n",
       "      <td>0.566667</td>\n",
       "      <td>0.177083</td>\n",
       "      <td>0.269841</td>\n",
       "      <td>96.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>4</td>\n",
       "      <td>0.300000</td>\n",
       "      <td>0.090000</td>\n",
       "      <td>0.138462</td>\n",
       "      <td>100.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>5</td>\n",
       "      <td>0.644898</td>\n",
       "      <td>0.385366</td>\n",
       "      <td>0.482443</td>\n",
       "      <td>410.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>accuracy</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>accuracy</td>\n",
       "      <td>0.564179</td>\n",
       "      <td>0.564179</td>\n",
       "      <td>0.564179</td>\n",
       "      <td>0.564179</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>macro avg</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>macro avg</td>\n",
       "      <td>0.522782</td>\n",
       "      <td>0.399607</td>\n",
       "      <td>0.428523</td>\n",
       "      <td>3685.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>weighted avg</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>weighted avg</td>\n",
       "      <td>0.561215</td>\n",
       "      <td>0.564179</td>\n",
       "      <td>0.553276</td>\n",
       "      <td>3685.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>0</td>\n",
       "      <td>0.570707</td>\n",
       "      <td>0.648029</td>\n",
       "      <td>0.606915</td>\n",
       "      <td>1395.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>1</td>\n",
       "      <td>0.475584</td>\n",
       "      <td>0.446215</td>\n",
       "      <td>0.460432</td>\n",
       "      <td>502.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>2</td>\n",
       "      <td>0.581132</td>\n",
       "      <td>0.651438</td>\n",
       "      <td>0.614280</td>\n",
       "      <td>1182.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>3</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>96.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>4</td>\n",
       "      <td>0.216667</td>\n",
       "      <td>0.130000</td>\n",
       "      <td>0.162500</td>\n",
       "      <td>100.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>5</td>\n",
       "      <td>0.644898</td>\n",
       "      <td>0.385366</td>\n",
       "      <td>0.482443</td>\n",
       "      <td>410.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>accuracy</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>accuracy</td>\n",
       "      <td>0.561465</td>\n",
       "      <td>0.561465</td>\n",
       "      <td>0.561465</td>\n",
       "      <td>0.561465</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>macro avg</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>macro avg</td>\n",
       "      <td>0.414831</td>\n",
       "      <td>0.376841</td>\n",
       "      <td>0.387762</td>\n",
       "      <td>3685.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>weighted avg</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>weighted avg</td>\n",
       "      <td>0.544872</td>\n",
       "      <td>0.561465</td>\n",
       "      <td>0.547602</td>\n",
       "      <td>3685.000000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                           model         index  precision    recall  f1-score  \\\n",
       "0                    Naive Bayes             0   0.568802  0.643011  0.603634   \n",
       "1                    Naive Bayes             1   0.474684  0.448207  0.461066   \n",
       "2                    Naive Bayes             2   0.581640  0.653976  0.615691   \n",
       "3                    Naive Bayes             3   0.566667  0.177083  0.269841   \n",
       "4                    Naive Bayes             4   0.300000  0.090000  0.138462   \n",
       "5                    Naive Bayes             5   0.644898  0.385366  0.482443   \n",
       "accuracy             Naive Bayes      accuracy   0.564179  0.564179  0.564179   \n",
       "macro avg            Naive Bayes     macro avg   0.522782  0.399607  0.428523   \n",
       "weighted avg         Naive Bayes  weighted avg   0.561215  0.564179  0.553276   \n",
       "0             Naive Bayes + Tree             0   0.570707  0.648029  0.606915   \n",
       "1             Naive Bayes + Tree             1   0.475584  0.446215  0.460432   \n",
       "2             Naive Bayes + Tree             2   0.581132  0.651438  0.614280   \n",
       "3             Naive Bayes + Tree             3   0.000000  0.000000  0.000000   \n",
       "4             Naive Bayes + Tree             4   0.216667  0.130000  0.162500   \n",
       "5             Naive Bayes + Tree             5   0.644898  0.385366  0.482443   \n",
       "accuracy      Naive Bayes + Tree      accuracy   0.561465  0.561465  0.561465   \n",
       "macro avg     Naive Bayes + Tree     macro avg   0.414831  0.376841  0.387762   \n",
       "weighted avg  Naive Bayes + Tree  weighted avg   0.544872  0.561465  0.547602   \n",
       "\n",
       "                  support  \n",
       "0             1395.000000  \n",
       "1              502.000000  \n",
       "2             1182.000000  \n",
       "3               96.000000  \n",
       "4              100.000000  \n",
       "5              410.000000  \n",
       "accuracy         0.564179  \n",
       "macro avg     3685.000000  \n",
       "weighted avg  3685.000000  \n",
       "0             1395.000000  \n",
       "1              502.000000  \n",
       "2             1182.000000  \n",
       "3               96.000000  \n",
       "4              100.000000  \n",
       "5              410.000000  \n",
       "accuracy         0.561465  \n",
       "macro avg     3685.000000  \n",
       "weighted avg  3685.000000  "
      ]
     },
     "execution_count": 56,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_test_filter = df_test\\\n",
    "                    .pipe(add_span_genes_chem)\\\n",
    "                    .pipe(filter_include_min_word_len)\n",
    "\n",
    "\n",
    "result_train_filter_predict_test_filter_gt = predict_all_classifiers(df_test_filter, train_result_filter)\n",
    "\n",
    "print_report_all_classifiers(df_test_filter[\"y\"], result_train_filter_predict_test_filter_gt,  all_labels)\n",
    "\n",
    "\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\\begin{tabular}{llrrrr}\n",
      "\\toprule\n",
      "             model &        index & precision & recall & f1-score & support \\\\\n",
      "\\midrule\n",
      "       Naive Bayes &            0 &      51.8 &   60.2 &     55.7 &    2018 \\\\\n",
      "       Naive Bayes &            1 &      51.1 &   34.6 &     41.3 &     771 \\\\\n",
      "       Naive Bayes &            2 &      46.1 &   67.5 &     54.8 &    1725 \\\\\n",
      "       Naive Bayes &            3 &      60.5 &   11.7 &     19.7 &     196 \\\\\n",
      "       Naive Bayes &            4 &      43.6 &    5.7 &     10.0 &     300 \\\\\n",
      "       Naive Bayes &            5 &      64.7 &   24.5 &     35.6 &     734 \\\\\n",
      "       Naive Bayes &     accuracy &      49.9 &   49.9 &     49.9 &       0 \\\\\n",
      "       Naive Bayes &    macro avg &      53.0 &   34.0 &     36.2 &    5744 \\\\\n",
      "       Naive Bayes & weighted avg &      51.5 &   49.9 &     47.3 &    5744 \\\\\n",
      "Naive Bayes + Tree &            0 &      52.0 &   60.5 &     55.9 &    2018 \\\\\n",
      "Naive Bayes + Tree &            1 &      51.3 &   34.5 &     41.2 &     771 \\\\\n",
      "Naive Bayes + Tree &            2 &      46.1 &   67.4 &     54.7 &    1725 \\\\\n",
      "Naive Bayes + Tree &            3 &       0.0 &    0.0 &      0.0 &     196 \\\\\n",
      "Naive Bayes + Tree &            4 &      29.9 &    7.7 &     12.2 &     300 \\\\\n",
      "Naive Bayes + Tree &            5 &      64.7 &   24.5 &     35.6 &     734 \\\\\n",
      "Naive Bayes + Tree &     accuracy &      49.6 &   49.6 &     49.6 &       0 \\\\\n",
      "Naive Bayes + Tree &    macro avg &      40.7 &   32.4 &     33.3 &    5744 \\\\\n",
      "Naive Bayes + Tree & weighted avg &      48.8 &   49.6 &     46.8 &    5744 \\\\\n",
      "\\bottomrule\n",
      "\\end{tabular}\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>model</th>\n",
       "      <th>index</th>\n",
       "      <th>precision</th>\n",
       "      <th>recall</th>\n",
       "      <th>f1-score</th>\n",
       "      <th>support</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>0</td>\n",
       "      <td>0.518139</td>\n",
       "      <td>0.601586</td>\n",
       "      <td>0.556753</td>\n",
       "      <td>2018.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>1</td>\n",
       "      <td>0.511494</td>\n",
       "      <td>0.346304</td>\n",
       "      <td>0.412993</td>\n",
       "      <td>771.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>2</td>\n",
       "      <td>0.461173</td>\n",
       "      <td>0.674783</td>\n",
       "      <td>0.547894</td>\n",
       "      <td>1725.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>3</td>\n",
       "      <td>0.605263</td>\n",
       "      <td>0.117347</td>\n",
       "      <td>0.196581</td>\n",
       "      <td>196.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>4</td>\n",
       "      <td>0.435897</td>\n",
       "      <td>0.056667</td>\n",
       "      <td>0.100295</td>\n",
       "      <td>300.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>5</td>\n",
       "      <td>0.647482</td>\n",
       "      <td>0.245232</td>\n",
       "      <td>0.355731</td>\n",
       "      <td>734.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>accuracy</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>accuracy</td>\n",
       "      <td>0.498781</td>\n",
       "      <td>0.498781</td>\n",
       "      <td>0.498781</td>\n",
       "      <td>0.498781</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>macro avg</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>macro avg</td>\n",
       "      <td>0.529908</td>\n",
       "      <td>0.340320</td>\n",
       "      <td>0.361708</td>\n",
       "      <td>5744.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>weighted avg</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>weighted avg</td>\n",
       "      <td>0.515345</td>\n",
       "      <td>0.498781</td>\n",
       "      <td>0.472978</td>\n",
       "      <td>5744.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>0</td>\n",
       "      <td>0.519591</td>\n",
       "      <td>0.604559</td>\n",
       "      <td>0.558864</td>\n",
       "      <td>2018.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>1</td>\n",
       "      <td>0.512524</td>\n",
       "      <td>0.345006</td>\n",
       "      <td>0.412403</td>\n",
       "      <td>771.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>2</td>\n",
       "      <td>0.460745</td>\n",
       "      <td>0.673623</td>\n",
       "      <td>0.547210</td>\n",
       "      <td>1725.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>3</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>196.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>4</td>\n",
       "      <td>0.298701</td>\n",
       "      <td>0.076667</td>\n",
       "      <td>0.122016</td>\n",
       "      <td>300.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>5</td>\n",
       "      <td>0.647482</td>\n",
       "      <td>0.245232</td>\n",
       "      <td>0.355731</td>\n",
       "      <td>734.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>accuracy</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>accuracy</td>\n",
       "      <td>0.496344</td>\n",
       "      <td>0.496344</td>\n",
       "      <td>0.496344</td>\n",
       "      <td>0.496344</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>macro avg</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>macro avg</td>\n",
       "      <td>0.406507</td>\n",
       "      <td>0.324181</td>\n",
       "      <td>0.332704</td>\n",
       "      <td>5744.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>weighted avg</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>weighted avg</td>\n",
       "      <td>0.488046</td>\n",
       "      <td>0.496344</td>\n",
       "      <td>0.467862</td>\n",
       "      <td>5744.000000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                           model         index  precision    recall  f1-score  \\\n",
       "0                    Naive Bayes             0   0.518139  0.601586  0.556753   \n",
       "1                    Naive Bayes             1   0.511494  0.346304  0.412993   \n",
       "2                    Naive Bayes             2   0.461173  0.674783  0.547894   \n",
       "3                    Naive Bayes             3   0.605263  0.117347  0.196581   \n",
       "4                    Naive Bayes             4   0.435897  0.056667  0.100295   \n",
       "5                    Naive Bayes             5   0.647482  0.245232  0.355731   \n",
       "accuracy             Naive Bayes      accuracy   0.498781  0.498781  0.498781   \n",
       "macro avg            Naive Bayes     macro avg   0.529908  0.340320  0.361708   \n",
       "weighted avg         Naive Bayes  weighted avg   0.515345  0.498781  0.472978   \n",
       "0             Naive Bayes + Tree             0   0.519591  0.604559  0.558864   \n",
       "1             Naive Bayes + Tree             1   0.512524  0.345006  0.412403   \n",
       "2             Naive Bayes + Tree             2   0.460745  0.673623  0.547210   \n",
       "3             Naive Bayes + Tree             3   0.000000  0.000000  0.000000   \n",
       "4             Naive Bayes + Tree             4   0.298701  0.076667  0.122016   \n",
       "5             Naive Bayes + Tree             5   0.647482  0.245232  0.355731   \n",
       "accuracy      Naive Bayes + Tree      accuracy   0.496344  0.496344  0.496344   \n",
       "macro avg     Naive Bayes + Tree     macro avg   0.406507  0.324181  0.332704   \n",
       "weighted avg  Naive Bayes + Tree  weighted avg   0.488046  0.496344  0.467862   \n",
       "\n",
       "                  support  \n",
       "0             2018.000000  \n",
       "1              771.000000  \n",
       "2             1725.000000  \n",
       "3              196.000000  \n",
       "4              300.000000  \n",
       "5              734.000000  \n",
       "accuracy         0.498781  \n",
       "macro avg     5744.000000  \n",
       "weighted avg  5744.000000  \n",
       "0             2018.000000  \n",
       "1              771.000000  \n",
       "2             1725.000000  \n",
       "3              196.000000  \n",
       "4              300.000000  \n",
       "5              734.000000  \n",
       "accuracy         0.496344  \n",
       "macro avg     5744.000000  \n",
       "weighted avg  5744.000000  "
      ]
     },
     "execution_count": 57,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "\n",
    "result_train_filter_predict_test_gt = predict_all_classifiers(df_test, train_result_filter)\n",
    "\n",
    "print_report_all_classifiers(df_test[\"y\"], result_train_filter_predict_test_gt,  all_labels)\n",
    "\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.4202044852836534"
      ]
     },
     "execution_count": 58,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sklearn.metrics.cohen_kappa_score(df_test[\"gold\"],\n",
    "                                  result_test_gt[NAIVE_BAYES][\"predictions\"]\n",
    "                                  )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.42339577433977704"
      ]
     },
     "execution_count": 59,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sklearn.metrics.cohen_kappa_score(df_test[\"gold\"],\n",
    "                                  result_test_gt[NAIVE_BAYES_WITH_TREE][\"predictions\"]\n",
    "                                  )"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Predict Test on Test Prediction fit "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Training Naive Bayes\n",
      "Max words :  315\n",
      "Training Naive Bayes + Tree\n",
      "Max words :  315\n",
      "Extracting features..for 5744\n",
      "Completed..\n",
      "\\begin{tabular}{llrrrr}\n",
      "\\toprule\n",
      "             model &        index & precision & recall & f1-score & support \\\\\n",
      "\\midrule\n",
      "       Naive Bayes &            1 &      65.5 &   56.2 &     60.5 &     771 \\\\\n",
      "       Naive Bayes &            2 &      78.2 &   60.8 &     68.4 &    1725 \\\\\n",
      "       Naive Bayes &            3 &      77.8 &   53.6 &     63.4 &     196 \\\\\n",
      "       Naive Bayes &            4 &      71.5 &   46.0 &     56.0 &     300 \\\\\n",
      "       Naive Bayes &            5 &      79.3 &   37.5 &     50.9 &     734 \\\\\n",
      "       Naive Bayes &    micro avg &      74.7 &   53.7 &     62.5 &    3726 \\\\\n",
      "       Naive Bayes &    macro avg &      74.4 &   50.8 &     59.8 &    3726 \\\\\n",
      "       Naive Bayes & weighted avg &      75.2 &   53.7 &     62.1 &    3726 \\\\\n",
      "Naive Bayes + Tree &            1 &      66.6 &   56.2 &     60.9 &     771 \\\\\n",
      "Naive Bayes + Tree &            2 &      78.5 &   60.8 &     68.5 &    1725 \\\\\n",
      "Naive Bayes + Tree &            3 &      77.8 &   53.6 &     63.4 &     196 \\\\\n",
      "Naive Bayes + Tree &            4 &      71.5 &   46.0 &     56.0 &     300 \\\\\n",
      "Naive Bayes + Tree &            5 &      79.3 &   37.5 &     50.9 &     734 \\\\\n",
      "Naive Bayes + Tree &    micro avg &      75.2 &   53.7 &     62.6 &    3726 \\\\\n",
      "Naive Bayes + Tree &    macro avg &      74.7 &   50.8 &     59.9 &    3726 \\\\\n",
      "Naive Bayes + Tree & weighted avg &      75.6 &   53.7 &     62.2 &    3726 \\\\\n",
      "\\bottomrule\n",
      "\\end{tabular}\n",
      "\n",
      "\\begin{tabular}{llrrrr}\n",
      "\\toprule\n",
      "             model &        index & precision & recall & f1-score & support \\\\\n",
      "\\midrule\n",
      "       Naive Bayes &            0 &      55.3 &   84.1 &     66.8 &    2018 \\\\\n",
      "       Naive Bayes &            1 &      65.5 &   56.2 &     60.5 &     771 \\\\\n",
      "       Naive Bayes &            2 &      78.2 &   60.8 &     68.4 &    1725 \\\\\n",
      "       Naive Bayes &            3 &      77.8 &   53.6 &     63.4 &     196 \\\\\n",
      "       Naive Bayes &            4 &      71.5 &   46.0 &     56.0 &     300 \\\\\n",
      "       Naive Bayes &            5 &      79.3 &   37.5 &     50.9 &     734 \\\\\n",
      "       Naive Bayes &     accuracy &      64.4 &   64.4 &     64.4 &       0 \\\\\n",
      "       Naive Bayes &    macro avg &      71.3 &   56.4 &     61.0 &    5744 \\\\\n",
      "       Naive Bayes & weighted avg &      68.2 &   64.4 &     63.7 &    5744 \\\\\n",
      "Naive Bayes + Tree &            0 &      55.6 &   84.9 &     67.2 &    2018 \\\\\n",
      "Naive Bayes + Tree &            1 &      66.6 &   56.2 &     60.9 &     771 \\\\\n",
      "Naive Bayes + Tree &            2 &      78.5 &   60.8 &     68.5 &    1725 \\\\\n",
      "Naive Bayes + Tree &            3 &      77.8 &   53.6 &     63.4 &     196 \\\\\n",
      "Naive Bayes + Tree &            4 &      71.5 &   46.0 &     56.0 &     300 \\\\\n",
      "Naive Bayes + Tree &            5 &      79.3 &   37.5 &     50.9 &     734 \\\\\n",
      "Naive Bayes + Tree &     accuracy &      64.6 &   64.6 &     64.6 &       0 \\\\\n",
      "Naive Bayes + Tree &    macro avg &      71.5 &   56.5 &     61.2 &    5744 \\\\\n",
      "Naive Bayes + Tree & weighted avg &      68.6 &   64.6 &     63.9 &    5744 \\\\\n",
      "\\bottomrule\n",
      "\\end{tabular}\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>model</th>\n",
       "      <th>index</th>\n",
       "      <th>precision</th>\n",
       "      <th>recall</th>\n",
       "      <th>f1-score</th>\n",
       "      <th>support</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>0</td>\n",
       "      <td>0.553490</td>\n",
       "      <td>0.840932</td>\n",
       "      <td>0.667585</td>\n",
       "      <td>2018.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>1</td>\n",
       "      <td>0.655068</td>\n",
       "      <td>0.561608</td>\n",
       "      <td>0.604749</td>\n",
       "      <td>771.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>2</td>\n",
       "      <td>0.781669</td>\n",
       "      <td>0.608116</td>\n",
       "      <td>0.684056</td>\n",
       "      <td>1725.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>3</td>\n",
       "      <td>0.777778</td>\n",
       "      <td>0.535714</td>\n",
       "      <td>0.634441</td>\n",
       "      <td>196.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>4</td>\n",
       "      <td>0.715026</td>\n",
       "      <td>0.460000</td>\n",
       "      <td>0.559838</td>\n",
       "      <td>300.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>5</td>\n",
       "      <td>0.792507</td>\n",
       "      <td>0.374659</td>\n",
       "      <td>0.508788</td>\n",
       "      <td>734.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>accuracy</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>accuracy</td>\n",
       "      <td>0.643628</td>\n",
       "      <td>0.643628</td>\n",
       "      <td>0.643628</td>\n",
       "      <td>0.643628</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>macro avg</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>macro avg</td>\n",
       "      <td>0.712590</td>\n",
       "      <td>0.563505</td>\n",
       "      <td>0.609909</td>\n",
       "      <td>5744.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>weighted avg</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>weighted avg</td>\n",
       "      <td>0.682283</td>\n",
       "      <td>0.643628</td>\n",
       "      <td>0.637047</td>\n",
       "      <td>5744.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>0</td>\n",
       "      <td>0.555772</td>\n",
       "      <td>0.849356</td>\n",
       "      <td>0.671893</td>\n",
       "      <td>2018.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>1</td>\n",
       "      <td>0.666154</td>\n",
       "      <td>0.561608</td>\n",
       "      <td>0.609430</td>\n",
       "      <td>771.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>2</td>\n",
       "      <td>0.785019</td>\n",
       "      <td>0.607536</td>\n",
       "      <td>0.684967</td>\n",
       "      <td>1725.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>3</td>\n",
       "      <td>0.777778</td>\n",
       "      <td>0.535714</td>\n",
       "      <td>0.634441</td>\n",
       "      <td>196.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>4</td>\n",
       "      <td>0.715026</td>\n",
       "      <td>0.460000</td>\n",
       "      <td>0.559838</td>\n",
       "      <td>300.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>5</td>\n",
       "      <td>0.792507</td>\n",
       "      <td>0.374659</td>\n",
       "      <td>0.508788</td>\n",
       "      <td>734.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>accuracy</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>accuracy</td>\n",
       "      <td>0.646414</td>\n",
       "      <td>0.646414</td>\n",
       "      <td>0.646414</td>\n",
       "      <td>0.646414</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>macro avg</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>macro avg</td>\n",
       "      <td>0.715376</td>\n",
       "      <td>0.564812</td>\n",
       "      <td>0.611560</td>\n",
       "      <td>5744.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>weighted avg</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>weighted avg</td>\n",
       "      <td>0.685578</td>\n",
       "      <td>0.646414</td>\n",
       "      <td>0.639462</td>\n",
       "      <td>5744.000000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                           model         index  precision    recall  f1-score  \\\n",
       "0                    Naive Bayes             0   0.553490  0.840932  0.667585   \n",
       "1                    Naive Bayes             1   0.655068  0.561608  0.604749   \n",
       "2                    Naive Bayes             2   0.781669  0.608116  0.684056   \n",
       "3                    Naive Bayes             3   0.777778  0.535714  0.634441   \n",
       "4                    Naive Bayes             4   0.715026  0.460000  0.559838   \n",
       "5                    Naive Bayes             5   0.792507  0.374659  0.508788   \n",
       "accuracy             Naive Bayes      accuracy   0.643628  0.643628  0.643628   \n",
       "macro avg            Naive Bayes     macro avg   0.712590  0.563505  0.609909   \n",
       "weighted avg         Naive Bayes  weighted avg   0.682283  0.643628  0.637047   \n",
       "0             Naive Bayes + Tree             0   0.555772  0.849356  0.671893   \n",
       "1             Naive Bayes + Tree             1   0.666154  0.561608  0.609430   \n",
       "2             Naive Bayes + Tree             2   0.785019  0.607536  0.684967   \n",
       "3             Naive Bayes + Tree             3   0.777778  0.535714  0.634441   \n",
       "4             Naive Bayes + Tree             4   0.715026  0.460000  0.559838   \n",
       "5             Naive Bayes + Tree             5   0.792507  0.374659  0.508788   \n",
       "accuracy      Naive Bayes + Tree      accuracy   0.646414  0.646414  0.646414   \n",
       "macro avg     Naive Bayes + Tree     macro avg   0.715376  0.564812  0.611560   \n",
       "weighted avg  Naive Bayes + Tree  weighted avg   0.685578  0.646414  0.639462   \n",
       "\n",
       "                  support  \n",
       "0             2018.000000  \n",
       "1              771.000000  \n",
       "2             1725.000000  \n",
       "3              196.000000  \n",
       "4              300.000000  \n",
       "5              734.000000  \n",
       "accuracy         0.643628  \n",
       "macro avg     5744.000000  \n",
       "weighted avg  5744.000000  \n",
       "0             2018.000000  \n",
       "1              771.000000  \n",
       "2             1725.000000  \n",
       "3              196.000000  \n",
       "4              300.000000  \n",
       "5              734.000000  \n",
       "accuracy         0.646414  \n",
       "macro avg     5744.000000  \n",
       "weighted avg  5744.000000  "
      ]
     },
     "execution_count": 60,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_test_prediction = load_valtest_pred(local_test_prediction_file)\n",
    "\n",
    "result_test_bp = train_and_predict_all_classifiers(df_test_prediction, min_df=1)\n",
    "\n",
    "#plot_tree(result_test_bp[NAIVE_BAYES_WITH_TREE][\"m\"])\n",
    "\n",
    "\n",
    "print_report_all_classifiers(df_test_prediction[\"y\"], result_test_bp,  pos_labels)\n",
    "\n",
    "print_report_all_classifiers(df_test_prediction[\"y\"], result_test_bp,  all_labels)\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.07715738936992478"
      ]
     },
     "execution_count": 61,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "p1 = get_top_discrimintary_keywords(result_test_bp[NAIVE_BAYES][\"m\"],0)\n",
    "p2 = get_top_discrimintary_keywords(train_result[NAIVE_BAYES][\"m\"],0)\n",
    "\n",
    "kl_divergence(p1,p2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 2 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "if NAIVE_BAYES_WITH_TREE in result_test_bp:\n",
    "    df_test_prediction[\"shortcut_pred_nbt\"] = result_test_bp[NAIVE_BAYES_WITH_TREE][\"predictions\"]\n",
    "    print_report(df_test_prediction.query(\"y == gold\")[\"y\"], df_test_prediction.query(\"y == gold\")[\"shortcut_pred_nbt\"], all_labels)\n",
    "    plot_confusionmatrix(df_test_prediction[\"y\"], df_test_prediction[\"shortcut_pred_nbt\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.5062389159900134"
      ]
     },
     "execution_count": 63,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sklearn.metrics.cohen_kappa_score(df_test_prediction[\"y\"],\n",
    "                                  result_test_gt[NAIVE_BAYES_WITH_TREE][\"predictions\"]\n",
    "                                  )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.5026810167988787"
      ]
     },
     "execution_count": 64,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sklearn.metrics.cohen_kappa_score(df_test_prediction[\"y\"],\n",
    "                                  result_test_gt[NAIVE_BAYES][\"predictions\"]\n",
    "                                  )"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Test BP "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\\begin{tabular}{llrrrr}\n",
      "\\toprule\n",
      "             model &        index & precision & recall & f1-score & support \\\\\n",
      "\\midrule\n",
      "       Naive Bayes &            0 &      55.7 &   59.9 &     57.7 &    2018 \\\\\n",
      "       Naive Bayes &            1 &      53.1 &   39.7 &     45.4 &     771 \\\\\n",
      "       Naive Bayes &            2 &      47.2 &   67.8 &     55.7 &    1725 \\\\\n",
      "       Naive Bayes &            3 &      71.2 &   26.5 &     38.7 &     196 \\\\\n",
      "       Naive Bayes &            4 &      60.7 &   27.3 &     37.7 &     300 \\\\\n",
      "       Naive Bayes &            5 &      64.6 &   27.7 &     38.7 &     734 \\\\\n",
      "       Naive Bayes &     accuracy &      52.6 &   52.6 &     52.6 &       0 \\\\\n",
      "       Naive Bayes &    macro avg &      58.8 &   41.5 &     45.7 &    5744 \\\\\n",
      "       Naive Bayes & weighted avg &      54.7 &   52.6 &     51.3 &    5744 \\\\\n",
      "Naive Bayes + Tree &            0 &      49.7 &   73.2 &     59.2 &    2018 \\\\\n",
      "Naive Bayes + Tree &            1 &      53.5 &   42.4 &     47.3 &     771 \\\\\n",
      "Naive Bayes + Tree &            2 &      61.3 &   58.2 &     59.7 &    1725 \\\\\n",
      "Naive Bayes + Tree &            3 &       0.0 &    0.0 &      0.0 &     196 \\\\\n",
      "Naive Bayes + Tree &            4 &      42.3 &   29.3 &     34.6 &     300 \\\\\n",
      "Naive Bayes + Tree &            5 &      64.6 &   27.7 &     38.7 &     734 \\\\\n",
      "Naive Bayes + Tree &     accuracy &      54.0 &   54.0 &     54.0 &       0 \\\\\n",
      "Naive Bayes + Tree &    macro avg &      45.2 &   38.5 &     39.9 &    5744 \\\\\n",
      "Naive Bayes + Tree & weighted avg &      53.5 &   54.0 &     51.8 &    5744 \\\\\n",
      "\\bottomrule\n",
      "\\end{tabular}\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>model</th>\n",
       "      <th>index</th>\n",
       "      <th>precision</th>\n",
       "      <th>recall</th>\n",
       "      <th>f1-score</th>\n",
       "      <th>support</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>0</td>\n",
       "      <td>0.556939</td>\n",
       "      <td>0.598612</td>\n",
       "      <td>0.577024</td>\n",
       "      <td>2018.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>1</td>\n",
       "      <td>0.531250</td>\n",
       "      <td>0.396887</td>\n",
       "      <td>0.454343</td>\n",
       "      <td>771.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>2</td>\n",
       "      <td>0.472346</td>\n",
       "      <td>0.678261</td>\n",
       "      <td>0.556878</td>\n",
       "      <td>1725.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>3</td>\n",
       "      <td>0.712329</td>\n",
       "      <td>0.265306</td>\n",
       "      <td>0.386617</td>\n",
       "      <td>196.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>4</td>\n",
       "      <td>0.607407</td>\n",
       "      <td>0.273333</td>\n",
       "      <td>0.377011</td>\n",
       "      <td>300.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>5</td>\n",
       "      <td>0.646497</td>\n",
       "      <td>0.276567</td>\n",
       "      <td>0.387405</td>\n",
       "      <td>734.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>accuracy</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>accuracy</td>\n",
       "      <td>0.525940</td>\n",
       "      <td>0.525940</td>\n",
       "      <td>0.525940</td>\n",
       "      <td>0.525940</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>macro avg</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>macro avg</td>\n",
       "      <td>0.587795</td>\n",
       "      <td>0.414828</td>\n",
       "      <td>0.456546</td>\n",
       "      <td>5744.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>weighted avg</th>\n",
       "      <td>Naive Bayes</td>\n",
       "      <td>weighted avg</td>\n",
       "      <td>0.547469</td>\n",
       "      <td>0.525940</td>\n",
       "      <td>0.513333</td>\n",
       "      <td>5744.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>0</td>\n",
       "      <td>0.496972</td>\n",
       "      <td>0.731913</td>\n",
       "      <td>0.591984</td>\n",
       "      <td>2018.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>1</td>\n",
       "      <td>0.535188</td>\n",
       "      <td>0.424125</td>\n",
       "      <td>0.473227</td>\n",
       "      <td>771.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>2</td>\n",
       "      <td>0.612569</td>\n",
       "      <td>0.582029</td>\n",
       "      <td>0.596908</td>\n",
       "      <td>1725.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>3</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>196.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>4</td>\n",
       "      <td>0.423077</td>\n",
       "      <td>0.293333</td>\n",
       "      <td>0.346457</td>\n",
       "      <td>300.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>5</td>\n",
       "      <td>0.646497</td>\n",
       "      <td>0.276567</td>\n",
       "      <td>0.387405</td>\n",
       "      <td>734.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>accuracy</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>accuracy</td>\n",
       "      <td>0.539519</td>\n",
       "      <td>0.539519</td>\n",
       "      <td>0.539519</td>\n",
       "      <td>0.539519</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>macro avg</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>macro avg</td>\n",
       "      <td>0.452384</td>\n",
       "      <td>0.384661</td>\n",
       "      <td>0.399330</td>\n",
       "      <td>5744.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>weighted avg</th>\n",
       "      <td>Naive Bayes + Tree</td>\n",
       "      <td>weighted avg</td>\n",
       "      <td>0.535106</td>\n",
       "      <td>0.539519</td>\n",
       "      <td>0.518357</td>\n",
       "      <td>5744.000000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                           model         index  precision    recall  f1-score  \\\n",
       "0                    Naive Bayes             0   0.556939  0.598612  0.577024   \n",
       "1                    Naive Bayes             1   0.531250  0.396887  0.454343   \n",
       "2                    Naive Bayes             2   0.472346  0.678261  0.556878   \n",
       "3                    Naive Bayes             3   0.712329  0.265306  0.386617   \n",
       "4                    Naive Bayes             4   0.607407  0.273333  0.377011   \n",
       "5                    Naive Bayes             5   0.646497  0.276567  0.387405   \n",
       "accuracy             Naive Bayes      accuracy   0.525940  0.525940  0.525940   \n",
       "macro avg            Naive Bayes     macro avg   0.587795  0.414828  0.456546   \n",
       "weighted avg         Naive Bayes  weighted avg   0.547469  0.525940  0.513333   \n",
       "0             Naive Bayes + Tree             0   0.496972  0.731913  0.591984   \n",
       "1             Naive Bayes + Tree             1   0.535188  0.424125  0.473227   \n",
       "2             Naive Bayes + Tree             2   0.612569  0.582029  0.596908   \n",
       "3             Naive Bayes + Tree             3   0.000000  0.000000  0.000000   \n",
       "4             Naive Bayes + Tree             4   0.423077  0.293333  0.346457   \n",
       "5             Naive Bayes + Tree             5   0.646497  0.276567  0.387405   \n",
       "accuracy      Naive Bayes + Tree      accuracy   0.539519  0.539519  0.539519   \n",
       "macro avg     Naive Bayes + Tree     macro avg   0.452384  0.384661  0.399330   \n",
       "weighted avg  Naive Bayes + Tree  weighted avg   0.535106  0.539519  0.518357   \n",
       "\n",
       "                  support  \n",
       "0             2018.000000  \n",
       "1              771.000000  \n",
       "2             1725.000000  \n",
       "3              196.000000  \n",
       "4              300.000000  \n",
       "5              734.000000  \n",
       "accuracy         0.525940  \n",
       "macro avg     5744.000000  \n",
       "weighted avg  5744.000000  \n",
       "0             2018.000000  \n",
       "1              771.000000  \n",
       "2             1725.000000  \n",
       "3              196.000000  \n",
       "4              300.000000  \n",
       "5              734.000000  \n",
       "accuracy         0.539519  \n",
       "macro avg     5744.000000  \n",
       "weighted avg  5744.000000  "
      ]
     },
     "execution_count": 65,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "result_train_predict_test_bp = predict_all_classifiers(df_test_prediction, train_result)\n",
    "\n",
    "print_report_all_classifiers(df_test_prediction[\"y\"], result_train_predict_test_bp,  all_labels)\n",
    "\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Large scale high quality"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "metadata": {},
   "outputs": [],
   "source": [
    "import random\n",
    "def randomly_sample(df, max_sample = 10000, seed=None):\n",
    "    frac = max_sample/len(df)\n",
    "    return df.groupby('y', group_keys=False).apply(lambda x: x.sample(frac=frac, random_state=seed)).copy()\n",
    "    \n",
    "    \n",
    "def multiple_random_sample_runs(df, max_sample = 10000, runs=10) :   \n",
    "    random.seed(42)\n",
    "    result = []\n",
    "    for i in range(runs):\n",
    "        new_seed = random.randint(10,1000)\n",
    "        sample_df = randomly_sample(df, seed = new_seed)\n",
    "    \n",
    "        result.append(sample_df)\n",
    "    return result\n",
    "        \n",
    "    \n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_highquality = load_valtest_pred(local_highquality_file)\\\n",
    "                .pipe(add_span_genes_chem)\\\n",
    "               # .pipe(filter_include_max_word_len, 19)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 68,
   "metadata": {},
   "outputs": [],
   "source": [
    "random_runs = multiple_random_sample_runs(df_highquality, runs=10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Training Naive Bayes\n",
      "Max words :  214\n",
      "Training Naive Bayes + Tree\n",
      "Max words :  214\n",
      "Extracting features..for 10000\n",
      "Completed..\n",
      "\\begin{tabular}{llrrrr}\n",
      "\\toprule\n",
      "             model &        index & precision & recall & f1-score & support \\\\\n",
      "\\midrule\n",
      "       Naive Bayes &            0 &      50.5 &   51.1 &     50.8 &    2493 \\\\\n",
      "       Naive Bayes &            1 &      56.0 &   55.7 &     55.9 &    2357 \\\\\n",
      "       Naive Bayes &            2 &      59.6 &   56.5 &     58.0 &    2492 \\\\\n",
      "       Naive Bayes &            3 &      22.2 &  100.0 &     36.4 &       2 \\\\\n",
      "       Naive Bayes &            4 &      49.3 &   77.9 &     60.4 &     213 \\\\\n",
      "       Naive Bayes &            5 &      62.3 &   61.9 &     62.1 &    2443 \\\\\n",
      "       Naive Bayes &     accuracy &      56.7 &   56.7 &     56.7 &       0 \\\\\n",
      "       Naive Bayes &    macro avg &      50.0 &   67.2 &     53.9 &   10000 \\\\\n",
      "       Naive Bayes & weighted avg &      56.9 &   56.7 &     56.7 &   10000 \\\\\n",
      "Naive Bayes + Tree &            0 &      51.5 &   50.7 &     51.1 &    2493 \\\\\n",
      "Naive Bayes + Tree &            1 &      55.8 &   57.3 &     56.6 &    2357 \\\\\n",
      "Naive Bayes + Tree &            2 &      59.5 &   56.5 &     58.0 &    2492 \\\\\n",
      "Naive Bayes + Tree &            3 &       0.0 &    0.0 &      0.0 &       2 \\\\\n",
      "Naive Bayes + Tree &            4 &      49.3 &   77.9 &     60.4 &     213 \\\\\n",
      "Naive Bayes + Tree &            5 &      62.4 &   61.9 &     62.1 &    2443 \\\\\n",
      "Naive Bayes + Tree &     accuracy &      57.0 &   57.0 &     57.0 &       0 \\\\\n",
      "Naive Bayes + Tree &    macro avg &      46.4 &   50.7 &     48.0 &   10000 \\\\\n",
      "Naive Bayes + Tree & weighted avg &      57.1 &   57.0 &     57.0 &   10000 \\\\\n",
      "\\bottomrule\n",
      "\\end{tabular}\n",
      "\n",
      "Training Naive Bayes\n",
      "Max words :  222\n",
      "Training Naive Bayes + Tree\n",
      "Max words :  222\n",
      "Extracting features..for 10000\n",
      "Completed..\n",
      "\\begin{tabular}{llrrrr}\n",
      "\\toprule\n",
      "             model &        index & precision & recall & f1-score & support \\\\\n",
      "\\midrule\n",
      "       Naive Bayes &            0 &      53.4 &   53.2 &     53.3 &    2493 \\\\\n",
      "       Naive Bayes &            1 &      54.6 &   56.1 &     55.3 &    2357 \\\\\n",
      "       Naive Bayes &            2 &      60.2 &   55.3 &     57.6 &    2492 \\\\\n",
      "       Naive Bayes &            3 &     100.0 &  100.0 &    100.0 &       2 \\\\\n",
      "       Naive Bayes &            4 &      45.5 &   81.2 &     58.3 &     213 \\\\\n",
      "       Naive Bayes &            5 &      62.4 &   61.9 &     62.1 &    2443 \\\\\n",
      "       Naive Bayes &     accuracy &      57.1 &   57.1 &     57.1 &       0 \\\\\n",
      "       Naive Bayes &    macro avg &      62.7 &   67.9 &     64.5 &   10000 \\\\\n",
      "       Naive Bayes & weighted avg &      57.4 &   57.1 &     57.1 &   10000 \\\\\n",
      "Naive Bayes + Tree &            0 &      54.7 &   52.8 &     53.7 &    2493 \\\\\n",
      "Naive Bayes + Tree &            1 &      54.4 &   59.5 &     56.9 &    2357 \\\\\n",
      "Naive Bayes + Tree &            2 &      60.2 &   55.3 &     57.6 &    2492 \\\\\n",
      "Naive Bayes + Tree &            3 &       0.0 &    0.0 &      0.0 &       2 \\\\\n",
      "Naive Bayes + Tree &            4 &      45.3 &   81.2 &     58.2 &     213 \\\\\n",
      "Naive Bayes + Tree &            5 &      63.2 &   60.7 &     61.9 &    2443 \\\\\n",
      "Naive Bayes + Tree &     accuracy &      57.5 &   57.5 &     57.5 &       0 \\\\\n",
      "Naive Bayes + Tree &    macro avg &      46.3 &   51.6 &     48.0 &   10000 \\\\\n",
      "Naive Bayes + Tree & weighted avg &      57.9 &   57.5 &     57.5 &   10000 \\\\\n",
      "\\bottomrule\n",
      "\\end{tabular}\n",
      "\n",
      "Training Naive Bayes\n",
      "Max words :  216\n",
      "Training Naive Bayes + Tree\n",
      "Max words :  216\n",
      "Extracting features..for 10000\n",
      "Completed..\n",
      "\\begin{tabular}{llrrrr}\n",
      "\\toprule\n",
      "             model &        index & precision & recall & f1-score & support \\\\\n",
      "\\midrule\n",
      "       Naive Bayes &            0 &      53.2 &   55.3 &     54.2 &    2493 \\\\\n",
      "       Naive Bayes &            1 &      53.9 &   55.8 &     54.8 &    2357 \\\\\n",
      "       Naive Bayes &            2 &      60.0 &   54.0 &     56.8 &    2492 \\\\\n",
      "       Naive Bayes &            3 &      66.7 &  100.0 &     80.0 &       2 \\\\\n",
      "       Naive Bayes &            4 &      42.7 &   74.6 &     54.4 &     213 \\\\\n",
      "       Naive Bayes &            5 &      62.9 &   60.6 &     61.7 &    2443 \\\\\n",
      "       Naive Bayes &     accuracy &      56.8 &   56.8 &     56.8 &       0 \\\\\n",
      "       Naive Bayes &    macro avg &      56.6 &   66.7 &     60.3 &   10000 \\\\\n",
      "       Naive Bayes & weighted avg &      57.2 &   56.8 &     56.9 &   10000 \\\\\n",
      "Naive Bayes + Tree &            0 &      54.0 &   55.5 &     54.7 &    2493 \\\\\n",
      "Naive Bayes + Tree &            1 &      53.8 &   57.7 &     55.7 &    2357 \\\\\n",
      "Naive Bayes + Tree &            2 &      60.0 &   54.0 &     56.8 &    2492 \\\\\n",
      "Naive Bayes + Tree &            3 &       0.0 &    0.0 &      0.0 &       2 \\\\\n",
      "Naive Bayes + Tree &            4 &      42.4 &   74.6 &     54.1 &     213 \\\\\n",
      "Naive Bayes + Tree &            5 &      63.6 &   59.8 &     61.7 &    2443 \\\\\n",
      "Naive Bayes + Tree &     accuracy &      57.1 &   57.1 &     57.1 &       0 \\\\\n",
      "Naive Bayes + Tree &    macro avg &      45.6 &   50.3 &     47.2 &   10000 \\\\\n",
      "Naive Bayes + Tree & weighted avg &      57.6 &   57.1 &     57.1 &   10000 \\\\\n",
      "\\bottomrule\n",
      "\\end{tabular}\n",
      "\n",
      "Training Naive Bayes\n",
      "Max words :  212\n",
      "Training Naive Bayes + Tree\n",
      "Max words :  212\n",
      "Extracting features..for 10000\n",
      "Completed..\n",
      "\\begin{tabular}{llrrrr}\n",
      "\\toprule\n",
      "             model &        index & precision & recall & f1-score & support \\\\\n",
      "\\midrule\n",
      "       Naive Bayes &            0 &      53.2 &   53.4 &     53.3 &    2493 \\\\\n",
      "       Naive Bayes &            1 &      55.0 &   56.0 &     55.5 &    2357 \\\\\n",
      "       Naive Bayes &            2 &      60.3 &   54.5 &     57.3 &    2492 \\\\\n",
      "       Naive Bayes &            3 &      40.0 &  100.0 &     57.1 &       2 \\\\\n",
      "       Naive Bayes &            4 &      39.2 &   73.7 &     51.2 &     213 \\\\\n",
      "       Naive Bayes &            5 &      62.1 &   62.0 &     62.0 &    2443 \\\\\n",
      "       Naive Bayes &     accuracy &      56.9 &   56.9 &     56.9 &       0 \\\\\n",
      "       Naive Bayes &    macro avg &      51.7 &   66.6 &     56.1 &   10000 \\\\\n",
      "       Naive Bayes & weighted avg &      57.3 &   56.9 &     56.9 &   10000 \\\\\n",
      "Naive Bayes + Tree &            0 &      54.3 &   52.9 &     53.6 &    2493 \\\\\n",
      "Naive Bayes + Tree &            1 &      54.6 &   57.6 &     56.1 &    2357 \\\\\n",
      "Naive Bayes + Tree &            2 &      60.2 &   54.9 &     57.4 &    2492 \\\\\n",
      "Naive Bayes + Tree &            3 &       0.0 &    0.0 &      0.0 &       2 \\\\\n",
      "Naive Bayes + Tree &            4 &      38.8 &   73.7 &     50.8 &     213 \\\\\n",
      "Naive Bayes + Tree &            5 &      62.6 &   61.8 &     62.2 &    2443 \\\\\n",
      "Naive Bayes + Tree &     accuracy &      57.1 &   57.1 &     57.1 &       0 \\\\\n",
      "Naive Bayes + Tree &    macro avg &      45.1 &   50.1 &     46.7 &   10000 \\\\\n",
      "Naive Bayes + Tree & weighted avg &      57.5 &   57.1 &     57.2 &   10000 \\\\\n",
      "\\bottomrule\n",
      "\\end{tabular}\n",
      "\n",
      "Training Naive Bayes\n",
      "Max words :  251\n",
      "Training Naive Bayes + Tree\n",
      "Max words :  251\n",
      "Extracting features..for 10000\n",
      "Completed..\n",
      "\\begin{tabular}{llrrrr}\n",
      "\\toprule\n",
      "             model &        index & precision & recall & f1-score & support \\\\\n",
      "\\midrule\n",
      "       Naive Bayes &            0 &      53.6 &   51.7 &     52.6 &    2493 \\\\\n",
      "       Naive Bayes &            1 &      54.1 &   57.0 &     55.5 &    2357 \\\\\n",
      "       Naive Bayes &            2 &      60.7 &   53.1 &     56.6 &    2492 \\\\\n",
      "       Naive Bayes &            3 &     100.0 &  100.0 &    100.0 &       2 \\\\\n",
      "       Naive Bayes &            4 &      40.1 &   79.3 &     53.3 &     213 \\\\\n",
      "       Naive Bayes &            5 &      62.3 &   63.9 &     63.1 &    2443 \\\\\n",
      "       Naive Bayes &     accuracy &      56.9 &   56.9 &     56.9 &       0 \\\\\n",
      "       Naive Bayes &    macro avg &      61.8 &   67.5 &     63.5 &   10000 \\\\\n",
      "       Naive Bayes & weighted avg &      57.3 &   56.9 &     56.9 &   10000 \\\\\n",
      "Naive Bayes + Tree &            0 &      54.7 &   51.6 &     53.1 &    2493 \\\\\n",
      "Naive Bayes + Tree &            1 &      54.1 &   59.0 &     56.4 &    2357 \\\\\n",
      "Naive Bayes + Tree &            2 &      60.7 &   53.1 &     56.6 &    2492 \\\\\n",
      "Naive Bayes + Tree &            3 &       0.0 &    0.0 &      0.0 &       2 \\\\\n",
      "Naive Bayes + Tree &            4 &      40.0 &   79.3 &     53.1 &     213 \\\\\n",
      "Naive Bayes + Tree &            5 &      62.9 &   63.7 &     63.2 &    2443 \\\\\n",
      "Naive Bayes + Tree &     accuracy &      57.2 &   57.2 &     57.2 &       0 \\\\\n",
      "Naive Bayes + Tree &    macro avg &      45.4 &   51.1 &     47.1 &   10000 \\\\\n",
      "Naive Bayes + Tree & weighted avg &      57.7 &   57.2 &     57.2 &   10000 \\\\\n",
      "\\bottomrule\n",
      "\\end{tabular}\n",
      "\n",
      "Training Naive Bayes\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Max words :  218\n",
      "Training Naive Bayes + Tree\n",
      "Max words :  218\n",
      "Extracting features..for 10000\n",
      "Completed..\n",
      "\\begin{tabular}{llrrrr}\n",
      "\\toprule\n",
      "             model &        index & precision & recall & f1-score & support \\\\\n",
      "\\midrule\n",
      "       Naive Bayes &            0 &      51.9 &   50.8 &     51.3 &    2493 \\\\\n",
      "       Naive Bayes &            1 &      55.5 &   56.2 &     55.8 &    2357 \\\\\n",
      "       Naive Bayes &            2 &      58.9 &   55.3 &     57.0 &    2492 \\\\\n",
      "       Naive Bayes &            3 &      40.0 &  100.0 &     57.1 &       2 \\\\\n",
      "       Naive Bayes &            4 &      43.5 &   75.6 &     55.2 &     213 \\\\\n",
      "       Naive Bayes &            5 &      62.4 &   62.9 &     62.7 &    2443 \\\\\n",
      "       Naive Bayes &     accuracy &      56.7 &   56.7 &     56.7 &       0 \\\\\n",
      "       Naive Bayes &    macro avg &      52.0 &   66.8 &     56.5 &   10000 \\\\\n",
      "       Naive Bayes & weighted avg &      56.9 &   56.7 &     56.7 &   10000 \\\\\n",
      "Naive Bayes + Tree &            0 &      52.7 &   50.5 &     51.6 &    2493 \\\\\n",
      "Naive Bayes + Tree &            1 &      55.4 &   57.8 &     56.6 &    2357 \\\\\n",
      "Naive Bayes + Tree &            2 &      58.9 &   55.3 &     57.0 &    2492 \\\\\n",
      "Naive Bayes + Tree &            3 &       0.0 &    0.0 &      0.0 &       2 \\\\\n",
      "Naive Bayes + Tree &            4 &      42.9 &   75.6 &     54.8 &     213 \\\\\n",
      "Naive Bayes + Tree &            5 &      62.8 &   62.6 &     62.7 &    2443 \\\\\n",
      "Naive Bayes + Tree &     accuracy &      56.9 &   56.9 &     56.9 &       0 \\\\\n",
      "Naive Bayes + Tree &    macro avg &      45.5 &   50.3 &     47.1 &   10000 \\\\\n",
      "Naive Bayes + Tree & weighted avg &      57.1 &   56.9 &     56.9 &   10000 \\\\\n",
      "\\bottomrule\n",
      "\\end{tabular}\n",
      "\n",
      "Training Naive Bayes\n",
      "Max words :  228\n",
      "Training Naive Bayes + Tree\n",
      "Max words :  228\n",
      "Extracting features..for 10000\n",
      "Completed..\n",
      "\\begin{tabular}{llrrrr}\n",
      "\\toprule\n",
      "             model &        index & precision & recall & f1-score & support \\\\\n",
      "\\midrule\n",
      "       Naive Bayes &            0 &      54.3 &   52.3 &     53.3 &    2493 \\\\\n",
      "       Naive Bayes &            1 &      55.3 &   58.4 &     56.8 &    2357 \\\\\n",
      "       Naive Bayes &            2 &      59.3 &   54.9 &     57.0 &    2492 \\\\\n",
      "       Naive Bayes &            3 &     100.0 &  100.0 &    100.0 &       2 \\\\\n",
      "       Naive Bayes &            4 &      44.4 &   78.4 &     56.7 &     213 \\\\\n",
      "       Naive Bayes &            5 &      64.0 &   63.4 &     63.7 &    2443 \\\\\n",
      "       Naive Bayes &     accuracy &      57.7 &   57.7 &     57.7 &       0 \\\\\n",
      "       Naive Bayes &    macro avg &      62.9 &   67.9 &     64.6 &   10000 \\\\\n",
      "       Naive Bayes & weighted avg &      57.9 &   57.7 &     57.7 &   10000 \\\\\n",
      "Naive Bayes + Tree &            0 &      55.6 &   52.1 &     53.8 &    2493 \\\\\n",
      "Naive Bayes + Tree &            1 &      55.3 &   60.1 &     57.6 &    2357 \\\\\n",
      "Naive Bayes + Tree &            2 &      59.3 &   54.9 &     57.0 &    2492 \\\\\n",
      "Naive Bayes + Tree &            3 &       0.0 &    0.0 &      0.0 &       2 \\\\\n",
      "Naive Bayes + Tree &            4 &      44.2 &   78.4 &     56.5 &     213 \\\\\n",
      "Naive Bayes + Tree &            5 &      64.1 &   63.4 &     63.7 &    2443 \\\\\n",
      "Naive Bayes + Tree &     accuracy &      58.0 &   58.0 &     58.0 &       0 \\\\\n",
      "Naive Bayes + Tree &    macro avg &      46.4 &   51.5 &     48.1 &   10000 \\\\\n",
      "Naive Bayes + Tree & weighted avg &      58.3 &   58.0 &     58.0 &   10000 \\\\\n",
      "\\bottomrule\n",
      "\\end{tabular}\n",
      "\n",
      "Training Naive Bayes\n",
      "Max words :  258\n",
      "Training Naive Bayes + Tree\n",
      "Max words :  258\n",
      "Extracting features..for 10000\n",
      "Completed..\n",
      "\\begin{tabular}{llrrrr}\n",
      "\\toprule\n",
      "             model &        index & precision & recall & f1-score & support \\\\\n",
      "\\midrule\n",
      "       Naive Bayes &            0 &      55.3 &   50.5 &     52.8 &    2493 \\\\\n",
      "       Naive Bayes &            1 &      54.5 &   57.6 &     56.0 &    2357 \\\\\n",
      "       Naive Bayes &            2 &      59.2 &   53.9 &     56.4 &    2492 \\\\\n",
      "       Naive Bayes &            3 &      66.7 &  100.0 &     80.0 &       2 \\\\\n",
      "       Naive Bayes &            4 &      42.4 &   80.3 &     55.5 &     213 \\\\\n",
      "       Naive Bayes &            5 &      62.5 &   65.2 &     63.8 &    2443 \\\\\n",
      "       Naive Bayes &     accuracy &      57.3 &   57.3 &     57.3 &       0 \\\\\n",
      "       Naive Bayes &    macro avg &      56.8 &   67.9 &     60.8 &   10000 \\\\\n",
      "       Naive Bayes & weighted avg &      57.5 &   57.3 &     57.2 &   10000 \\\\\n",
      "Naive Bayes + Tree &            0 &      55.8 &   50.9 &     53.2 &    2493 \\\\\n",
      "Naive Bayes + Tree &            1 &      54.8 &   58.4 &     56.5 &    2357 \\\\\n",
      "Naive Bayes + Tree &            2 &      59.1 &   54.0 &     56.4 &    2492 \\\\\n",
      "Naive Bayes + Tree &            3 &       0.0 &    0.0 &      0.0 &       2 \\\\\n",
      "Naive Bayes + Tree &            4 &      42.4 &   80.3 &     55.5 &     213 \\\\\n",
      "Naive Bayes + Tree &            5 &      62.7 &   65.1 &     63.9 &    2443 \\\\\n",
      "Naive Bayes + Tree &     accuracy &      57.5 &   57.5 &     57.5 &       0 \\\\\n",
      "Naive Bayes + Tree &    macro avg &      45.8 &   51.4 &     47.6 &   10000 \\\\\n",
      "Naive Bayes + Tree & weighted avg &      57.8 &   57.5 &     57.4 &   10000 \\\\\n",
      "\\bottomrule\n",
      "\\end{tabular}\n",
      "\n",
      "Training Naive Bayes\n",
      "Max words :  227\n",
      "Training Naive Bayes + Tree\n",
      "Max words :  227\n",
      "Extracting features..for 10000\n",
      "Completed..\n",
      "\\begin{tabular}{llrrrr}\n",
      "\\toprule\n",
      "             model &        index & precision & recall & f1-score & support \\\\\n",
      "\\midrule\n",
      "       Naive Bayes &            0 &      53.0 &   51.4 &     52.2 &    2493 \\\\\n",
      "       Naive Bayes &            1 &      55.2 &   56.8 &     56.0 &    2357 \\\\\n",
      "       Naive Bayes &            2 &      61.0 &   56.2 &     58.5 &    2492 \\\\\n",
      "       Naive Bayes &            3 &      28.6 &  100.0 &     44.4 &       2 \\\\\n",
      "       Naive Bayes &            4 &      45.5 &   73.2 &     56.1 &     213 \\\\\n",
      "       Naive Bayes &            5 &      62.3 &   64.1 &     63.2 &    2443 \\\\\n",
      "       Naive Bayes &     accuracy &      57.4 &   57.4 &     57.4 &       0 \\\\\n",
      "       Naive Bayes &    macro avg &      50.9 &   67.0 &     55.1 &   10000 \\\\\n",
      "       Naive Bayes & weighted avg &      57.6 &   57.4 &     57.4 &   10000 \\\\\n",
      "Naive Bayes + Tree &            0 &      53.6 &   51.1 &     52.4 &    2493 \\\\\n",
      "Naive Bayes + Tree &            1 &      55.2 &   57.7 &     56.4 &    2357 \\\\\n",
      "Naive Bayes + Tree &            2 &      60.8 &   56.5 &     58.5 &    2492 \\\\\n",
      "Naive Bayes + Tree &            3 &       0.0 &    0.0 &      0.0 &       2 \\\\\n",
      "Naive Bayes + Tree &            4 &      45.5 &   73.2 &     56.1 &     213 \\\\\n",
      "Naive Bayes + Tree &            5 &      62.5 &   64.0 &     63.3 &    2443 \\\\\n",
      "Naive Bayes + Tree &     accuracy &      57.6 &   57.6 &     57.6 &       0 \\\\\n",
      "Naive Bayes + Tree &    macro avg &      46.3 &   50.4 &     47.8 &   10000 \\\\\n",
      "Naive Bayes + Tree & weighted avg &      57.8 &   57.6 &     57.6 &   10000 \\\\\n",
      "\\bottomrule\n",
      "\\end{tabular}\n",
      "\n",
      "Training Naive Bayes\n",
      "Max words :  234\n",
      "Training Naive Bayes + Tree\n",
      "Max words :  234\n",
      "Extracting features..for 10000\n",
      "Completed..\n",
      "\\begin{tabular}{llrrrr}\n",
      "\\toprule\n",
      "             model &        index & precision & recall & f1-score & support \\\\\n",
      "\\midrule\n",
      "       Naive Bayes &            0 &      54.7 &   54.5 &     54.6 &    2493 \\\\\n",
      "       Naive Bayes &            1 &      55.2 &   55.5 &     55.3 &    2357 \\\\\n",
      "       Naive Bayes &            2 &      59.2 &   56.9 &     58.1 &    2492 \\\\\n",
      "       Naive Bayes &            3 &      66.7 &  100.0 &     80.0 &       2 \\\\\n",
      "       Naive Bayes &            4 &      52.7 &   73.7 &     61.4 &     213 \\\\\n",
      "       Naive Bayes &            5 &      63.1 &   63.4 &     63.2 &    2443 \\\\\n",
      "       Naive Bayes &     accuracy &      57.9 &   57.9 &     57.9 &       0 \\\\\n",
      "       Naive Bayes &    macro avg &      58.6 &   67.3 &     62.1 &   10000 \\\\\n",
      "       Naive Bayes & weighted avg &      58.0 &   57.9 &     57.9 &   10000 \\\\\n",
      "Naive Bayes + Tree &            0 &      56.0 &   53.8 &     54.9 &    2493 \\\\\n",
      "Naive Bayes + Tree &            1 &      55.2 &   58.0 &     56.6 &    2357 \\\\\n",
      "Naive Bayes + Tree &            2 &      59.3 &   57.0 &     58.1 &    2492 \\\\\n",
      "Naive Bayes + Tree &            3 &       0.0 &    0.0 &      0.0 &       2 \\\\\n",
      "Naive Bayes + Tree &            4 &      52.2 &   73.7 &     61.1 &     213 \\\\\n",
      "Naive Bayes + Tree &            5 &      63.5 &   63.1 &     63.3 &    2443 \\\\\n",
      "Naive Bayes + Tree &     accuracy &      58.3 &   58.3 &     58.3 &       0 \\\\\n",
      "Naive Bayes + Tree &    macro avg &      47.7 &   50.9 &     49.0 &   10000 \\\\\n",
      "Naive Bayes + Tree & weighted avg &      58.4 &   58.3 &     58.3 &   10000 \\\\\n",
      "\\bottomrule\n",
      "\\end{tabular}\n",
      "\n"
     ]
    }
   ],
   "source": [
    "def compute_nb_multiple_runs(multi_runs):\n",
    "    result = []\n",
    "    for df in multi_runs:\n",
    "        result_highquality_bp = train_and_predict_all_classifiers(df, min_df=1)\n",
    "        print_report_all_classifiers(df[\"y\"], result_highquality_bp,  all_labels)\n",
    "\n",
    "\n",
    "        df[\"nb_predictions\"]=result_highquality_bp[NAIVE_BAYES][\"predictions\"]\n",
    "        \n",
    "        result.append( result_highquality_bp )\n",
    "    return result\n",
    "        \n",
    "random_runs_results = compute_nb_multiple_runs(random_runs)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 70,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['x', 'y', 'y_raw', 'abstract_id', 'abstract', 'participant1_id',\n",
       "       'participant1', 'participant2_id', 'participant2', 'annotations',\n",
       "       'relationship_type', 'relationship_group', 'is_eval', 'label',\n",
       "       'NEGATIVE', 'CPR:3', 'CPR:4', 'CPR:5', 'CPR:6', 'CPR:9', 'prediction',\n",
       "       'confidence', 'confidence_std', 'raw_confidence',\n",
       "       'RecordInTrainingData', 'gold', 'gold_raw', 'x_span', 'x_span_word_len',\n",
       "       'nb_predictions'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 70,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "random_runs[1].columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 71,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "NEGATIVE    2493\n",
       "CPR:4       2492\n",
       "CPR:9       2443\n",
       "CPR:3       2357\n",
       "CPR:6        213\n",
       "CPR:5          2\n",
       "Name: y_raw, dtype: int64"
      ]
     },
     "execution_count": 71,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "random_runs[0].y_raw.value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 72,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>x</th>\n",
       "      <th>y_raw</th>\n",
       "      <th>y</th>\n",
       "      <th>nb_predictions</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>19593</th>\n",
       "      <td>6-Pentadecanylsalicylic acid, referred to as CHEMIG1 (C15:0), was found to inhibit the _CHEMICAL_ peroxidation competitively catalyzed by _GENE_ (EC 1.13.11.12, Type 1) with an IC50 of 14.3 microM (4.88 microg/mL). This inhibition is a reversible reaction without pro-oxidant effects. The inhibition kinetics analyzed by Dixon plots indicates that CHEMIG1 (C15:0) is a competitive inhibitor and the inhibition constant, KI, was established as 6.4 microM. The hydrophilic head (salicylic acid) portion first chelates the CHEMIG2 in the active site and then the hydrophobic tail portion begins reversibly interacting with the GENEIG0 where the CHEMIG2 is located. The inhibition of CHEMIG1 (C15:0) can be explained by a combination of CHEMIG2 ion-chelation and hydrophobic interaction abilities because of its specific structural feature.</td>\n",
       "      <td>CPR:9</td>\n",
       "      <td>5</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30213</th>\n",
       "      <td>CHEMIG0 is classically seen as an inactive reservoir for the production of dehydroepiandrosterone. GENEIG10 is the enzyme that catalyzes the hydrolysis of CHEMIG4 to CHEMIG5 which can then be further metabolized to other CHEMIG9 hormones. Recent studies, however, indicate that CHEMIG4 can mediate biological effects without being converted to dehydroepiandrosterone. This study aims to evaluate whether CHEMIG4 itself influences the differentiation of PC-12 cells or if its desulfation to CHEMIG7 is required. CHEMIG7 and CHEMIG4 both influence the differentiation of chromaffin PC-12 cells. Blocking CHEMIG9 sulfatase activity and thereby the conversion of CHEMIG4 to CHEMIG7 by the enzyme blocker CHEMIG3 showed that the effect of CHEMIG4 is independent of its conversion to dehydroepiandrosterone. CHEMIG2 similar to dehydroepiandrosterone, reduced nerve growth factor-induced neurite outgrowth of PC-12 cells and the expression of synaptosomal-associated membrane protein of 25 kDa, increased the expression of GENEIG6 and significantly increased CHEMIG8 release of PC-12 cells. In addition, dehydroepiandrosterone sulfate, _CHEMICAL_ and membrane impermeable CHEMIG1 all significantly reduced NGF-induced MAPK _GENE_ signaling after 5 min. In summary, this study provides evidence that dehydroepiandrosterone sulfate, independent of its conversion to dehydroepiandrosterone, directs PC-12 cells' differentiation to a neuroendocrine direction. Furthermore, employing membrane-impermeable dehydroepiandrosterone-BSA indicates the involvement of plasma-membrane bound receptors.</td>\n",
       "      <td>CPR:4</td>\n",
       "      <td>2</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34902</th>\n",
       "      <td>The GENEIG0 mRNA encodes a GENEIG3 factor in Escherichia coli. It is one of a growing number of mRNAs found to be regulated by small RNAs (sRNA). Translation initiation of GENEIG0 mRNA is enhanced by two sRNAs, GENEIG1 and RprA, that pair to the same site near the GENEIG0 start codon in the presence of the GENEIG4 protein. In this work, we examine the interaction of GENEIG8 with GENEIG2 and two portions of the GENEIG0 mRNA leader region. One GENEIG0 RNA, rpoS-L, contained the entire 565-nucleotide leader region, while the other, rpoS-S, contained the 199-nucleotide sequence surrounding the start codon. An GENEIG6 assay indicated both GENEIG0 RNAs have similar secondary structures in the translation initiation region. Hfq formed two complexes with GENEIG2 in a gel mobility assay with binding parameters similar to values previously determined for DsrA. Unlike DsrA, GENEIG4 binding to _GENE_ was inhibited by _CHEMICAL_ and influenced by Hfq mutations on both the distal and proximal surfaces. Hfq increased the level of GENEIG2 binding to both GENEIG0 RNAs but showed a much larger enhancement when rpoS-L, the entire leader region, was examined. The lower affinity of GENEIG2 for GENEIG7 versus GENEIG5 in the absence of Hfq suggests that GENEIG4 overcomes an inhibitory structure within GENEIG7 in stimulating GENEIG2 binding. Similar results were obtained with DsrA. The results indicate that the full upstream leader sequence of GENEIG0 mRNA influences Hfq-facilitated annealing of GENEIG2 and GENEIG1 and is likely to be involved in its regulation.</td>\n",
       "      <td>CPR:4</td>\n",
       "      <td>2</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24484</th>\n",
       "      <td>A CHEMIG2 (PES) membrane was modified by blending with a co-polymer of _CHEMICAL_ (AA) and CHEMIG3 (VP), followed by immobilization of _GENE_ (BSA) onto the surface. The scanning electron microscopy results showed that PES had good miscibility with the co-polymer. X-ray photoelectron spectroscopy confirmed the existence of P(VP-AA) co-polymer on the surface of the blended membrane and the existence of GENEIG1 after the immobilization process. The amount of GENEIG1 immobilized on the surface of the membranes was determined. It was found that the protein adsorption amounts from BSA, GENEIG4 and diluted human plasma solutions decreased significantly after modification. According to the circular dichroism results, the proteins kept more alpha-helix conformation in the modified membranes than in the pure PES membrane. The number of the adhered platelets was reduced, and the morphology change for the adherent platelets was also suppressed by the modification with BSA. The SEM morphological observation of the cells and the CHEMIG0 (MTT) assay demonstrated that the BSA-modified PES membrane surface promoted endothelial cell adhesion and proliferation.</td>\n",
       "      <td>NEGATIVE</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34229</th>\n",
       "      <td>The solution structure of the growth factor receptor-bound protein 2 (Grb2) _GENE_ complexed with a high-affinity inhibitor containing a _CHEMICAL_ mimetic within a macrocyclic platform was determined by nuclear magnetic resonance (NMR) spectroscopy. Unambiguous assignments of the bound inhibitor and intermolecular NOEs between the GENEIG2 and the inhibitor was accomplished using perdeuterated GENEIG1 protein. The well-defined solution structure of the complex was obtained and compared to those by X-ray crystallography. Since the crystal structure of the Grb2 GENEIG0 formed a domain-swapped dimer and several inhibitors were bound to a hinge region, there were appreciable differences between the solution and crystal structures. Based on the binding interactions between the inhibitor and the Grb2 GENEIG0 in solution, we proposed a design of second-generation inhibitors that could be expected to have higher affinity.</td>\n",
       "      <td>CPR:4</td>\n",
       "      <td>2</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   x  \\\n",
       "19593                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           6-Pentadecanylsalicylic acid, referred to as CHEMIG1 (C15:0), was found to inhibit the _CHEMICAL_ peroxidation competitively catalyzed by _GENE_ (EC 1.13.11.12, Type 1) with an IC50 of 14.3 microM (4.88 microg/mL). This inhibition is a reversible reaction without pro-oxidant effects. The inhibition kinetics analyzed by Dixon plots indicates that CHEMIG1 (C15:0) is a competitive inhibitor and the inhibition constant, KI, was established as 6.4 microM. The hydrophilic head (salicylic acid) portion first chelates the CHEMIG2 in the active site and then the hydrophobic tail portion begins reversibly interacting with the GENEIG0 where the CHEMIG2 is located. The inhibition of CHEMIG1 (C15:0) can be explained by a combination of CHEMIG2 ion-chelation and hydrophobic interaction abilities because of its specific structural feature.   \n",
       "30213  CHEMIG0 is classically seen as an inactive reservoir for the production of dehydroepiandrosterone. GENEIG10 is the enzyme that catalyzes the hydrolysis of CHEMIG4 to CHEMIG5 which can then be further metabolized to other CHEMIG9 hormones. Recent studies, however, indicate that CHEMIG4 can mediate biological effects without being converted to dehydroepiandrosterone. This study aims to evaluate whether CHEMIG4 itself influences the differentiation of PC-12 cells or if its desulfation to CHEMIG7 is required. CHEMIG7 and CHEMIG4 both influence the differentiation of chromaffin PC-12 cells. Blocking CHEMIG9 sulfatase activity and thereby the conversion of CHEMIG4 to CHEMIG7 by the enzyme blocker CHEMIG3 showed that the effect of CHEMIG4 is independent of its conversion to dehydroepiandrosterone. CHEMIG2 similar to dehydroepiandrosterone, reduced nerve growth factor-induced neurite outgrowth of PC-12 cells and the expression of synaptosomal-associated membrane protein of 25 kDa, increased the expression of GENEIG6 and significantly increased CHEMIG8 release of PC-12 cells. In addition, dehydroepiandrosterone sulfate, _CHEMICAL_ and membrane impermeable CHEMIG1 all significantly reduced NGF-induced MAPK _GENE_ signaling after 5 min. In summary, this study provides evidence that dehydroepiandrosterone sulfate, independent of its conversion to dehydroepiandrosterone, directs PC-12 cells' differentiation to a neuroendocrine direction. Furthermore, employing membrane-impermeable dehydroepiandrosterone-BSA indicates the involvement of plasma-membrane bound receptors.   \n",
       "34902                   The GENEIG0 mRNA encodes a GENEIG3 factor in Escherichia coli. It is one of a growing number of mRNAs found to be regulated by small RNAs (sRNA). Translation initiation of GENEIG0 mRNA is enhanced by two sRNAs, GENEIG1 and RprA, that pair to the same site near the GENEIG0 start codon in the presence of the GENEIG4 protein. In this work, we examine the interaction of GENEIG8 with GENEIG2 and two portions of the GENEIG0 mRNA leader region. One GENEIG0 RNA, rpoS-L, contained the entire 565-nucleotide leader region, while the other, rpoS-S, contained the 199-nucleotide sequence surrounding the start codon. An GENEIG6 assay indicated both GENEIG0 RNAs have similar secondary structures in the translation initiation region. Hfq formed two complexes with GENEIG2 in a gel mobility assay with binding parameters similar to values previously determined for DsrA. Unlike DsrA, GENEIG4 binding to _GENE_ was inhibited by _CHEMICAL_ and influenced by Hfq mutations on both the distal and proximal surfaces. Hfq increased the level of GENEIG2 binding to both GENEIG0 RNAs but showed a much larger enhancement when rpoS-L, the entire leader region, was examined. The lower affinity of GENEIG2 for GENEIG7 versus GENEIG5 in the absence of Hfq suggests that GENEIG4 overcomes an inhibitory structure within GENEIG7 in stimulating GENEIG2 binding. Similar results were obtained with DsrA. The results indicate that the full upstream leader sequence of GENEIG0 mRNA influences Hfq-facilitated annealing of GENEIG2 and GENEIG1 and is likely to be involved in its regulation.   \n",
       "24484                                                                                                                                                                                                                                                                                                                                                                                                                                      A CHEMIG2 (PES) membrane was modified by blending with a co-polymer of _CHEMICAL_ (AA) and CHEMIG3 (VP), followed by immobilization of _GENE_ (BSA) onto the surface. The scanning electron microscopy results showed that PES had good miscibility with the co-polymer. X-ray photoelectron spectroscopy confirmed the existence of P(VP-AA) co-polymer on the surface of the blended membrane and the existence of GENEIG1 after the immobilization process. The amount of GENEIG1 immobilized on the surface of the membranes was determined. It was found that the protein adsorption amounts from BSA, GENEIG4 and diluted human plasma solutions decreased significantly after modification. According to the circular dichroism results, the proteins kept more alpha-helix conformation in the modified membranes than in the pure PES membrane. The number of the adhered platelets was reduced, and the morphology change for the adherent platelets was also suppressed by the modification with BSA. The SEM morphological observation of the cells and the CHEMIG0 (MTT) assay demonstrated that the BSA-modified PES membrane surface promoted endothelial cell adhesion and proliferation.   \n",
       "34229                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                The solution structure of the growth factor receptor-bound protein 2 (Grb2) _GENE_ complexed with a high-affinity inhibitor containing a _CHEMICAL_ mimetic within a macrocyclic platform was determined by nuclear magnetic resonance (NMR) spectroscopy. Unambiguous assignments of the bound inhibitor and intermolecular NOEs between the GENEIG2 and the inhibitor was accomplished using perdeuterated GENEIG1 protein. The well-defined solution structure of the complex was obtained and compared to those by X-ray crystallography. Since the crystal structure of the Grb2 GENEIG0 formed a domain-swapped dimer and several inhibitors were bound to a hinge region, there were appreciable differences between the solution and crystal structures. Based on the binding interactions between the inhibitor and the Grb2 GENEIG0 in solution, we proposed a design of second-generation inhibitors that could be expected to have higher affinity.   \n",
       "\n",
       "          y_raw  y  nb_predictions  \n",
       "19593     CPR:9  5               0  \n",
       "30213     CPR:4  2               2  \n",
       "34902     CPR:4  2               2  \n",
       "24484  NEGATIVE  0               0  \n",
       "34229     CPR:4  2               2  "
      ]
     },
     "execution_count": 72,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "random_runs[0].query(\"x_span_word_len < 15\").sample(n=5)[[\"x\",\"y_raw\",\"y\",\"nb_predictions\"]]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 73,
   "metadata": {},
   "outputs": [],
   "source": [
    "def compute_multiple_runs_cohen_kappa(runs_df, runs_results):\n",
    "    result = []\n",
    "    for i, (df, df_results) in enumerate(zip(runs_df, runs_results)):\n",
    "        score_nb = sklearn.metrics.cohen_kappa_score(df[\"y\"],\n",
    "                                  df_results[NAIVE_BAYES][\"predictions\"]\n",
    "                                  )\n",
    "        score_nbt = sklearn.metrics.cohen_kappa_score(df[\"y\"],\n",
    "                                  df_results[NAIVE_BAYES_WITH_TREE][\"predictions\"]\n",
    "                                  )\n",
    "        \n",
    "        result.append({\n",
    "            \"run\" : i,\n",
    "            \"size\" : len(df),\n",
    "            \"score_nb\": score_nb,\n",
    "            \"score_nbt\": score_nbt\n",
    "        })\n",
    "    result = pd.DataFrame(result)    \n",
    "    return result"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 74,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_k = compute_multiple_runs_cohen_kappa(random_runs, random_runs_results)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 78,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>run</th>\n",
       "      <th>size</th>\n",
       "      <th>score_nb</th>\n",
       "      <th>score_nbt</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>10000</td>\n",
       "      <td>0.433055</td>\n",
       "      <td>0.436499</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>10000</td>\n",
       "      <td>0.438833</td>\n",
       "      <td>0.444061</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>10000</td>\n",
       "      <td>0.434391</td>\n",
       "      <td>0.438115</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>3</td>\n",
       "      <td>10000</td>\n",
       "      <td>0.435542</td>\n",
       "      <td>0.438881</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>4</td>\n",
       "      <td>10000</td>\n",
       "      <td>0.436081</td>\n",
       "      <td>0.440987</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>5</td>\n",
       "      <td>10000</td>\n",
       "      <td>0.432676</td>\n",
       "      <td>0.435873</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>6</td>\n",
       "      <td>10000</td>\n",
       "      <td>0.446160</td>\n",
       "      <td>0.450286</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>7</td>\n",
       "      <td>10000</td>\n",
       "      <td>0.441443</td>\n",
       "      <td>0.444284</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>8</td>\n",
       "      <td>10000</td>\n",
       "      <td>0.442399</td>\n",
       "      <td>0.444536</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>9</td>\n",
       "      <td>10000</td>\n",
       "      <td>0.447668</td>\n",
       "      <td>0.452749</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   run   size  score_nb  score_nbt\n",
       "0    0  10000  0.433055   0.436499\n",
       "1    1  10000  0.438833   0.444061\n",
       "2    2  10000  0.434391   0.438115\n",
       "3    3  10000  0.435542   0.438881\n",
       "4    4  10000  0.436081   0.440987\n",
       "5    5  10000  0.432676   0.435873\n",
       "6    6  10000  0.446160   0.450286\n",
       "7    7  10000  0.441443   0.444284\n",
       "8    8  10000  0.442399   0.444536\n",
       "9    9  10000  0.447668   0.452749"
      ]
     },
     "execution_count": 78,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_k"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 79,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>score_nb</th>\n",
       "      <th>score_nbt</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>score_nb_mean</th>\n",
       "      <td>0.438825</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>score_nb_sem</th>\n",
       "      <td>0.001702</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>score_nbt_mean</th>\n",
       "      <td>NaN</td>\n",
       "      <td>0.442627</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>score_nbt_sem</th>\n",
       "      <td>NaN</td>\n",
       "      <td>0.001794</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                score_nb  score_nbt\n",
       "score_nb_mean   0.438825        NaN\n",
       "score_nb_sem    0.001702        NaN\n",
       "score_nbt_mean       NaN   0.442627\n",
       "score_nbt_sem        NaN   0.001794"
      ]
     },
     "execution_count": 79,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_k.agg(score_nb_mean = (\"score_nb\", \"mean\"), score_nb_sem = (\"score_nb\", \"sem\"),  \n",
    "        \n",
    "        score_nbt_mean = (\"score_nbt\", \"mean\"), score_nbt_sem = (\"score_nbt\", \"sem\"),  \n",
    "        )"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.9"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 1
}